0001564590-20-036135.txt : 20200804 0001564590-20-036135.hdr.sgml : 20200804 20200804162333 ACCESSION NUMBER: 0001564590-20-036135 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 77 CONFORMED PERIOD OF REPORT: 20200630 FILED AS OF DATE: 20200804 DATE AS OF CHANGE: 20200804 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VAPOTHERM INC CENTRAL INDEX KEY: 0001253176 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38740 FILM NUMBER: 201073634 BUSINESS ADDRESS: STREET 1: 100 DOMAIN DRIVE CITY: EXETER STATE: NH ZIP: 03833 BUSINESS PHONE: 603-658-0411 MAIL ADDRESS: STREET 1: 100 DOMAIN DRIVE CITY: EXETER STATE: NH ZIP: 03833 10-Q 1 vapo-10q_20200630.htm 10-Q vapo-10q_20200630.htm
false 2020 Q2 0001253176 --12-31 Accelerated Filer NH P1Y P10Y P3Y9M29D P6Y1M6D P7Y1M6D 0.002 1.079 P4M24D 0.016 1.158 P6M 0001253176 2020-01-01 2020-06-30 xbrli:shares 0001253176 2020-07-29 iso4217:USD 0001253176 2020-06-30 0001253176 2019-12-31 iso4217:USD xbrli:shares 0001253176 2020-04-01 2020-06-30 0001253176 2019-04-01 2019-06-30 0001253176 2019-01-01 2019-06-30 0001253176 us-gaap:CommonStockMember 2019-12-31 0001253176 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-12-31 0001253176 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001253176 us-gaap:RetainedEarningsMember 2019-12-31 0001253176 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001253176 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001253176 2020-01-01 2020-03-31 0001253176 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0001253176 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001253176 us-gaap:CommonStockMember 2020-03-31 0001253176 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2020-03-31 0001253176 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001253176 us-gaap:RetainedEarningsMember 2020-03-31 0001253176 2020-03-31 0001253176 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001253176 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001253176 us-gaap:CommonStockMember vapo:AtTheMarketOfferingMember 2020-04-01 2020-06-30 0001253176 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember vapo:AtTheMarketOfferingMember 2020-04-01 2020-06-30 0001253176 vapo:AtTheMarketOfferingMember 2020-04-01 2020-06-30 0001253176 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0001253176 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001253176 us-gaap:CommonStockMember 2020-06-30 0001253176 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2020-06-30 0001253176 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001253176 us-gaap:RetainedEarningsMember 2020-06-30 0001253176 us-gaap:CommonStockMember 2018-12-31 0001253176 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2018-12-31 0001253176 us-gaap:RetainedEarningsMember 2018-12-31 0001253176 2018-12-31 0001253176 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001253176 2019-01-01 2019-03-31 0001253176 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001253176 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001253176 us-gaap:CommonStockMember 2019-03-31 0001253176 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-03-31 0001253176 us-gaap:RetainedEarningsMember 2019-03-31 0001253176 2019-03-31 0001253176 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0001253176 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001253176 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0001253176 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001253176 us-gaap:CommonStockMember 2019-06-30 0001253176 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-06-30 0001253176 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001253176 us-gaap:RetainedEarningsMember 2019-06-30 0001253176 2019-06-30 0001253176 vapo:AtTheMarketOfferingMember 2020-01-01 2020-06-30 0001253176 us-gaap:EmployeeStockMember 2020-01-01 2020-06-30 0001253176 us-gaap:WarrantMember 2020-01-01 2020-06-30 vapo:System 0001253176 us-gaap:CommonStockMember us-gaap:IPOMember 2018-11-15 2018-11-16 0001253176 us-gaap:CommonStockMember us-gaap:IPOMember 2018-11-16 0001253176 us-gaap:CommonStockMember 2019-08-01 2019-08-31 0001253176 us-gaap:CommonStockMember 2019-08-31 0001253176 vapo:AtTheMarketAgreementMember vapo:JefferiesLimitedLiabilityCompanyMember 2019-12-20 2019-12-20 0001253176 vapo:AtTheMarketAgreementMember 2020-04-01 2020-04-30 0001253176 us-gaap:CommonStockMember 2020-05-01 2020-05-31 0001253176 us-gaap:CommonStockMember 2020-05-31 vapo:Segment 0001253176 us-gaap:NonUsMember 2020-06-30 0001253176 us-gaap:NonUsMember 2019-12-31 0001253176 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2020-06-30 0001253176 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2019-12-31 0001253176 us-gaap:ShippingAndHandlingMember 2020-04-01 2020-06-30 0001253176 us-gaap:ShippingAndHandlingMember 2019-04-01 2019-06-30 0001253176 us-gaap:ShippingAndHandlingMember 2020-01-01 2020-06-30 0001253176 us-gaap:ShippingAndHandlingMember 2019-01-01 2019-06-30 xbrli:pure 0001253176 vapo:SolusMedicalLimitedMember 2020-01-01 2020-06-30 0001253176 vapo:SolusMedicalLimitedMember 2019-02-28 2019-02-28 0001253176 vapo:SolusMedicalLimitedMember 2019-01-01 2019-12-31 0001253176 vapo:SolusMedicalLimitedMember srt:ScenarioForecastMember 2020-01-01 2020-12-31 0001253176 vapo:SolusMedicalLimitedMember 2019-02-28 0001253176 vapo:SolusMedicalLimitedMember us-gaap:GeneralAndAdministrativeExpenseMember 2019-01-01 2019-12-31 0001253176 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2020-06-30 0001253176 vapo:AmendmentToFinancingArrangementMember vapo:CommonStockWarrantsMember 2019-03-22 0001253176 us-gaap:MeasurementInputExpectedDividendRateMember 2020-06-30 0001253176 us-gaap:MeasurementInputRiskFreeInterestRateMember 2020-06-30 0001253176 us-gaap:MeasurementInputPriceVolatilityMember 2020-06-30 0001253176 country:US 2020-06-30 0001253176 country:US 2019-12-31 vapo:Customer 0001253176 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-04-01 2020-06-30 0001253176 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-04-01 2019-06-30 0001253176 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-06-30 0001253176 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-06-30 0001253176 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-06-30 0001253176 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-12-31 0001253176 us-gaap:CustomerContractsMember 2020-01-01 2020-06-30 0001253176 us-gaap:CustomerContractsMember 2020-06-30 0001253176 us-gaap:RevolvingCreditFacilityMember vapo:BusinessFinancingAgreementMember vapo:WesternAllianceBankMember 2016-11-16 0001253176 us-gaap:RevolvingCreditFacilityMember vapo:BusinessFinancingAgreementMember vapo:WesternAllianceBankMember 2016-11-15 2016-11-16 0001253176 us-gaap:RevolvingCreditFacilityMember vapo:BusinessFinancingAgreementMember vapo:WesternAllianceBankMember 2018-04-30 0001253176 us-gaap:RevolvingCreditFacilityMember vapo:BusinessFinancingAgreementMember vapo:WesternAllianceBankMember 2018-04-01 2018-04-30 0001253176 vapo:CreditCardProgramMember us-gaap:RevolvingCreditFacilityMember vapo:BusinessFinancingAgreementMember vapo:WesternAllianceBankMember 2019-03-21 0001253176 vapo:CreditCardProgramMember us-gaap:RevolvingCreditFacilityMember vapo:TwoThousandNineteenAmendedRevolverAgreementMember vapo:WesternAllianceBankMember 2019-03-22 0001253176 vapo:WesternAllianceBankMember us-gaap:RevolvingCreditFacilityMember vapo:TwoThousandTwentyAmendedRevolverAgreementMember 2020-06-30 0001253176 vapo:WesternAllianceBankMember us-gaap:RevolvingCreditFacilityMember vapo:TwoThousandNineteenAmendedRevolverAgreementMember 2019-12-31 0001253176 vapo:PerceptiveCreditHoldingsIILPMember vapo:CreditAgreementAndGuarantyMember vapo:TermLoanMember 2018-04-06 vapo:Tranche 0001253176 vapo:PerceptiveCreditHoldingsIILPMember vapo:CreditAgreementAndGuarantyMember vapo:TermLoanMember 2018-04-05 2018-04-06 0001253176 vapo:DebtInstrumentFirstTrancheMember vapo:PerceptiveCreditHoldingsIILPMember vapo:CreditAgreementAndGuarantyMember vapo:TermLoanMember 2018-04-05 2018-04-06 0001253176 vapo:PerceptiveCreditHoldingsIILPMember vapo:TermLoanMember vapo:CreditAgreementAndGuarantyMember vapo:DebtInstrumentSecondTrancheMember 2018-07-19 2018-07-20 0001253176 vapo:PerceptiveCreditHoldingsIILPMember vapo:TermLoanMember vapo:CreditAgreementAndGuarantyMember vapo:DebtInstrumentSecondTrancheMember 2018-07-20 0001253176 vapo:TermLoanMember vapo:FirstAmendmentToCreditAgreementAndGuarantyMember vapo:PerceptiveCreditHoldingsIILPMember 2018-09-26 2018-09-27 0001253176 vapo:TermLoanMember vapo:FirstAmendmentToCreditAgreementAndGuarantyMember vapo:PerceptiveCreditHoldingsIILPMember vapo:DebtInstrumentThirdTrancheMember 2018-09-26 2018-09-27 0001253176 vapo:TermLoanMember vapo:FirstAmendmentToCreditAgreementAndGuarantyMember vapo:PerceptiveCreditHoldingsIILPMember vapo:DebtInstrumentThirdTrancheMember 2018-09-27 0001253176 vapo:PerceptiveCreditHoldingsIILPMember vapo:TermLoanMember vapo:CreditAgreementAndGuarantyMember 2019-03-21 2019-03-22 0001253176 vapo:PerceptiveCreditHoldingsIILPMember vapo:TermLoanMember vapo:CreditAgreementAndGuarantyMember 2019-03-22 0001253176 vapo:PerceptiveCreditHoldingsIILPMember vapo:TermLoanMember vapo:FirstAmendmentToCreditAgreementAndGuarantyMember vapo:CreditCardProgramMember 2019-03-21 0001253176 vapo:PerceptiveCreditHoldingsIILPMember vapo:TermLoanMember vapo:SecondAmendmentToCreditAgreementAndGuarantyMember vapo:CreditCardProgramMember 2019-03-22 0001253176 vapo:PerceptiveCreditHoldingsIILPMember vapo:TermLoanMember vapo:ThirdAmendmentToCreditAgreementAndGuarantyMember 2020-06-16 2020-06-16 0001253176 vapo:PerceptiveCreditHoldingsIILPMember vapo:TermLoanMember vapo:ThirdAmendmentToCreditAgreementAndGuarantyMember 2020-01-01 2020-06-30 0001253176 vapo:PerceptiveCreditHoldingsIILPMember vapo:TermLoanMember vapo:ThirdAmendmentToCreditAgreementAndGuarantyMember 2020-06-30 0001253176 us-gaap:LoansPayableMember 2020-06-30 0001253176 vapo:CommonStockWarrantsMember 2019-12-31 0001253176 vapo:CommonStockWarrantsMember 2020-01-01 2020-06-30 0001253176 vapo:CommonStockWarrantsMember 2020-06-30 0001253176 vapo:CommonStockWarrantsMember srt:WeightedAverageMember 2019-12-31 0001253176 vapo:CommonStockWarrantsMember srt:WeightedAverageMember 2020-01-01 2020-06-30 0001253176 vapo:CommonStockWarrantsMember srt:WeightedAverageMember 2020-06-30 0001253176 vapo:CommonStockWarrantsMember 2020-06-10 2020-06-10 0001253176 vapo:CommonStockWarrantsMember 2020-06-10 0001253176 us-gaap:SubsequentEventMember vapo:CommonStockWarrantsMember 2020-07-10 2020-07-10 0001253176 us-gaap:SubsequentEventMember vapo:CommonStockWarrantsMember 2020-07-10 0001253176 vapo:CapitalEquipmentProductRevenueMember country:US 2020-04-01 2020-06-30 0001253176 vapo:CapitalEquipmentProductRevenueMember us-gaap:NonUsMember 2020-04-01 2020-06-30 0001253176 vapo:CapitalEquipmentProductRevenueMember 2020-04-01 2020-06-30 0001253176 vapo:CapitalEquipmentProductRevenueMember country:US 2020-01-01 2020-06-30 0001253176 vapo:CapitalEquipmentProductRevenueMember us-gaap:NonUsMember 2020-01-01 2020-06-30 0001253176 vapo:CapitalEquipmentProductRevenueMember 2020-01-01 2020-06-30 0001253176 vapo:DisposableProductRevenueMember country:US 2020-04-01 2020-06-30 0001253176 vapo:DisposableProductRevenueMember us-gaap:NonUsMember 2020-04-01 2020-06-30 0001253176 vapo:DisposableProductRevenueMember 2020-04-01 2020-06-30 0001253176 vapo:DisposableProductRevenueMember country:US 2020-01-01 2020-06-30 0001253176 vapo:DisposableProductRevenueMember us-gaap:NonUsMember 2020-01-01 2020-06-30 0001253176 vapo:DisposableProductRevenueMember 2020-01-01 2020-06-30 0001253176 vapo:ProductRevenueMember country:US 2020-04-01 2020-06-30 0001253176 vapo:ProductRevenueMember us-gaap:NonUsMember 2020-04-01 2020-06-30 0001253176 vapo:ProductRevenueMember 2020-04-01 2020-06-30 0001253176 vapo:ProductRevenueMember country:US 2020-01-01 2020-06-30 0001253176 vapo:ProductRevenueMember us-gaap:NonUsMember 2020-01-01 2020-06-30 0001253176 vapo:ProductRevenueMember 2020-01-01 2020-06-30 0001253176 vapo:CapitalEquipmentLeaseRevenueMember country:US 2020-04-01 2020-06-30 0001253176 vapo:CapitalEquipmentLeaseRevenueMember us-gaap:NonUsMember 2020-04-01 2020-06-30 0001253176 vapo:CapitalEquipmentLeaseRevenueMember 2020-04-01 2020-06-30 0001253176 vapo:CapitalEquipmentLeaseRevenueMember country:US 2020-01-01 2020-06-30 0001253176 vapo:CapitalEquipmentLeaseRevenueMember us-gaap:NonUsMember 2020-01-01 2020-06-30 0001253176 vapo:CapitalEquipmentLeaseRevenueMember 2020-01-01 2020-06-30 0001253176 vapo:OtherLeaseRevenueMember country:US 2020-04-01 2020-06-30 0001253176 vapo:OtherLeaseRevenueMember us-gaap:NonUsMember 2020-04-01 2020-06-30 0001253176 vapo:OtherLeaseRevenueMember 2020-04-01 2020-06-30 0001253176 vapo:OtherLeaseRevenueMember country:US 2020-01-01 2020-06-30 0001253176 vapo:OtherLeaseRevenueMember us-gaap:NonUsMember 2020-01-01 2020-06-30 0001253176 vapo:OtherLeaseRevenueMember 2020-01-01 2020-06-30 0001253176 us-gaap:ServiceOtherMember country:US 2020-04-01 2020-06-30 0001253176 us-gaap:ServiceOtherMember us-gaap:NonUsMember 2020-04-01 2020-06-30 0001253176 us-gaap:ServiceOtherMember 2020-04-01 2020-06-30 0001253176 us-gaap:ServiceOtherMember country:US 2020-01-01 2020-06-30 0001253176 us-gaap:ServiceOtherMember us-gaap:NonUsMember 2020-01-01 2020-06-30 0001253176 us-gaap:ServiceOtherMember 2020-01-01 2020-06-30 0001253176 country:US 2020-04-01 2020-06-30 0001253176 us-gaap:NonUsMember 2020-04-01 2020-06-30 0001253176 country:US 2020-01-01 2020-06-30 0001253176 us-gaap:NonUsMember 2020-01-01 2020-06-30 0001253176 country:US vapo:CapitalEquipmentProductRevenueMember 2019-04-01 2019-06-30 0001253176 us-gaap:NonUsMember vapo:CapitalEquipmentProductRevenueMember 2019-04-01 2019-06-30 0001253176 vapo:CapitalEquipmentProductRevenueMember 2019-04-01 2019-06-30 0001253176 country:US vapo:CapitalEquipmentProductRevenueMember 2019-01-01 2019-06-30 0001253176 us-gaap:NonUsMember vapo:CapitalEquipmentProductRevenueMember 2019-01-01 2019-06-30 0001253176 vapo:CapitalEquipmentProductRevenueMember 2019-01-01 2019-06-30 0001253176 country:US vapo:DisposableProductRevenueMember 2019-04-01 2019-06-30 0001253176 us-gaap:NonUsMember vapo:DisposableProductRevenueMember 2019-04-01 2019-06-30 0001253176 vapo:DisposableProductRevenueMember 2019-04-01 2019-06-30 0001253176 country:US vapo:DisposableProductRevenueMember 2019-01-01 2019-06-30 0001253176 us-gaap:NonUsMember vapo:DisposableProductRevenueMember 2019-01-01 2019-06-30 0001253176 vapo:DisposableProductRevenueMember 2019-01-01 2019-06-30 0001253176 country:US vapo:ProductRevenueMember 2019-04-01 2019-06-30 0001253176 us-gaap:NonUsMember vapo:ProductRevenueMember 2019-04-01 2019-06-30 0001253176 vapo:ProductRevenueMember 2019-04-01 2019-06-30 0001253176 country:US vapo:ProductRevenueMember 2019-01-01 2019-06-30 0001253176 us-gaap:NonUsMember vapo:ProductRevenueMember 2019-01-01 2019-06-30 0001253176 vapo:ProductRevenueMember 2019-01-01 2019-06-30 0001253176 country:US vapo:LeaseRevenueMember 2019-04-01 2019-06-30 0001253176 vapo:LeaseRevenueMember 2019-04-01 2019-06-30 0001253176 country:US vapo:LeaseRevenueMember 2019-01-01 2019-06-30 0001253176 vapo:LeaseRevenueMember 2019-01-01 2019-06-30 0001253176 country:US us-gaap:ServiceOtherMember 2019-04-01 2019-06-30 0001253176 us-gaap:NonUsMember us-gaap:ServiceOtherMember 2019-04-01 2019-06-30 0001253176 us-gaap:ServiceOtherMember 2019-04-01 2019-06-30 0001253176 country:US us-gaap:ServiceOtherMember 2019-01-01 2019-06-30 0001253176 us-gaap:NonUsMember us-gaap:ServiceOtherMember 2019-01-01 2019-06-30 0001253176 us-gaap:ServiceOtherMember 2019-01-01 2019-06-30 0001253176 country:US 2019-04-01 2019-06-30 0001253176 us-gaap:NonUsMember 2019-04-01 2019-06-30 0001253176 country:US 2019-01-01 2019-06-30 0001253176 us-gaap:NonUsMember 2019-01-01 2019-06-30 0001253176 us-gaap:CostOfSalesMember 2020-04-01 2020-06-30 0001253176 us-gaap:CostOfSalesMember 2019-04-01 2019-06-30 0001253176 us-gaap:CostOfSalesMember 2020-01-01 2020-06-30 0001253176 us-gaap:CostOfSalesMember 2019-01-01 2019-06-30 0001253176 us-gaap:ResearchAndDevelopmentExpenseMember 2020-04-01 2020-06-30 0001253176 us-gaap:ResearchAndDevelopmentExpenseMember 2019-04-01 2019-06-30 0001253176 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-06-30 0001253176 us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-06-30 0001253176 us-gaap:SellingAndMarketingExpenseMember 2020-04-01 2020-06-30 0001253176 us-gaap:SellingAndMarketingExpenseMember 2019-04-01 2019-06-30 0001253176 us-gaap:SellingAndMarketingExpenseMember 2020-01-01 2020-06-30 0001253176 us-gaap:SellingAndMarketingExpenseMember 2019-01-01 2019-06-30 0001253176 us-gaap:GeneralAndAdministrativeExpenseMember 2020-04-01 2020-06-30 0001253176 us-gaap:GeneralAndAdministrativeExpenseMember 2019-04-01 2019-06-30 0001253176 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-06-30 0001253176 us-gaap:GeneralAndAdministrativeExpenseMember 2019-01-01 2019-06-30 0001253176 us-gaap:RestrictedStockMember 2019-12-31 0001253176 us-gaap:RestrictedStockMember 2020-01-01 2020-06-30 0001253176 us-gaap:RestrictedStockMember 2020-06-30 0001253176 us-gaap:EmployeeStockMember 2018-11-30 0001253176 us-gaap:EmployeeStockMember 2020-06-30 0001253176 us-gaap:CommonStockMember 2020-01-01 2020-06-30 0001253176 us-gaap:EmployeeStockMember us-gaap:CommonStockMember 2020-06-30 0001253176 us-gaap:EmployeeStockMember 2018-11-01 2018-11-30 0001253176 us-gaap:EmployeeStockMember srt:MinimumMember 2020-01-01 2020-06-30 0001253176 us-gaap:EmployeeStockMember srt:MaximumMember 2020-01-01 2020-06-30 0001253176 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-06-30 0001253176 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-06-30 0001253176 us-gaap:WarrantMember 2020-01-01 2020-06-30 0001253176 us-gaap:WarrantMember 2019-01-01 2019-06-30 0001253176 us-gaap:RestrictedStockMember 2020-01-01 2020-06-30 0001253176 us-gaap:RestrictedStockMember 2019-01-01 2019-06-30 0001253176 us-gaap:EmployeeStockMember 2020-01-01 2020-06-30 0001253176 srt:MinimumMember 2020-01-01 2020-06-30

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2020

OR

    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______ to _______

Commission file number: 001-38740

Vapotherm, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

46-2259298

(State or other jurisdiction

of incorporation or organization)

(I.R.S. Employer

Identification Number)

100 Domain Drive

 

Exeter, N.H.

(Address of principal executive offices)

03833

(Zip Code)

 

(603) 658-0011

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.001 par value per share

VAPO

New York Stock Exchange

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes   No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes   No 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

Accelerated filer

Non-accelerated filer

 

Smaller reporting company

Emerging growth company

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes    No 

 

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.     Yes  ☒    No  

 

As of July 29, 2020, there were 25,570,243 outstanding common shares of Vapotherm, Inc.

 


Vapotherm, Inc.

Form 10-Q

For the Quarterly Period Ended June 30, 2020

 

TABLE OF CONTENTS

 

 

 

Page No.

Note Regarding Forward-Looking Statements

3

 

PART I. FINANCIAL INFORMATION

Item 1

Condensed Consolidated Financial Statements (interim periods unaudited)

5

 

Condensed Consolidated Balance Sheets - June 30, 2020 and December 31, 2019

5

 

Condensed Consolidated Statements of Comprehensive Loss – Three and six months ended June 30, 2020 and 2019

6

 

Condensed Consolidated Statements of Stockholders’ Equity - Three and six months ended June 30, 2020 and 2019

7

 

Condensed Consolidated Statements of Cash Flows – Six months ended June 30, 2020 and 2019

9

 

Notes to Condensed Consolidated Financial Statements

10

Item 2

Management’s Discussion and Analysis of Financial Condition and Results of Operations

27

Item 3

Quantitative and Qualitative Disclosures About Market Risk

36

Item 4

Controls and Procedures

36

 

 

 

PART II. OTHER INFORMATION

Item 1

Legal Proceedings

37

Item 1A

Risk Factors

37

Item 6

Exhibits

41

Exhibit Index

41

Signatures

42

 

2


NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this Quarterly Report on Form 10-Q are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential” or “continue” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements include, but are not limited to, statements concerning:

 

estimates regarding the annual total addressable market for our Precision Flow systems and future product offerings, future results of operations, financial position, capital requirements and our needs for additional financing;

 

commercial success and market acceptance of our Precision Flow systems, our Oxygen Assist Module and any future products we may seek to commercialize;

 

competitive companies and technologies in our industry;

 

our ability to increase and sustain the increased production capacity of our Precision Flow systems in response to the increased demand for our Precision Flow systems from the COVID-19 pandemic, and the ability of our carriers to make timely delivery of our Precision Flow systems during the COVID-19 pandemic;

 

our ability to enhance our Precision Flow systems and our Oxygen Assist Module, expand our indications and develop and commercialize additional products;

 

our business model and strategic plans for our products, technologies and business, including our implementation thereof;

 

our ability to accurately forecast customer demand for our products and manage our inventory, particularly in light of the ongoing COVID-19 pandemic;

 

our ability to expand, manage and maintain our direct sales and marketing organizations in the United States and United Kingdom, and to market and sell our Precision Flow systems and Oxygen Assist Module in markets outside of the United States;

 

our ability to hire and retain our senior management and other highly qualified personnel;

 

our ability to obtain additional financing in the future;

 

our ability to commercialize or obtain regulatory approvals for our products, or the effect of delays in commercializing or obtaining regulatory approvals;

 

U.S. Food and Drug Administration or other United States or foreign regulatory actions affecting us or the healthcare industry generally, including healthcare reform measures in the United States and international markets;

 

the timing or likelihood of regulatory filings and approvals;

 

our ability to establish and maintain intellectual property protection for our high velocity therapy, Precision Flow systems and our Oxygen Assist Module, and our ability to avoid claims of infringement;

 

the volatility of the trading price of our common stock; and

 

our expectations about market trends.

3


The forward-looking statements in this Quarterly Report on Form 10-Q are only predictions and are based largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. These forward-looking statements speak only as of the date of this Quarterly Report on Form 10-Q and are subject to a number of known and unknown risks, uncertainties and assumptions, including those described in the “Risk Factors” section of our Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on March 4, 2020, our Quarterly Report on Form 10-Q filed with the SEC on May 5, 2020, this Quarterly Report on Form 10-Q, and in our other filings with the SEC. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified and some of which are beyond our control, you should not rely on these forward-looking statements as predictions of future events. The events and circumstances reflected in our forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. Moreover, we operate in an evolving environment. Any forward-looking statements made herein speak only as of the date of this Quarterly Report on Form 10-Q, and you should not rely on forward-looking statements as predictions of future events. New risk factors and uncertainties may emerge from time to time, and it is not possible for management to predict all risk factors and uncertainties. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

We use “Vapotherm,” “Precision Flow,” “High Velocity Therapy”, “HVT”, “Hi-VNI,” “OAM,” and other marks as trademarks in the United States and/or in other countries. This Quarterly Report on Form 10-Q contains references to our trademarks and service marks and to those belonging to other entities. Solely for convenience, trademarks and trade names referred to in this Quarterly Report on Form 10-Q, including logos, artwork and other visual displays, may appear without the ® or TM symbols, but such references are not intended to indicate in any way that we will not assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensor to these trademarks and trade names. We do not intend our use or display of other entities’ trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of us by, any other entity.

Unless otherwise indicated, information contained in this Quarterly Report on Form 10-Q concerning our industry and the markets in which we operate, including our general expectations, market position and market opportunity, is based on our management’s estimates and research, as well as industry and general publications and research, surveys and studies conducted by third parties. We believe that the information from these third-party publications, research, surveys and studies included in this Quarterly Report on Form 10-Q is reliable. Management’s estimates are derived from publicly available information, their knowledge of our industry and their assumptions based on such information and knowledge, which we believe to be reasonable. This data involves a number of assumptions and limitations which are necessarily subject to a high degree of uncertainty and risk due to a variety of factors, including those described in the “Risk Factors” section of our Annual Report on Form 10-K filed with the SEC on March 4, 2020, our Quarterly Report on Form 10-Q filed with the SEC on May 5, 2020, and this Quarterly Report on Form 10-Q. These and other factors could cause our future performance to differ materially from our assumptions and estimates.

Unless the context requires otherwise, references to “Vapotherm,” the “Company,” “we,” “us,” and “our,” refer to Vapotherm, Inc. and its consolidated subsidiary unless stated or the context otherwise requires.

 

4


PART I. FINANCIAL INFORMATION

 

ITEM 1.        FINANCIAL STATEMENTS

 

VAPOTHERM, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share amounts)

 

 

 

June 30, 2020

 

 

December 31, 2019

 

 

 

(unaudited)

 

 

 

 

 

Assets

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

148,344

 

 

$

71,655

 

Accounts receivable, net

 

 

16,452

 

 

 

8,243

 

Inventories

 

 

18,641

 

 

 

9,137

 

Prepaid expenses and other current assets

 

 

4,500

 

 

 

4,066

 

Total current assets

 

 

187,937

 

 

 

93,101

 

Property and equipment, net

 

 

17,204

 

 

 

15,086

 

Restricted cash

 

 

1,853

 

 

 

1,852

 

Goodwill

 

 

547

 

 

 

588

 

Intangible assets, net

 

 

275

 

 

 

353

 

Deferred income tax assets

 

 

66

 

 

 

66

 

Other long-term assets

 

 

954

 

 

 

844

 

Total assets

 

$

208,836

 

 

$

111,890

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

Accounts payable

 

$

6,789

 

 

$

3,375

 

Contract liabilities

 

 

261

 

 

 

137

 

Accrued expenses and other current liabilities

 

 

15,801

 

 

 

9,187

 

Short-term line of credit

 

 

4,492

 

 

 

3,491

 

Total current liabilities

 

 

27,343

 

 

 

16,190

 

Long-term loans payable, net

 

 

41,929

 

 

 

41,787

 

Other long-term liabilities

 

 

604

 

 

 

174

 

Total liabilities

 

 

69,876

 

 

 

58,151

 

Commitments and contingencies (Note 9)

 

 

 

 

 

 

 

 

Stockholders' equity

 

 

 

 

 

 

 

 

Preferred stock ($0.001 par value) 25,000,000 shares authorized; no shares issued

   and outstanding as of June 30, 2020 and December 31, 2019

 

 

-

 

 

 

-

 

Common stock ($0.001 par value) 175,000,000 shares authorized as of

   June 30, 2020 and December 31, 2019, 25,493,058 and 20,851,531

   shares issued and outstanding as of June 30, 2020 and

   December 31, 2019, respectively

 

 

26

 

 

 

21

 

Additional paid-in capital

 

 

426,282

 

 

 

319,115

 

Accumulated other comprehensive income (loss)

 

 

(31

)

 

 

44

 

Accumulated deficit

 

 

(287,317

)

 

 

(265,441

)

Total stockholders' equity

 

 

138,960

 

 

 

53,739

 

Total liabilities and stockholders’ equity

 

$

208,836

 

 

$

111,890

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

5


Vapotherm, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(Unaudited)

(In thousands, except share and per share amounts)

 

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

 

2020

 

 

2019

 

2020

 

 

2019

 

Net revenue

 

$

35,152

 

 

$

11,986

 

$

54,267

 

 

$

24,285

 

Cost of revenue

 

 

17,544

 

 

 

6,527

 

 

27,442

 

 

 

13,647

 

Gross profit

 

 

17,608

 

 

 

5,459

 

 

26,825

 

 

 

10,638

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

3,895

 

 

 

3,167

 

 

7,257

 

 

 

6,440

 

Sales and marketing

 

 

14,858

 

 

 

9,432

 

 

28,175

 

 

 

18,593

 

General and administrative

 

 

5,627

 

 

 

4,532

 

 

10,878

 

 

 

9,411

 

Total operating expenses

 

 

24,380

 

 

 

17,131

 

 

46,310

 

 

 

34,444

 

Loss from operations

 

 

(6,772

)

 

 

(11,672

)

 

(19,485

)

 

 

(23,806

)

Other (expense) income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency loss

 

 

(25

)

 

 

-

 

 

(1

)

 

 

(9

)

Interest income

 

 

60

 

 

 

213

 

 

185

 

 

 

416

 

Interest expense

 

 

(1,295

)

 

 

(1,421

)

 

(2,590

)

 

 

(2,445

)

Other

 

 

-

 

 

 

-

 

 

15

 

 

 

-

 

Net loss

 

$

(8,032

)

 

$

(12,880

)

$

(21,876

)

 

$

(25,844

)

Other comprehensive income (loss), net of tax:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments

 

 

(4

)

 

 

2

 

 

(75

)

 

 

2

 

Total other comprehensive income (loss)

 

$

(4

)

 

$

2

 

$

(75

)

 

$

2

 

Total comprehensive loss

 

$

(8,036

)

 

$

(12,878

)

$

(21,951

)

 

$

(25,842

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per share attributable to common stockholders - basic and diluted

 

$

(0.35

)

 

$

(0.76

)

$

(0.99

)

 

$

(1.52

)

Weighted-average number of shares used in calculating net

   loss per share, basic and diluted

 

 

23,090,613

 

 

 

17,055,628

 

 

21,986,774

 

 

 

17,019,002

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

6


 

VAPOTHERM, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(Unaudited)

(In thousands, except share amounts)

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

Accumulated

Other

 

 

 

 

 

 

 

 

 

 

 

Common Stock

 

 

Paid-in

 

 

Comprehensive

 

 

Accumulated

 

 

Stockholders'

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Income (Loss)

 

 

Deficit

 

 

Equity

 

Balance at December 31, 2019

 

 

20,851,531

 

 

$

21

 

 

$

319,115

 

 

$

44

 

 

$

(265,441

)

 

$

53,739

 

Issuance of common stock upon exercise of warrants

 

 

24,687

 

 

 

 

 

 

 

40

 

 

 

 

 

 

 

 

 

 

 

40

 

Issuance of restricted stock

 

 

40,931

 

 

 

 

 

 

 

58

 

 

 

 

 

 

 

 

 

 

 

58

 

Stock-based compensation expense

 

 

 

 

 

 

 

 

 

 

1,447

 

 

 

 

 

 

 

 

 

 

 

1,447

 

Foreign currency translation adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(71

)

 

 

 

 

 

 

(71

)

Net loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(13,844

)

 

 

(13,844

)

Balance at March 31, 2020

 

 

20,917,149

 

 

$

21

 

 

$

320,660

 

 

$

(27

)

 

$

(279,285

)

 

$

41,369

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of common stock in connection with public offering, net

 

 

3,852,500

 

 

 

4

 

 

 

93,823

 

 

 

-

 

 

 

-

 

 

 

93,827

 

Issuance of common stock in connection with at-the-market offering, net

 

 

511,648

 

 

 

1

 

 

 

9,783

 

 

 

-

 

 

 

-

 

 

 

9,784

 

Issuance of common stock upon exercise of options

 

 

99,206

 

 

 

-

 

 

 

227

 

 

 

-

 

 

 

-

 

 

 

227

 

Issuance of common stock under the Employee Stock Purchase Plan

 

 

36,389

 

 

 

-

 

 

 

359

 

 

 

-

 

 

 

-

 

 

 

359

 

Issuance of common stock upon exercise of warrants

 

 

41,066

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Issuance of restricted stock

 

 

35,100

 

 

 

-

 

 

 

53

 

 

 

-

 

 

 

-

 

 

 

53

 

Stock-based compensation expense

 

 

-

 

 

 

-

 

 

 

1,377

 

 

 

-

 

 

 

-

 

 

 

1,377

 

Foreign currency translation adjustments

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(4

)

 

 

-

 

 

 

(4

)

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(8,032

)

 

 

(8,032

)

Balance at June 30, 2020

 

 

25,493,058

 

 

$

26

 

 

$

426,282

 

 

$

(31

)

 

$

(287,317

)

 

$

138,960

 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.


7


 

VAPOTHERM, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY, continued

(Unaudited)

(In thousands, except share amounts)

 

 

 

 

 

 

 

 

 

Additional

 

 

Accumulated

Other

 

 

 

 

 

 

 

 

 

 

 

Common Stock

 

 

Paid-in

 

 

Comprehensive

 

 

Accumulated

 

 

Stockholders'

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Income

 

 

Deficit

 

 

Equity

 

Balance at December 31, 2018

 

 

16,782,837

 

 

$

17

 

 

$

265,926

 

 

$

-

 

 

$

(214,382

)

 

$

51,561

 

Issuance of common stock warrants

 

 

 

 

 

 

 

 

 

 

293

 

 

 

 

 

 

 

 

 

 

 

293

 

Issuance of stock upon exercise of options

 

 

268

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

-

 

 

 

-

 

Issuance of restricted stock

 

 

116,580

 

 

 

-

 

 

 

226

 

 

 

 

 

 

 

-

 

 

 

226

 

Stock-based compensation expense

 

 

-

 

 

 

-

 

 

 

1,903

 

 

 

 

 

 

 

-

 

 

 

1,903

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

(12,964

)

 

 

(12,964

)

Balance at March 31, 2019

 

 

16,899,685

 

 

$

17

 

 

$

268,348

 

 

$

-

 

 

$

(227,346

)

 

$

41,019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of common stock upon exercise of warrants

 

 

12,164

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Issuance of common stock upon exercise of options

 

 

122,497

 

 

 

-

 

 

 

193

 

 

 

-

 

 

 

-

 

 

 

193

 

Issuance of common stock upon repayment of non-recourse loan

 

 

79,854

 

 

 

-

 

 

 

144

 

 

 

-

 

 

 

-

 

 

 

144

 

Issuance of restricted stock

 

 

52,168

 

 

 

-

 

 

 

159

 

 

 

-

 

 

 

-

 

 

 

159

 

Stock-based compensation expense

 

 

-

 

 

 

-

 

 

 

712

 

 

 

-

 

 

 

-

 

 

 

712

 

Foreign currency translation adjustments

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2

 

 

 

-

 

 

 

2

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(12,880

)

 

 

(12,880

)

Balance at June 30, 2019

 

 

17,166,368

 

 

$

17

 

 

$

269,556

 

 

$

2

 

 

$

(240,226

)

 

$

29,349

 

 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 

8


 

VAPOTHERM, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended June 30,

 

 

 

2020

 

 

2019

 

Cash flows from operating activities

 

 

 

 

 

 

 

 

Net loss

 

$

(21,876

)

 

$

(25,844

)

Adjustments to reconcile net loss to net cash used in operating activities

 

 

 

 

 

 

 

 

Stock-based compensation expense

 

 

2,824

 

 

 

2,615

 

Depreciation and amortization

 

 

2,148

 

 

 

1,407

 

Provision for bad debts

 

 

282

 

 

 

64

 

Provision for inventories

 

 

(327

)

 

 

697

 

Loss on disposal of property and equipment

 

 

3

 

 

 

81

 

Amortization of discount on debt

 

 

127

 

 

 

108

 

Changes in operating assets and liabilities, net of acquisition:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(8,542

)

 

 

144

 

Inventories

 

 

(9,204

)

 

 

2,292

 

Prepaid expenses and other assets

 

 

(547

)

 

 

398

 

Accounts payable

 

 

3,380

 

 

 

(1,229

)

Contract liabilities

 

 

125

 

 

 

(16

)

Accrued expenses and other current liabilities

 

 

6,932

 

 

 

397

 

Net cash used in operating activities

 

 

(24,675

)

 

 

(18,886

)

Cash flows from investing activities

 

 

 

 

 

 

 

 

Purchases of property and equipment

 

 

(3,839

)

 

 

(2,164

)

Acquisition of business, net of cash acquired

 

 

-

 

 

 

(1,560

)

Net cash used in investing activities

 

 

(3,839

)

 

 

(3,724

)

Cash flows from financing activities

 

 

 

 

 

 

 

 

Proceeds from issuance of common stock in connection with public offering, net

 

 

94,156

 

 

 

-

 

Proceeds from issuance of common stock in connection with at-the-market offering, net

 

 

9,926

 

 

 

-

 

Common stock offering costs

 

 

(471

)

 

 

-

 

Proceeds from issuance of common stock under the Employee Stock Purchase Plan

 

 

359

 

 

 

-

 

Short-term line of credit

 

 

995

 

 

 

(7

)

Proceeds from exercise of stock options and purchase of restricted stock

 

 

267

 

 

 

337

 

Proceeds on loans

 

 

-

 

 

 

10,500

 

Debt issuance costs

 

 

-

 

 

 

(322

)

Net cash provided by financing activities

 

 

105,232

 

 

 

10,508

 

Effect of exchange rate changes on cash, cash equivalents and restricted cash

 

 

(28

)

 

 

(13

)

Net increase (decrease) in cash, cash equivalents and restricted cash

 

 

76,690

 

 

 

(12,115

)

Cash, cash equivalents and restricted cash

 

 

 

 

 

 

 

 

Beginning of period

 

 

73,507

 

 

 

60,022

 

End of period

 

$

150,197

 

 

$

47,907

 

Supplemental disclosures of cash flow information

 

 

 

 

 

 

 

 

Interest paid during the period

 

$

2,422

 

 

$

2,290

 

Property and equipment purchases in accounts payable and accrued expenses

 

$

341

 

 

$

115

 

Issuance of warrants in conjunction with debt draw down

 

-

 

 

$

293

 

Issuance of common stock upon vesting of restricted stock

 

$

111

 

 

$

385

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

9


VAPOTHERM, INC.

Notes to Unaudited Condensed Consolidated Financial Statements

(In thousands, except share and per share amounts)

 

1. Description of Business

Vapotherm, Inc. (the “Company”) was founded in 1993 and reincorporated under the laws of the State of Delaware in 2013. Since inception, the Company has focused on the development and commercialization of its proprietary high velocity products that are used to treat patients of all ages suffering from respiratory distress. The Company’s high velocity therapy delivers non-invasive ventilatory support by providing heated, humidified and oxygenated air at a high velocity to patients through a comfortable small-bore nasal interface. The Company’s Precision Flow systems, which use high velocity therapy, are clinically validated alternatives to, and address many limitations of, the current standard of care for the treatment of respiratory distress in a hospital setting.

The Company offers four versions of its Precision Flow systems: Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic and Precision Flow Heliox. The Company generates revenue from sales of its Precision Flow systems and related disposable products utilized with its Precision Flow systems. The Company also generates revenue from sales of the Precision Flow system’s companion products, which include the Vapotherm Transfer Unit 2.0, the Q50 compressor and various adaptors. The Company offers different options to its hospital customers for acquiring Precision Flow capital units, ranging from the purchase of the Precision Flow capital units with payment in full at the time of purchase, to financed purchases of the Precision Flow capital units, to bundled discounts involving the placement of Precision Flow capital units for use by the customer at no upfront charge in connection with the customer’s ongoing purchase of disposable products.

The Company sells Precision Flow systems to hospitals through a direct sales force in the United States and in the United Kingdom and through distributors in select other countries outside of the United States and United Kingdom. In addition, the Company utilizes clinical educators who are typically experienced users of high velocity therapy and who focus on medical education efforts to facilitate adoption and increase utilization. The Company is focused on physicians, respiratory therapists and nurses who work in acute hospital settings, including the emergency department (“ED”) and adult, pediatric and neonatal intensive care units (the “ICUs”). The Company’s relationship with these clinicians is particularly important, as it enables its products to follow patients through the care continuum.

In March 2020, the World Health Organization declared a global pandemic related to the novel coronavirus (“COVID-19”). The Company’s high velocity therapy is a first-line therapy for treating respiratory distress, which is experienced by many COVID-19 patients. The Journal of the American Medical Association published data from mainland China in April 2020 suggesting that 19% of all COVID-19 patients experience respiratory distress and require some amount of respiratory support. The Company’s hospital customers around the world are using its technology to support the respiratory distress experienced by many COVID-19 patients so that they can triage their sickest patients using a limited number of ventilators. As a result, the Company has seen a significant increase in worldwide demand for its products from both new and existing accounts in the first six months of 2020.

Since inception, the Company has financed its operations primarily through public offerings of its common stock, private placements of its convertible preferred stock, sales of its Precision Flow systems and amounts borrowed under its credit facilities. The Company has devoted the majority of its resources to research and development activities related to its Precision Flow systems, including regulatory initiatives and sales and marketing activities. The Company has invested heavily in its sales and marketing function by increasing the number of sales representatives and clinical educators to facilitate adoption and increase utilization of its high velocity therapy products and expanded its digital marketing initiatives and medical education programs.

The Company is subject to risks common to companies in the medical device industry, including, but not limited to, risks relating to the successful development and commercialization of its Precision Flow products, fluctuations in operating results and financial risks, protection of proprietary knowledge and patent risks, dependence on key personnel and collaborative partners, competition, technological and manufacturing risks, customer acceptance and demand, compliance with the Food and Drug Administration and other governmental regulations, management of growth and effectiveness of marketing by the Company and by third parties.

On November 16, 2018, the Company completed an initial public offering of 4,600,000 shares of common stock, which included the full exercise by the underwriters of their option to purchase 600,000 shares of common stock, at a price of $14.00 per share, which raised net proceeds of $57.4 million after deducting the underwriting discount of $4.5 million and offering expenses of $2.5 million.

On February 28, 2019, the Company acquired its United Kingdom based distributor. See Note 3 “Business Combinations” to these condensed consolidated financial statements for details of this transaction.

10


VAPOTHERM, INC.

Notes to Unaudited Condensed Consolidated Financial Statements

(In thousands, except share and per share amounts)

 

In August 2019, the Company completed a public offering of 3,570,750 shares of common stock, which included the full exercise by the underwriters of their option to purchase 465,750 shares of common stock, at a price of $14.50 per share, which raised net proceeds of $48.3 million after deducting the underwriting discount of $3.1 million and offering expenses of $0.4 million.

On December 20, 2019, the Company entered into an Open Market Sales Agreement (the “ATM Agreement”) with Jefferies LLC (“Jefferies”) under which the Company may offer and sell its common stock having aggregate sales proceeds of up to $50.0 million from time to time through Jefferies as its sales agents. During April 2020, the Company sold 511,648 shares of common stock pursuant to the ATM Agreement for gross proceeds of $10.2 million, or $9.8 million net of commissions and offering expenses.

In May 2020, the Company completed a public offering of 3,852,500 shares of common stock, which included the full exercise by the underwriters of their option to purchase 502,500 shares of common stock, at a price of $26.00 per share, which raised net proceeds of $93.8 million after deducting the underwriting discount of $6.0 million and offering expenses of $0.3 million.

 

2. Summary of Significant Accounting Policies

 

Basis of Presentation

 

The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The information included in this Quarterly Report on Form 10-Q should be read in conjunction with our audited consolidated financial statements and the accompanying notes included in our Annual Report on Form 10-K for the year ended December 31, 2019 (the “2019 Form 10-K”). Our accounting policies are described in the “Notes to Consolidated Financial Statements” in our 2019 Form 10-K and updated, as necessary, in this report. The year-end condensed consolidated balance sheet data presented for comparative purposes was derived from our audited financial statements but does not include all disclosures required by U.S. GAAP.

Principles of Consolidation

These condensed consolidated financial statements include the financial statements of Solus Medical Ltd. (“Solus”), a wholly owned subsidiary of the Company based in the United Kingdom, which was acquired in the first quarter of 2019. All intercompany accounts and transactions have been eliminated upon consolidation.

Segment Information

Operating segments are defined as components of an enterprise for which separate discrete financial information is available and evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company globally manages the business within one reporting segment, Vapotherm, Inc. and two reporting units, Vapotherm and Solus. Segment information is consistent with how management reviews the business, makes investing and resource allocation decisions and assesses operating performance.

 

The majority of the Company’s long-term assets are located in the United States. Long-term assets located outside the United States total $0.1 million as of each of June 30, 2020 and December 31, 2019.

Use of Estimates

The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires the Company to make judgments, assumptions, and estimates that affect the reported amounts of assets, liabilities, revenue and expenses, and the related disclosure of contingent assets and liabilities. The Company evaluates its estimates on an ongoing basis. The Company bases its estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Significant estimates relied upon in preparing these condensed consolidated financial statements include calculation of stock-based compensation, valuation of warrants, fair values of acquired assets and liabilities, including goodwill and intangibles assets, realizability of inventories, allowance for bad debt, accrued expenses and the valuation allowances against deferred income tax assets. Actual results may differ from these estimates.

11


VAPOTHERM, INC.

Notes to Unaudited Condensed Consolidated Financial Statements

(In thousands, except share and per share amounts)

 

Unaudited Interim Financial Information

The accompanying condensed consolidated balance sheet as of June 30, 2020, and the condensed consolidated statements of comprehensive loss, stockholders’ equity and of cash flows for the three and six months ended June 30, 2020 and 2019 are unaudited. The unaudited interim condensed consolidated financial statements have been prepared on the same basis as the audited annual consolidated financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of June 30, 2020 and the results of its operations and its cash flows for the three and six months ended June 30, 2020 and 2019. The financial data and other information disclosed in these notes related to the three and six months ended June 30, 2020 and 2019 are also unaudited. The results of operations for the three and six months ended June 30, 2020 are not necessarily indicative of the operating results for the full year or for any other subsequent interim period.

 

Reclassification

Certain amounts in 2019 have been reclassified to conform to the presentation in 2020.

Concentrations of Credit Risk

As of June 30, 2020, the Company’s financial instruments were comprised of cash and cash equivalents, restricted cash, accounts receivable, accounts payable and debt, the carrying amounts of which approximated fair value due to the short-term nature and market interest rates. All of the Company’s cash and cash equivalents are maintained at creditworthy financial institutions. At June 30, 2020, deposits exceed the amount of any insurance provided.

The Company extends credit to customers in the normal course of business but does not require collateral or any other security to support amounts due. Management performs ongoing credit evaluations of the Company’s customers. An allowance for potentially uncollectible accounts is provided based on history, economic conditions, and composition of the accounts receivable aging. In some cases, the Company makes allowances for specific customers based on these and other factors. Provisions for the allowance for doubtful accounts are recorded in general and administrative expenses in the accompanying condensed consolidated statements of comprehensive loss.

 

Foreign Currency and Foreign Operations

The functional currency of the Company is the currency of the primary economic environment in which the entity operates, which is the U.S. dollar. For our non-U.S. subsidiary that transacts in a functional currency other than the U.S. dollar, assets and liabilities are translated at current rates of exchange as of the balance sheet date. Income and expense items are translated at the average foreign currency exchange rates for the period. Adjustments resulting from the translation of the financial statements of its foreign operations into U.S. dollars are excluded from the determination of net loss and are recorded in accumulated other comprehensive income (loss), a separate component of stockholders’ equity.

Realized foreign currency gains or losses arising from transactions denominated in foreign currencies are recorded in other (expense) income in the condensed consolidated statements of comprehensive loss. Unrealized foreign currency gains or losses arising from transactions denominated in foreign currencies are recorded in accumulated other comprehensive income (loss).

 

Cash, Cash Equivalents, and Restricted Cash

 

The Company considers all highly liquid temporary investments purchased with original maturities of 90 days or less to be cash equivalents. The Company holds restricted cash related to certificates of deposits and collateral in relation to lease agreements. As of June 30, 2020, $0.5 million of our $150.2 million of cash, cash equivalents and restricted cash balance was located outside the United States.

 

12


VAPOTHERM, INC.

Notes to Unaudited Condensed Consolidated Financial Statements

(In thousands, except share and per share amounts)

 

The following table presents the components of total cash, cash equivalents, and restricted cash as set forth in the Company’s condensed consolidated statements of cash flows:

 

 

 

June 30,

2020

 

 

December 31,

2019

 

Cash and cash equivalents

 

$

148,344

 

 

$

71,655

 

Restricted cash

 

 

1,853

 

 

 

1,852

 

Total cash, cash equivalents, and restricted cash

 

$

150,197

 

 

$

73,507

 

 

Product Warranty

 

The Company provides its customers with a standard one-year warranty on its capital equipment sales. Warranty costs are accrued based on actual historical trends and estimated at time of sale. The warranty liability is included within accrued expenses and other liabilities in the condensed consolidated balance sheets. A roll-forward of the Company’s warranty liability from December 31, 2019 to June 30, 2020 is as follows:

 

Balance at December 31, 2019

 

$

225

 

Provisions for warranty obligations

 

 

670

 

Settlements

 

 

(127

)

Balance at June 30, 2020

 

$

768

 

 

Insurance

Effective January 1, 2020, the Company was self-insured for certain obligations related to health insurance. The Company also purchases stop-loss insurance to protect itself from material losses. Judgments and estimates are used in determining the potential value associated with reported claims and for events that have occurred but have not been reported. The Company’s estimates consider expected claim experience and other factors. Receivables for insurance recoveries are recorded as assets, on an undiscounted basis. The Company’s liabilities are based on estimates, and, while the Company believes that its accruals are adequate, the ultimate liability may be significantly different from the amounts recorded. Changes in claims experience, the Company’s ability to settle claims or other estimates and judgments used by management could have a material impact on the amount and timing of expense for any period.

 

Revenue Recognition

The Company’s revenue is primarily derived from the sale of products, leases and services. Product revenue consists of capital equipment and single-use disposables that are shipped and billed to customers both domestically and internationally. The Company’s main capital equipment products are the Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, Vapotherm Transfer Unit 2.0 and Q50 compressor. The Company’s main disposable products are single-use disposables and nasal interfaces, or cannulas, and adaptors. Lease revenue consists of two components which include capital equipment that the Company leases out to its customers and, in certain situations, an allocation from disposable revenue to other lease revenue upon the sale of disposable products in bundled arrangements involving the placement of Precision Flow capital units for use by the customer at no upfront charge in connection with the customer’s ongoing purchase of disposable products. Service revenue consists of fees associated with routine service of capital units and the sale of extended service contracts and preventative maintenance plans, which are purchased by a small portion of the Company’s customer base. In addition, the Company sells small quantities of component parts in the United States, United Kingdom and to third-party international service centers who provide service on Precision Flow capital units outside of the United States. Freight revenue is based upon actual freight costs plus a percentage markup of such costs associated with the shipment of products domestically, and to a lesser extent, internationally, and is included in service revenue. Rebates and fees consist of contractually obligated administrative fees and percentage-of-sales rebates paid to Group Purchasing Organizations (“GPOs”), Integrated Delivery Networks (“IDNs”) and distributor partners and accounted for as a reduction of service revenue.

13


VAPOTHERM, INC.

Notes to Unaudited Condensed Consolidated Financial Statements

(In thousands, except share and per share amounts)

 

Under Financial Accounting Standard Board (“FASB”) Accounting Standards Codifications (“ASC”) 606, Revenue from Contracts with Customers (“ASC 606”), revenue is recognized when a customer obtains control of promised goods or services, in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and assesses whether each promised good or service is distinct and determines those that are performance obligations. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. Sales, value-added, and other taxes collected on behalf of third parties are excluded from revenue. The Company’s standard payment terms are generally 30 days from the date of sale.

Contracts with customers may contain multiple performance obligations. For such arrangements, the transaction price is allocated to each performance obligation based on the estimated relative stand-alone selling prices of the promised products or services underlying each performance obligation. The Company determines stand-alone selling prices based on the price at which the performance obligation is sold separately. If the stand-alone selling price is not observable through past transactions, the Company estimates the stand-alone selling price taking into account available information such as market conditions and internally approved pricing guidelines related to the performance obligations.

When determining the transaction price of a contract, an adjustment is made if payment from a customer occurs either significantly before or significantly after performance, resulting in a significant financing component. Applying the practical expedient in paragraph ASC 606-10-32-18, the Company does not assess whether a significant financing component exists if the period between when the Company performs its obligations under the contract and when the customer pays is one year or less. None of the Company’s contracts contained a significant financing component during the six months ended June 30, 2020 or 2019.

The Company’s contracts with its customers have a duration of less than one year. Therefore, the Company has elected to apply the practical expedient in paragraph ASC 340-40-25-4 and recognizes the incremental costs of obtaining contracts as an expense. These costs are included in sales and marketing expense in the accompanying condensed consolidated statements of comprehensive loss.

Lease Revenue

The Company also enters into agreements to lease its capital equipment. For such sales, the Company accounts for revenue under ASC 840, Leases, and assesses and classifies these transactions as sales-type or operating leases based on whether the lease transfers ownership of the equipment to the lessee by the end of the lease term. This criterion is met in situations in which the lease agreement provides for the transfer of title at or shortly after the end of the lease term. Equipment included in arrangements including transfer of title are accounted for as sales-type leases and the Company recognizes the total value of the lease payments due over the lease term to revenue at the inception of the lease. The Company records the current value of future lease payments under prepaid expenses and other current assets in the accompanying condensed consolidated balance sheets; these amounts totaled $1.8 and $0.9 million at June 30, 2020 and December 31, 2019, respectively. Equipment included in arrangements that do not include the transfer of title, nor any of the capital lease criteria, are accounted for as operating leases and revenue is recognized on a straight-line basis as it becomes receivable monthly over the term of the lease.

The Company also enters into agreements involving the placement of Precision Flow capital units for use by the customer at no upfront charge in connection with the customer’s ongoing purchase of disposable products. In these bundled arrangements, revenue recognized for the sale of the disposables is allocated between disposable revenue and other lease revenue based on the estimated relative stand-alone selling prices of the individual performance obligations.

14


VAPOTHERM, INC.

Notes to Unaudited Condensed Consolidated Financial Statements

(In thousands, except share and per share amounts)

 

Shipping and Handling Costs

Amounts billed to customers for shipping and handling are included in service revenue. Shipping and handling costs are included in costs of sales. The total costs of shipping and handling for the three months ended June 30, 2020 and 2019 was $0.8 and $0.2 million, respectively. Shipping and handlings costs for the six months ended June 30, 2020 and 2019 totaled $1.1 and $0.5 million, respectively.

Sales and Value-Added Taxes

When required by local jurisdictions, the Company bills its customers for sales tax and value-added tax calculated on each sales invoice and records a liability for the sales and value-added tax payable, which is included in accrued expenses and other liabilities in the condensed consolidated balance sheets. Sales tax and value-added tax billed to a customer are not included in the Company’s revenue.

Timing and Amount of Revenue Recognition

The Company recognizes revenue on product sales and service of its capital equipment and product sales of disposables to its end users. In each instance, revenue is generally recognized when the customer obtains control of the Company’s product, which generally occurs at a point in time upon shipment based on the contractual shipping terms of a contract.

Product and service revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or services to a customer. To the extent the transaction price includes variable consideration, the Company estimates the amount of variable consideration that should be included in the transaction price utilizing the expected value amount method to which the Company expects to be entitled. As such, revenue on sales is recorded net of prompt pay discounts and payments made to GPOs, IDNs and distributors. Variable consideration is included in the transaction price if, in the Company’s judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. Determination of whether to include estimated amounts in the transaction price is based largely on an assessment of the Company’s anticipated performance and all information (historical, current and forecasted) that is reasonably available. The Company believes that the estimates it has established are reasonable based upon current facts and circumstances. Applying different judgments to the same facts and circumstances could result in different estimates.

Stock-Based Compensation

The Company maintains an equity incentive plan to provide long-term incentives for employees, consultants, and members of the board of directors. The plan allows for the issuance of non-statutory and incentive stock options, restricted stock, unrestricted stock, stock units, including restricted stock units, and stock appreciation rights to employees, consultants and non-employee directors. The Company recognizes stock-based compensation expense for awards of equity instruments to employees and non-employees based on the grant date fair value of those awards in accordance with ASC Topic 718, Stock Compensation (“ASC 718”). ASC 718 requires all equity-based compensation awards, including grants of restricted shares and stock options, to be recognized as expense in the condensed consolidated statements of comprehensive loss based on their grant date fair values.

The fair value of each option grant is estimated on the grant date using the Black-Scholes option pricing model. The fair value is then amortized on a straight-line basis over the requisite service period of the awards, which is generally the vesting period. For performance-based awards, the related compensation cost is amortized over the performance period on an accelerated attribution basis. Compensation cost associated with performance awards is based on fair value on the date of grant and the number of units expected to be earned after assessing the probability that certain performance criteria will be met and the associated targeted payout level that is forecasted will be achieved. Cumulative adjustments are recorded each quarter to reflect estimated outcomes of the performance-related conditions until the results are determined and settled. Use of a valuation model requires management to make certain assumptions with respect to selected model inputs, including the expected life (weighted average period of time that the options granted are expected to be outstanding), the volatility of the Company’s common stock and an assumed risk-free interest rate. Expected volatility is calculated based on historical volatility of a group of publicly traded companies that the Company considers a peer group. The expected life is estimated using the simplified method for “plain vanilla” options. The risk-free interest rate is based on U.S. Treasury rates with a remaining term that approximates the expected life assumed at the date of grant. No dividend yield is assumed as the Company does not pay, and does not expect to pay, dividends on its common stock. The Company estimates forfeitures based on historical experience with pre-vested forfeitures. To the extent actual forfeitures differ from the estimate, the difference is recorded to compensation expense in the period of the forfeiture.

15


VAPOTHERM, INC.

Notes to Unaudited Condensed Consolidated Financial Statements

(In thousands, except share and per share amounts)

 

The Company recognizes stock-based expense for shares issued pursuant to its 2018 Employee Stock Purchase Plan (“ESPP”) on a straight-line basis over the related offering period. The Company estimates the fair value of shares to be issued under the ESPP based on a combination of options valued using the Black-Scholes option pricing model. The expected life is determined based on the contractual term. Dividend yield and forfeiture rates are estimated in a manner similar to option grants described above and expected volatility is based on the Company’s historical volatility.

 

Income Tax

The Company accounts for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the condensed consolidated financial statements or in the Company’s tax returns. Deferred taxes are determined based on the difference between the financial reporting and tax basis of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of deferred tax assets will not be realized, a valuation allowance is established through a charge to income tax expense. Potential for recovery of deferred tax assets is evaluated by estimating the future taxable profits expected and considering prudent and feasible tax planning strategies.

The Company accounts for uncertainty in income taxes recognized in the condensed consolidated financial statements by applying a two-step process to determine the amount of tax benefit to be recognized. First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities. If the tax position is deemed more likely than not to be sustained, the tax position is then assessed to determine the amount of benefit to recognize in the condensed consolidated financial statements. The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement. The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate as well as the related net interest and penalties.

The Company’s major tax jurisdictions are the United States, New Hampshire and the United Kingdom. There is no provision or benefit for income taxes for the three or six months ended June 30, 2020 or 2019 because the Company has historically incurred operating losses and maintains a full valuation allowance against its United States net deferred tax assets.

Utilization of the net operating loss and tax credit carryforwards may be subject to a substantial annual limitation under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended (the “Code”) due to ownership change limitations that have occurred previously or that could occur in the future. These ownership changes may limit the amount of net operating loss and tax credit carryforwards that can be utilized to offset future taxable income and reduce taxes, respectively. The Company has not currently completed an evaluation of ownership changes through June 30, 2020 or December 31, 2019 to assess whether utilization of the Company’s net operating loss and tax credit carryforwards would be subject to an annual limitation under Sections 382 and 383 of the Code. To the extent an ownership change is determined to have occurred under Sections 382 and 383 of the Code, the net operating loss and tax credit carryforwards may be subject to limitation.

 

Recently Issued Accounting Pronouncements

 

As an emerging growth company (“EGC”), the Jumpstart Our Business Startups Act (the “JOBS Act”) allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The Company has elected to use the adoption dates applicable to private companies. As a result, the Company’s consolidated financial statements may not be comparable to the financial statements of issuers who are required to comply with the effective date for new or revised accounting standards that are applicable to public companies. The Company expects it will no longer qualify as an EGC as of December 31, 2020 and, at that time, will begin to adopt accounting pronouncements at dates applicable to public companies.

16


VAPOTHERM, INC.

Notes to Unaudited Condensed Consolidated Financial Statements

(In thousands, except share and per share amounts)

 

Leases (Topic 842):

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) (“ASU 2016-02”). ASU 2016-02 establishes a comprehensive new lease accounting model. The new standard clarifies the definitions of a lease, requires a dual approach to lease classification similar to current lease classifications, and causes lessees to recognize leases on the balance sheet as a lease liability with a corresponding right-of-use asset for leases with a lease term of more than twelve months. In July 2018, the FASB issued ASU No. 2018-11 Leases (Topic 842) (“ASU 2018-11”) which provided another transition method in addition to the existing transition method by allowing entities to initially apply the new leases standard at the adoption date. In June 2020, the FASB issued ASU 2020-05, Revenue from Contracts with Customers (Topic 606) and Leases (Topic 842), which defers the effective date for ASU 2016-02 to annual periods beginning after December 15, 2021 and interim periods beginning after December 15, 2022 for private companies or EGCs following private company adoption dates. The standard was effective for public companies for periods beginning after December 31, 2018. The new standard originally required a modified retrospective transition for capital or operating leases existing at or entered into after the beginning of the earliest comparative period presented in the financial statements, but it does not require transition accounting for leases that expire prior to the date of the initial application. The Company expects to adopt the new standard in the fourth quarter of 2020. The Company is in the process of adopting the new standard, including evaluating completeness, measuring the impacts, establishing incremental borrowing rates, and designing and implementing processes and controls for adoption and post adoption periods. The Company expects the most significant effects of adoption to relate to (1) the recognition of new right-of-use assets and lease liabilities on the balance sheet for the Company’s facilities and certain other operating leases; and (2) the need to provide new disclosures about the Company’s leasing activities related to the amount, timing and uncertainty of cash flows arising from leases.

 

Credit Losses (Topic 326):

 

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). This standard requires that credit losses be reported using an expected losses model rather than the incurred losses model that is currently used and establishes additional disclosures related to credit risks. In November 2019, the FASB issued ASU 2019-10, Financial Instruments-Credit Losses (Topic 326), Derivative and Hedging (Topic 815) and Leases (Topic 842), which defers the effective date for ASU 2016-13 to interim and annual periods beginning after December 15, 2022 for private companies, EGCs following private company adoption dates, or public entities meeting the definition of smaller reporting companies as of the date of issuance of this update. The Company has not yet determined the effects, if any, that the adoption of ASU 2016-13 may have on its financial position, results of operations, cash flows, or disclosures.

 

3. Business Combinations

On February 28, 2019, the Company completed the acquisition of all outstanding equity securities of Solus, whose principal assets included intangible assets related to supplier agreements. The Company undertook the acquisition to accelerate its penetration in the United Kingdom market. The purchase price, net of cash acquired, of $2.0 million was funded with an initial cash payment of approximately $1.6 million and a settlement of a $0.4 million receivable from a preexisting relationship. Additionally, the Company recognized $1.0 million in contingent consideration as compensation expense during 2019 and expects to recognize contingent consideration of $1.2 million as compensation expense in 2020. The acquisition has been accounted for as an acquisition of a business.

17


VAPOTHERM, INC.

Notes to Unaudited Condensed Consolidated Financial Statements

(In thousands, except share and per share amounts)

 

The following table summarizes the purchase price allocation that includes the fair values of the separately identifiable assets acquired and liabilities assumed as of February 28, 2019:

 

 

 

 

 

Cash

$

466

 

Accounts receivable

411

 

Inventory

492

 

Prepaids and other assets

3

 

Property and equipment

1

 

Goodwill

592

 

Intangible assets

455

 

Total assets acquired

 

2,420

 

Accounts payable and accrued expenses

 

(241

)

Contract liabilities

 

(75

)

Deferred taxes

 

(78

)

Total liabilities assumed

 

(394

)

Total purchase price

$

2,026

 

 

 

 

 

 

The excess of purchase consideration over the fair value of net tangible and identifiable intangible assets acquired was recorded as goodwill. The fair values assigned to tangible and identifiable intangible assets acquired and liabilities assumed are based on management’s estimates and assumptions.

In determining the purchase price allocation, the Company considered, among other factors, the opportunity provided by a supplier agreement with the National Health Service. The fair value of the intangible assets associated with this agreement were estimated using a discounted cash flow method with the application of the multi-period excess earnings method. Under this method, an intangible asset’s fair value is equal to the present value of the incremental after-tax cash flows attributable to only the subject intangible assets after deducting contributory asset charges. An income and expenses forecast was built based upon specific intangible asset revenue and expense estimates.

The rate used to discount the estimated future net cash flows to their present values for each intangible asset was based upon a weighted average cost of capital calculation. The discount rate was determined after consideration of market rates of return on debt and equity capital, the weighted average return on invested capital and the risk associated with achieving forecasted sales related to the assets acquired from Solus.

The total weighted average amortization period for the intangible assets is approximately 3.83 years. The intangible assets are being amortized on a straight-line basis, which is consistent with the pattern that the economic benefits of the intangible assets are expected to be utilized based upon estimated cash flows generated from such assets. Goodwill associated with the acquisition was primarily attributable to the market expansion opportunity in the United Kingdom. The goodwill attributable to the United Kingdom jurisdiction is not deductible for tax purposes.

The Company has included the financial results of Solus in the condensed consolidated financial statements from the date of acquisition. The transaction costs associated with the acquisition were approximately $0.2 million and were recorded in general and administrative expense as incurred during 2019.

18


VAPOTHERM, INC.

Notes to Unaudited Condensed Consolidated Financial Statements

(In thousands, except share and per share amounts)

 

Pro Forma Financial Information

The following unaudited pro forma information for the three and six months ended June 30, 2019 presents consolidated information as if the Solus acquisition occurred on January 1, 2019, which is the first day of the Company’s fiscal year 2019:

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2019

 

 

2019

 

Net revenue

 

$

11,986

 

 

$

24,522

 

Net loss

 

$

(12,880

)

 

$

(25,788

)

Net loss per share, basic

 

$

(0.76

)

 

$

(1.52

)

 

4. Fair Value Measurements

In accordance with ASC 820, Fair Value Measurements and Disclosures, the Company generally defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company uses a three-tier fair value hierarchy, which classifies the inputs used in measuring fair values. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements), and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are described below:

 

 

Level 1 – inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.

 

 

Level 2 – inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. If the asset or liability has a specified (contractual) term, a Level 2 input must be observable for substantially the full term of the asset or liability.

 

 

Level 3 – inputs are unobservable inputs for the asset or liability in which there is little, if any, market activity for the asset or liability at the measurement date.

The Company’s cash equivalents primarily consist of money market deposits which total approximately $132.8 million at June 30, 2020 and are valued based on Level 1 of the fair value hierarchy. As described in Note 8 “Debt”, during 2019, the Company granted warrants to purchase 19,789 shares of common stock in connection with an amendment to its financing arrangement. These equity-classified warrants were valued using the Black-Scholes pricing model, which falls within Level 3 of the fair value hierarchy.

The assumptions used in the Black-Scholes pricing model were as follows at the date of grant:

 

Expected dividend yield

 

0.0

%

Risk free interest rate

 

2.4

%

Expected stock price volatility

 

60.9

%

Expected term (years)

 

10.0

 

 

19


VAPOTHERM, INC.

Notes to Unaudited Condensed Consolidated Financial Statements

(In thousands, except share and per share amounts)

 

5. Accounts Receivable

Accounts receivable consists of the following:

 

 

 

June 30,

2020

 

 

December 31,

2019

 

United States

 

$

10,614

 

 

$

5,574

 

International

 

 

6,428

 

 

 

2,908

 

Total accounts receivable

 

 

17,042

 

 

 

8,482

 

Less: Allowance for doubtful accounts

 

 

(590

)

 

 

(239

)

Accounts receivable, net of allowance for doubtful

   accounts

 

$

16,452

 

 

$

8,243

 

 

No individual customer accounted for 10% or more of revenue for the three or six months ended June 30, 2020 or 2019. No individual customers accounted for 10% or more of total accounts receivable at either June 30, 2020 or December 31, 2019.

 

6. Inventories

Inventories consist of the following:

 

 

 

June 30,

2020

 

 

December 31,

2019

 

Component parts

 

$

9,010

 

 

$

4,948

 

Finished goods

 

 

9,631

 

 

 

4,189

 

Total inventory

 

$

18,641

 

 

$

9,137

 

 

7. Goodwill and Intangible Assets

The changes in the carrying amount of goodwill and intangible assets during 2020 are as follows:

 

 

 

Goodwill

 

 

Intangible Assets

 

Balance at December 31, 2019

 

$

588

 

 

$

353

 

Acquired during the period

 

 

-

 

 

 

-

 

Amortization

 

 

-

 

 

 

(56

)

Foreign currency exchange rate changes

 

 

(41

)

 

 

(22

)

Balance at June 30, 2020

 

$

547

 

 

$

275

 

 

The following table presents a summary of acquired intangible assets:

 

 

 

As of June 30, 2020

 

 

 

Period of

amortization

 

 

Gross

Carrying

Amount

 

 

Accumulated

Amortization

 

Customer agreements

 

 

3.83

 

 

$

423

 

 

$

(148

)

Total identifiable intangible assets

 

 

 

 

 

$

423

 

 

$

(148

)

 

20


VAPOTHERM, INC.

Notes to Unaudited Condensed Consolidated Financial Statements

(In thousands, except share and per share amounts)

 

8. Debt

Revolving Credit Line

On November 16, 2016, the Company entered a Business Financing Agreement (the “Revolver Agreement”) with Western Alliance Bank, an Arizona corporation, which replaced its then-existing revolving line of credit. The Revolver Agreement made available $7.0 million of revolving credit upon the closing date. Availability under the Revolver Agreement is calculated based upon 80% of the eligible receivables (net of pre-paid deposits, pre-billed invoices, other offsets, and contras related to each specific account debtor). The original maturity date was September 30, 2018. The Company refinanced the Revolver Agreement in April 2018, increasing the credit line to $7.5 million and extending the maturity date to September 30, 2020 (the “Amended Revolver Agreement”). The principal is due upon maturity. On March 22, 2019, the Company entered into an amendment to the Amended Revolver Agreement (as amended, the “2019 Amended Revolver Agreement”), which increased the allowable permitted indebtedness under the 2019 Amended Revolver Agreement in connection with the Company’s credit card program from $0.3 million to $0.5 million. On July 7, 2020, the Company entered into a second amendment to the Amended Revolver Agreement (as amended, the “2020 Amended Revolver Agreement”) which, under certain circumstances, reduces the amount of funds required to be held on deposit with Western Alliance Bank.

At June 30, 2020 the interest rate was 5.25%. The outstanding balance under the 2020 Amended Revolver Agreement was $4.5 million at June 30, 2020 and there was $3.0 million remaining availability based on eligible receivables. At December 31, 2019, the interest rate was 6.50%. The outstanding balance under the 2019 Amended Revolver Agreement was $3.5 million at December 31, 2019 and the remaining availability based on eligible receivables was $0.8 million. The 2020 Amended Revolver Agreement requires the Company to comply with a minimum liquidity covenant at all times. As of June 30, 2020, the Company was in compliance with all covenants.

The 2020 Amended Revolving Agreement is secured by substantially all of the Company’s assets, excluding intellectual property.

Term Loans

On April 6, 2018, the Company entered into a Credit Agreement and Guaranty (the “Credit Agreement and Guaranty”) with Perceptive Credit Holdings II, LP (“Perceptive”). Pursuant to the Credit Agreement and Guaranty, a total of $42.5 million was available in three tranches. The first tranche was drawn down in the amount of $20.0 million on the closing date, April 6, 2018, which paid off a former loan agreement in full. In connection with this draw down, the Company granted Perceptive warrants to purchase 37,693 shares of Series D preferred stock which were converted into warrants to purchase shares of common stock at the time of the initial public offering. The warrants had an exercise price of $15.92 per share, were fully vested upon issuance, were exercisable at the option of the holder, in whole or in part, and would have expired in April 2028.

On July 20, 2018, pursuant to the Credit Agreement and Guaranty, the Company drew down the second tranche of $10.0 million. In connection with this draw down, the Company granted Perceptive warrants to purchase 18,846 shares of Series D preferred stock which were converted into warrants to purchase shares of common stock at the time of the initial public offering. The warrants had an exercise price of $15.92 per share, were fully vested upon issuance, were exercisable at the option of the holder, in whole or in part, and would have expired in July 2028.

On September 27, 2018, the Company entered into the first amendment to the Credit Agreement and Guaranty (as amended, the “Amended Credit Agreement and Guaranty”) with Perceptive. Pursuant to the Amended Credit Agreement and Guaranty, the Company was permitted to draw the final $12.5 million of availability at any time through March 31, 2019 and the minimum 2018 revenue requirement of $43.2 million that was required to draw down the final tranche was eliminated. Concurrently with the closing of the Amendment, the Company drew down $2.0 million of the remaining $12.5 million available. In connection with this draw down, the Company granted to Perceptive warrants to purchase 3,769 shares of its Series D preferred stock which were converted into warrants to purchase shares of common stock at the time of the initial public offering. The warrants had an exercise price of $15.92 per share, were fully vested upon issuance, were exercisable at the option of the holder, in whole or in part, and would have expired in September 2028.

21


VAPOTHERM, INC.

Notes to Unaudited Condensed Consolidated Financial Statements

(In thousands, except share and per share amounts)

 

On March 22, 2019, the Company drew the remaining $10.5 million of availability under the Amended Credit Agreement and Guaranty. In connection with this draw down, the Company granted Perceptive warrants to purchase 19,789 shares of common stock. The warrants had an exercise price of $15.92 per share, were fully vested upon issuance, were exercisable at the option of the holder, in whole or in part, and would have expired in March 2029.

On March 22, 2019, the Company entered into a second amendment to the Amended Credit Agreement and Guaranty increasing the allowable permitted indebtedness in connection with the Company’s credit card program from $0.3 million to $0.5 million.

On June 10, 2020, Perceptive exercised all of its outstanding warrants. See Note 10 “Warrants” for further details.

On June 16, 2020, the Company entered into a third amendment to the Amended Credit Agreement and Guaranty (the “2020 Amended Credit Agreement and Guaranty”), which amended the prepayment premium by clarifying the methodology for calculating Perceptive’s annualized internal rate of return under the term loan.

Pursuant to the 2020 Amended Credit Agreement and Guaranty, the outstanding principal amount accrues interest at an annual rate equal to 9.06% plus the greater of (a) one-month LIBOR and (b) 1.75% per year. At June 30, 2020, the interest rate was 10.81%. The outstanding balance, including accretion of the additional final payment due upon maturity and described below, was $42.6 million at June 30, 2020 and there was no remaining availability. The 2020 Amended Credit Agreement and Guaranty is secured by substantially all of the Company’s assets, including intellectual property. 

On the maturity date, in addition to the payment of principal and accrued interest, the Company will be required to make a payment of 0.5% of the total amount borrowed under the 2020 Amended Credit Agreement and Guaranty unless the Company has already made such a payment in connection with an acceleration or prepayment of borrowings under the agreement. In the event the Company prepays all or part of the amounts borrowed under the 2020 Amended Credit and Guaranty prior to the maturity date, the Company will be subject to additional prepayment fees which decrease as the time to maturity decreases. The 2020 Amended Credit Agreement and Guaranty requires the Company to comply with a minimum liquidity covenant at all times and a minimum revenue covenant measured at the end of each fiscal quarter. As of June 30, 2020, the Company was in compliance with all covenants.

The annual principal maturities of the Company’s term loans as of June 30, 2020 are as follows:

 

2020

 

 

-

 

2021

 

 

-

 

2022

 

 

-

 

2023

 

 

42,592

 

Less: Discount on loans payable

 

 

(663

)

Long-term loans payable

 

$

41,929

 

 

 

9. Commitments and Contingencies

Legal Matters

From time to time, the Company may become involved in various legal proceedings, including those that may arise in the ordinary course of business. The Company believes there is no litigation pending that could have, individually, or in the aggregate, a material adverse effect on the results of its operations or financial condition.

 

22


VAPOTHERM, INC.

Notes to Unaudited Condensed Consolidated Financial Statements

(In thousands, except share and per share amounts)

 

10. Warrants

The Company’s warrant activity is summarized as follows:

 

 

 

Common Stock Warrants

 

 

 

Number of

Shares

 

 

Weighted

Average

Exercise

Price

 

Outstanding at December 31, 2019

 

 

182,076

 

 

$

14.84

 

Warrants granted

 

 

-

 

 

 

-

 

Warrants exercised

 

 

(80,097

)

 

 

15.92

 

Outstanding at June 30, 2020

 

 

101,979

 

 

$

14.00

 

 

On June 10, 2020, a warrant to purchase 80,097 shares of common stock was exercised on a net exercise basis. Upon exercise, the exercise price of $15.92 per share was satisfied through the Company’s withholding of 39,031 of the warrant shares and issuing 41,066 shares of common stock.

 

On July 10, 2020, a warrant to purchase 20,891 shares of common stock held was exercised on a net exercise basis. Upon exercise, the exercise price of $14.00 per share was satisfied through the Company’s withholding of 6,905 of the warrant shares and issuing 13,986 shares of common stock to the holder.

 

11. Revenue

Disaggregated Revenue

The following table shows the Company’s net revenue disaggregated into categories the Company considers meaningful to depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors:

 

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

 

2020

 

2020

 

 

 

US

 

 

International

 

 

Total

 

US

 

 

International

 

 

Total

 

Net revenue by:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product Revenue

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capital Equipment

 

$

14,079

 

 

$

5,226

 

 

$

19,305

 

$

17,380

 

 

$

6,923

 

 

$

24,303

 

Disposable

 

 

9,441

 

 

 

3,722

 

 

 

13,163

 

 

19,135

 

 

 

6,458

 

 

 

25,593

 

Subtotal Product Revenue

 

 

23,520

 

 

 

8,948

 

 

 

32,468

 

 

36,515

 

 

 

13,381

 

 

 

49,896

 

Lease Revenue

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

Capital Equipment

 

 

1,620

 

 

 

14

 

 

 

1,634

 

 

2,247

 

 

 

31

 

 

 

2,278

 

Other

 

 

435

 

 

 

76

 

 

 

511

 

 

752

 

 

 

151

 

 

 

903

 

Service and Other Revenue

 

 

107

 

 

 

432

 

 

 

539

 

 

509

 

 

 

681

 

 

 

1,190

 

Total Revenue

 

$

25,682

 

 

$

9,470

 

 

$

35,152

 

$

40,023

 

 

$

14,244

 

 

$

54,267

 

 

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

 

2019

 

2019

 

 

 

US

 

 

International

 

 

Total

 

US

 

 

International

 

 

Total

 

Net revenue by:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product Revenue

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capital Equipment

 

$

1,599

 

 

$

1,046

 

 

$

2,645

 

$

3,109

 

 

$

1,551

 

 

$

4,660

 

Disposable

 

 

6,514

 

 

 

2,016

 

 

 

8,530

 

 

14,061

 

 

 

3,488

 

 

 

17,549

 

Subtotal Product Revenue

 

 

8,113

 

 

 

3,062

 

 

 

11,175

 

 

17,170

 

 

 

5,039

 

 

 

22,209

 

Lease Revenue

 

 

284

 

 

 

-

 

 

 

284

 

 

947

 

 

 

-

 

 

 

947

 

Service and Other Revenue

 

 

281

 

 

 

246

 

 

 

527

 

 

610

 

 

 

519

 

 

 

1,129

 

Total Revenue

 

$

8,678

 

 

$

3,308

 

 

$

11,986

 

$

18,727

 

 

$

5,558

 

 

$

24,285

 

23


VAPOTHERM, INC.

Notes to Unaudited Condensed Consolidated Financial Statements

(In thousands, except share and per share amounts)

 

 

United States and International net revenue is based on the customer location to which the product is shipped. No individual foreign country represents more than 10% of the Company’s total revenue.

Contract Balances from Contracts with Customers

Contract liabilities consist of deferred revenue and other contract liabilities associated with rebates and fees payable to GPOs, IDNs and distributor partners. Deferred revenues are included in accrued expenses and other liabilities in the accompanying consolidated balance sheets. The following table presents changes in contract liabilities during the six months ended June 30, 2020:

 

 

 

Contract

Liabilities

 

 

Deferred

Revenue

 

Balance at December 31, 2019

 

$

137

 

 

$

344

 

Additions

 

 

261

 

 

 

1,195

 

Subtractions

 

 

(137

)

 

 

(469

)

Balance at June 30, 2020

 

$

261

 

 

$

1,070

 

 

12. Stock-Based Compensation

Stock-based compensation expense was allocated based on the employees’ and non-employees’ functions as follows:

 

 

 

Three Months Ended

June 30,

 

 

Six Months Ended

June 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Cost of goods sold

 

$

74

 

 

$

27

 

 

$

145

 

 

$

138

 

Research and development

 

 

199

 

 

 

(10

)

 

 

400

 

 

 

255

 

Sales and marketing

 

 

480

 

 

 

246

 

 

 

920

 

 

 

759

 

General and administrative

 

 

624

 

 

 

449

 

 

 

1,359

 

 

 

1,463

 

Total

 

$

1,377

 

 

$

712

 

 

$

2,824

 

 

$

2,615

 

 

Stock Options

 

The Company granted options to purchase 938,910 shares of common stock at exercise prices ranging from $10.60 to $39.01 per share, with a weighted average exercise price of $12.47 per share, during the six months ended June 30, 2020. The Company granted options to purchase 776,196 shares of common stock at exercise prices ranging from $17.15 to $19.28 per share, with a weighted average exercise price of $17.18 per share, during the six months ended June 30, 2019. The weighted average fair value of stock options granted during the six months ended June 30, 2020 and 2019 was $9.16 and $11.97, respectively.

 

The weighted average assumptions used in the Black-Scholes options pricing model are as follows:

 

 

 

 

Six Months Ended June 30,

 

 

 

2020

 

 

2019

 

Expected dividend yield

 

 

0.0

%

 

 

0.0

%

Risk free interest rate

 

 

1.7

%

 

 

2.5

%

Expected stock price volatility

 

 

87.6

%

 

 

70.0

%

Expected term (years)

 

 

6.1

 

 

 

7.1

 

 

24


VAPOTHERM, INC.

Notes to Unaudited Condensed Consolidated Financial Statements

(In thousands, except share and per share amounts)

 

Restricted Stock

A summary of restricted stock activity for the six months ended June 30, 2020 is as follows:

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

Grant Date

 

 

 

Shares

 

 

Fair Value

 

Unvested at December 31, 2019

 

 

229,913

 

 

$

3.76

 

Granted/purchased

 

 

53,445

 

 

 

13.31

 

Vested

 

 

(76,063

)

 

 

3.44

 

Canceled

 

 

(500

)

 

 

10.97

 

Unvested at June 30, 2020

 

 

206,795

 

 

$

4.02

 

 

Employee Stock Purchase Plan

 

In connection with our initial public offering in November 2018, the Company’s board of directors adopted the ESPP and a total of 166,500 shares of common stock were initially reserved for issuance under the ESPP. The number of shares of common stock available for issuance under the ESPP is increased on the first day of each calendar year beginning January 1, 2019 and each year thereafter until 2028 by the lessor of (i) 1% of the number of shares of common stock issued and outstanding on the immediately preceding December 31, and (ii) the number of shares of common stock determined by the Company’s board of directors up to such an initial maximum of 1,741,300 shares of common stock. The number of shares of common stock reserved under the plan at June 30, 2020 totals 512,048.

 

The ESPP provides for successive discreet offering periods of approximately six months or as determined by the plan administrator. The first offering period began on January 2, 2020. As of June 30, 2020, 36,389 shares of common stock were purchased by employees under the ESPP at a price of $9.88 per share, resulting in cash proceeds of $0.4 million.

The ESPP permits eligible employees to elect to purchase shares of common stock through fixed whole percentage contributions from eligible compensation during each offering period, not to exceed 10% of the eligible compensation a participant receives during an offering period and not to accrue at a rate which exceeds $25,000 of the fair value of the stock (determined on the grant date(s)) for each calendar year. A participant may purchase the lower of (a) a number of shares of common stock determined by dividing such participant’s accumulated payroll deductions on the exercise date by the option price, (b) 5,000 shares, or (c) such other lesser maximum number of shares as shall have been established by the plan administrator.

 

Amounts deducted and accumulated by the participant will be used to purchase shares of common stock at the end of each offering period. The purchase price of the shares will be 85% of the lower of the fair value of common stock on the first trading day of each offering period or on the purchase date. Participants may end their participation during an offering period up to ten days in advance of the exercise date and will be paid their accumulated contributions that have not been used to purchase shares of common stock. Participation ends automatically upon termination of employment.

 

The fair value of the purchase right for the ESPP option is estimated on the date of grant using the Black-Scholes pricing model with the following assumptions during 2020:

 

Expected dividend yield

 

0.0%

 

Risk free interest rate

 

0.2% - 1.6%

 

Expected stock price volatility

 

107.9% - 115.8%

 

Expected term (years)

 

0.4 - 0.5

 

 

25


VAPOTHERM, INC.

Notes to Unaudited Condensed Consolidated Financial Statements

(In thousands, except share and per share amounts)

 

13. Net Loss Per Share

 

The Company excluded the following potential common shares, based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:

 

 

 

As of June 30,

 

 

 

2020

 

 

2019

 

Options to purchase common stock

 

 

1,826,614

 

 

 

1,397,432

 

Warrants to purchase common stock

 

 

101,979

 

 

 

182,076

 

Unvested restricted stock

 

 

206,795

 

 

 

305,220

 

Employee stock purchase plan shares

 

 

19,473

 

 

-

 

 

 

 

2,154,861

 

 

 

1,884,728

 

 

 

14. Related Party Transactions

 

See Note 8 “Debt” for a discussion of the Company’s Amended Credit Agreement and Guaranty and related transactions with Perceptive, a holder of more than 5% of the Company’s common stock.

 

 

26


 

ITEM 2.        MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed consolidated financial statements for the fiscal quarter ended June 30, 2020, included elsewhere in this Quarterly Report on Form 10-Q. In addition to historical financial information, the following discussion and analysis contains forward-looking statements that involve risks, uncertainties and assumptions. Some of the numbers included herein have been rounded for the convenience of presentation. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors, including those discussed under the “Risk Factors” section of our 2019 Form 10-K filed with the SEC on March 4, 2020, our Quarterly Report on Form 10-Q filed with the SEC on May 5, 2020, and this Quarterly Report on Form 10-Q.

Vapotherm, Inc. is a global medical technology company focused on the development and commercialization of our proprietary high velocity therapy products that are used to treat patients of all ages suffering from respiratory distress. Our high velocity therapy delivers non-invasive ventilatory support by providing heated, humidified and oxygenated air at a high velocity to patients through a comfortable small-bore nasal interface. Our Precision Flow systems, which use high velocity therapy, are clinically validated alternatives to, and address many limitations of, the current standard of care for the treatment of respiratory distress in a hospital setting. As of June 30, 2020, more than 2.3 million patients have been treated with our Precision Flow systems, and we have a global installed base of over 22,000 capital units.

The efficacy of Vapotherm’s products is supported by a significant body of clinical evidence across multiple patient populations suffering from respiratory distress. We have developed the only high velocity nasal insufflation device clinically validated as an alternative to non-invasive positive pressure ventilation (“NIPPV”) while addressing many of its limitations, including through our sponsored 204 patient, multisite randomized controlled trial in the emergency department (“ED”) which was published in the July 2018 issue of Annals of Emergency Medicine. Additionally, in April 2020 Heart and Lung, the Journal of Cardiopulmonary and Acute Care, published a subgroup analysis from this ED study that showed high velocity therapy may provide ventilatory support similar to NIPPV in patients presenting with acute hypercapnic respiratory failure.

In March 2020, the World Health Organization declared a global pandemic related to the novel coronavirus (“COVID-19”). Vapotherm’s high velocity therapy is a first-line therapy for treating respiratory distress, which is experienced by many COVID-19 patients. The Journal of the American Medical Association published data from mainland China in April 2020 suggesting that 19% of all COVID-19 patients experience respiratory distress and require some amount of respiratory support. Our hospital customers around the world are using our technology to treat the respiratory distress experienced by many COVID-19 patients so that they can triage their sickest patients to a limited number of ventilators. As a result, we have seen a significant increase in worldwide demand for our products from both new and existing accounts in the first six months of 2020. Our operations team, with support from our primarily domestic supply chain, has increased our production capacity to more than twenty times our pre-COVID-19 production capacity, including adding additional shifts and production lines. Looking ahead, our focus is on managing our production levels and supply chain to meet customer demand during this pandemic. The recent increase in demand for our products has been accompanied by gross profit headwinds, such as increases in air freight costs and expediting fees for components, a higher mix of capital equipment and international revenue, and many related risks to our business. The full extent of the impact of the COVID-19 pandemic will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID-19 and the actions to treat or contain COVID-19 or to otherwise limit its impact, among others.

 

We currently offer four versions of our Precision Flow systems: Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic and Precision Flow Heliox. We also initiated a limited release of our Oxygen Assist Module to certain United Kingdom neonatal intensive care unit accounts in the first quarter of 2020 and to certain adult intensive care unit accounts in Germany and Austria in the second quarter of 2020 for adult hypoxic patients, and we may expand those limited releases to additional United Kingdom and European accounts. The Oxygen Assist Module is designed to be used with all versions of our Precision Flow systems except for the Precision Flow Heliox. Our Oxygen Assist Module is designed to help clinicians maintain the pulse oxygen saturation (“SpO2”) within the target SpO2 range over a significantly greater proportion of time while requiring significantly fewer manual adjustments to the equipment. Maintenance of the prescribed oxygen saturation range may reduce the health risks associated with dosing too much, or too little, oxygen. We intend to fully launch the Oxygen Assist Module commercially throughout the United Kingdom and Europe by the end of 2020, at which time we believe we will begin generating revenue from the product.

 

In the United States, the Oxygen Assist Module was granted Breakthrough Device Designation by the United States Food and Drug Administration (“FDA”) on April 2, 2020 for the following indication: The Oxygen Assist Module (OAM) is an optional module used only with the Vapotherm Precision Flow and is indicated for on-demand titration of oxygen into warm humidified breathing gases delivered to spontaneously breathing patients based on continuous non-invasive monitoring of blood oxygen saturation. OAM is intended to treat pediatric patients (neonates and infants ≥1000g) in monitored clinical environments (e.g., NICU). We are continuing to work on an Investigational Device Exemption and, if authorized, plan to initiate a neonate study by the end of the year.

27


 

We generate revenue from sales of our Precision Flow systems and the related disposable products utilized with our Precision Flow systems. To a lesser extent, we generate revenue from sales of the Precision Flow system’s companion products, which include the Vapotherm Transfer Unit 2.0, the Q50 compressor and various adaptors. We offer different options to our hospital customers for acquiring Precision Flow capital units, ranging from the purchase of the Precision Flow capital units with payment in full at the time of purchase, to the financed purchase of Precision Flow capital units, to bundled discounts involving the placement of Precision Flow capital units for use by the customer at no upfront charge in connection with the customer’s ongoing purchase of disposable products.

We sell our Precision Flow systems to hospitals through a direct sales organization in the United States and in the United Kingdom and through distributors in other select countries outside of the United States and United Kingdom. We intend to fully launch our Oxygen Assist Module commercially throughout the United Kingdom and Europe by the end of 2020 through a direct sales organization in the United Kingdom and through distributors in other select countries in Europe. In addition, we have clinical educators who are experienced users of high velocity therapy and who focus on our medical education efforts to facilitate adoption and increase utilization. We focus on physicians, respiratory therapists and nurses who work in acute hospital settings, including the ED and adult, pediatric and neonatal ICUs. Our relationship with these clinicians is particularly important, as it enables our products to follow patients through the care continuum. We have sold our Precision Flow systems to over 1,600 hospitals across the United States, where they have been primarily deployed in the ICU setting.

We assemble our Precision Flow systems in our facility in New Hampshire and we rely on third-party suppliers for a majority of the components of our products, including many single source suppliers. Historically, we maintained higher levels of inventory to protect ourselves from supply interruptions, and, as a result, we were subject to the risk of inventory obsolescence and expiration, which could lead to inventory impairment charges. Currently, however, as we seek to fulfill increased demand in connection with the COVID-19 pandemic, there have been times where we were not able to carry higher levels of inventory, and as a result, we have experienced and may in the future experience supply interruptions. We currently ship our Precision Flow systems from our facility in New Hampshire directly to our United States customers and many of our international distributors on a purchase order basis. Warehousing and shipping operations for some of our international distributors are handled by a third-party vendor with facilities located in the Netherlands. While our customers have the right to return purchased products subject to a restocking fee, our historical return experience has been immaterial. However, although we have priority shipping status with our carriers, as a result of the COVID-19 pandemic, we have experienced, and may in the future experience, shipping delays throughout the United States and internationally, and as a result, there have been and may in the future be delays in our ability to ship our product to customers and distributors in a timely manner, which may potentially result in a greater percentage of returned product than we have historically experienced.

Since inception, we have financed our operations primarily through public offerings of our common stock, private placements of our convertible preferred stock, sales of our Precision Flow systems and amounts borrowed under our credit facilities. We have devoted the majority of our resources to research and development activities related to our Precision Flow systems including regulatory initiatives and sales and marketing activities. We have invested heavily in our sales and marketing function by increasing the number of sales representatives and clinical educators to facilitate adoption and increase utilization of our high velocity therapy products and expanded our digital marketing initiatives and medical education programs. For the second quarter of 2020, we generated revenue of $35.2 million and had a net loss of $8.0 million compared to revenue of $12.0 million and a net loss of $12.9 million for the second quarter of 2019. Our accumulated deficit as of June 30, 2020 was $287.3 million. In the second quarter of 2020, 73.1% of our revenue was derived in the United States and 26.9% was derived outside the United States. No single customer accounted for more than 10% of our revenue.

We intend to continue to make significant investments in our sales and marketing organization by increasing the number of U.S. sales representatives, expanding our international marketing programs and expanding direct to clinician digital marketing efforts to help facilitate further adoption among existing hospital accounts as well as broaden awareness of our products to new hospitals. We also expect to continue to make investments in research and development, regulatory affairs and clinical studies to develop future generations of our high velocity therapy products, support regulatory submissions and demonstrate the clinical efficacy of our new products. In addition, as we seek to maintain our current increased production capacity and explore further expansion thereof to satisfy COVID-19 related demand, we expect to continue to make investments in our production capabilities. Because of these and other factors, we expect to continue to incur net losses for the next several years and we may require additional funding, which may include future equity, including sales under our at-the-market sales agreement with Jefferies LLC dated December 20, 2019 under which we may offer and sell from time to time our common stock having aggregate sales proceeds of up to $50.0 million, and debt financings. During the first six months of 2020, the Company sold 511,648 shares of its common stock through its at-the-market stock offering program. The sales generated net proceeds of approximately $9.8 million, net of sales commissions and offering expenses. As of June 30, 2020, there was approximately $39.7 million in remaining capacity under the at-the-market stock offering program.

 

28


 

Results of Operations

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

 

(in thousands)

 

Net revenue

 

$

35,152

 

 

$

11,986

 

 

$

54,267

 

 

$

24,285

 

Cost of revenue

 

 

17,544

 

 

 

6,527

 

 

 

27,442

 

 

 

13,647

 

Gross profit

 

 

17,608

 

 

 

5,459

 

 

 

26,825

 

 

 

10,638

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

3,895

 

 

 

3,167

 

 

 

7,257

 

 

 

6,440

 

Sales and marketing

 

 

14,858

 

 

 

9,432

 

 

 

28,175

 

 

 

18,593

 

General and administrative

 

 

5,627

 

 

 

4,532

 

 

 

10,878

 

 

 

9,411

 

Total operating expenses

 

 

24,380

 

 

 

17,131

 

 

 

46,310

 

 

 

34,444

 

Loss from operations

 

 

(6,772

)

 

 

(11,672

)

 

 

(19,485

)

 

 

(23,806

)

Other expense, net

 

 

(1,260

)

 

 

(1,208

)

 

 

(2,391

)

 

 

(2,038

)

Net loss

 

$

(8,032

)

 

$

(12,880

)

 

$

(21,876

)

 

$

(25,844

)

 

 

 

 

Revenue

 

 

 

Three Months Ended June 30,

 

 

 

 

 

 

 

 

 

 

 

2020

 

 

2019

 

 

Change

 

 

 

(in thousands, except percentages)

 

 

 

 

 

 

 

 

 

 

 

Amount

 

 

% of Revenue

 

 

Amount

 

 

% of Revenue

 

 

$

 

 

%

 

Product Revenue:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capital Equipment

 

$

19,305

 

 

 

54.9

%

 

$

2,645

 

 

 

22.0

%

 

$

16,660

 

 

 

629.9

%

Disposable

 

 

13,163

 

 

 

37.5

%

 

 

8,530

 

 

 

71.2

%

 

 

4,633

 

 

 

54.3

%

Subtotal Product Revenue

 

 

32,468

 

 

 

92.4

%

 

 

11,175

 

 

 

93.2

%

 

 

21,293

 

 

 

190.5

%

Lease Revenue

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capital Equipment

 

$

1,634

 

 

 

4.6

%

 

$

284

 

 

 

2.4

%

 

$

1,350

 

 

 

475.35

%

Other

 

 

511

 

 

 

1.5

%

 

 

-

 

 

-

 

 

 

511

 

 

 

100.0

%

Service and Other Revenue

 

 

539

 

 

 

1.5

%

 

 

527

 

 

 

4.4

%

 

 

12

 

 

 

2.3

%

Total Revenue

 

$

35,152

 

 

 

100.0

%

 

$

11,986

 

 

 

100.0

%

 

$

23,166

 

 

 

193.3

%

 

Revenue increased $23.2 million, or 193.3%, to $35.2 million for the second quarter of 2020 compared to $12.0 million for the second quarter of 2019. The increase in revenue was primarily attributable to a $16.7 million and $4.6 million increase in capital equipment and disposable revenue, respectively. Capital equipment revenue increased 629.9% in the second quarter of 2020 primarily due to increased sales of our Precision Flow units as a result of increased demand related to the COVID-19 pandemic and increased average selling prices in both the United States and International markets. Disposable revenue increased 54.3% in the second quarter of 2020 primarily driven by an increase in the worldwide installed base of Precision Flow units and increased utilization due to the COVID-19 pandemic. Lease revenue also increased primarily due to a higher volume of leases of our Precision Flow units and, to a lesser extent, due to higher utilization of disposables for Precision Flow units under placement arrangements.

Revenue information by geography is summarized as follows:

 

 

 

Three Months Ended June 30,

 

 

 

 

 

 

 

 

 

 

 

2020

 

 

2019

 

 

Change

 

 

 

(in thousands, except percentages)

 

 

 

 

 

 

 

 

 

 

 

Amount

 

 

% of Revenue

 

 

Amount

 

 

% of Revenue

 

 

$

 

 

%

 

United States

 

$

25,682

 

 

 

73.1

%

 

$

8,678

 

 

 

72.4

%

 

$

17,004

 

 

 

195.9

%

International

 

 

9,470

 

 

 

26.9

%

 

 

3,308

 

 

 

27.6

%

 

 

6,162

 

 

 

186.3

%

Total Revenue

 

$

35,152

 

 

 

100.0

%

 

$

11,986

 

 

 

100.0

%

 

$

23,166

 

 

 

193.3

%

 

29


 

Revenue generated in the United States increased $17.0 million, or 195.9%, to $25.7 million for the second quarter of 2020, compared to $8.7 million for the second quarter of 2019. Revenue generated in our International markets increased $6.2 million, or 186.3%, to $9.5 million for the second quarter of 2020, compared to $3.3 million for the second quarter of 2019. Both United States and International revenue growth was primarily driven by an increase in the number of Precision Flow units sold year over year due to the COVID-19 pandemic, an increase in single-use disposable sales due to higher installed bases of Precision Flow units, and increased average selling prices.

 

 

 

Six Months Ended June 30,

 

 

 

 

 

 

 

 

 

 

 

2020

 

 

2019

 

 

Change

 

 

 

(in thousands, except percentages)

 

 

 

Amount

 

 

% of Revenue

 

 

Amount

 

 

% of Revenue

 

 

$

 

 

%

 

Product Revenue:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capital

 

$

24,303

 

 

 

44.8

%

 

$

4,660

 

 

 

19.2

%

 

$

19,643

 

 

 

421.5

%

Disposable

 

 

25,593

 

 

 

47.1

%

 

 

17,549

 

 

 

72.3

%

 

 

8,044

 

 

 

45.8

%

Subtotal Product Revenue

 

 

49,896

 

 

 

91.9

%

 

 

22,209

 

 

 

91.5

%

 

 

27,687

 

 

 

124.7

%

Lease Revenue

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capital Equipment

 

 

2,278

 

 

 

4.2

%

 

 

947

 

 

 

3.9

%

 

 

1,331

 

 

 

140.5

%

Other

 

 

903

 

 

 

1.7

%

 

 

-

 

 

 

-

 

 

 

903

 

 

 

100.0

%

Service and Other Revenue

 

 

1,190

 

 

 

2.2

%

 

 

1,129

 

 

 

4.6

%

 

 

61

 

 

 

5.4

%

Total Revenue

 

$

54,267

 

 

 

100.0

%

 

$

24,285

 

 

 

100.0

%

 

$

29,982

 

 

 

123.5

%

 

Revenue increased $30.0 million, or 123.5%, to $54.3 million for the first six months of 2020 compared to $24.3 million for the first six months of 2019. The increase in revenue was primarily attributable to a $19.6 million and $8.0 million increase in capital equipment and disposable revenue, respectively. Capital equipment revenue increased 421.5% in the first six months of 2020 primarily due to increased sales of our Precision Flow units as a result of increased demand related to the COVID-19 pandemic and increased average selling prices. Disposable revenue increased 45.8% in the first six months of 2020 primarily driven by an increase in the worldwide installed base of Precision Flow units due to the COVID-19 pandemic. Lease revenue also increased primarily due to a higher volume of leases of our Precision Flow units and, to a lesser extent, due to higher utilization of disposables for Precision Flow units under placement arrangements.

 

Revenue information by geography is summarized as follows:

 

 

 

Six Months Ended June 30,

 

 

 

 

 

 

 

 

 

 

 

2020

 

 

2019

 

 

Change

 

 

 

(in thousands, except percentages)

 

 

 

Amount

 

 

% of Revenue

 

 

Amount

 

 

% of Revenue

 

 

$

 

 

%

 

United States

 

$

40,023

 

 

 

73.8

%

 

$

18,727

 

 

 

77.1

%

 

$

21,296

 

 

 

113.7

%

International

 

 

14,244

 

 

 

26.2

%

 

 

5,558

 

 

 

22.9

%

 

 

8,686

 

 

 

156.3

%

Total Revenue

 

$

54,267

 

 

 

100.0

%

 

$

24,285

 

 

 

100.0

%

 

$

29,982

 

 

 

123.5

%

 

Revenue generated in the United States increased $21.3 million, or 113.7%, to $40.0 million for the first six months of 2020, compared to $18.7 million for the first six months of 2019. Revenue generated in our International markets increased $8.7 million, or 156.3%, to $14.2 million for the first six months of 2020, compared to $5.6 million for the first six months of 2019. Both United States and International revenue growth was primarily driven by an increase in the number of Precision Flow units sold year over year due to COVID-19 as well as an increase in single-use disposable sales due to higher installed bases of Precision Flow units.

Cost of Revenue and Gross Profit

 

Cost of revenue increased $11.0 million, or 168.8%, to $17.5 million in the second quarter of 2020 compared to $6.5 million in the second quarter of 2019. Cost of revenue increased $13.8 million, or 101.1%, to $27.4 million in the first six months of 2020 compared to $13.6 million in the first six months of 2019. These increases were primarily due to higher materials and labor costs due to a rapid increase in sales volumes of our Precision Flow units and disposables in order to meet demand related to the COVID-19 pandemic.

 

30


 

Gross profit increased to 50.1% in the second quarter of 2020 compared to 45.5% in the second quarter of 2019. Gross profit increased to 49.4% in the first six months of 2020 compared to 43.8% in the first six months of 2019. Gross profit was positively impacted by improved overhead absorption due to higher production throughput. Partially offsetting these positive factors were higher labor costs and increased supplier freight and expediting fees to meet the rapid increase in production capacity, and to a lesser extent a higher mix of Precision Flow systems. Gross profit was also positively impacted by higher average selling prices of capital equipment in the United States and International markets, partially offset by lower average selling prices of disposables in International markets.

Research and Development Expenses

Research and development expenses increased $0.7 million, or 23.0%, to $3.9 million in the second quarter of 2020 compared to $3.2 million in the second quarter of 2019. As a percentage of revenue, research and development expenses decreased to 11.1% in the second quarter of 2020 compared to 26.4% in the second quarter of 2019.

Research and development expenses increased $0.8 million, or 12.7%, to $7.3 million in the first six months of 2020 compared to $6.4 million in the first six months of 2019. As a percentage of revenue, research and development expenses decreased to 13.4% in the first six months of 2020 compared to 26.5% in the first six months of 2019.

The increase in research and development expenses in both comparison periods was due to increased employee-related expenses and stock-based compensation. Additionally, the increase in research and development expenses during the first six months of 2020 was related to increased product development and prototype costs.

Sales and Marketing Expenses

Sales and marketing expenses increased $5.4 million, or 57.5%, to $14.9 million in the second quarter of 2020 compared to $9.4 million in the second quarter of 2019. As a percentage of revenue, sales and marketing expenses decreased to 42.3% in the second quarter of 2020 compared to 78.7% in the second quarter of 2019.

Sales and marketing expenses increased $9.6 million, or 51.5%, to $28.2 million in the first six months of 2020 compared to $18.6 million in the first six months of 2019. As a percentage of revenue, sales and marketing expenses decreased to 51.9% in the first six months of 2020 compared to 76.6% in the first six months of 2019.

The increase in sales and marketing expenses in both comparison periods was primarily due to increased sales commissions as a result of increased revenue due to the COVID-19 pandemic along with increases in the size of the sales and marketing organization and increased stock-based compensation. The increase in sales and marketing expenses in both comparison periods was partially offset by a reduction in travel expenses due to COVID-19. Additionally, the increase in sales and marketing expenses during the first six months of 2020 was also partially offset by a reduction in marketing initiatives and training costs.

General and Administrative Expenses

General and administrative expenses increased $1.1 million, or 24.2%, to $5.6 million in the second quarter of 2020 compared to $4.5 million in the second quarter of 2019. As a percentage of revenue, general and administrative expenses decreased to 16.0% in the second quarter of 2020 compared to 37.8% in the second quarter of 2019.

General and administrative expenses increased $1.5 million, or 15.6%, to $10.9 million in the first six months of 2020 compared to $9.4 million in the first six months of 2019. As a percentage of revenue, general and administrative expenses decreased to 20.0% in the first six months of 2020 compared to 38.8% in the first six months of 2019.

The increase in general and administrative expenses in both comparison periods was primarily due to increases in employee-related expenses, insurance and reserves for bad debt offset by reductions in travel expenses and legal costs. Additionally, the increase in general and administrative expenses during the second quarter of 2020 was related to increased stock-based compensation.

31


 

Other Expense, Net

Other expense, net increased $0.1 million, or 4.3%, to $1.3 million in the second quarter of 2020 compared to $1.2 million in the second quarter of 2019. Other expense, net increased $0.4 million, or 17.3%, to $2.4 million in the first six months of 2020 compared to $2.0 million in the first six months of 2019. The increase in other expense, net in the second quarter of 2020 was due to decreased interest income primarily due to lower interest rates on invested balances, partially offset by a decrease in interest expense primarily due to lower interest rates on outstanding borrowings. The increase in other expense, net in the first six months of 2020 was due to a decreased interest income primarily due to lower interest rates on invested balances partially offset by an increase in interest expense primarily related to additional borrowings under our credit facilities.

Liquidity and Capital Resources

As of June 30, 2020, we had cash, cash equivalents and restricted cash of $150.2 million and an accumulated deficit of $287.3 million. Our primary sources of capital to date have been from public offerings of our common stock, private placements of our convertible preferred stock, sales of our Precision Flow systems and amounts borrowed under credit facilities. Since inception, we have raised a total of $162.6 million in net proceeds from private placements of our convertible preferred stock. On November 16, 2018, we completed an initial public offering of 4,600,000 shares of common stock at a price of $14.00 per share, which raised net proceeds of $57.4 million. In August 2019, we completed a public offering of 3,570,750 shares of common stock, which included the full exercise by the underwriters of their option to purchase 465,750 shares of common stock, at a price of $14.50 per share, which raised net proceeds of $48.3 million after deducting the underwriting discount of $3.1 million and offering expenses of $0.4 million.

On December 20, 2019, the Company entered into an Open Market Sales Agreement (the “ATM Agreement”) with Jefferies LLC (“Jefferies”) under which the Company may offer and sell its common stock having aggregate sales proceeds of up to $50.0 million from time to time through Jefferies as its sales agents. During April 2020, we sold 511,648 shares of common stock pursuant to the ATM Agreement for gross proceeds of $10.2 million, or $9.8 million net of commissions and offering expenses.

In May 2020, we completed a public offering of 3,852,500 shares of common stock, which included the full exercise by the underwriters of their option to purchase 502,500 shares of common stock, at a price of $26.00 per share, which raised net proceeds of $93.8 million after deducting the underwriting discount of $6.0 million and offering expenses of $0.3 million.

As of June 30, 2020, we had $4.5 million of outstanding borrowings and $3.0 million availability under the 2020 Amended Revolver Agreement. As of June 30, 2020, we had $42.6 million of term debt outstanding under our 2020 Amended Credit Agreement and Guaranty.

We believe that our existing cash resources and availability under our line of credit facility will be sufficient to meet our capital requirements and fund our operations for at least the next 12 months. If these sources are insufficient to satisfy our liquidity requirements, we may seek to sell additional equity or make additional borrowings under our existing line of credit facility or enter new debt financing arrangements. If we raise additional funds by issuing equity securities, our stockholders would experience dilution. Debt financing, if available, may involve covenants restricting our operations or our ability to incur additional debt. Any debt financing or additional equity that we raise may contain terms that are not favorable to us or our stockholders. Additional financing may not be available at all, or may be available only in amounts or on terms unacceptable to us. If we are unable to obtain additional financing, we may be required to delay the development, commercialization and marketing of our Precision Flow systems and Oxygen Assist Module.

Cash Flows

The following table presents a summary of our cash flows for the periods indicated:

 

 

 

Six Months Ended June 30,

 

 

 

2020

 

 

2019

 

 

 

(in thousands)

 

Net cash provided by (used in):

 

 

 

 

 

 

 

 

Operating activities

 

$

(24,675

)

 

$

(18,886

)

Investing activities

 

 

(3,839

)

 

 

(3,724

)

Financing activities

 

 

105,232

 

 

 

10,508

 

Effect of exchange rate changes on cash, cash equivalents

   and restricted cash

 

 

(28

)

 

 

(13

)

Net increase (decrease) in cash, cash equivalents and restricted cash

 

$

76,690

 

 

$

(12,115

)

 

32


 

Operating Activities

The net cash used in operating activities was $24.7 million in the first six months of 2020 and consisted primarily of a net loss of $21.9 million and an increase in operating assets of $7.9 million partially offset by $5.1 million in non-cash charges. Non-cash charges consisted primarily of stock-based compensation expense and depreciation and amortization expense.

The net cash used in operating activities was $18.9 million in the first six months of 2019 and consisted primarily of a net loss of $25.8 million, partially offset by $4.9 million in non-cash charges and a decrease of $2.0 million in net operating assets. Non-cash charges consisted primarily of stock-based compensation expense, depreciation and amortization expense, and provision for inventories.

Investing Activities

Net cash used in investing activities for the first six months of 2020 and 2019 consisted of purchases of property and equipment of $3.8 million and $2.1 million, respectively. In addition, the net cash used in investing activities in the first six months of 2019 included $1.6 million to acquire Solus.

Financing Activities

Net cash provided by financing activities was $105.2 million in the first six months of 2020 and consisted of proceeds from the issuance of common stock in connection with public and at-the-market offerings of $94.2 and $9.9 million, respectively, borrowings of $1.0 million under our short-term line of credit, and proceeds from common stock issuances in connection with our ESPP and stock option exercises of $0.4 and $0.3 million, respectively, partially offset by common stock offering costs of $0.5 million.

Net cash provided by financing activities was $10.5 million in the first six months of 2019 and primarily consisted of borrowings of $10.5 million under our credit facilities.

 

Indebtedness

Revolving Line of Credit

In November 2016, we entered into the Revolver Agreement with Western Alliance Bank, which provided for $7.0 million of available borrowings. Availability under the Revolving Facility is calculated based upon 80% of the eligible receivables (net of pre-paid deposits, pre-billed invoices, other offsets, and contras related to each specific account debtor).

Interest is paid monthly on the average outstanding balance at the Wall Street Journal Prime Rate plus 1.75%, floating, subject to a floor of 3.5%. The interest rate was 5.25% at June 30, 2020.

On April 6, 2018, we amended and restated the Revolving Facility (the “Amended Revolver Agreement”) to extend the maturity date from September 30, 2018 to September 30, 2020 and increase the revolving line of credit to $7.5 million. On March 22, 2019, we amended and restated the Amended Revolver Agreement (the “2019 Amended Revolver Agreement”), which increased the allowable permitted indebtedness under the 2019 Amended Revolver Agreement in connection with our credit card program from $0.3 million to $0.5 million. On July 7, 2020, we entered into a second amendment to the Amended Revolver Agreement (as amended, the “2020 Amended Revolver Agreement”), which, under certain circumstances, reduces the amount of funds required to be held on deposit with Western Alliance Bank.

The outstanding balance under the 2020 Amended Revolver Agreement was $4.5 million at June 30, 2020. The remaining amount available to borrow based on eligible receivables was $3.0 million at June 30, 2020. The 2020 Amended Revolver Agreement is secured by substantially all of our assets, excluding intellectual property.

Term Debt

On April 6, 2018, we entered into the Credit Agreement and Guaranty with Perceptive. The Credit Agreement and Guaranty initially provided for a term loan facility in the amount of $42.5 million, available in three tranches, of which the first tranche of $20.0 million was drawn upon closing. This first tranche paid off the borrowings under a former loan arrangement. A second tranche of $10.0 million was drawn on July 20, 2018. The availability of the final tranche of $12.5 million was dependent upon the Company achieving a minimum of $43.2 million in revenue in 2018. On September 27, 2018, the Credit Agreement and Guaranty was amended to remove this revenue requirement and extend the final draw down date to March 31, 2019. We borrowed $2.0 million from this third tranche on September 27, 2018. On March 22, 2019, we drew the remaining $10.5 million under the Amended Credit Agreement and Guaranty increasing the total outstanding balance to $42.5 million. We also entered into a second amendment to the Amended Credit Agreement and Guaranty increasing the allowable permitted indebtedness in connection with our credit card program from $0.3 million to $0.5 million. On June 16, 2020, we entered into a third amendment to the Amended Credit Agreement and Guaranty (the “2020 Amended Credit Agreement and Guaranty”), which amended the prepayment premium by clarifying the methodology for calculating Perceptive’s annualized internal rate of return under the term loan.

33


 

The outstanding principal amount of the 2020 Amended Credit Agreement and Guaranty accrues interest at an annual rate equal to the applicable margin of 9.06% plus the greater of (a) one-month LIBOR and (b) 1.75% per year. The term loan is secured by substantially all our personal property including intellectual property. All unpaid and accrued unpaid interest with respect to each such term loan is due and payable in full on the maturity date at April 6, 2023. On the maturity date, in addition to the payment principal and accrued interest, we will be required to make a payment of 0.5% of the total amount borrowed under the 2020 Amended Credit Agreement and Guaranty, unless we have already made such payment in connection with an acceleration or prepayment of borrowings under the term loan. In the event we prepay all or part of this term loan facility prior to the maturity date, we may be subject to additional prepayment fees which decrease as the time to maturity decreases.

We issued warrants to Perceptive to purchase 37,693, 18,846 and 3,769 shares of our Series D convertible preferred stock at an exercise price of $15.92 per share in April 2018, July 2018 and September 2018, respectively. In connection with our initial public offering in November 2018 these warrants converted to common stock warrants at an exercise price of $15.92. Each of the warrants has a term of 10 years. In connection with the draw down on March 22, 2019, we granted warrants to purchase 19,789 shares of common stock. The warrants had an exercise price of $15.92 per share, were fully vested upon issuance, were exercisable at the option of the holder, in whole or in part, and would have expired by March 2029. On June 10, 2020, Perceptive exercised all of its outstanding warrants in a cashless exercise transaction resulting in the issuance of 41,066 shares of common stock to Perceptive.

We were in compliance with all debt covenants under both the 2020 Amended Revolver Agreement and 2020 Amended Credit Agreement and Guaranty at June 30, 2020.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements, as defined by applicable regulations of the SEC, that have or are reasonably likely to have a current or future effect on our financial condition, revenue or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

Critical Accounting Policies and Estimates

 

This management’s discussion and analysis of financial condition and results of operations is based on our condensed consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported revenue and expenses during the reporting periods. We monitor and analyze these items for changes in facts and circumstances, and material changes in these estimates could occur in the future. We base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Changes in estimates are reflected in reported results for the period in which they become known. Actual results may differ materially from these estimates under different assumptions or conditions.

 

For further information regarding our critical accounting policies, see Note 2 “Summary of Significant Accounting Policies” of Notes to Consolidated Financial Statements and our critical accounting policies within the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our 2019 Form 10-K. There have been no changes in our accounting policies except for certain new policies or enhanced policy descriptions, which are discussed below related to self-insurance, other lease revenues, and stock compensation expense related to our 2018 Employee Stock Purchase Program (ESPP”).

 

Insurance

Effective January 1, 2020, we are self-insured for certain obligations related to health insurance. We also purchase stop-loss insurance to protect us from material losses. Judgments and estimates are used in determining the potential value associated with reported claims and for events that have occurred, but have not been reported. Our estimates consider expected claim experience and other factors. Receivables for insurance recoveries are recorded as assets, on an undiscounted basis. Our liabilities are based on estimates, and, while we believe that our accruals are adequate, the ultimate liability may be significantly different from the amounts recorded. Changes in claims experience, our ability to settle claims or other estimates and judgments used by us could have a material impact on the amount and timing of expense for any period.

 

34


 

Lease Revenue

We enter into agreements to lease our capital equipment. For such sales, we account for revenue under ASC 840, Leases, and assess and classify these transactions as sales-type or operating leases based on whether the lease transfers ownership of the equipment to the lessee by the end of the lease term. This criterion is met in situations in which the lease agreement provides for the transfer of title at or shortly after the end of the lease term in exchange for the payment of a nominal fee, for example, the minimum required by statutory regulation to transfer title. Equipment included in arrangements including transfer of title are accounted for as sales-type leases and we recognize the total value of the lease payments due over the lease term to revenue at the inception of the lease. We record the current value of future lease payments under prepaid expenses and other current assets in the condensed consolidated balance sheets and these amounts totaled $1.8 and $0.9 million at June 30, 2020 and December 31, 2019, respectively. Equipment included in arrangements that do not include the transfer of title, nor any of the capital lease criteria, are accounted for as operating leases and revenue is recognized on a straight-line basis as it becomes receivable monthly over the term of the lease.

We also enter into agreements involving the placement of Precision Flow capital units for use by the customer at no upfront charge in connection with the customer’s ongoing purchase of disposable products. In these bundled arrangements, revenue recognized for the sale of the disposables is allocated between disposable revenue and other lease revenue based on the estimated relative stand-alone selling prices of the individual performance obligations.

Stock-Based Compensation

We maintain an equity incentive plan to provide long-term incentives for employees, consultants, and members of the board of directors. The plan allows for the issuance of non-statutory and incentive stock options to employees and non-statutory stock options to consultants and non-employee directors.

We recognize stock-based compensation expense for awards of equity instruments to employees and non-employees based on the grant date fair value of those awards in accordance with ASC Topic 718, Stock Compensation (ASC 718). ASC 718 requires all equity-based compensation awards, including grants of restricted shares and stock options, to be recognized as expense in the condensed consolidated statements of comprehensive loss based on their grant date fair values.

The fair value of each option grant is estimated on the grant date using the Black-Scholes option pricing model. The fair value is then amortized on a straight-line basis over the requisite service period of the awards, which is generally the vesting period. For performance-based awards, the related compensation cost is amortized over the performance period on an accelerated attribution basis. Compensation cost associated with performance awards is based on fair value on the date of grant and the number of units expected to be earned after assessing the probability that certain performance criteria will be met and the associated targeted payout level that is forecasted will be achieved. Cumulative adjustments are recorded each quarter to reflect estimated outcomes of the performance-related conditions until the results are determined and settled. Use of a valuation model requires management to make certain assumptions with respect to selected model inputs, including the expected life (weighted average period of time that the options granted are expected to be outstanding), the volatility of our common stock and an assumed risk-free interest rate. Expected volatility is calculated based on historical volatility of a group of publicly traded companies that we consider a peer group. The expected life is estimated using the simplified method for “plain vanilla” options. The risk-free interest rate is based on U.S. Treasury rates with a remaining term that approximates the expected life assumed at the date of grant. No dividend yield is assumed as we do not pay, and do not expect to pay, dividends on our common stock. We estimate forfeitures based on historical experience with pre-vested forfeitures. To the extent actual forfeitures differ from the estimate, the difference is recorded to compensation expense in the period of the forfeiture.

We recognize stock-based expense for shares issued pursuant to our ESPP on a straight-line basis over the related offering period. We estimate the fair value of shares to be issued under the ESPP based on a combination of options valued using the Black-Scholes option-pricing model. The expected life is determined based on the contractual term. Expected volatility, dividend yield and forfeiture rates are estimated in a manner similar to option grants described above.

 

Recent Accounting Pronouncements

A discussion of recent accounting pronouncements is included in Note 2 to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.

JOBS Act

As a company with (i) less than $1.07 billion in revenue during our last fiscal year (ii) a market value of our common stock of less than $700.0 million as of our most recently completed second quarter and (iii) less than $1.0 billion of non-convertible debt over a three-year period, we qualify as an “emerging growth company,” as defined in the JOBS Act, as of the date of our last annual evaluation which occurred on December 31, 2019. An emerging growth company may take advantage of reduced reporting requirements that are otherwise applicable to public companies. We expect we will no longer qualify as an emerging growth company as of December 31, 2020 and, at that time, will begin to adopt accounting pronouncements at dates applicable to public companies.

35


 

ITEM 3.        QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a “smaller reporting company,” we are not required to provide the information required by this item.

ITEM 4.        CONTROLS AND PROCEDURES

(a)

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) at the end of the period covered by this quarterly report.

Based on this evaluation, we concluded that, as of such date, our disclosure controls and procedures were effective to provide reasonable assurance that the information required to be disclosed by us in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

We recognize that any controls system, no matter how well designed and operated, can provide only reasonable assurance of achieving its objectives, and our management necessarily applies its judgment in evaluating the benefits of possible controls and procedures relative to their costs.

(b)

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the period covered by this quarterly report that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act).

36


 

PART II. OTHER INFORMATION

From time to time, the Company may become involved in various legal proceedings, including those that may arise in the ordinary course of business. The Company believes there is currently no litigation pending that could have, individually, or in the aggregate, a material adverse effect on the results of its operations or financial condition.

ITEM 1A.     RISK FACTORS

In addition to the other information set forth in this quarterly report, you should carefully consider the factors discussed in “Risk Factors” in our 2019 Form 10-K which could materially affect our business, financial condition or future results. Except as set forth below, there have been no material changes from the risk factors previously disclosed in the “Risk Factors” section of our Annual Report on Form 10-K filed with the SEC on March 4, 2020, our Quarterly Report on Form 10-Q filed with the SEC on May 5, 2020, and in our other filings with the SEC.

A pandemic, epidemic or outbreak of an infectious disease, such as COVID-19, has and may in the future adversely affect our business.

If a pandemic, epidemic or outbreak of an infectious disease occurs, our business may be adversely affected. Such events may result in a period of business and manufacturing disruption or in an inability to scale our production to meet increased demand in a cost-effective manner or at all, any of which could materially affect our business, financial condition and results of operations. For example, in 2019, a novel strain of coronavirus, COVID-19, was identified in Wuhan, China. This virus has now spread globally, and United States residents and businesses were hit especially hard during March, April, and May in major urban centers like New York City. Additionally, as stay-at-home orders were lifted and businesses in the United States and in some other areas in the world began to reopen in May and June following extended shutdowns, new hot spots of COVID-19 infection have emerged and are continuing to emerge. A resurgence in the outbreak and spread of COVID-19 may result in renewed stay-at-home orders and mandatory closings for non-essential businesses. The spread of COVID-19 during the first and second quarters of 2020 resulted in certain disruptions to our business and may in the future result in additional disruptions to our business. Examples of such disruptions include without limitation the following:

 

The health and wellbeing of our employees, including our sales representatives and clinical educators who may visit our hospital customers, as well as that of our distributors and suppliers, is at risk– if a critical threshold of our personnel, or the personnel of our distributors or suppliers, were to be diagnosed with COVID-19, placed in quarantine due to potential exposure to COVID-19, or need to care for family members diagnosed with COVID-19, such developments may result in significant business, manufacturing, or distribution disruption.

 

As we scaled production to meet increased demand and as we continue to scale production further, we have asked, and will likely continue to ask, employees and suppliers to work extended and unusual hours and we and many of our suppliers have onboarded, and may in the future onboard, a significant number of personnel. While we require these personnel to complete all required training and education before they begin working, and we believe our suppliers, to the extent applicable, do as well, many of the new personnel do not have prior experience with the specific production skills they are being hired to perform and/or otherwise do not have prior experience manufacturing medical devices, and while we have not seen a negative impact to our quality management system or product quality to date, any of the foregoing may result in a negative impact on our quality management system and product quality in the future.

 

As we scaled production to meet increased demand, and as we continue to scale production further, our employees or suppliers have in the past and may in the future change production processes or fail to document such changes to keep up with our production needs. While we have not seen a negative impact to our quality management system and product quality to date, these changes and/or failure to document such changes may have a negative impact on our quality management system and product quality in the future.

37


 

 

Demand for our products increased at the same time that we began to experience limitations in our supply chain, which has resulted, and may in the future result, in a shortage of supply, increased costs of products, materials, and components and delays in the timely delivery thereof, which has required, and may in the future require, that we pass through expenses or otherwise increase our pricing in certain instances for our customers and distributors. Some of our customers and distributors have, and others in the future may, reject these pricing increases, negatively impacting our business. Similarly, the demand we placed on our suppliers at the same time their sub-suppliers began to face limitations led to our suppliers seeking to pass through expenses or otherwise increase pricing for products, materials, and components we required to meet our production needs, and this may occur again in the future. 

 

Some of our suppliers have been, and some of our suppliers may in the future be, partially or, at times, wholly precluded from delivering to us products, materials, and components in the quantities needed on a timely basis, for a variety of reasons, including, without limitation, an evolving understanding of how international, federal, and/or state authorities define “essential business”, their inability to remain open due to lost business in other parts of their portfolios, or because of international, federal, and/or state prioritization orders requiring our suppliers to produce for governmental entities and/or other manufacturers before they produce for us.

 

We have had to develop alternative sources of supply for certain products, materials, and components as a result of the partial or, at times, complete inability of some of some of our suppliers to meet our production needs. Although we have successfully been able to develop and validate these alternate sources of supply to date, doing so is time-consuming, difficult, and costly, and if we need to develop and validate alternative sources of supply in the future for any reason, including if any of our suppliers were to cease operations altogether, discontinue production of our key products, materials, and/or components, or go into extended backorder, we may not be able to do so in a timeframe acceptable to meet customer demand. Additionally, we have had to go to secondary broker markets for some of our alternative sourcing needs, which represent a greater risk for counterfeit products, materials and/or components. Although we were able to validate the products, materials and/or components we purchased from secondary broker markets to date, we may not be able to do so in the future which may result in a negative impact on our quality management system and product quality.

 

Customer demand has necessitated weekly and, in some cases, daily shipments of certain products, materials, and/or components from our suppliers to meet our production targets, and customer demand in the future may necessitate similar delivery frequencies. We have had to and may in the future have to shut down production temporarily if there are delays in the shipments of those products, materials and/or components.

 

Federal authorities may restrict our ability to export products outside the United States, which could negatively impact our business, operations, and relationships with our international distributors and customers in a significant and long-term way that we may not be able to rebuild for an extended period of time, or at all.

 

While we have priority shipping status with our carriers, we have experienced shipping delays throughout the United States and internationally, and as a result, there have been and may continue to be delays in our ability to ship our product to customers and distributors in a timely manner, potentially resulting in returned product, and we have faced and may in the future face extraordinary freight fees, including air freight fees and expedition fees for all modes of transportation.

 

Travel restrictions have impeded, and may in the future continue to impede, our ability to qualify and retain new suppliers or audit our existing suppliers, which may have a negative impact on our quality management system and our product quality in the future.

 

Travel restrictions and hospital limitations or denials of access for non-patients have impacted, and may in the future continue to impact, the ability of our direct sales team and clinical educators in the United States and United Kingdom and our distributors and suppliers in many other countries to access physicians and clinicians in order to train them on our products at a time when we are onboarding many new customers who have no prior experience using our products. We have been training our customers and distributors on our products through online training modules. We are not certain that these alternative means will be as effective as our standard training methods, and while we have not seen a negative impact to our complaint rates to date, we may see higher complaint rates in the future, particularly from new customers who are less familiar with our products.

38


 

 

Travel restrictions have prevented, and may in the future continue to prevent, physicians and other caregivers from traveling to attend our training programs, which has resulted, and may in the future continue to result, in fewer physicians trained in person on high velocity therapy, and in the United Kingdom and in Europe, on our Oxygen Assist Module.

 

Travel restrictions have impeded, and may in the future continue to impede, our ability to meet with distributors, negatively impacting our business in a number of ways, including without limitation our ability to train our existing distributors on new products such as the Oxygen Assist Module.

 

Some of our hospital customers in the United States may in the future be unable to continue with business operations as usual or at all due to lost business in other parts of their operations, which may negatively impact or eliminate our business with these customers. Similarly, some of our distributors may in the future be unable to continue with business operations as usual or at all due to lost business in other parts of their portfolios, which may negatively impact or eliminate our business with these distributors and their customers in the countries they serve.

 

We have asked most employees who are not directly involved in our production, shipping, quality, regulatory, and product development efforts to work from home and, while we have not seen a negative impact so far, this could impact our ability to effectively plan, execute, communicate and maintain our corporate culture. The increase in working remotely could also increase our cyber security risk, create data accessibility concerns, and make us more susceptible to communication disruptions, any of which could adversely impact our business operations.

 

Stay at home orders have significantly restricted individuals from traveling outside the home, which has limited and may in the future limit our ability to hire new employees or backfill terminated employees. Additionally, the federal unemployment compensation subsidy passed into law in connection with the COVID-19 pandemic created incentives for certain individuals to stay home rather than seek to enter the job market, which also may have limited our ability to hire new employees and backfill terminated employees. The federal unemployment compensation subsidy expired on July 31, 2020, but may be modified or extended in the near term, and any such change may continue to limit our ability to hire new employees and backfill terminated employees in the future.

 

Our competitors, potentially including companies that we have not previously considered competitors due to their historical operation outside of the respiratory space or even outside of the medical device space entirely, may in the future secure significant purchase agreements from the federal government or various states before we are able to do so, may be selected instead of us, or may be added to these agreements after initially being excluded, and any of the foregoing could limit our access to or preclude us altogether from those commercial opportunities.

 

The transmission risk of different respiratory support modalities for COVID-19 has not been studied extensively. Our assessment of the issue suggests that the Precision Flow, its disposable patient circuits, and its accessories, including the Vapotherm Transfer Unit, the Q50 compressor, and, in the United Kingdom and Europe, the Oxygen Assist Module, do not represent a heightened risk, particularly when (1) used in COVID-19 cohorts or when adequately disinfected between patients, and (2) a simple surgical mask is placed over the patient’s nose and mouth while delivering high velocity nasal insufflation; however, this assessment could prove to be incorrect upon further analysis or new third party information.

 

The FDA or any foreign regulatory body may disagree with our interpretation that our promotional materials, sales practices, and training related to the use of our products on patients in respiratory distress who are suffering from COVID-19 are on label and they could request we modify our promotional materials, sales practices, or training or subject us to regulatory or enforcement actions, including the issuance of an untitled letter, warning letter, injunction, seizure, civil fine or criminal penalties. It is also possible that other federal, state, or foreign enforcement authorities might take action under other regulatory authority, such as false claims laws, if they consider our business activities to constitute promotion of an off-label use, which could result in significant penalties, including, but not limited to, criminal, civil and administrative penalties, damages, fines, disgorgement, exclusion from participation in government healthcare programs and the curtailment of our operations.

 

A significant disruption to our business resulting in an inability to build and ship product to customers for an extended period of time may impair our ability to maintain compliance with our debt covenants.

39


 

 

Equity and debt markets in general and Vapotherm securities in particular have experienced significant volatility since the spread of COVID-19 into the United States for a variety of reasons, including, without limitation, media coverage of COVID-19, its impacts, and specific COVID-19 related technologies such as invasive mechanical ventilators and high flow nasal cannula in general and Vapotherm’s Precision Flow, an advanced form of high flow nasal cannula capable of delivering high velocity therapy, in particular. Should significant volatility continue or should the markets in general or Vapotherm securities in particular experience declines due to the economic impact of the COVID-19 pandemic, we may not be able to raise capital or seek other sources of financing at a reasonable valuation or at all.

In addition, the increase in demand we are currently experiencing for our products to treat the respiratory distress of patients suffering from COVID-19 may not continue after the COVID-19 pandemic subsides. Moreover, the increase in demand may result in decreased demand for our products after the COVID-19 pandemic subsides as hospitals may have a large surplus of ventilators and other respiratory support equipment, including high flow nasal cannula devices, potentially including Vapotherm’s Precision Flow systems. Additionally, we were awarded a blanket purchase agreement from the Department of Defense and may in the future be compelled to or otherwise enter into other blanket purchase agreements or supply agreements with domestic or foreign governmental entities, and orders may not materialize thereunder for a variety of reasons, including without limitation, the COVID-19 pandemic subsiding or any decision by the relevant domestic or foreign governmental entity to otherwise cancel or alter their purchase order or supply agreement. Even if any such agreement is ultimately fulfilled, the domestic or foreign governmental entity might fail to adequately distribute and install our technology in hospitals where the potential exists for it to generate an ongoing disposable revenue stream. As a result, any present increase or potential future increase in our capital or disposable revenue may not be sustained and our revenue may significantly decrease after the COVID-19 pandemic subsides, which could have an adverse effect on our business. Any sudden and significant decrease in demand may result in a substantial inventory position, which could also have an adverse effect on our business.

The full extent to which COVID-19 impacts our business will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID-19 and the actions to treat or contain COVID-19 or to otherwise limit its impact, among others. To the extent the COVID-19 pandemic adversely affects our business and financial results, it may also have the effect of heightening many of the other risks described in this “Risk Factors” section and in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019, such as those relating to our significant amount of indebtedness, our need to generate sufficient cash flows to service our substantial indebtedness and our ability to comply with the covenants contained in the agreements that govern our indebtedness.

 

We expect that we will no longer qualify as an “emerging growth company” following December 31, 2020 and that we will incur significant additional costs once we no longer qualify as an “emerging growth company.”

 

Commencing December 31, 2020, we expect we will no longer qualify as an “emerging growth company,” and the reduced disclosure requirements applicable to emerging growth companies will no longer apply to us. As a result, we will no longer be permitted to take advantage of the reduced regulatory and reporting requirements described above. Once we are no longer an emerging growth company, we expect to incur additional expenses and devote substantial management effort toward ensuring compliance with those additional requirements applicable to companies that are not emerging growth companies, including the auditor attestation requirements for internal controls. Compliance with these additional laws, rules and regulations will increase our legal and financial compliance costs, make some activities more difficult, time consuming or costly and increase demand on our systems and resources. In addition, management’s attention may be diverted from other business concerns and our costs and expenses will increase, which could harm our business and operating results. We may also need to hire more employees in the future or engage additional outside consultants to comply with these requirements, which would increase our costs and expenses.

 

40


 

ITEM 6.        EXHIBITS

The exhibits filed as part of this quarterly report are set forth on the Exhibit Index, which is incorporated herein by reference.

EXHIBIT INDEX

 

Exhibit

Number

 

Description

 

 

 

    3.1

 

Tenth Amended and Restated Certificate of Incorporation (previously filed as Exhibit 3.1 to the Current Report Form 8-K filed on November 20, 2018 (File No. 001-38740) and incorporated herein by reference)

 

 

 

    3.2

 

Certificate of Amendment to Tenth Amended and Restated Certificate of Incorporation of Vapotherm, Inc. (previously filed as Exhibit 3.1 to the Current Report Form 8-K filed on June 24, 2020 (File No. 001-38740) and incorporated herein by reference)

 

 

 

  10.1

 

Amendment No. 2 to Amended and Restated Business Finance Agreement, dated July 7, 2020, between Vapotherm, Inc. and Western Alliance Bank

 

 

 

  10.2

 

Amendment No. 3 to Credit Agreement and Guaranty, dated June 16, 2020, between Vapotherm, Inc. and Perceptive Credit Holdings II, LP

 

 

 

  31.1

 

Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

  31.2

 

Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

  32.1

 

Certifications of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

  32.2

 

Certifications of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

101.INS

 

XBRL Instance Document

 

 

 

101.SCH

 

XBRL Taxonomy Extension Schema Document

 

 

 

101.CAL

 

XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

101.DEF

 

XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

101.LAB

 

XBRL Taxonomy Extension Label Linkbase Document

 

 

 

101.PRE

 

XBRL Taxonomy Extension Presentation Linkbase Document

 

41


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

VAPOTHERM, INC.

 

 

 

August 4, 2020

By:

/s/ Joseph Army

 

 

Joseph Army

 

 

President and Chief Executive Officer

 

August 4, 2020

By:

/s/ John Landry

 

 

John Landry

 

 

Vice President and Chief Financial Officer

 

42

EX-10.1 2 vapo-ex101_133.htm EX-10.1 vapo-ex101_133.htm

 

Exhibit 10.1

SECOND AMENDMENT TO AMENDED AND RESTATED BUSINESS FINANCING AGREEMENT

This Second Amendment to Amended and Restated Business Financing Agreement (this “Amendment”) is entered into as of July 7, 2020, by and between WESTERN ALLIANCE BANK, an Arizona corporation (“Bank”) and VAPOTHERM, INC. (“Borrower”).

RECITALS

Borrower and Bank are parties to that certain Amended and Restated Business Financing Agreement dated as of April 6, 2018 (as amended from time to time, including by that certain First Amendment to Amended and Restated Business Financing Agreement dated as of March 22, 2019, collectively, the “Agreement”).  The parties desire to amend the Agreement in accordance with the terms of this Amendment.

NOW, THEREFORE, the parties agree as follows:

1.Section 6.6a) of the Agreement is hereby amended and restated as follows:

“a)Maintain Collateral Accounts of Borrower and Guarantors at Lender which hold at least the lesser of (i) one hundred percent (100%) of the combined aggregate cash and Cash Equivalents of Borrower and Guarantors (less any amounts maintained in Excluded Accounts), and (ii) Fifty-Five Million Dollars ($55,000,000) in aggregate cash and Cash Equivalents of Borrower and Guarantors; provided that while the Perceptive Indebtedness is outstanding, Borrower’s Collateral Accounts at Lender shall be subject to a Control Agreement in favor of Perceptive.  The provisions of the previous sentence shall not apply to (i) Deposit Accounts, Securities Accounts and/or Commodities Accounts exclusively used for (x) payroll or (y) payroll taxes and other employee wage and benefit payments to or for the benefit of Borrower’s, or any Subsidiaries, employees; in each case of clauses (x) and (y), so long as the amounts in such accounts do not exceed amounts reasonably determined by the Borrower to be necessary to pay such obligations for the immediately following payment cycle; and (ii) other Deposit Accounts, Securities Accounts and/or Commodities Accounts so long as amounts in such other accounts do not exceed One Hundred Thousand Dollars ($100,000) in the aggregate at any one time (the foregoing accounts identified in clauses (i) and (ii), collectively the “Excluded Accounts”).”

 

2.Section 6 of the Agreement is hereby amended by adding the following new clause c) in appropriate alphabetical order:

“c)

Notwithstanding anything to the contrary contained herein, the Borrower shall not be required to deliver Control Agreements in favor of Lender with respect to Deposit Accounts, Securities Accounts or Commodities Accounts maintained at any institution that is not the Lender, in each case, so long as the Borrower is in compliance with Section 6.6(a) hereof.”

3.No course of dealing on the part of Bank or its officers, nor any failure or delay in the exercise of any right by Bank, shall operate as a waiver thereof, and any single or partial exercise of any such right shall not preclude any later exercise of any such right.  Bank’s failure at any time to require strict performance by Borrower of any provision shall not affect any right of Bank thereafter to demand strict compliance and performance.  Any suspension or waiver of a right must be in writing signed by an officer of Bank.

4.Unless otherwise defined, all initially capitalized terms in this Amendment shall be as defined in the Agreement.  The Agreement, as amended hereby, shall be and remain in full force and effect in accordance with its respective terms and hereby is ratified and confirmed in all respects.  Except as expressly set forth herein, the execution, delivery, and performance of this Amendment shall not operate as a waiver of, or as an amendment of, any right, power, or remedy of Bank under the Agreement, as in effect prior to the date hereof.

-1-


 

5.Borrower represents and warrants that (a) the representations and warranties set forth in each Loan Document (as defined in the Agreement) shall, in each case, be true and correct in all material respects with the same effect as if then made (or in the case of any representation and warranty subject to a materiality qualifier, true and correct in all respects), unless stated to relate solely to an earlier date, in which case such representations and warranties shall be true and correct in all material respects as of such earlier date; provided that with respect to the representations and warranties set forth in Section 5.1 of the Agreement, the Perfection Certificate is accurate and complete as of the date the financial statements required under Section 6.2(a)(A) of the Credit Agreement for March 2020 were delivered , and that (b) no Event of Default has occurred and is continuing.  

6.As a condition to the effectiveness of this Amendment, Bank shall have received, in form and substance satisfactory to Bank, the following:

(a)this Amendment, duly executed by Borrower;

(b)all reasonable and documented Bank Expenses incurred through the date of this Amendment, which may be debited from any of Borrower's accounts; and

(c)such other documents, and completion of such other matters, as Bank may reasonably deem necessary or appropriate.

7.This Amendment may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one instrument.

 

-2-


 

IN WITNESS WHEREOF, the undersigned have executed this Amendment as of the first date above written.

 

 

VAPOTHERM, INC.

 

 

 

 

 

 

 

 

 

By:

 

/s/ John R. Landry

 

 

 

 

 

Name:

 

 

 

 

 

 

 

Title:

 

Vice President and Chief Financial Officer

 

 

WESTERN ALLIANCE BANK, an Arizona corporation

 

 

 

 

 

 

 

 

 

By:

 

/s/ Dave Dailey

 

 

 

 

 

Name:

 

 

 

 

 

 

 

Title:

 

Senior Vice President

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

[Signature Page to Second Amendment to Amended and Restated Business Financing Agreement]

 

EX-10.2 3 vapo-ex102_132.htm EX-10.2 vapo-ex102_132.htm

 

Exhibit 10.2

 

AMENDMENT NO. 3 TO CREDIT AGREEMENT AND GUARANTY

 

This AMENDMENT NO. 3 TO CREDIT AGREEMENT AND GUARANTY, dated as of June 16, 2020 (this Amendment”), is made by and among VAPOTHERM, INC., a Delaware corporation (the Borrower”), certain Subsidiaries of the Borrower that are signatories hereto, the Lenders signatories hereto and PERCEPTIVE CREDIT HOLDINGS II, LP, as administrative agent for the Lenders (in such capacity, the “Administrative Agent”). Unless otherwise defined herein or the context otherwise requires, terms used in this Amendment, including its preamble and recitals, have the meanings provided in the Credit Agreement (defined below).

 

W I T N E S S E T H:

 

WHEREAS, the Borrower, certain Subsidiary Guarantors, the Administrative Agent and the Lenders have entered into that certain Credit Agreement and Guaranty, dated as of April 6, 2018 (as amended or otherwise modified, the “Credit Agreement”);

 

WHEREAS, pursuant to Section 3.03 of the Credit Agreement, the Borrower is required to pay the Prepayment Premium upon the prepayment of all or any portion of the Loans;

 

WHEREAS, the parties to the Credit Agreement have agreed, among other things, to clarify the calculation of the Prepayment Premium and to amend the Credit Agreement accordingly;

 

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

 

ARTICLE I

AMENDMENTS TO CREDIT AGREEMENT

 

SECTION 1.1. Amendments to Section 1.01. Effective on the Third Amendment Effective Date (as defined below), Section 1.01 of the Credit Agreement is hereby amended as follows:

 

(a)

Each of the following definitions in Section 1.01 of the Credit Agreement is hereby amended and restated in its entirety as follows:

 

Prepayment Premium” means with respect to any prepayment of principal of the Loans referenced in clause (a) or (b) of Section 3.03 occurring (i) on or prior to the second anniversary of the Closing Date, an amount (not to be less than zero) such that the Return on the principal amount being prepaid pursuant to such prepayment is at least equal to a twenty percent (20%) Annualized Internal Rate of Return for the Lenders, (ii) at any time after the second anniversary of the Closing Date and on or prior to the fourth anniversary of the Closing Date, an amount (not to be less than zero) such that the Return on the principal amount being prepaid pursuant to such prepayment is at least equal to a seventeen percent (17%) Annualized Internal Rate of Return for the Lenders, and (iii) at any time after the fourth anniversary of the Closing Date and prior to the Maturity Date, an amount (not to be less than zero) such that the Return on the principal amount being prepaid pursuant to such prepayment is at least equal to a fifteen percent (15%) Annualized Internal Rate of Return for the Lenders.

ny-1936167


 

 

Return” means, at the time of any prepayment of the type described in clause (a) or (b) of Section 3.03, an amount equal to the sum of (in each case without duplication) (i) all amounts that will be paid to the Lenders in cash at the time of such prepayment, including amounts required to be paid pursuant to Section 3.03 in respect of interest, fees and Prepayment Premiums as a result of such prepayment (but excluding any portion of such prepayment constituting principal or any portion of interest to the extent accrued at the Default Rate), plus, (ii) without duplication, (x) with respect to the portion of such prepayment constituting principal, all amounts paid in cash to the Lenders prior to the time of such prepayment, including in respect of interest, fees and Prepayment Premiums (but excluding any portion of interest to the extent accrued at the Default Rate), and (y) the aggregate Warrant Return received by the Lenders as of the time of such prepayment; provided that allocations of interest, fees, Prepayment Premiums or other applicable amounts will be pro-rated on the basis of the principal amount being prepaid relative to the aggregate original principal amount of Loans made hereunder as of the time of any applicable prepayment.

 

Warrant Return” means $1,341,624.75.

 

(b)

The following definition is added to Section 1.01 of the Credit Agreement in appropriate alphabetical order:

 

Annualized Internal Rate of Return” means an annual discount rate that results in a net present value equal to zero when such discount rate is applied to any Return, as calculated using the XIRR function in Microsoft Excel using a series of monthly cash flows and the corresponding dates associated with each cash flow; provided that the first value (representing the capital contribution (or equivalent) made by the Lenders) shall be a negative value.

 

ARTICLE II

CONDITIONS PRECEDENT

 

This Amendment shall become effective upon, and shall be subject to, the prior or simultaneous satisfaction of each of the following conditions in a manner reasonably satisfactory to the Lenders and the Administrative Agent (the date when all such conditions are so satisfied being the “Third Amendment Effective Date”):

 

SECTION 2.1. Counterparts. The Lenders and the Administrative Agent shall have received counterparts of this Amendment executed on behalf of the Borrower.

 

SECTION 2.2. Effective Date Certificate. The Lenders and the Administrative Agent shall have received a certificate, dated as of the date hereof and duly executed and delivered by a Responsible Officer of the Borrower certifying as to the matters set forth in Articles III and IV hereof, in form and substance reasonably satisfactory to the Administrative Agent.

 

SECTION 2.3. Costs and Expenses, etc. The Lenders and the Administrative Agent shall have received all fees, costs and expenses due and payable pursuant to Section 14.03 of the Credit Agreement (including without limitation the reasonable and documented fees and expenses of Morrison & Foerster LLP, counsel to the Lenders and the Administrative Agent), if then invoiced, together with any other fees separately agreed to by the Borrower and the Administrative Agent.

ny-1936167


 

ARTICLE III

REPRESENTATIONS AND WARRANTIES

 

To induce the Lenders and the Administrative Agent to enter into this Amendment, the Borrower represents and warrants to the Lenders and the Administrative Agent as set forth below.

 

SECTION 3.1. Representations and Warranties, etc. Immediately prior to, and immediately after giving effect to, this Amendment, the following statements shall be true and correct:

 

(a)

the representations and warranties set forth in each Loan Document (as defined in the Credit Agreement) shall, in each case, be true and correct in all material respects with the same effect as if then made (or in the case of any representation and warranty subject to a materiality qualifier, true and correct in all respects), unless stated to relate solely to an earlier date, in which case such representations and warranties shall be true and correct in all material respects as of such earlier date;

 

(b)

the Borrower has full power, authority and legal right to enter into this Amendment and perform its obligations under this Amendment and each Loan Document as amended hereby or thereby;

 

(c)

the transactions contemplated by this Amendment are within the Borrower’s corporate powers and have been duly authorized by all necessary corporate and, if required, by all necessary shareholder action. This Amendment has been duly executed and delivered by the Borrower;

 

(d)

none of the transactions contemplated by this Amendment (i) requires any Governmental Approval of, registration or filing with, or any other action by, any Governmental Authority or any other Person, except for such as have been obtained or made and are in full force and effect, (ii) will violate (1) any applicable Law, the violation of which could reasonably be expected to result in a Material Adverse Effect, (2) any Organic Document of any Obligor or any of its Subsidiaries or (3) any order of any Governmental Authority the violation of which could reasonably be expected to result in a Material Adverse Effect, (iii) will violate or result in a default under any Contract binding upon any Obligor or any of its Subsidiaries that, individually or in the aggregate, could reasonably be expected (x) to result in a Material Adverse Effect or (y) solely in respect of any Material Agreement, to give rise to any rights thereunder to require any payments to be made by any such Person, any Obligor or any of their respective Subsidiaries and (iv) will result in the creation or imposition of any Lien (other than Permitted Liens) on any asset of any Obligor or any of its Subsidiaries; and

 

(e)

no Default or Event of Default shall have then occurred and be continuing.

 

ny-1936167


 

ARTICLE IV

CONFIRMATION

 

SECTION 4.1. Guarantees, Security Interest, Continued Effectiveness. The Borrower hereby consents to the modifications made to the Loan Documents pursuant to this Amendment and hereby agrees that, after giving effect to this Amendment, each Loan Document to which it is a party is and shall continue to be in full force and effect and the same are hereby ratified in all respects, except that upon the occurrence of the effectiveness of this Amendment, all references in such Loan Documents to the “Credit Agreement”, “Loan Documents”, “thereunder”, “thereof”, or words of similar import shall mean the Credit Agreement and the other Loan Documents, as amended or otherwise modified by this Amendment.

 

SECTION 4.2. Validity, etc. The Borrower hereby represents and warrants, as of the date hereof, that immediately after giving effect to this Amendment, each Loan Document, in each case as modified by this Amendment (where applicable and whether directly or indirectly), to which it is a party continues to be a legal, valid and binding obligation of such Obligor, enforceable against such Person in accordance with its terms, subject to the effects of bankruptcy, insolvency, reorganization, moratorium and other similar laws relating to or affecting creditors’ rights generally, general equitable principles (whether considered in a proceeding in equity or at law).

 

ARTICLE V

MISCELLANEOUS

 

SECTION 5.1. No Waiver. Except as expressly provided herein, (i) nothing contained herein shall be deemed to constitute a waiver of any other existing or future Default or Event of Default or compliance with any term or condition contained in the Credit Agreement or any of the other Loan Documents or constitute a course of conduct or dealing among the parties and (ii) the Lenders and the Administrative Agent reserve all rights, privileges and remedies under the Credit Agreement and the other Loan Documents.

 

SECTION 5.2. Cross-References. References in this Amendment to any Article or Section are, unless otherwise specified, to such Article or Section of this Amendment.

 

SECTION 5.3. Loan Document Pursuant to Credit Agreement. This Amendment is a Loan Document executed pursuant to the Credit Agreement and shall (unless otherwise expressly indicated therein) be construed, administered and applied in accordance with all of the terms and provisions of the Credit Agreement, as amended hereby.

 

SECTION 5.4. Successors and Assigns. This Amendment shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns.

 

SECTION 5.5. Counterparts. This Amendment may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument and any of the parties hereto may execute this Amendment by signing any such counterpart. Delivery of an executed signature page of this Amendment by facsimile transmission or electronic transmission (in PDF format) shall be effective as delivery of a manually executed counterpart hereof.

 

ny-1936167


 

SECTION 5.6. Governing Law. THIS AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE INTERNAL LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF LAWS THAT WOULD RESULT IN THE APPLICATION OF THE LAWS OF ANY OTHER JURISDICTION; PROVIDED THAT SECTION 5-1401 OF THE NEW YORK GENERAL OBLIGATIONS LAW SHALL APPLY.

 

SECTION 5.7. Full Force and Effect; Limited Amendment. Except as expressly  amended hereby, the Borrower agrees that all of the representations, warranties, terms, covenants, conditions and other provisions of the Credit Agreement and the other Loan Documents shall remain unchanged and shall continue to be, and shall remain, in full force and effect in accordance with their respective terms. The amendments and other waivers and modifications set forth in this Amendment shall be limited precisely as provided for herein to the provisions expressly amended herein or otherwise modified or waived hereby and shall not be deemed to be an amendment to, waiver of, consent to or modification of any other term or provision of the Credit Agreement or any other Loan Document or of any transaction or further or future action on the part of any Credit Party which would require the consent of the Lenders under the Credit Agreement or any of the Loan Documents.

 

[Signature pages to follow]

 

ny-1936167


 

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed and delivered as of the day and year first above written.

 

 

BORROWER:

 

 

 

 

VAPOTHERM, INC.

 

 

 

 

By:

/s/ John R. Landry

 

Title:

Vice President and Chief Financial Officer

 

 

ny-1936167


 

 

 

ADMINISTRATIVE AGENT:

 

 

 

 

 

PERCEPTIVE CREDIT HOLDINGS II, LP

 

 

 

 

 

By

Perceptive Credit Opportunities GP, LLC, its General Partner

 

 

 

 

 

By

/s/ Sandeep Dixit

 

 

Title:

Chief Credit Officer

 

 

 

 

 

By

/s/ Sam Chawla

 

 

Title:

Portfolio Manager

 

 

ny-1936167


 

 

 

LENDER:

 

 

 

 

 

PERCEPTIVE CREDIT HOLDINGS II, LP

 

 

 

 

 

By

Perceptive Credit Opportunities GP, LLC, its General Partner

 

 

 

 

 

By

/s/ Sandeep Dixit

 

 

Title:

Chief Credit Officer

 

 

 

 

 

By

/s/ Sam Chawla

 

 

Title:

Portfolio Manager

 

 

 

ny-1936167

EX-31.1 4 vapo-ex311_9.htm EX-31.1 vapo-ex311_9.htm

Exhibit 31.1

CERTIFICATION PURSUANT TO RULE 13a-14(a)/15d-14(a)

OF THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Joseph Army, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q of Vapotherm, Inc.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

 

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

/s/ JOSEPH ARMY

Joseph Army

President and Chief Executive Officer

(Principal Executive Officer)

 

Date:     August 4, 2020

 

EX-31.2 5 vapo-ex312_8.htm EX-31.2 vapo-ex312_8.htm

Exhibit 31.2

CERTIFICATION PURSUANT TO RULE 13a-14(a)/15d-14(a)

OF THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, John Landry, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q of Vapotherm, Inc.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

 

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

/S/ JOHN LANDRY

John Landry

Vice President and Chief Financial Officer

(Principal Financial Officer and Principal Accounting Officer)

 

Date:     August 4, 2020

 

EX-32.1 6 vapo-ex321_10.htm EX-32.1 vapo-ex321_10.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Vapotherm, Inc. (the “Company”) for the quarterly period ended June 30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Joseph Army, President and Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)the information contained in the Report fairly presents, in all material aspects, the financial condition and results of operations of the Company.

This certificate is being furnished solely for purposes of Section 906 and is not being filed as part of the Report.

 

/s/ JOSEPH ARMY

Joseph Army

President and Chief Executive Officer

(Principal Executive Officer)

 

Date:     August 4, 2020

 

 

EX-32.2 7 vapo-ex322_7.htm EX-32.2 vapo-ex322_7.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Vapotherm, Inc. (the “Company”) for the quarterly period ended June 30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, John Landry, Vice President and Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)the information contained in the Report fairly presents, in all material aspects, the financial condition and results of operations of the Company.

This certificate is being furnished solely for purposes of Section 906 and is not being filed as part of the Report.

 

/s/ JOHN LANDRY

John Landry

Vice President and Chief Financial Officer

(Principal Financial Officer and Principal Accounting Officer)

 

Date:     August 4, 2020

 

 

EX-101.SCH 8 vapo-20200630.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 100010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) link:calculationLink link:presentationLink link:definitionLink 100020 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (Unaudited) link:calculationLink link:presentationLink link:definitionLink 100030 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) link:calculationLink link:presentationLink link:definitionLink 100040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCK STOCKHOLDERS' EQUITY (unaudited) link:calculationLink link:presentationLink link:definitionLink 100050 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) link:calculationLink link:presentationLink link:definitionLink 100060 - Disclosure - Description of Business link:calculationLink link:presentationLink link:definitionLink 100070 - Disclosure - Summary of Significant Accounting Policies link:calculationLink link:presentationLink link:definitionLink 100080 - Disclosure - Business Combinations link:calculationLink link:presentationLink link:definitionLink 100090 - Disclosure - Fair Value Measurements link:calculationLink link:presentationLink link:definitionLink 100100 - Disclosure - Accounts Receivable link:calculationLink link:presentationLink link:definitionLink 100110 - Disclosure - Inventories link:calculationLink link:presentationLink link:definitionLink 100120 - Disclosure - Goodwill and Intangible Assets link:calculationLink link:presentationLink link:definitionLink 100130 - Disclosure - Debt link:calculationLink link:presentationLink link:definitionLink 100140 - Disclosure - Commitments and Contingencies link:calculationLink link:presentationLink link:definitionLink 100150 - Disclosure - Warrants link:calculationLink link:presentationLink link:definitionLink 100160 - Disclosure - Revenue link:calculationLink link:presentationLink link:definitionLink 100170 - Disclosure - Stock-Based Compensation link:calculationLink link:presentationLink link:definitionLink 100180 - Disclosure - Net Loss Per Share link:calculationLink link:presentationLink link:definitionLink 100190 - Disclosure - Related Party Transactions link:calculationLink link:presentationLink link:definitionLink 100200 - Disclosure - Summary of Significant Accounting Policies (Policies) link:calculationLink link:presentationLink link:definitionLink 100210 - Disclosure - Summary of Significant Accounting Policies (Tables) link:calculationLink link:presentationLink link:definitionLink 100220 - Disclosure - Business Combinations (Tables) link:calculationLink link:presentationLink link:definitionLink 100230 - Disclosure - Fair Value Measurements (Tables) link:calculationLink link:presentationLink link:definitionLink 100240 - Disclosure - Accounts Receivable (Tables) link:calculationLink link:presentationLink link:definitionLink 100250 - Disclosure - Inventories (Tables) link:calculationLink link:presentationLink link:definitionLink 100260 - Disclosure - Goodwill and Intangible Assets (Tables) link:calculationLink link:presentationLink link:definitionLink 100270 - Disclosure - Debt (Tables) link:calculationLink link:presentationLink link:definitionLink 100280 - Disclosure - Warrants (Tables) link:calculationLink link:presentationLink link:definitionLink 100290 - Disclosure - Revenue (Tables) link:calculationLink link:presentationLink link:definitionLink 100300 - Disclosure - Stock Plans and Stock-Based Compensation (Tables) link:calculationLink link:presentationLink link:definitionLink 100310 - Disclosure - Net Loss Per Share (Tables) link:calculationLink link:presentationLink link:definitionLink 100320 - Disclosure - Description of Business - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100330 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100340 - Disclosure - Summary of Significant Accounting Policies - Components of Cash, Cash Equivalents and Restricted Cash (Details) link:calculationLink link:presentationLink link:definitionLink 100350 - Disclosure - Summary of Significant Accounting Policies - Summary of Roll-Forward Warranty Liability (Details) link:calculationLink link:presentationLink link:definitionLink 100360 - Disclosure - Business Combinations - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100370 - Disclosure - Business Combinations - Summary of Purchase Price Allocation (Details) link:calculationLink link:presentationLink link:definitionLink 100380 - Disclosure - Business Combinations - Summary of Business Acquisition Pro Forma Information (Details) link:calculationLink link:presentationLink link:definitionLink 100390 - Disclosure - Fair Value Measurements - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100400 - Disclosure - Fair Value Measurements - Schedule of Assumptions Used in Black-Scholes Options Pricing Model at the Date of Grant (Details) link:calculationLink link:presentationLink link:definitionLink 100410 - Disclosure - Accounts Receivable - Summary of Accounts Receivable (Details) link:calculationLink link:presentationLink link:definitionLink 100420 - Disclosure - Accounts Receivable - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100430 - Disclosure - Inventories - Schedule of Inventories (Details) link:calculationLink link:presentationLink link:definitionLink 100440 - Disclosure - Goodwill and Intangible Assets - Schedule of Changes in Carrying Amount of Goodwill and Intangible Assets (Details) link:calculationLink link:presentationLink link:definitionLink 100450 - Disclosure - Goodwill and Intangible Assets - Summary of Acquired Intangible Assets (Details) link:calculationLink link:presentationLink link:definitionLink 100460 - Disclosure - Debt - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100470 - Disclosure - Debt - Schedule of Annual Principal Maturities of Term Loans (Details) link:calculationLink link:presentationLink link:definitionLink 100480 - Disclosure - Warrants - Summary of Warrants Activity (Details) link:calculationLink link:presentationLink link:definitionLink 100490 - Disclosure - Warrants - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100500 - Disclosure - Revenue - Net Revenue Disaggregated into Categories (Details) link:calculationLink link:presentationLink link:definitionLink 100510 - Disclosure - Revenue - Schedule of Changes in Contract Liabilities (Details) link:calculationLink link:presentationLink link:definitionLink 100520 - Disclosure - Stock-Based Compensation - Summary of Allocated Stock Based Compensation Expense (Details) link:calculationLink link:presentationLink link:definitionLink 100530 - Disclosure - Stock-Based Compensation - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100540 - Disclosure - Stock-Based Compensation - Schedule of Weighted Average Assumptions Used in Black-Scholes Options Pricing Model (Details) link:calculationLink link:presentationLink link:definitionLink 100550 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Activity (Details) link:calculationLink link:presentationLink link:definitionLink 100560 - Disclosure - Net Loss Per Share - Schedule of Computation of Diluted Net Loss Per Share Attributable to Common Stockholders (Details) link:calculationLink link:presentationLink link:definitionLink 100570 - Disclosure - Related Party Transactions - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 9 vapo-20200630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 10 vapo-20200630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 11 vapo-20200630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Cover [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Entity Registrant Name Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Ex Transition Period Entity Ex Transition Period Entity Common Stock, Shares Outstanding Entity Common Stock Shares Outstanding Entity Shell Company Entity Shell Company Entity Current Reporting Status Entity Current Reporting Status Entity Interactive Data Current Entity Interactive Data Current Entity File Number Entity File Number Entity Incorporation, State or Country Code Entity Incorporation State Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address Address Line1 Entity Address, City or Town Entity Address City Or Town Entity Address, State or Province Entity Address State Or Province Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Document Quarterly Report Document Quarterly Report Document Transition Report Document Transition Report Title of 12(b) Security Security12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Statement Of Financial Position [Abstract] Assets Assets [Abstract] Current assets Assets Current [Abstract] Cash and cash equivalents Cash And Cash Equivalents At Carrying Value Accounts receivable, net Accounts Receivable Net Current Inventories Inventory Net Prepaid expenses and other current assets Prepaid Expense And Other Assets Current Total current assets Assets Current Property and equipment, net Property Plant And Equipment Net Restricted cash Restricted Cash Noncurrent Goodwill Goodwill Intangible assets, net Intangible Assets Net Excluding Goodwill Deferred income tax assets Deferred Income Tax Assets Net Other long-term assets Other Assets Noncurrent Total assets Assets Liabilities and Stockholders’ Equity Liabilities And Stockholders Equity [Abstract] Current liabilities Liabilities Current [Abstract] Accounts payable Accounts Payable Current Contract liabilities Contract With Customer Liability Accrued expenses and other current liabilities Accrued Liabilities Current Short-term line of credit Lines Of Credit Current Total current liabilities Liabilities Current Long-term loans payable, net Long Term Loans Payable Other long-term liabilities Other Liabilities Noncurrent Total liabilities Liabilities Commitments and contingencies (Note 9) Commitments And Contingencies Stockholders' equity Stockholders Equity [Abstract] Preferred stock ($0.001 par value) 25,000,000 shares authorized; no shares issued and outstanding as of June 30, 2020 and December 31, 2019 Preferred Stock Value Common stock ($0.001 par value) 175,000,000 shares authorized as of June 30, 2020 and December 31, 2019, 25,493,058 and 20,851,531 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively Common Stock Value Additional paid-in capital Additional Paid In Capital Common Stock Accumulated other comprehensive income (loss) Accumulated Other Comprehensive Income Loss Net Of Tax Accumulated deficit Retained Earnings Accumulated Deficit Total stockholders' equity Stockholders Equity Total liabilities and stockholders’ equity Liabilities And Stockholders Equity Preferred stock, par value Preferred Stock Par Or Stated Value Per Share Preferred stock, shares authorized Preferred Stock Shares Authorized Preferred stock, shares issued Preferred Stock Shares Issued Preferred stock, shares outstanding Preferred Stock Shares Outstanding Common stock, par value Common Stock Par Or Stated Value Per Share Common stock, shares authorized Common Stock Shares Authorized Common stock, shares issued Common Stock Shares Issued Common stock, shares outstanding Common Stock Shares Outstanding Income Statement [Abstract] Net revenue Revenues Cost of revenue Cost Of Revenue Gross profit Gross Profit Operating expenses Operating Expenses [Abstract] Research and development Research And Development Expense Sales and marketing Selling And Marketing Expense General and administrative General And Administrative Expense Total operating expenses Operating Expenses Loss from operations Operating Income Loss Other (expense) income Nonoperating Income Expense [Abstract] Foreign currency loss Foreign Currency Transaction Gain Loss Before Tax Interest income Investment Income Interest Interest expense Interest Expense Other Other Nonoperating Income Expense Net loss Net Income Loss Other comprehensive income (loss), net of tax: Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent [Abstract] Foreign currency translation adjustments Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax Total other comprehensive income (loss) Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent Total comprehensive loss Comprehensive Income Net Of Tax Net loss per share attributable to common stockholders - basic and diluted Earnings Per Share Basic And Diluted Weighted-average number of shares used in calculating net loss per share, basic and diluted Weighted Average Number Of Share Outstanding Basic And Diluted Issuance of common stock upon exercise of warrants shares. Issuance of common stock upon exercise of warrants value. Stock issued during period value repayment of non-recourse loans. Issuance of common stock warrants. Statement Of Stockholders Equity [Abstract] Statement [Table] Statement [Table] Equity Components Statement Equity Components [Axis] Equity Component Equity Component [Domain] Common Stock Common Stock [Member] Additional Paid-in Capital Common Stock Including Additional Paid In Capital [Member] Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income [Member] Accumulated Deficit Retained Earnings [Member] Sale of Stock Subsidiary Sale Of Stock [Axis] Sale of Stock Sale Of Stock Name Of Transaction [Domain] At-the-market. At The Market Facility At The Market Facility [Member] At-the-market offering. At-The-Market offering At The Market Offering [Member] Statement [Line Items] Statement [Line Items] Beginning balance Beginning balance, shares Shares Outstanding Issuance of common stock, net Stock Issued During Period Value New Issues Issuance of common stock, net, Shares Stock Issued During Period Shares New Issues Issuance of common stock upon exercise of options Stock Issued During Period Value Stock Options Exercised Issuance of common stock upon exercise of options, shares Stock Issued During Period Shares Stock Options Exercised Issuance of common stock upon repayment of non-recourse loan Stock Issued During Period Value Repayment Of Non Recourse Loans Stock issued during period shares repayment of non-recourse loans. Issuance of common stock upon repayment of non-recourse loan, Shares Stock Issued During Period Shares Repayment Of Non Recourse Loans Issuance of common stock under the Employee Stock Purchase Plan Stock Issued During Period Value Employee Stock Purchase Plan Issuance of common stock under the Employee Stock Purchase Plan, shares Stock Issued During Period Shares Employee Stock Purchase Plans Issuance of common stock warrants Issuance Of Common Stock Warrants Issuance of common stock upon exercise of warrants Issuance Of Common Stock Upon Exercise Of Warrants Value Issuance of common stock upon exercise of warrants, shares Issuance Of Common Stock Upon Exercise Of Warrants Shares Issuance of restricted stock Stock Issued During Period Value Restricted Stock Award Gross Issuance of restricted stock, shares Stock Issued During Period Shares Restricted Stock Award Gross Stock-based compensation expense Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value Foreign currency translation adjustments Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax Net loss Ending balance Ending balance, shares Provision for inventories. Proceeds from exercise of stock options and purchase of restricted stock. Issuance of warrant in conjunction with debt draw down. Statement Of Cash Flows [Abstract] Employee Stock Purchase Plan Employee Stock [Member] Cash flows from operating activities Net Cash Provided By Used In Operating Activities [Abstract] Net loss Profit Loss Adjustments to reconcile net loss to net cash used in operating activities Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Stock-based compensation expense Share Based Compensation Depreciation and amortization Depreciation And Amortization Provision for bad debts Provision For Doubtful Accounts Provision for inventories Provision For Inventories Loss on disposal of property and equipment Gain Loss On Sale Of Property Plant Equipment Amortization of discount on debt Amortization Of Debt Discount Premium Changes in operating assets and liabilities, net of acquisition: Increase Decrease In Operating Capital [Abstract] Accounts receivable Increase Decrease In Accounts Receivable Inventories Increase Decrease In Inventories Prepaid expenses and other assets Increase Decrease In Prepaid Deferred Expense And Other Assets Accounts payable Increase Decrease In Accounts Payable Contract liabilities Increase Decrease In Contract With Customer Liability Accrued expenses and other current liabilities Increase Decrease In Accrued Liabilities And Other Operating Liabilities Net cash used in operating activities Net Cash Provided By Used In Operating Activities Cash flows from investing activities Net Cash Provided By Used In Investing Activities [Abstract] Purchases of property and equipment Payments To Acquire Property Plant And Equipment Acquisition of business, net of cash acquired Payments To Acquire Businesses Net Of Cash Acquired Net cash used in investing activities Net Cash Provided By Used In Investing Activities Cash flows from financing activities Net Cash Provided By Used In Financing Activities [Abstract] Proceeds from issuance of common stock Proceeds From Issuance Of Common Stock Common stock offering costs Payments Of Stock Issuance Costs Proceeds from issuance of common stock under the Employee Stock Purchase Plan Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Short-term line of credit Proceeds From Short Term Debt Proceeds from exercise of stock options and purchase of restricted stock Proceeds From Exercise Of Stock Options And Purchase Of Restricted Stock Proceeds on loans Proceeds From Issuance Of Long Term Debt Debt issuance costs Payments Of Debt Issuance Costs Net cash provided by financing activities Net Cash Provided By Used In Financing Activities Effect of exchange rate changes on cash, cash equivalents and restricted cash Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Net increase (decrease) in cash, cash equivalents and restricted cash Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Cash, cash equivalents and restricted cash Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract] Beginning of period Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents End of period Supplemental disclosures of cash flow information Supplemental Cash Flow Information [Abstract] Interest paid during the period Interest Paid Net Property and equipment purchases in accounts payable and accrued expenses Capital Expenditures Incurred But Not Yet Paid Issuance of warrants in conjunction with debt draw down Issuance Of Warrant In Conjunction With Debt Draw Down Issuance of common stock upon vesting of restricted stock Stock Issued1 Organization Consolidation And Presentation Of Financial Statements [Abstract] Description of Business Business Description And Basis Of Presentation [Text Block] Accounting Policies [Abstract] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Business Combinations [Abstract] Business Combinations Business Combination Disclosure [Text Block] Fair Value Disclosures [Abstract] Fair Value Measurements Fair Value Disclosures [Text Block] Receivables [Abstract] Accounts Receivable Financing Receivables [Text Block] Inventory Disclosure [Abstract] Inventories Inventory Disclosure [Text Block] Goodwill And Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Goodwill And Intangible Assets Disclosure [Text Block] Debt Disclosure [Abstract] Debt Debt Disclosure [Text Block] Commitments And Contingencies Disclosure [Abstract] Commitments and Contingencies Commitments And Contingencies Disclosure [Text Block] The entire disclosure of warrants. Warrants And Rights Note Disclosure [Abstract] Warrants Warrants [Text Block] Revenue From Contract With Customer [Abstract] Revenue Revenue From Contract With Customer [Text Block] Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] Stock-Based Compensation Disclosure Of Compensation Related Costs Share Based Payments [Text Block] Earnings Per Share [Abstract] Net Loss Per Share Earnings Per Share [Text Block] Related Party Transactions [Abstract] Related Party Transactions Related Party Transactions Disclosure [Text Block] Basis of Presentation Basis Of Accounting Policy Policy [Text Block] Principles of Consolidation Consolidation Policy [Text Block] Segment Information Segment Reporting Policy Policy [Text Block] Use of Estimates Use Of Estimates Unaudited interim financial information. Unaudited Interim Financial Information Unaudited Interim Financial Information Policy [Text Block] Reclassification Prior Period Reclassification Adjustment Description Concentrations of Credit Risk Concentration Risk Credit Risk Foreign Currency and Foreign Operations Foreign Currency Transactions And Translations Policy [Text Block] Cash, Cash Equivalents, and Restricted Cash Cash And Cash Equivalents Restricted Cash And Cash Equivalents Policy Product warranty. Product Warranty Product Warranty Policy [Text Block] Insurance Self Insurance Reserve Policy [Text Block] Revenue Recognition Revenue Recognition Policy [Text Block] Lease Revenue Lessee Leases Policy [Text Block] Shipping and Handling Costs Cost Of Sales Policy [Text Block] Sales and value added taxes. Sales and Value-Added Taxes Sales And Value Added Taxes Policy [Text Block] Timing and Amount of Revenue Recognition Long Duration Contracts Revenue Recognition Policy Stock-Based Compensation Compensation Related Costs Policy [Text Block] Income Tax Income Tax Policy [Text Block] Recently Adopted Accounting Pronouncements New Accounting Pronouncements Policy Policy [Text Block] Schedule of cash and cash equivalents and restricted cash. Components of Cash, Cash Equivalents and Restricted Cash Schedule Of Cash And Cash Equivalents And Restricted Cash Table [Text Block] Summary of Roll-Forward Warranty Liability Schedule Of Product Warranty Liability Table [Text Block] Summary of Purchase Price Allocation Schedule Of Recognized Identified Assets Acquired And Liabilities Assumed Table [Text Block] Summary of Business Acquisition Pro Forma Information Business Acquisition Pro Forma Information [Text Block] Warrants Warrant [Member] Schedule of Assumptions Used in Black-Scholes Options Pricing Model at the Date of Grant Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques Table [Text Block] Summary of Accounts Receivable Schedule Of Accounts Notes Loans And Financing Receivable [Text Block] Schedule of Inventories Schedule Of Inventory Current Table [Text Block] Schedule of Changes in Carrying Amount of Goodwill and Intangible Assets Schedule Of Intangible Assets And Goodwill Table [Text Block] Summary of Acquired Intangible Assets Schedule Of Acquired Finite Lived Intangible Assets By Major Class [Text Block] Schedule of Annual Principal Maturities of Term Loans Schedule Of Maturities Of Long Term Debt Table [Text Block] Summary of Warrants Activity Schedule Of Stockholders Equity Note Warrants Or Rights [Text Block] Net Revenue Disaggregated into Categories Disaggregation Of Revenue Table [Text Block] Schedule of Changes in Contract Liabilities Contract With Customer Asset And Liability Table [Text Block] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Summary of Allocated Stock Based Compensation Expense Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block] Schedule of Weighted Average Assumptions Used in Black-Scholes Options Pricing Model Schedule Of Share Based Payment Award Employee Stock Purchase Plan Valuation Assumptions Table [Text Block] Summary of Restricted Stock Activity Schedule Of Sharebased Compensation Restricted Stock And Restricted Stock Units Activity Table [Text Block] Schedule of Computation of Diluted Net Loss Per Share Attributable to Common Stockholders Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block] Proceeds from issuance of common stock net of underwriting discounts and offering expenses. Underwriting discount. Offering expenses . Shares issued during period on exercise of underwriter option to purchase shares. Entity reincorporation year. Number of versions of precision flow systems. Organization consolidation and presentation of financial statements. Organization consolidation and presentation of financial statements. Organization Consolidation And Presentation Of Financial Statements [Table] Organization Consolidation And Presentation Of Financial Statements [Table] Initial Public Offering I P O [Member] At the market agreement. ATM Agreement At The Market Agreement [Member] Counterparty Name Counterparty Name [Axis] Counterparty Name Repurchase Agreement Counterparty Name [Domain] Jefferies Limited Liability Company. Jefferies LLC Jefferies Limited Liability Company [Member] Organization Consolidation And Presentation Of Financial Statements [Line Items] Organization Consolidation And Presentation Of Financial Statements [Line Items] Entity founded year Year Founded Entity reincorporated year Entity Reincorporation Year Number of versions of precision flow systems Number Of Versions Of Precision Flow Systems Number of shares issued Exercise of underwriters option to purchase shares Shares Issued During Period On Exercise Of Underwriters Option To Purchase Shares Public offering price of common stock Shares Issued Price Per Share Proceeds from initial offering net of underwriting discounts and offering costs Proceeds From Issuance Of Common Stock Net Of Underwriting Discounts And Offering Expenses Underwriting discount Underwriting Discount Offering expenses Offering Expenses Proceeds from issuance of common stock gross. Gross proceeds from issuance of common stock Proceeds From Issuance Of Common Stock Gross Summary of significant accounting policies. Summary of significant accounting policies. Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Geographical Statement Geographical [Axis] Geographical Segment Geographical [Domain] Outside U.S. Non Us [Member] Balance Sheet Location Balance Sheet Location [Axis] Balance Sheet Location Balance Sheet Location [Domain] Prepaid Expenses and Other Current Assets Prepaid Expenses And Other Current Assets [Member] Product and Service Product Or Service [Axis] Product and Service Products And Services [Domain] Shipping and Handling Shipping And Handling [Member] Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items] Number of reporting segment Number Of Reportable Segments Number of reporting units Number Of Reporting Units Long-term assets Noncurrent Assets Cash and cash equivalents maturity date description. Maturity period of highly liquid investments with original maturities Cash And Cash Equivalents Maturity Date Description Cash, cash equivalents and restricted cash balance Total cash, cash equivalents, and restricted cash Standard product warranty period. Standard product warranty period Standard Product Warranty Period Balance, beginning of period Standard Product Warranty Accrual Provisions for warranty obligations Standard Product Warranty Accrual Warranties Issued Settlements Standard Product Warranty Accrual Payments Balance, end of period Standard payment terms to customer. Standard payment term to customer Standard Payment Terms To Customer Revenue, performance obligation, description of payment terms Revenue Performance Obligation Description Of Payment Terms Revenue, remaining performance obligation, amount Revenue Remaining Performance Obligation Current value of future lease payments Operating Leases Future Minimum Payments Receivable Shipping and handling costs Operating Costs And Expenses Dividend yield assumed Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate Provision or benefit for income taxes Income Tax Expense Benefit Business combination settlement of accounts receivable. Business combination of contingent consideration as compensation to be recognized. Schedule Of Business Acquisitions By Acquisition [Table] Schedule Of Business Acquisitions By Acquisition [Table] Business Acquisition Business Acquisition [Axis] Business Acquisition, Acquiree Business Acquisition Acquiree [Domain] Solus Medical Limited. Solus Solus Medical Limited [Member] Scenario Statement Scenario [Axis] Scenario Scenario Unspecified [Domain] Scenario Forecast Scenario Forecast [Member] Income Statement Location Income Statement Location [Axis] Income Statement Location Income Statement Location [Domain] General and administrative General And Administrative Expense [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Acquisition date Business Acquisition Effective Date Of Acquisition1 Purchase price, net of cash acquired Initial cash payment Payments To Acquire Businesses Gross Settlement of receivable from preexisting relationship Business Combination Settlement Of Accounts Receivable Contingent consideration as compensation expense Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 Contingent consideration as compensation to be recognized Business Combination Of Contingent Consideration As Compensation To Be Recognized Cash Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents Accounts receivable Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables Inventory Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory Prepaids and other assets Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets Property and equipment Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment Intangible assets Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill Total assets acquired Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets Accounts payable and accrued expenses Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable Contract liabilities Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Deferred Revenue Deferred taxes Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities Total liabilities assumed Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities Total purchase price Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net Weighted average amortization period for intangible assets Acquired Finite Lived Intangible Assets Weighted Average Useful Life Transaction costs associated with acquisition Business Combination Acquisition Related Costs Net revenue Business Acquisitions Pro Forma Revenue Net loss Business Acquisitions Pro Forma Net Income Loss Net loss per share, basic Business Acquisition Pro Forma Earnings Per Share Basic Class Of Warrant Or Right [Table] Class Of Warrant Or Right [Table] Fair Value Hierarchy and NAV Fair Value By Fair Value Hierarchy Level [Axis] Fair Value Hierarchy and NAV Fair Value Measurements Fair Value Hierarchy [Domain] Level 1 Fair Value Inputs Level1 [Member] Cash and Cash Equivalents Cash And Cash Equivalents [Axis] Cash and Cash Equivalents Restricted Cash And Cash Equivalents Cash And Cash Equivalents [Member] Money Market Deposits Money Market Funds [Member] Debt Instrument Debt Instrument [Axis] Debt Instrument, Name Debt Instrument Name [Domain] Amendment to financing arrangement. Amendment To Financing Arrangement Amendment To Financing Arrangement [Member] Class of Stock Statement Class Of Stock [Axis] Class of Stock Class Of Stock [Domain] Common stock warrants. Common Stock Warrants Common Stock Warrants [Member] Class Of Warrant Or Right [Line Items] Class Of Warrant Or Right [Line Items] Cash equivalents Cash And Cash Equivalents Fair Value Disclosure Granted warrants to purchase shares Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Measurement Input Type Measurement Input Type [Axis] Measurement Input Type Measurement Input Type [Domain] Expected Dividend Yield Measurement Input Expected Dividend Rate [Member] Risk Free Interest Rate Measurement Input Risk Free Interest Rate [Member] Expected Stock Price Volatility Measurement Input Price Volatility [Member] Key inputs used in valuation Warrants And Rights Outstanding Measurement Input Expected term (years) Warrants And Rights Outstanding Term Schedule Of Accounts Notes Loans And Financing Receivable [Table] Schedule Of Accounts Notes Loans And Financing Receivable [Table] United States UNITED STATES International Accounts Notes And Loans Receivable [Line Items] Accounts Notes And Loans Receivable [Line Items] Total accounts receivable Accounts Receivable Gross Current Less: Allowance for doubtful accounts Allowance For Doubtful Accounts Receivable Current Accounts receivable, net of allowance for doubtful accounts Number of customer. Concentration Risk Benchmark Concentration Risk By Benchmark [Axis] Concentration Risk Benchmark Concentration Risk Benchmark [Domain] Revenue Sales Revenue Net [Member] Accounts Receivable Accounts Receivable [Member] Concentration Risk Type Concentration Risk By Type [Axis] Concentration Risk Type Concentration Risk Type [Domain] Customer Concentration Risk Customer Concentration Risk [Member] Number of customer accounted more than 10% Number Of Customer Percentage of concentration risk Concentration Risk Percentage1 Component parts Inventory Parts And Components Net Of Reserves Finished goods Inventory Finished Goods Net Of Reserves Total inventory Goodwill Goodwill Roll Forward Balance at December 31, 2019 Acquired during the period Goodwill Acquired During Period Foreign currency exchange rate changes Goodwill Foreign Currency Translation Gain Loss Balance at June 30, 2020 Intangible Assets Finite Lived Intangible Assets Roll Forward Balance at December 31, 2019 Finite Lived Intangible Assets Net Acquired during the period Finitelived Intangible Assets Acquired1 Amortization Amortization Of Intangible Assets Foreign currency exchange rate changes Finite Lived Intangible Assets Foreign Currency Translation Gain Loss Balance at June 30, 2020 Schedule Of Acquired Finite Lived Intangible Asset By Major Class [Table] Schedule Of Acquired Finite Lived Intangible Asset By Major Class [Table] Finite-Lived Intangible Assets by Major Class Finite Lived Intangible Assets By Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name Finite Lived Intangible Assets Major Class Name [Domain] Customer Agreements Customer Contracts [Member] Acquired Finite Lived Intangible Assets [Line Items] Acquired Finite Lived Intangible Assets [Line Items] Period of amortization Finite Lived Intangible Asset Useful Life Gross Carrying Amount Finite Lived Intangible Assets Gross Accumulated Amortization Finite Lived Intangible Assets Accumulated Amortization Percentage of eligible receivables used as base to calculate line of credit availability. Debt Instrument [Table] Debt Instrument [Table] Lender Name Line Of Credit Facility [Axis] Line of Credit Facility, Lender Line Of Credit Facility Lender [Domain] Western alliance bank. Western Alliance Bank Western Alliance Bank [Member] Credit Facility Credit Facility [Axis] Credit Facility Credit Facility [Domain] Revolving Credit Line Revolving Credit Facility [Member] Business financing agreement. Revolver Agreement Business Financing Agreement [Member] Two thousand nineteen amended revolver agreement. 2019 Amended Revolver Agreement Two Thousand Nineteen Amended Revolver Agreement [Member] Collaborative Arrangement and Arrangement Other than Collaborative Type Of Arrangement [Axis] Collaborative Arrangement and Arrangement Other than Collaborative Arrangements And Nonarrangement Transactions [Member] Credit card program. Credit Card Program Credit Card Program [Member] Two thousand twenty amended revolver agreement. 2020 Amended Revolver Agreement Two Thousand Twenty Amended Revolver Agreement [Member] Perceptive Credit Holdings II, LP. Perceptive Credit Holdings II, LP Perceptive Credit Holdings I I L P [Member] Long-term Debt, Type Longterm Debt Type [Axis] Long-term Debt, Type Longterm Debt Type [Domain] Term loan. Term Loan Term Loan [Member] Credit agreement and guaranty. Credit Agreement and Guaranty Credit Agreement And Guaranty [Member] Debt instrument, first tranche. First Tranche Debt Instrument First Tranche [Member] Debt instrument, second tranche. Debt Instrument Second Tranche Debt Instrument Second Tranche [Member] First amendment to credit agreement and guaranty. First Amendment to Credit Agreement and Guaranty First Amendment To Credit Agreement And Guaranty [Member] Debt instrument, third tranche. Debt Instrument Third Tranche Debt Instrument Third Tranche [Member] Second amendment to credit agreement and guaranty. Second Amendment to Credit Agreement and Guaranty Second Amendment To Credit Agreement And Guaranty [Member] Third amendment to credit agreement and guaranty. 2020 Amended Credit Agreement and Guaranty Third Amendment To Credit Agreement And Guaranty [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Line of credit made available under agreement Line Of Credit Facility Maximum Borrowing Capacity Percentage of eligible receivables used as base to calculate line of credit availability Percentage Of Eligible Receivables Used As Base To Calculate Line Of Credit Availability Line of credit, maturity date Line Of Credit Facility Expiration Date1 Line of credit, interest rate Line Of Credit Facility Interest Rate At Period End Outstanding balance under line of credit Line Of Credit Line of credit, remaining availability under agreement Line Of Credit Facility Remaining Borrowing Capacity Debt instrument, number of tranches. Class of warrant or right, expiration month and year. Term loan, face amount Debt Instrument Face Amount Number of tranches available under agreement Debt Instrument Number Of Tranches Proceeds from term loan Warrants exercise price Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Warrants expiration, month and year Class Of Warrant Or Right Expiration Month And Year Debt instrument available to be drawn. Minimum revenue requirement to draw final tranche. Term loan available to be drawn Debt Instrument Available To Be Drawn Minimum revenue requirement to draw final tranche Minimum Revenue Requirement To Draw Final Tranche Debt instrument remaining availability under agreement. Term loan, interest rate Debt Instrument Interest Rate During Period Debt instrument rate Debt Instrument Basis Spread On Variable Rate1 Debt instrument, description Debt Instrument Description Term loan, remaining availability under agreement Debt Instrument Remaining Availability Under Agreement Line of credit facility percentage of amount borrowed. Line of credit, covenant compliance description Line Of Credit Facility Covenant Compliance Line of credit facility percentage of amount borrowed Line Of Credit Facility Percentage Of Amount Borrowed Loans Payable Loans Payable [Member] 2020 Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year 2021 Long Term Debt Maturities Repayments Of Principal In Year Two 2022 Long Term Debt Maturities Repayments Of Principal In Year Three 2023 Long Term Debt Maturities Repayments Of Principal In Year Four Less: Discount on loans payable Debt Instrument Unamortized Discount Long-term loans payable Long Term Debt Class of warrant or right granted. Class of warrant or right exercised. Statistical Measurement Range [Axis] Statistical Measurement Range [Member] Weighted Average Weighted Average [Member] Minimum [Member] Minimum [Member] Maximum [Member] Maximum [Member] Number of shares, beginning balance Class Of Warrant Or Right Outstanding Number of shares, warrants granted Class Of Warrant Or Right Granted Number of shares, warrants exercised Class Of Warrant Or Right Exercised Number of shares, ending balance Class of warrant or right exercise price of warrants or rights granted. Class of warrant or right exercise price of warrants or rights exercised. Weighted average exercise price, beginning balance Weighted average exercise price, warrants granted Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Granted Weighted average exercise price, warrants exercised Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Exercised Weighted average exercise price, ending balance Class of warrant or right number of warrants withhold upon warrants exercise. Subsequent Event Type Subsequent Event Type [Axis] Subsequent Event Type Subsequent Event Type [Domain] Subsequent Event Subsequent Event [Member] Warrants to purchase of common stock shares, net exercised Number of warrants withhold upon warrants exercise Class Of Warrant Or Right Number Of Warrants Withhold Upon Warrants Exercise Disaggregation Of Revenue [Table] Disaggregation Of Revenue [Table] Capital equipment product revenue. Product Revenue, Capital Equipment Capital Equipment Product Revenue [Member] Disposable product revenue. Product Revenue, Disposable Disposable Product Revenue [Member] Product revenue. Subtotal Product Revenue Product Revenue [Member] Capital equipment lease revenue. Lease Revenue, Capital Equipment Capital Equipment Lease Revenue [Member] Other lease revenue. Lease Revenue, Other Other Lease Revenue [Member] Service and Other Revenue Service Other [Member] US Lease revenue. Lease Revenue Lease Revenue [Member] Disaggregation Of Revenue [Line Items] Disaggregation Of Revenue [Line Items] Total Revenue Revenue From Contract With Customer Excluding Assessed Tax Increase in contract with customer liability current. Decrease in contract with customer liability current. Contract Liabilities Contract With Customer Liability [Abstract] Balance at December 31, 2019 Contract With Customer Liability Current Additions Increase In Contract With Customer Liability Current Subtractions Decrease In Contract With Customer Liability Current Balance at June 30, 2020 Increase in deferred revenue current. Decrease in deferred revenue current. Deferred Revenue Deferred Revenue And Credits Current [Abstract] Balance at December 31, 2019 Deferred Revenue Current Additions Increase In Deferred Revenue Current Subtractions Decrease In Deferred Revenue Current Balance at June 30, 2020 Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Cost of goods sold Cost Of Sales [Member] Research and development Research And Development Expense [Member] Sales and marketing Selling And Marketing Expense [Member] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Allocated stock based compensation expense Allocated Share Based Compensation Expense Stock options, granted Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Exercise price range, lower range limit Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Exercise price range, upper range limit Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Weighted average exercise price Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price Weighted average fair value of stock options granted Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value Minimum Maximum Expected dividend yield Risk free interest rate Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Expected stock price volatility Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Expected term (years) Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 Share-based compensation arrangement by share-based payment award, equity instruments other than options, grants/purchases in period. Award Type Award Type [Axis] Award Type Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain] Restricted Stock Restricted Stock [Member] Shares, Unvested, Beginning balance Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Shares, Granted/purchased Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants Purchases In Period Shares, Vested Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Shares, Canceled Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period Shares, Unvested Ending balance Share-based compensation arrangement by share-based payment award, equity instruments other than options, grants/purchases in period, weighted average grant date fair value. Weighted Average Grant Date Fair Value, Unvested, Beginning balance Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Granted/purchased Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants Purchases In Period Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Vested Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Canceled Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Unvested Ending balance Common stock reserved and available for future issuance maximum cumulative increase percentage on immediate preceding year end common stock issued and outstanding. Initial maximum number of common stock determined by board of directors. Common stock reserved and available for future issuance, cumulatively increase description. Common stock reserved for issuance Common Stock Capital Shares Reserved For Future Issuance Common stock reserved and available for future issuance maximum cumulative increase percentage on immediate preceding year end common stock issued and outstanding Common Stock Reserved And Available For Future Issuance Maximum Cumulative Increase Percentage On Immediate Preceding Year End Common Stock Issued And Outstanding Common stock reserved and available for issuance cumulatively increase description Common Stock Reserved And Available For Future Issuance Cumulatively Increase Description Initial maximum number of common stock determined by board of directors Initial Maximum Number Of Common Stock Determined By Board Of Directors Common stock shares issued Common stock price per share Cash proceeds from issuance of common stock Maximum amount of shares a participant can accrue at discounted rate of the fair market value. Maximum percentage to purchase shares of eligible compensation a participant receives during each offering period Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Rate Maximum amount of shares a participant can accrue at discounted rate of the fair market value. Maximum Amount Of Shares Participant Can Accrue At Discounted Rate Of Fair Market Value Maximum number of shares per participant Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee Purchase price as a percentage of its market price on first trading day of each offering period Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent Risk free interest rate, minimum Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum Risk free interest rate, maximum Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum Expected stock price volatility, minimum Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum Expected stock price volatility, maximum Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Antidilutive Securities Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis] Antidilutive Securities, Name Antidilutive Securities Name [Domain] Options to Purchase Common Stock Employee Stock Option [Member] Warrants to Purchase Common Stock Unvested Restricted Stock Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount Percentage of common stock held by stockholder. Schedule Of Related Party Transactions By Related Party [Table] Schedule Of Related Party Transactions By Related Party [Table] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Percentage of common stock held by holder Percentage Of Common Stock Held By Stockholder EX-101.PRE 12 vapo-20200630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 13 vapo-10q_20200630_htm.xml IDEA: XBRL DOCUMENT 0001253176 2020-01-01 2020-06-30 0001253176 2020-07-29 0001253176 2020-06-30 0001253176 2019-12-31 0001253176 2020-04-01 2020-06-30 0001253176 2019-04-01 2019-06-30 0001253176 2019-01-01 2019-06-30 0001253176 us-gaap:CommonStockMember 2019-12-31 0001253176 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-12-31 0001253176 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001253176 us-gaap:RetainedEarningsMember 2019-12-31 0001253176 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001253176 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001253176 2020-01-01 2020-03-31 0001253176 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0001253176 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001253176 us-gaap:CommonStockMember 2020-03-31 0001253176 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2020-03-31 0001253176 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001253176 us-gaap:RetainedEarningsMember 2020-03-31 0001253176 2020-03-31 0001253176 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001253176 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001253176 us-gaap:CommonStockMember vapo:AtTheMarketOfferingMember 2020-04-01 2020-06-30 0001253176 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember vapo:AtTheMarketOfferingMember 2020-04-01 2020-06-30 0001253176 vapo:AtTheMarketOfferingMember 2020-04-01 2020-06-30 0001253176 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0001253176 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001253176 us-gaap:CommonStockMember 2020-06-30 0001253176 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2020-06-30 0001253176 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001253176 us-gaap:RetainedEarningsMember 2020-06-30 0001253176 us-gaap:CommonStockMember 2018-12-31 0001253176 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2018-12-31 0001253176 us-gaap:RetainedEarningsMember 2018-12-31 0001253176 2018-12-31 0001253176 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001253176 2019-01-01 2019-03-31 0001253176 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001253176 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001253176 us-gaap:CommonStockMember 2019-03-31 0001253176 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-03-31 0001253176 us-gaap:RetainedEarningsMember 2019-03-31 0001253176 2019-03-31 0001253176 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0001253176 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001253176 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0001253176 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001253176 us-gaap:CommonStockMember 2019-06-30 0001253176 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-06-30 0001253176 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001253176 us-gaap:RetainedEarningsMember 2019-06-30 0001253176 2019-06-30 0001253176 vapo:AtTheMarketOfferingMember 2020-01-01 2020-06-30 0001253176 us-gaap:EmployeeStockMember 2020-01-01 2020-06-30 0001253176 us-gaap:WarrantMember 2020-01-01 2020-06-30 0001253176 us-gaap:CommonStockMember us-gaap:IPOMember 2018-11-15 2018-11-16 0001253176 us-gaap:CommonStockMember us-gaap:IPOMember 2018-11-16 0001253176 us-gaap:CommonStockMember 2019-08-01 2019-08-31 0001253176 us-gaap:CommonStockMember 2019-08-31 0001253176 vapo:JefferiesLimitedLiabilityCompanyMember vapo:AtTheMarketAgreementMember 2019-12-20 2019-12-20 0001253176 vapo:AtTheMarketAgreementMember 2020-04-01 2020-04-30 0001253176 us-gaap:CommonStockMember 2020-05-01 2020-05-31 0001253176 us-gaap:CommonStockMember 2020-05-31 0001253176 us-gaap:NonUsMember 2020-06-30 0001253176 us-gaap:NonUsMember 2019-12-31 0001253176 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2020-06-30 0001253176 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2019-12-31 0001253176 us-gaap:ShippingAndHandlingMember 2020-04-01 2020-06-30 0001253176 us-gaap:ShippingAndHandlingMember 2019-04-01 2019-06-30 0001253176 us-gaap:ShippingAndHandlingMember 2020-01-01 2020-06-30 0001253176 us-gaap:ShippingAndHandlingMember 2019-01-01 2019-06-30 0001253176 vapo:SolusMedicalLimitedMember 2020-01-01 2020-06-30 0001253176 vapo:SolusMedicalLimitedMember 2019-02-28 2019-02-28 0001253176 vapo:SolusMedicalLimitedMember 2019-01-01 2019-12-31 0001253176 srt:ScenarioForecastMember vapo:SolusMedicalLimitedMember 2020-01-01 2020-12-31 0001253176 vapo:SolusMedicalLimitedMember 2019-02-28 0001253176 vapo:SolusMedicalLimitedMember us-gaap:GeneralAndAdministrativeExpenseMember 2019-01-01 2019-12-31 0001253176 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2020-06-30 0001253176 vapo:AmendmentToFinancingArrangementMember vapo:CommonStockWarrantsMember 2019-03-22 0001253176 us-gaap:MeasurementInputExpectedDividendRateMember 2020-06-30 0001253176 us-gaap:MeasurementInputRiskFreeInterestRateMember 2020-06-30 0001253176 us-gaap:MeasurementInputPriceVolatilityMember 2020-06-30 0001253176 country:US 2020-06-30 0001253176 country:US 2019-12-31 0001253176 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-04-01 2020-06-30 0001253176 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-04-01 2019-06-30 0001253176 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-06-30 0001253176 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-06-30 0001253176 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-06-30 0001253176 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-12-31 0001253176 us-gaap:CustomerContractsMember 2020-01-01 2020-06-30 0001253176 us-gaap:CustomerContractsMember 2020-06-30 0001253176 us-gaap:RevolvingCreditFacilityMember vapo:BusinessFinancingAgreementMember vapo:WesternAllianceBankMember 2016-11-16 0001253176 us-gaap:RevolvingCreditFacilityMember vapo:BusinessFinancingAgreementMember vapo:WesternAllianceBankMember 2016-11-15 2016-11-16 0001253176 us-gaap:RevolvingCreditFacilityMember vapo:BusinessFinancingAgreementMember vapo:WesternAllianceBankMember 2018-04-30 0001253176 us-gaap:RevolvingCreditFacilityMember vapo:BusinessFinancingAgreementMember vapo:WesternAllianceBankMember 2018-04-01 2018-04-30 0001253176 us-gaap:RevolvingCreditFacilityMember vapo:BusinessFinancingAgreementMember vapo:WesternAllianceBankMember vapo:CreditCardProgramMember 2019-03-21 0001253176 us-gaap:RevolvingCreditFacilityMember vapo:TwoThousandNineteenAmendedRevolverAgreementMember vapo:WesternAllianceBankMember vapo:CreditCardProgramMember 2019-03-22 0001253176 us-gaap:RevolvingCreditFacilityMember vapo:TwoThousandTwentyAmendedRevolverAgreementMember vapo:WesternAllianceBankMember 2020-06-30 0001253176 us-gaap:RevolvingCreditFacilityMember vapo:TwoThousandNineteenAmendedRevolverAgreementMember vapo:WesternAllianceBankMember 2019-12-31 0001253176 vapo:CreditAgreementAndGuarantyMember vapo:PerceptiveCreditHoldingsIILPMember vapo:TermLoanMember 2018-04-06 0001253176 vapo:CreditAgreementAndGuarantyMember vapo:PerceptiveCreditHoldingsIILPMember vapo:TermLoanMember 2018-04-05 2018-04-06 0001253176 vapo:CreditAgreementAndGuarantyMember vapo:PerceptiveCreditHoldingsIILPMember vapo:TermLoanMember vapo:DebtInstrumentFirstTrancheMember 2018-04-05 2018-04-06 0001253176 vapo:CreditAgreementAndGuarantyMember vapo:PerceptiveCreditHoldingsIILPMember vapo:TermLoanMember vapo:DebtInstrumentSecondTrancheMember 2018-07-19 2018-07-20 0001253176 vapo:CreditAgreementAndGuarantyMember vapo:PerceptiveCreditHoldingsIILPMember vapo:TermLoanMember vapo:DebtInstrumentSecondTrancheMember 2018-07-20 0001253176 vapo:FirstAmendmentToCreditAgreementAndGuarantyMember vapo:PerceptiveCreditHoldingsIILPMember vapo:TermLoanMember 2018-09-26 2018-09-27 0001253176 vapo:FirstAmendmentToCreditAgreementAndGuarantyMember vapo:PerceptiveCreditHoldingsIILPMember vapo:TermLoanMember vapo:DebtInstrumentThirdTrancheMember 2018-09-26 2018-09-27 0001253176 vapo:FirstAmendmentToCreditAgreementAndGuarantyMember vapo:PerceptiveCreditHoldingsIILPMember vapo:TermLoanMember vapo:DebtInstrumentThirdTrancheMember 2018-09-27 0001253176 vapo:CreditAgreementAndGuarantyMember vapo:PerceptiveCreditHoldingsIILPMember vapo:TermLoanMember 2019-03-21 2019-03-22 0001253176 vapo:CreditAgreementAndGuarantyMember vapo:PerceptiveCreditHoldingsIILPMember vapo:TermLoanMember 2019-03-22 0001253176 vapo:FirstAmendmentToCreditAgreementAndGuarantyMember vapo:PerceptiveCreditHoldingsIILPMember vapo:TermLoanMember vapo:CreditCardProgramMember 2019-03-21 0001253176 vapo:SecondAmendmentToCreditAgreementAndGuarantyMember vapo:PerceptiveCreditHoldingsIILPMember vapo:TermLoanMember vapo:CreditCardProgramMember 2019-03-22 0001253176 vapo:ThirdAmendmentToCreditAgreementAndGuarantyMember vapo:PerceptiveCreditHoldingsIILPMember vapo:TermLoanMember 2020-06-16 2020-06-16 0001253176 vapo:ThirdAmendmentToCreditAgreementAndGuarantyMember vapo:PerceptiveCreditHoldingsIILPMember vapo:TermLoanMember 2020-01-01 2020-06-30 0001253176 vapo:ThirdAmendmentToCreditAgreementAndGuarantyMember vapo:PerceptiveCreditHoldingsIILPMember vapo:TermLoanMember 2020-06-30 0001253176 us-gaap:LoansPayableMember 2020-06-30 0001253176 vapo:CommonStockWarrantsMember 2019-12-31 0001253176 vapo:CommonStockWarrantsMember 2020-01-01 2020-06-30 0001253176 vapo:CommonStockWarrantsMember 2020-06-30 0001253176 srt:WeightedAverageMember vapo:CommonStockWarrantsMember 2019-12-31 0001253176 srt:WeightedAverageMember vapo:CommonStockWarrantsMember 2020-01-01 2020-06-30 0001253176 srt:WeightedAverageMember vapo:CommonStockWarrantsMember 2020-06-30 0001253176 vapo:CommonStockWarrantsMember 2020-06-10 2020-06-10 0001253176 vapo:CommonStockWarrantsMember 2020-06-10 0001253176 vapo:CommonStockWarrantsMember us-gaap:SubsequentEventMember 2020-07-10 2020-07-10 0001253176 vapo:CommonStockWarrantsMember us-gaap:SubsequentEventMember 2020-07-10 0001253176 vapo:CapitalEquipmentProductRevenueMember country:US 2020-04-01 2020-06-30 0001253176 vapo:CapitalEquipmentProductRevenueMember us-gaap:NonUsMember 2020-04-01 2020-06-30 0001253176 vapo:CapitalEquipmentProductRevenueMember 2020-04-01 2020-06-30 0001253176 vapo:CapitalEquipmentProductRevenueMember country:US 2020-01-01 2020-06-30 0001253176 vapo:CapitalEquipmentProductRevenueMember us-gaap:NonUsMember 2020-01-01 2020-06-30 0001253176 vapo:CapitalEquipmentProductRevenueMember 2020-01-01 2020-06-30 0001253176 vapo:DisposableProductRevenueMember country:US 2020-04-01 2020-06-30 0001253176 vapo:DisposableProductRevenueMember us-gaap:NonUsMember 2020-04-01 2020-06-30 0001253176 vapo:DisposableProductRevenueMember 2020-04-01 2020-06-30 0001253176 vapo:DisposableProductRevenueMember country:US 2020-01-01 2020-06-30 0001253176 vapo:DisposableProductRevenueMember us-gaap:NonUsMember 2020-01-01 2020-06-30 0001253176 vapo:DisposableProductRevenueMember 2020-01-01 2020-06-30 0001253176 vapo:ProductRevenueMember country:US 2020-04-01 2020-06-30 0001253176 vapo:ProductRevenueMember us-gaap:NonUsMember 2020-04-01 2020-06-30 0001253176 vapo:ProductRevenueMember 2020-04-01 2020-06-30 0001253176 vapo:ProductRevenueMember country:US 2020-01-01 2020-06-30 0001253176 vapo:ProductRevenueMember us-gaap:NonUsMember 2020-01-01 2020-06-30 0001253176 vapo:ProductRevenueMember 2020-01-01 2020-06-30 0001253176 vapo:CapitalEquipmentLeaseRevenueMember country:US 2020-04-01 2020-06-30 0001253176 vapo:CapitalEquipmentLeaseRevenueMember us-gaap:NonUsMember 2020-04-01 2020-06-30 0001253176 vapo:CapitalEquipmentLeaseRevenueMember 2020-04-01 2020-06-30 0001253176 vapo:CapitalEquipmentLeaseRevenueMember country:US 2020-01-01 2020-06-30 0001253176 vapo:CapitalEquipmentLeaseRevenueMember us-gaap:NonUsMember 2020-01-01 2020-06-30 0001253176 vapo:CapitalEquipmentLeaseRevenueMember 2020-01-01 2020-06-30 0001253176 vapo:OtherLeaseRevenueMember country:US 2020-04-01 2020-06-30 0001253176 vapo:OtherLeaseRevenueMember us-gaap:NonUsMember 2020-04-01 2020-06-30 0001253176 vapo:OtherLeaseRevenueMember 2020-04-01 2020-06-30 0001253176 vapo:OtherLeaseRevenueMember country:US 2020-01-01 2020-06-30 0001253176 vapo:OtherLeaseRevenueMember us-gaap:NonUsMember 2020-01-01 2020-06-30 0001253176 vapo:OtherLeaseRevenueMember 2020-01-01 2020-06-30 0001253176 us-gaap:ServiceOtherMember country:US 2020-04-01 2020-06-30 0001253176 us-gaap:ServiceOtherMember us-gaap:NonUsMember 2020-04-01 2020-06-30 0001253176 us-gaap:ServiceOtherMember 2020-04-01 2020-06-30 0001253176 us-gaap:ServiceOtherMember country:US 2020-01-01 2020-06-30 0001253176 us-gaap:ServiceOtherMember us-gaap:NonUsMember 2020-01-01 2020-06-30 0001253176 us-gaap:ServiceOtherMember 2020-01-01 2020-06-30 0001253176 country:US 2020-04-01 2020-06-30 0001253176 us-gaap:NonUsMember 2020-04-01 2020-06-30 0001253176 country:US 2020-01-01 2020-06-30 0001253176 us-gaap:NonUsMember 2020-01-01 2020-06-30 0001253176 vapo:CapitalEquipmentProductRevenueMember country:US 2019-04-01 2019-06-30 0001253176 vapo:CapitalEquipmentProductRevenueMember us-gaap:NonUsMember 2019-04-01 2019-06-30 0001253176 vapo:CapitalEquipmentProductRevenueMember 2019-04-01 2019-06-30 0001253176 vapo:CapitalEquipmentProductRevenueMember country:US 2019-01-01 2019-06-30 0001253176 vapo:CapitalEquipmentProductRevenueMember us-gaap:NonUsMember 2019-01-01 2019-06-30 0001253176 vapo:CapitalEquipmentProductRevenueMember 2019-01-01 2019-06-30 0001253176 vapo:DisposableProductRevenueMember country:US 2019-04-01 2019-06-30 0001253176 vapo:DisposableProductRevenueMember us-gaap:NonUsMember 2019-04-01 2019-06-30 0001253176 vapo:DisposableProductRevenueMember 2019-04-01 2019-06-30 0001253176 vapo:DisposableProductRevenueMember country:US 2019-01-01 2019-06-30 0001253176 vapo:DisposableProductRevenueMember us-gaap:NonUsMember 2019-01-01 2019-06-30 0001253176 vapo:DisposableProductRevenueMember 2019-01-01 2019-06-30 0001253176 vapo:ProductRevenueMember country:US 2019-04-01 2019-06-30 0001253176 vapo:ProductRevenueMember us-gaap:NonUsMember 2019-04-01 2019-06-30 0001253176 vapo:ProductRevenueMember 2019-04-01 2019-06-30 0001253176 vapo:ProductRevenueMember country:US 2019-01-01 2019-06-30 0001253176 vapo:ProductRevenueMember us-gaap:NonUsMember 2019-01-01 2019-06-30 0001253176 vapo:ProductRevenueMember 2019-01-01 2019-06-30 0001253176 vapo:LeaseRevenueMember country:US 2019-04-01 2019-06-30 0001253176 vapo:LeaseRevenueMember 2019-04-01 2019-06-30 0001253176 vapo:LeaseRevenueMember country:US 2019-01-01 2019-06-30 0001253176 vapo:LeaseRevenueMember 2019-01-01 2019-06-30 0001253176 us-gaap:ServiceOtherMember country:US 2019-04-01 2019-06-30 0001253176 us-gaap:ServiceOtherMember us-gaap:NonUsMember 2019-04-01 2019-06-30 0001253176 us-gaap:ServiceOtherMember 2019-04-01 2019-06-30 0001253176 us-gaap:ServiceOtherMember country:US 2019-01-01 2019-06-30 0001253176 us-gaap:ServiceOtherMember us-gaap:NonUsMember 2019-01-01 2019-06-30 0001253176 us-gaap:ServiceOtherMember 2019-01-01 2019-06-30 0001253176 country:US 2019-04-01 2019-06-30 0001253176 us-gaap:NonUsMember 2019-04-01 2019-06-30 0001253176 country:US 2019-01-01 2019-06-30 0001253176 us-gaap:NonUsMember 2019-01-01 2019-06-30 0001253176 us-gaap:CostOfSalesMember 2020-04-01 2020-06-30 0001253176 us-gaap:CostOfSalesMember 2019-04-01 2019-06-30 0001253176 us-gaap:CostOfSalesMember 2020-01-01 2020-06-30 0001253176 us-gaap:CostOfSalesMember 2019-01-01 2019-06-30 0001253176 us-gaap:ResearchAndDevelopmentExpenseMember 2020-04-01 2020-06-30 0001253176 us-gaap:ResearchAndDevelopmentExpenseMember 2019-04-01 2019-06-30 0001253176 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-06-30 0001253176 us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-06-30 0001253176 us-gaap:SellingAndMarketingExpenseMember 2020-04-01 2020-06-30 0001253176 us-gaap:SellingAndMarketingExpenseMember 2019-04-01 2019-06-30 0001253176 us-gaap:SellingAndMarketingExpenseMember 2020-01-01 2020-06-30 0001253176 us-gaap:SellingAndMarketingExpenseMember 2019-01-01 2019-06-30 0001253176 us-gaap:GeneralAndAdministrativeExpenseMember 2020-04-01 2020-06-30 0001253176 us-gaap:GeneralAndAdministrativeExpenseMember 2019-04-01 2019-06-30 0001253176 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-06-30 0001253176 us-gaap:GeneralAndAdministrativeExpenseMember 2019-01-01 2019-06-30 0001253176 us-gaap:RestrictedStockMember 2019-12-31 0001253176 us-gaap:RestrictedStockMember 2020-01-01 2020-06-30 0001253176 us-gaap:RestrictedStockMember 2020-06-30 0001253176 us-gaap:EmployeeStockMember 2018-11-30 0001253176 us-gaap:EmployeeStockMember 2020-06-30 0001253176 us-gaap:CommonStockMember 2020-01-01 2020-06-30 0001253176 us-gaap:CommonStockMember us-gaap:EmployeeStockMember 2020-06-30 0001253176 us-gaap:EmployeeStockMember 2018-11-01 2018-11-30 0001253176 srt:MinimumMember us-gaap:EmployeeStockMember 2020-01-01 2020-06-30 0001253176 srt:MaximumMember us-gaap:EmployeeStockMember 2020-01-01 2020-06-30 0001253176 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-06-30 0001253176 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-06-30 0001253176 us-gaap:WarrantMember 2020-01-01 2020-06-30 0001253176 us-gaap:WarrantMember 2019-01-01 2019-06-30 0001253176 us-gaap:RestrictedStockMember 2020-01-01 2020-06-30 0001253176 us-gaap:RestrictedStockMember 2019-01-01 2019-06-30 0001253176 us-gaap:EmployeeStockMember 2020-01-01 2020-06-30 0001253176 srt:MinimumMember 2020-01-01 2020-06-30 shares iso4217:USD iso4217:USD shares vapo:System vapo:Segment pure vapo:Customer vapo:Tranche false 2020 Q2 0001253176 --12-31 Accelerated Filer NH P1Y P10Y P3Y9M29D P6Y1M6D P7Y1M6D 0.002 1.079 P4M24D 0.016 1.158 P6M 10-Q true 2020-06-30 false 001-38740 Vapotherm, Inc. DE 46-2259298 100 Domain Drive Exeter 03833 603 658-0011 Common Stock, $0.001 par value per share VAPO NYSE Yes Yes true true false false 25570243 148344000 71655000 16452000 8243000 18641000 9137000 4500000 4066000 187937000 93101000 17204000 15086000 1853000 1852000 547000 588000 275000 353000 66000 66000 954000 844000 208836000 111890000 6789000 3375000 261000 137000 15801000 9187000 4492000 3491000 27343000 16190000 41929000 41787000 604000 174000 69876000 58151000 0.001 0.001 25000000 25000000 0 0 0 0 0.001 0.001 175000000 175000000 25493058 25493058 20851531 20851531 26000 21000 426282000 319115000 -31000 44000 -287317000 -265441000 138960000 53739000 208836000 111890000 35152000 11986000 54267000 24285000 17544000 6527000 27442000 13647000 17608000 5459000 26825000 10638000 3895000 3167000 7257000 6440000 14858000 9432000 28175000 18593000 5627000 4532000 10878000 9411000 24380000 17131000 46310000 34444000 -6772000 -11672000 -19485000 -23806000 -25000 -1000 -9000 60000 213000 185000 416000 1295000 1421000 2590000 2445000 15000 -8032000 -12880000 -21876000 -25844000 -4000 2000 -75000 2000 -4000 2000 -75000 2000 -8036000 -12878000 -21951000 -25842000 -0.35 -0.76 -0.99 -1.52 23090613 17055628 21986774 17019002 20851531 21000 319115000 44000 -265441000 53739000 24687 40000 40000 40931 58000 58000 1447000 1447000 -71000 -71000 -13844000 -13844000 20917149 21000 320660000 -27000 -279285000 41369000 3852500 4000 93823000 93827000 511648 1000 9783000 9784000 99206 227000 227000 36389 359000 359000 41066 35100 53000 53000 1377000 1377000 -4000 -4000 -8032000 -8032000 25493058 26000 426282000 -31000 -287317000 138960000 16782837 17000 265926000 -214382000 51561000 293000 293000 268 116580 226000 226000 1903000 1903000 -12964000 -12964000 16899685 17000 268348000 -227346000 41019000 12164 122497 193000 193000 79854 144000 144000 52168 159000 159000 712000 712000 2000 2000 -12880000 -12880000 17166368 17000 269556000 2000 -240226000 29349000 -21876000 -25844000 2824000 2615000 2148000 1407000 282000 64000 -327000 697000 -3000 -81000 127000 108000 8542000 -144000 9204000 -2292000 547000 -398000 3380000 -1229000 125000 -16000 6932000 397000 -24675000 -18886000 3839000 2164000 1560000 -3839000 -3724000 94156000 9926000 471000 359000 995000 -7000 267000 337000 10500000 322000 105232000 10508000 -28000 -13000 76690000 -12115000 73507000 60022000 150197000 47907000 2422000 2290000 341000 115000 293000 111000 385000 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1. Description of Business </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vapotherm, Inc. (the “Company”) was founded in 1993 and reincorporated under the laws of the State of Delaware in 2013. Since inception, the Company has focused on the development and commercialization of its proprietary high velocity products that are used to treat patients of all ages suffering from respiratory distress. The Company’s high velocity therapy delivers non-invasive ventilatory support by providing heated, humidified and oxygenated air at a high velocity to patients through a comfortable small-bore nasal interface. The Company’s Precision Flow systems, which use high velocity therapy, are clinically validated alternatives to, and address many limitations of, the current standard of care for the treatment of respiratory distress in a hospital setting. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company offers four versions of its Precision Flow systems: Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic and Precision Flow Heliox. The Company generates revenue from sales of its Precision Flow systems and related disposable products utilized with its Precision Flow systems. The Company also generates revenue from sales of the Precision Flow system’s companion products, which include the Vapotherm Transfer Unit 2.0, the Q50 compressor and various adaptors. The Company offers different options to its hospital customers for acquiring Precision Flow capital units, ranging from the purchase of the Precision Flow capital units with payment in full at the time of purchase, to financed purchases of the Precision Flow capital units, to bundled discounts involving the placement of Precision Flow capital units for use by the customer at no upfront charge in connection with the customer’s ongoing purchase of disposable products.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company sells Precision Flow systems to hospitals through a direct sales force in the United States and in the United Kingdom and through distributors in select other countries outside of the United States and United Kingdom. In addition, the Company utilizes clinical educators who are typically experienced users of high velocity therapy and who focus on medical education efforts to facilitate adoption and increase utilization. The Company is focused on physicians, respiratory therapists and nurses who work in acute hospital settings, including the emergency department (“ED”) and adult, pediatric and neonatal intensive care units (the “ICUs”). The Company’s relationship with these clinicians is particularly important, as it enables its products to follow patients through the care continuum. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2020, the World Health Organization declared a global pandemic related to the novel coronavirus (“COVID-19”). The Company’s high velocity therapy is a first-line therapy for treating respiratory distress, which is experienced by many COVID-19 patients. The Journal of the American Medical Association published data from mainland China in April 2020 suggesting that 19% of all COVID-19 patients experience respiratory distress and require some amount of respiratory support. The Company’s hospital customers around the world are using its technology to support the respiratory distress experienced by many COVID-19 patients so that they can triage their sickest patients using a limited number of ventilators. As a result, the Company has seen a significant increase in worldwide demand for its products from both new and existing accounts in the first six months of 2020.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Since inception, the Company has financed its operations primarily through public offerings of its common stock, private placements of its convertible preferred stock, sales of its Precision Flow systems and amounts borrowed under its credit facilities. The Company has devoted the majority of its resources to research and development activities related to its Precision Flow systems, including regulatory initiatives and sales and marketing activities. The Company has invested heavily in its sales and marketing function by increasing the number of sales representatives and clinical educators to facilitate adoption and increase utilization of its high velocity therapy products and expanded its digital marketing initiatives and medical education programs. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is subject to risks common to companies in the medical device industry, including, but not limited to, risks relating to the successful development and commercialization of its Precision Flow products, fluctuations in operating results and financial risks, protection of proprietary knowledge and patent risks, dependence on key personnel and collaborative partners, competition, technological and manufacturing risks, customer acceptance and demand, compliance with the Food and Drug Administration and other governmental regulations, management of growth and effectiveness of marketing by the Company and by third parties. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On November 16, 2018, the Company completed an initial public offering of 4,600,000 shares of common stock, which included the full exercise by the underwriters of their option to purchase 600,000 shares of common stock, at a price of $14.00 per share, which raised net proceeds of $57.4 million after deducting the underwriting discount of $4.5 million and offering expenses of $2.5 million.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On February 28, 2019, the Company acquired its United Kingdom based distributor. See Note 3 “Business Combinations” to these condensed consolidated financial statements for details of this transaction.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2019, the Company completed a public offering of 3,570,750 shares of common stock, which included the full exercise by the underwriters of their option to purchase 465,750 shares of common stock, at a price of $14.50 per share, which raised net proceeds of $48.3 million after deducting the underwriting discount of $3.1 million and offering expenses of $0.4 million. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December 20, 2019, the Company entered into an Open Market Sales Agreement (the “ATM Agreement”) with Jefferies LLC (“Jefferies”) under which the Company may offer and sell its common stock having aggregate sales proceeds of up to $50.0 million from time to time through Jefferies as its sales agents. During April 2020, the Company sold 511,648 shares of common stock pursuant to the ATM Agreement for gross proceeds of $10.2 million, or $9.8 million net of commissions and offering expenses. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In May 2020, the Company completed a public offering of 3,852,500 shares of common stock, which included the full exercise by the underwriters of their option to purchase 502,500 shares of common stock, at a price of $26.00 per share, which raised net proceeds of $93.8 million after deducting the underwriting discount of $6.0 million and offering expenses of $0.3 million. </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"> </p> 1993 2013 4 4600000 600000 14.00 57400000 4500000 2500000 3570750 465750 14.50 48300000 3100000 400000 50000000.0 511648 10200000 9800000 3852500 502500 26.00 93800000 6000000.0 300000 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2. Summary of Significant Accounting Policies </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Basis of Presentation</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). <span style="color:#000000;">The information included in this Quarterly Report on Form 10-Q should be read in conjunction with our audited consolidated financial statements and the accompanying notes included in our Annual Report on Form 10-K for the year ended December 31, 2019 (the “2019 Form 10-K”). Our accounting policies are described in the “</span><span style="font-style:italic;color:#000000;">Notes to Consolidated Financial Statements</span><span style="color:#000000;">” in our 2019 Form 10-K and updated, as necessary, in this report. The year-end </span>condensed<span style="color:#000000;"> consolidated balance sheet data presented for comparative purposes was derived from our audited financial statements but does not include all disclosures required by U.S. GAAP.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Principles of Consolidation </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These condensed consolidated financial statements include the financial statements of Solus Medical Ltd. (“Solus”), a wholly owned subsidiary of the Company based in the United Kingdom, which was acquired in the first quarter of 2019. All intercompany accounts and transactions have been eliminated upon consolidation. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Segment Information</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating segments are defined as components of an enterprise for which separate discrete financial information is available and evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company globally manages the business within one reporting segment, Vapotherm, Inc. and two reporting units, Vapotherm and Solus. Segment information is consistent with how management reviews the business, makes investing and resource allocation decisions and assesses operating performance. </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:8.37%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The majority of the Company’s long-term assets are located in the United States. Long-term assets located outside the United States total $0.1 million as of each of June 30, 2020 and December 31, 2019. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires the Company to make judgments, assumptions, and estimates that affect the reported amounts of assets, liabilities, revenue and expenses, and the related disclosure of contingent assets and liabilities. The Company evaluates its estimates on an ongoing basis. The Company bases its estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Significant estimates relied upon in preparing these condensed consolidated financial statements include calculation of stock-based compensation, valuation of warrants, fair values of acquired assets and liabilities, including goodwill and intangibles assets, realizability of inventories, allowance for bad debt, accrued expenses and the valuation allowances against deferred income tax assets. Actual results may differ from these estimates. </p> <p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Unaudited Interim Financial Information</p> <p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:8.37%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying<span style="color:#000000;"> condensed</span> consolidated balance sheet as of June 30, 2020, and the <span style="color:#000000;">condensed</span> consolidated statements of comprehensive loss, stockholders’ equity and of cash flows for the three and six months ended June 30, 2020 and 2019 are unaudited. The unaudited interim <span style="color:#000000;">condensed</span> consolidated financial statements have been prepared on the same basis as the audited annual consolidated financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of June 30, 2020 and the results of its operations and its cash flows for the three and six months ended June 30, 2020 and 2019. The financial data and other information disclosed in these notes related to the three and six months ended June 30, 2020 and 2019 are also unaudited. The results of operations for the three and six months ended June 30, 2020 are not necessarily indicative of the operating results for the full year or for any other subsequent interim period.</p> <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Reclassification</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain amounts in 2019 have been reclassified to conform to the presentation in 2020. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentrations of Credit Risk </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of June 30, 2020, the Company’s financial instruments were comprised of cash and cash equivalents, restricted cash, accounts receivable, accounts payable and debt, the carrying amounts of which approximated fair value due to the short-term nature and market interest rates. All of the Company’s cash and cash equivalents are maintained at creditworthy financial institutions. At June 30, 2020, deposits exceed the amount of any insurance provided. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company extends credit to customers in the normal course of business but does not require collateral or any other security to support amounts due. Management performs ongoing credit evaluations of the Company’s customers. An allowance for potentially uncollectible accounts is provided based on history, economic conditions, and composition of the accounts receivable aging. In some cases, the Company makes allowances for specific customers based on these and other factors. Provisions for the allowance for doubtful accounts are recorded in general and administrative expenses in the accompanying condensed consolidated statements of comprehensive loss. </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p> <p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Foreign Currency and Foreign Operations</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The functional currency of the Company is the currency of the primary economic environment in which the entity operates, which is the U.S. dollar. <span style="color:#000000;">For our non-U.S. subsidiary that transacts in a functional currency other than the U.S. dollar, assets and liabilities are translated at current rates of exchange as of the balance sheet date. Income and expense items are translated at the average foreign currency exchange rates for the period. Adjustments resulting from the translation of the financial statements of its foreign operations into U.S. dollars are excluded from the determination of net loss and are recorded in accumulated other comprehensive income (loss), a separate component of stockholders’ equity.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Realized foreign currency gains or losses arising from transactions denominated in foreign currencies are recorded in other (expense) income in the condensed consolidated statements of <span style="color:#000000;">comprehensive loss. </span>Unrealized foreign currency gains or losses arising from transactions denominated in foreign currencies are recorded in accumulated other comprehensive income (loss).</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Cash, Cash Equivalents, and Restricted Cash</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:8.37%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company considers all highly liquid temporary investments purchased with original maturities of 90 days or less to be cash equivalents. The Company holds restricted cash related to certificates of deposits and collateral in relation to lease agreements. As <span style="Background-color:#FFFFFF;">of June 30, 2020, $0.5 million of our $150.2 million of cash, cash equivalents and restricted cash balance was located outside the United States.</span></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:8.37%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents the components of total cash, cash equivalents, and restricted cash as set forth in the Company’s condensed consolidated statements of cash flows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">148,344</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71,655</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,853</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,852</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash, cash equivalents, and restricted cash</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150,197</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73,507</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Product Warranty </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company provides its customers with a standard <span style="-sec-ix-hidden:F_000415">one-year</span> warranty on its capital equipment sales. Warranty costs are accrued based on actual historical trends and estimated at time of sale. The warranty liability is included within accrued expenses and other liabilities in the condensed consolidated balance sheets. A roll-forward of the Company’s warranty liability from December 31, 2019 to June 30, 2020 is as follows: </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">225</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provisions for warranty obligations</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">670</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Settlements</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(127</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at June 30, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">768</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Insurance </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effective January 1, 2020, the Company was self-insured for certain obligations related to health insurance. The Company also purchases stop-loss insurance to protect itself from material losses. Judgments and estimates are used in determining the potential value associated with reported claims and for events that have occurred but have not been reported. The Company’s estimates consider expected claim experience and other factors. Receivables for insurance recoveries are recorded as assets, on an undiscounted basis. The Company’s liabilities are based on estimates, and, while the Company believes that its accruals are adequate, the ultimate liability may be significantly different from the amounts recorded. Changes in claims experience, the Company’s ability to settle claims or other estimates and judgments used by management could have a material impact on the amount and timing of expense for any period. </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Revenue Recognition </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s revenue is primarily derived from the sale of products, leases and services. Product revenue consists of capital equipment and single-use disposables that are shipped and billed to customers both domestically and internationally. The Company’s main capital equipment products are the Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, Vapotherm Transfer Unit 2.0 and Q50 compressor. The Company’s main disposable products are single-use disposables and nasal interfaces, or cannulas, and adaptors. Lease revenue consists of two components which include capital equipment that the Company leases out to its customers and, in certain situations, an allocation from disposable revenue to other lease revenue upon the sale of disposable products in bundled arrangements involving the placement of Precision Flow capital units for use by the customer at no upfront charge in connection with the customer’s ongoing purchase of disposable products. Service revenue consists of fees associated with routine service of capital units and the sale of extended service contracts and preventative maintenance plans, which are purchased by a small portion of the Company’s customer base. In addition, the Company sells small quantities of component parts in the United States, United Kingdom and to third-party international service centers who provide service on Precision Flow capital units outside of the United States. Freight revenue is based upon actual freight costs plus a percentage markup of such costs associated with the shipment of products domestically, and to a lesser extent, internationally, and is included in service revenue. Rebates and fees consist of contractually obligated administrative fees and percentage-of-sales rebates paid to Group Purchasing Organizations (“GPOs”), Integrated Delivery Networks (“IDNs”) and distributor partners and accounted for as a reduction of service revenue. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under Financial Accounting Standard Board (“FASB”) Accounting Standards Codifications (“ASC”) 606, Revenue from Contracts with Customers (“ASC 606”), revenue is recognized when a customer obtains control of promised goods or services, in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and assesses whether each promised good or service is distinct and determines those that are performance obligations. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. Sales, value-added, and other taxes collected on behalf of third parties are excluded from revenue. The Company’s standard payment terms are generally 30 days from the date of sale. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contracts with customers may contain multiple performance obligations. For such arrangements, the transaction price is allocated to each performance obligation based on the estimated relative stand-alone selling prices of the promised products or services underlying each performance obligation. The Company determines stand-alone selling prices based on the price at which the performance obligation is sold separately. If the stand-alone selling price is not observable through past transactions, the Company estimates the stand-alone selling price taking into account available information such as market conditions and internally approved pricing guidelines related to the performance obligations. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">When determining the transaction price of a contract, an adjustment is made if payment from a customer occurs either significantly before or significantly after performance, resulting in a significant financing component. Applying the practical expedient in paragraph ASC 606-10-32-18, the Company does not assess whether a significant financing component exists if the period between when the Company performs its obligations under the contract and when the customer pays is one year or less. None of the Company’s contracts contained a significant financing component during the six months ended June 30, 2020 or 2019. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s contracts with its customers have a duration of less than one year. Therefore, the Company has elected to apply the practical expedient in paragraph ASC 340-40-25-4 and recognizes the incremental costs of obtaining contracts as an expense. These costs are included in sales and marketing expense in the accompanying condensed consolidated statements of comprehensive loss.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Lease Revenue </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company also enters into agreements to lease its capital equipment. For such sales, the Company accounts for revenue under ASC 840, Leases, and assesses and classifies these transactions as sales-type or operating leases based on whether the lease transfers ownership of the equipment to the lessee by the end of the lease term. This criterion is met in situations in which the lease agreement provides for the transfer of title at or shortly after the end of the lease term. Equipment included in arrangements including transfer of title are accounted for as sales-type leases and the Company recognizes the total value of the lease payments due over the lease term to revenue at the inception of the lease. The Company records the current value of future lease payments under prepaid expenses and other current assets in the accompanying condensed consolidated balance sheets; these amounts totaled $1.8 and $0.9 million at June 30, 2020 and December 31, 2019, respectively. Equipment included in arrangements that do not include the transfer of title, nor any of the capital lease criteria, are accounted for as operating leases and revenue is recognized on a straight-line basis as it becomes receivable monthly over the term of the lease. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company also enters into agreements involving the placement of Precision Flow capital units for use by the customer at no upfront charge in connection with the customer’s ongoing purchase of disposable products. In these bundled arrangements, revenue recognized for the sale of the disposables is allocated between disposable revenue and other lease revenue based on the estimated relative stand-alone selling prices of the individual performance obligations. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Shipping and Handling Costs </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amounts billed to customers for shipping and handling are included in service revenue. Shipping and handling costs are included in costs of sales. The total costs of shipping and handling for the three months ended June 30, 2020 and 2019 was $0.8 and $0.2 million, respectively. Shipping and handlings costs for the six months ended June 30, 2020 and 2019 totaled $1.1 and $0.5 million, respectively. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Sales and Value-Added Taxes </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">When required by local jurisdictions, the Company bills its customers for sales tax and value-added tax calculated on each sales invoice and records a liability for the sales and value-added tax payable, which is included in accrued expenses and other liabilities in the condensed consolidated balance sheets. Sales tax and value-added tax billed to a customer are not included in the Company’s revenue. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Timing and Amount of Revenue Recognition </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes revenue on product sales and service of its capital equipment and product sales of disposables to its end users. In each instance, revenue is generally recognized when the customer obtains control of the Company’s product, which generally occurs at a point in time upon shipment based on the contractual shipping terms of a contract. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product and service revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or services to a customer. To the extent the transaction price includes variable consideration, the Company estimates the amount of variable consideration that should be included in the transaction price utilizing the expected value amount method to which the Company expects to be entitled. As such, revenue on sales is recorded net of prompt pay discounts and payments made to GPOs, IDNs and distributors. Variable consideration is included in the transaction price if, in the Company’s judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. Determination of whether to include estimated amounts in the transaction price is based largely on an assessment of the Company’s anticipated performance and all information (historical, current and forecasted) that is reasonably available. The Company believes that the estimates it has established are reasonable based upon current facts and circumstances. Applying different judgments to the same facts and circumstances could result in different estimates. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Stock-Based Compensation </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company maintains an equity incentive plan to provide long-term incentives for employees, consultants, and members of the board of directors. The plan allows for the issuance of non-statutory and incentive stock options, restricted stock, unrestricted stock, stock units, including restricted stock units, and stock appreciation rights to employees, consultants and non-employee directors. The Company recognizes stock-based compensation expense for awards of equity instruments to employees and non-employees based on the grant date fair value of those awards in accordance with ASC Topic 718, Stock Compensation (“ASC 718”). ASC 718 requires all equity-based compensation awards, including grants of restricted shares and stock options, to be recognized as expense in the condensed consolidated statements of comprehensive loss based on their grant date fair values.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of each option grant is estimated on the grant date using the Black-Scholes option pricing model. The fair value is then amortized on a straight-line basis over the requisite service period of the awards, which is generally the vesting period. For performance-based awards, the related compensation cost is amortized over the performance period on an accelerated attribution basis. Compensation cost associated with performance awards is based on fair value on the date of grant and the number of units expected to be earned after assessing the probability that certain performance criteria will be met and the associated targeted payout level that is forecasted will be achieved. Cumulative adjustments are recorded each quarter to reflect estimated outcomes of the performance-related conditions until the results are determined and settled. Use of a valuation model requires management to make certain assumptions with respect to selected model inputs, including the expected life (weighted average period of time that the options granted are expected to be outstanding), the volatility of the Company’s common stock and an assumed risk-free interest rate. Expected volatility is calculated based on historical volatility of a group of publicly traded companies that the Company considers a peer group. The expected life is estimated using the simplified method for “plain vanilla” options. The risk-free interest rate is based on U.S. Treasury rates with a remaining term that approximates the expected life assumed at the date of grant. No dividend yield is assumed as the Company does not pay, and does not expect to pay, dividends on its common stock. The Company estimates forfeitures based on historical experience with pre-vested forfeitures. To the extent actual forfeitures differ from the estimate, the difference is recorded to compensation expense in the period of the forfeiture.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes stock-based expense</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shares issued pursuant to its 2018 Employee Stock Purchase Plan (“ESPP”) on a straight-line basis over the </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">related </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">offering period. The Company estimates the fair value of shares to be issued under the ESPP based on a combination of options valued</span><span style="font-weight:bold;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">using the Black-Scholes option</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">pricing model. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The expected life is determined based on the contractual term.</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> D</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ividend yield and forfeiture rates are </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">estimated in a manner similar to option grants described above</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and expected volatility is based on the Company’s historical volatility</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </span></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Income Tax </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accounts for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the condensed consolidated financial statements or in the Company’s tax returns. Deferred taxes are determined based on the difference between the financial reporting and tax basis of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of deferred tax assets will not be realized, a valuation allowance is established through a charge to income tax expense. Potential for recovery of deferred tax assets is evaluated by estimating the future taxable profits expected and considering prudent and feasible tax planning strategies. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accounts for uncertainty in income taxes recognized in the condensed consolidated financial statements by applying a two-step process to determine the amount of tax benefit to be recognized. First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities. If the tax position is deemed more likely than not to be sustained, the tax position is then assessed to determine the amount of benefit to recognize in the condensed consolidated financial statements. The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement. The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate as well as the related net interest and penalties. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s major tax jurisdictions are the United States, New Hampshire and the United Kingdom. There is no provision or benefit for income taxes for the three or six months ended June 30, 2020 or 2019 because the Company has historically incurred operating losses and maintains a full valuation allowance against its United States net deferred tax assets. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Utilization of the net operating loss and tax credit carryforwards may be subject to a substantial annual limitation under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended (the “Code”) due to ownership change limitations that have occurred previously or that could occur in the future. These ownership changes may limit the amount of net operating loss and tax credit carryforwards that can be utilized to offset future taxable income and reduce taxes, respectively. The Company has not currently completed an evaluation of ownership changes through June 30, 2020 or December 31, 2019 to assess whether utilization of the Company’s net operating loss and tax credit carryforwards would be subject to an annual limitation under Sections 382 and 383 of the Code. To the extent an ownership change is determined to have occurred under Sections 382 and 383 of the Code, the net operating loss and tax credit carryforwards may be subject to limitation. </p> <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Recently Issued Accounting Pronouncements </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As an emerging growth company (“EGC”), the Jumpstart Our Business Startups Act (the “JOBS Act”) allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The Company has elected to use the adoption dates applicable to private companies. As a result, the Company’s consolidated financial statements may not be comparable to the financial statements of issuers who are required to comply with the effective date for new or revised accounting standards that are applicable to public companies. The Company expects it will no longer qualify as an EGC as of December 31, 2020 and, at that time, will begin to adopt accounting pronouncements at dates applicable to public companies.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Leases (Topic 842): </span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) (“ASU 2016-02”). ASU 2016-02 establishes a comprehensive new lease accounting model. The new standard clarifies the definitions of a lease, requires a dual approach to lease classification similar to current lease classifications, and causes lessees to recognize leases on the balance sheet as a lease liability with a corresponding right-of-use asset for leases with a lease term of more than twelve months. In July 2018, the FASB issued ASU No. 2018-11 Leases (Topic 842) (“ASU 2018-11”) which provided another transition method in addition to the existing transition method by allowing entities to initially apply the new leases standard at the adoption date. In June 2020, the FASB issued ASU 2020-05, Revenue from Contracts with Customers (Topic 606) and Leases (Topic 842), which defers the effective date for ASU 2016-02 to annual periods beginning after December 15, 2021 and interim periods beginning after December 15, 2022 for private companies or EGCs following private company adoption dates. The standard was effective for public companies for periods beginning after December 31, 2018. The new standard originally required a modified retrospective transition for capital or operating leases existing at or entered into after the beginning of the earliest comparative period presented in the financial statements, but it does not require transition accounting for leases that expire prior to the date of the initial application. The Company expects to adopt the new standard in the fourth quarter of 2020. The Company is in the process of adopting the new standard, including evaluating completeness, measuring the impacts, establishing incremental borrowing rates, and designing and implementing processes and controls for adoption and post adoption periods. The Company expects the most significant effects of adoption to relate to (1) the recognition of new right-of-use assets and lease liabilities on the balance sheet for the Company’s facilities and certain other operating leases; and (2) the need to provide new disclosures about the Company’s leasing activities related to the amount, timing and uncertainty of cash flows arising from leases.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Credit Losses (Topic 326):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:8.37%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). This standard requires that credit losses be reported using an expected losses model rather than the incurred losses model that is currently used and establishes additional disclosures related to credit risks. <span style="color:#000000;">In November 2019, the FASB issued ASU 2019-10, Financial Instruments-Credit Losses (Topic 326), Derivative and Hedging (Topic 815) and Leases (Topic 842), which defers the effective date for ASU 2016-13 to interim and annual periods beginning after December 15, 2022 for private companies, EGCs following private company adoption dates, or public entities meeting the definition of smaller reporting companies as of the date of issuance of this update. The Company has not yet determined the effects, if any, that the adoption of ASU 2016-13 may have on its financial position, results of operations, cash flows, or disclosures. </span></p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Basis of Presentation</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). <span style="color:#000000;">The information included in this Quarterly Report on Form 10-Q should be read in conjunction with our audited consolidated financial statements and the accompanying notes included in our Annual Report on Form 10-K for the year ended December 31, 2019 (the “2019 Form 10-K”). Our accounting policies are described in the “</span><span style="font-style:italic;color:#000000;">Notes to Consolidated Financial Statements</span><span style="color:#000000;">” in our 2019 Form 10-K and updated, as necessary, in this report. The year-end </span>condensed<span style="color:#000000;"> consolidated balance sheet data presented for comparative purposes was derived from our audited financial statements but does not include all disclosures required by U.S. GAAP.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Principles of Consolidation </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These condensed consolidated financial statements include the financial statements of Solus Medical Ltd. (“Solus”), a wholly owned subsidiary of the Company based in the United Kingdom, which was acquired in the first quarter of 2019. All intercompany accounts and transactions have been eliminated upon consolidation. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Segment Information</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating segments are defined as components of an enterprise for which separate discrete financial information is available and evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company globally manages the business within one reporting segment, Vapotherm, Inc. and two reporting units, Vapotherm and Solus. Segment information is consistent with how management reviews the business, makes investing and resource allocation decisions and assesses operating performance. </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:8.37%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The majority of the Company’s long-term assets are located in the United States. Long-term assets located outside the United States total $0.1 million as of each of June 30, 2020 and December 31, 2019. </p> 1 2 100000 100000 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires the Company to make judgments, assumptions, and estimates that affect the reported amounts of assets, liabilities, revenue and expenses, and the related disclosure of contingent assets and liabilities. The Company evaluates its estimates on an ongoing basis. The Company bases its estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Significant estimates relied upon in preparing these condensed consolidated financial statements include calculation of stock-based compensation, valuation of warrants, fair values of acquired assets and liabilities, including goodwill and intangibles assets, realizability of inventories, allowance for bad debt, accrued expenses and the valuation allowances against deferred income tax assets. Actual results may differ from these estimates. </p> <p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Unaudited Interim Financial Information</p> <p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:8.37%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying<span style="color:#000000;"> condensed</span> consolidated balance sheet as of June 30, 2020, and the <span style="color:#000000;">condensed</span> consolidated statements of comprehensive loss, stockholders’ equity and of cash flows for the three and six months ended June 30, 2020 and 2019 are unaudited. The unaudited interim <span style="color:#000000;">condensed</span> consolidated financial statements have been prepared on the same basis as the audited annual consolidated financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of June 30, 2020 and the results of its operations and its cash flows for the three and six months ended June 30, 2020 and 2019. The financial data and other information disclosed in these notes related to the three and six months ended June 30, 2020 and 2019 are also unaudited. The results of operations for the three and six months ended June 30, 2020 are not necessarily indicative of the operating results for the full year or for any other subsequent interim period.</p> <p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Reclassification</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain amounts in 2019 have been reclassified to conform to the presentation in 2020. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentrations of Credit Risk </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of June 30, 2020, the Company’s financial instruments were comprised of cash and cash equivalents, restricted cash, accounts receivable, accounts payable and debt, the carrying amounts of which approximated fair value due to the short-term nature and market interest rates. All of the Company’s cash and cash equivalents are maintained at creditworthy financial institutions. At June 30, 2020, deposits exceed the amount of any insurance provided. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company extends credit to customers in the normal course of business but does not require collateral or any other security to support amounts due. Management performs ongoing credit evaluations of the Company’s customers. An allowance for potentially uncollectible accounts is provided based on history, economic conditions, and composition of the accounts receivable aging. In some cases, the Company makes allowances for specific customers based on these and other factors. Provisions for the allowance for doubtful accounts are recorded in general and administrative expenses in the accompanying condensed consolidated statements of comprehensive loss. </p> <p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Foreign Currency and Foreign Operations</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The functional currency of the Company is the currency of the primary economic environment in which the entity operates, which is the U.S. dollar. <span style="color:#000000;">For our non-U.S. subsidiary that transacts in a functional currency other than the U.S. dollar, assets and liabilities are translated at current rates of exchange as of the balance sheet date. Income and expense items are translated at the average foreign currency exchange rates for the period. Adjustments resulting from the translation of the financial statements of its foreign operations into U.S. dollars are excluded from the determination of net loss and are recorded in accumulated other comprehensive income (loss), a separate component of stockholders’ equity.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Realized foreign currency gains or losses arising from transactions denominated in foreign currencies are recorded in other (expense) income in the condensed consolidated statements of <span style="color:#000000;">comprehensive loss. </span>Unrealized foreign currency gains or losses arising from transactions denominated in foreign currencies are recorded in accumulated other comprehensive income (loss).</p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Cash, Cash Equivalents, and Restricted Cash</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:8.37%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company considers all highly liquid temporary investments purchased with original maturities of 90 days or less to be cash equivalents. The Company holds restricted cash related to certificates of deposits and collateral in relation to lease agreements. As <span style="Background-color:#FFFFFF;">of June 30, 2020, $0.5 million of our $150.2 million of cash, cash equivalents and restricted cash balance was located outside the United States.</span></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:8.37%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents the components of total cash, cash equivalents, and restricted cash as set forth in the Company’s condensed consolidated statements of cash flows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">148,344</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71,655</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,853</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,852</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash, cash equivalents, and restricted cash</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150,197</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73,507</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 90 days 500000 150200000 <p style="margin-top:2pt;margin-bottom:0pt;text-indent:8.37%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents the components of total cash, cash equivalents, and restricted cash as set forth in the Company’s condensed consolidated statements of cash flows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">148,344</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71,655</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,853</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,852</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash, cash equivalents, and restricted cash</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150,197</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73,507</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 148344000 71655000 1853000 1852000 150197000 73507000 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Product Warranty </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company provides its customers with a standard <span style="-sec-ix-hidden:F_000415">one-year</span> warranty on its capital equipment sales. Warranty costs are accrued based on actual historical trends and estimated at time of sale. The warranty liability is included within accrued expenses and other liabilities in the condensed consolidated balance sheets. A roll-forward of the Company’s warranty liability from December 31, 2019 to June 30, 2020 is as follows: </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">225</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provisions for warranty obligations</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">670</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Settlements</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(127</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at June 30, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">768</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> A roll-forward of the Company’s warranty liability from December 31, 2019 to June 30, 2020 is as follows: <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">225</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provisions for warranty obligations</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">670</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Settlements</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(127</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at June 30, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">768</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> 225000 670000 127000 768000 <p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Insurance </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effective January 1, 2020, the Company was self-insured for certain obligations related to health insurance. The Company also purchases stop-loss insurance to protect itself from material losses. Judgments and estimates are used in determining the potential value associated with reported claims and for events that have occurred but have not been reported. The Company’s estimates consider expected claim experience and other factors. Receivables for insurance recoveries are recorded as assets, on an undiscounted basis. The Company’s liabilities are based on estimates, and, while the Company believes that its accruals are adequate, the ultimate liability may be significantly different from the amounts recorded. Changes in claims experience, the Company’s ability to settle claims or other estimates and judgments used by management could have a material impact on the amount and timing of expense for any period. </p> <p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Revenue Recognition </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s revenue is primarily derived from the sale of products, leases and services. Product revenue consists of capital equipment and single-use disposables that are shipped and billed to customers both domestically and internationally. The Company’s main capital equipment products are the Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, Vapotherm Transfer Unit 2.0 and Q50 compressor. The Company’s main disposable products are single-use disposables and nasal interfaces, or cannulas, and adaptors. Lease revenue consists of two components which include capital equipment that the Company leases out to its customers and, in certain situations, an allocation from disposable revenue to other lease revenue upon the sale of disposable products in bundled arrangements involving the placement of Precision Flow capital units for use by the customer at no upfront charge in connection with the customer’s ongoing purchase of disposable products. Service revenue consists of fees associated with routine service of capital units and the sale of extended service contracts and preventative maintenance plans, which are purchased by a small portion of the Company’s customer base. In addition, the Company sells small quantities of component parts in the United States, United Kingdom and to third-party international service centers who provide service on Precision Flow capital units outside of the United States. Freight revenue is based upon actual freight costs plus a percentage markup of such costs associated with the shipment of products domestically, and to a lesser extent, internationally, and is included in service revenue. Rebates and fees consist of contractually obligated administrative fees and percentage-of-sales rebates paid to Group Purchasing Organizations (“GPOs”), Integrated Delivery Networks (“IDNs”) and distributor partners and accounted for as a reduction of service revenue. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under Financial Accounting Standard Board (“FASB”) Accounting Standards Codifications (“ASC”) 606, Revenue from Contracts with Customers (“ASC 606”), revenue is recognized when a customer obtains control of promised goods or services, in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and assesses whether each promised good or service is distinct and determines those that are performance obligations. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. Sales, value-added, and other taxes collected on behalf of third parties are excluded from revenue. The Company’s standard payment terms are generally 30 days from the date of sale. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contracts with customers may contain multiple performance obligations. For such arrangements, the transaction price is allocated to each performance obligation based on the estimated relative stand-alone selling prices of the promised products or services underlying each performance obligation. The Company determines stand-alone selling prices based on the price at which the performance obligation is sold separately. If the stand-alone selling price is not observable through past transactions, the Company estimates the stand-alone selling price taking into account available information such as market conditions and internally approved pricing guidelines related to the performance obligations. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">When determining the transaction price of a contract, an adjustment is made if payment from a customer occurs either significantly before or significantly after performance, resulting in a significant financing component. Applying the practical expedient in paragraph ASC 606-10-32-18, the Company does not assess whether a significant financing component exists if the period between when the Company performs its obligations under the contract and when the customer pays is one year or less. None of the Company’s contracts contained a significant financing component during the six months ended June 30, 2020 or 2019. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s contracts with its customers have a duration of less than one year. Therefore, the Company has elected to apply the practical expedient in paragraph ASC 340-40-25-4 and recognizes the incremental costs of obtaining contracts as an expense. These costs are included in sales and marketing expense in the accompanying condensed consolidated statements of comprehensive loss.</p> P30D When determining the transaction price of a contract, an adjustment is made if payment from a customer occurs either significantly before or significantly after performance, resulting in a significant financing component. Applying the practical expedient in paragraph ASC 606-10-32-18, the Company does not assess whether a significant financing component exists if the period between when the Company performs its obligations under the contract and when the customer pays is one year or less. 0 0 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Lease Revenue </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company also enters into agreements to lease its capital equipment. For such sales, the Company accounts for revenue under ASC 840, Leases, and assesses and classifies these transactions as sales-type or operating leases based on whether the lease transfers ownership of the equipment to the lessee by the end of the lease term. This criterion is met in situations in which the lease agreement provides for the transfer of title at or shortly after the end of the lease term. Equipment included in arrangements including transfer of title are accounted for as sales-type leases and the Company recognizes the total value of the lease payments due over the lease term to revenue at the inception of the lease. The Company records the current value of future lease payments under prepaid expenses and other current assets in the accompanying condensed consolidated balance sheets; these amounts totaled $1.8 and $0.9 million at June 30, 2020 and December 31, 2019, respectively. Equipment included in arrangements that do not include the transfer of title, nor any of the capital lease criteria, are accounted for as operating leases and revenue is recognized on a straight-line basis as it becomes receivable monthly over the term of the lease. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company also enters into agreements involving the placement of Precision Flow capital units for use by the customer at no upfront charge in connection with the customer’s ongoing purchase of disposable products. In these bundled arrangements, revenue recognized for the sale of the disposables is allocated between disposable revenue and other lease revenue based on the estimated relative stand-alone selling prices of the individual performance obligations. </p> 1800000 900000 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Shipping and Handling Costs </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amounts billed to customers for shipping and handling are included in service revenue. Shipping and handling costs are included in costs of sales. The total costs of shipping and handling for the three months ended June 30, 2020 and 2019 was $0.8 and $0.2 million, respectively. Shipping and handlings costs for the six months ended June 30, 2020 and 2019 totaled $1.1 and $0.5 million, respectively. </p> 800000 200000 1100000 500000 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Sales and Value-Added Taxes </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">When required by local jurisdictions, the Company bills its customers for sales tax and value-added tax calculated on each sales invoice and records a liability for the sales and value-added tax payable, which is included in accrued expenses and other liabilities in the condensed consolidated balance sheets. Sales tax and value-added tax billed to a customer are not included in the Company’s revenue. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Timing and Amount of Revenue Recognition </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes revenue on product sales and service of its capital equipment and product sales of disposables to its end users. In each instance, revenue is generally recognized when the customer obtains control of the Company’s product, which generally occurs at a point in time upon shipment based on the contractual shipping terms of a contract. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product and service revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or services to a customer. To the extent the transaction price includes variable consideration, the Company estimates the amount of variable consideration that should be included in the transaction price utilizing the expected value amount method to which the Company expects to be entitled. As such, revenue on sales is recorded net of prompt pay discounts and payments made to GPOs, IDNs and distributors. Variable consideration is included in the transaction price if, in the Company’s judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. Determination of whether to include estimated amounts in the transaction price is based largely on an assessment of the Company’s anticipated performance and all information (historical, current and forecasted) that is reasonably available. The Company believes that the estimates it has established are reasonable based upon current facts and circumstances. Applying different judgments to the same facts and circumstances could result in different estimates. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Stock-Based Compensation </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company maintains an equity incentive plan to provide long-term incentives for employees, consultants, and members of the board of directors. The plan allows for the issuance of non-statutory and incentive stock options, restricted stock, unrestricted stock, stock units, including restricted stock units, and stock appreciation rights to employees, consultants and non-employee directors. The Company recognizes stock-based compensation expense for awards of equity instruments to employees and non-employees based on the grant date fair value of those awards in accordance with ASC Topic 718, Stock Compensation (“ASC 718”). ASC 718 requires all equity-based compensation awards, including grants of restricted shares and stock options, to be recognized as expense in the condensed consolidated statements of comprehensive loss based on their grant date fair values.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of each option grant is estimated on the grant date using the Black-Scholes option pricing model. The fair value is then amortized on a straight-line basis over the requisite service period of the awards, which is generally the vesting period. For performance-based awards, the related compensation cost is amortized over the performance period on an accelerated attribution basis. Compensation cost associated with performance awards is based on fair value on the date of grant and the number of units expected to be earned after assessing the probability that certain performance criteria will be met and the associated targeted payout level that is forecasted will be achieved. Cumulative adjustments are recorded each quarter to reflect estimated outcomes of the performance-related conditions until the results are determined and settled. Use of a valuation model requires management to make certain assumptions with respect to selected model inputs, including the expected life (weighted average period of time that the options granted are expected to be outstanding), the volatility of the Company’s common stock and an assumed risk-free interest rate. Expected volatility is calculated based on historical volatility of a group of publicly traded companies that the Company considers a peer group. The expected life is estimated using the simplified method for “plain vanilla” options. The risk-free interest rate is based on U.S. Treasury rates with a remaining term that approximates the expected life assumed at the date of grant. No dividend yield is assumed as the Company does not pay, and does not expect to pay, dividends on its common stock. The Company estimates forfeitures based on historical experience with pre-vested forfeitures. To the extent actual forfeitures differ from the estimate, the difference is recorded to compensation expense in the period of the forfeiture.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes stock-based expense</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shares issued pursuant to its 2018 Employee Stock Purchase Plan (“ESPP”) on a straight-line basis over the </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">related </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">offering period. The Company estimates the fair value of shares to be issued under the ESPP based on a combination of options valued</span><span style="font-weight:bold;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">using the Black-Scholes option</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">pricing model. </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The expected life is determined based on the contractual term.</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> D</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ividend yield and forfeiture rates are </span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">estimated in a manner similar to option grants described above</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and expected volatility is based on the Company’s historical volatility</span><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </span></p> 0 <p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Income Tax </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accounts for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the condensed consolidated financial statements or in the Company’s tax returns. Deferred taxes are determined based on the difference between the financial reporting and tax basis of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of deferred tax assets will not be realized, a valuation allowance is established through a charge to income tax expense. Potential for recovery of deferred tax assets is evaluated by estimating the future taxable profits expected and considering prudent and feasible tax planning strategies. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accounts for uncertainty in income taxes recognized in the condensed consolidated financial statements by applying a two-step process to determine the amount of tax benefit to be recognized. First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities. If the tax position is deemed more likely than not to be sustained, the tax position is then assessed to determine the amount of benefit to recognize in the condensed consolidated financial statements. The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement. The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate as well as the related net interest and penalties. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s major tax jurisdictions are the United States, New Hampshire and the United Kingdom. There is no provision or benefit for income taxes for the three or six months ended June 30, 2020 or 2019 because the Company has historically incurred operating losses and maintains a full valuation allowance against its United States net deferred tax assets. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Utilization of the net operating loss and tax credit carryforwards may be subject to a substantial annual limitation under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended (the “Code”) due to ownership change limitations that have occurred previously or that could occur in the future. These ownership changes may limit the amount of net operating loss and tax credit carryforwards that can be utilized to offset future taxable income and reduce taxes, respectively. The Company has not currently completed an evaluation of ownership changes through June 30, 2020 or December 31, 2019 to assess whether utilization of the Company’s net operating loss and tax credit carryforwards would be subject to an annual limitation under Sections 382 and 383 of the Code. To the extent an ownership change is determined to have occurred under Sections 382 and 383 of the Code, the net operating loss and tax credit carryforwards may be subject to limitation. </p> 0 0 0 0 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Recently Issued Accounting Pronouncements </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As an emerging growth company (“EGC”), the Jumpstart Our Business Startups Act (the “JOBS Act”) allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The Company has elected to use the adoption dates applicable to private companies. As a result, the Company’s consolidated financial statements may not be comparable to the financial statements of issuers who are required to comply with the effective date for new or revised accounting standards that are applicable to public companies. The Company expects it will no longer qualify as an EGC as of December 31, 2020 and, at that time, will begin to adopt accounting pronouncements at dates applicable to public companies.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Leases (Topic 842): </span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) (“ASU 2016-02”). ASU 2016-02 establishes a comprehensive new lease accounting model. The new standard clarifies the definitions of a lease, requires a dual approach to lease classification similar to current lease classifications, and causes lessees to recognize leases on the balance sheet as a lease liability with a corresponding right-of-use asset for leases with a lease term of more than twelve months. In July 2018, the FASB issued ASU No. 2018-11 Leases (Topic 842) (“ASU 2018-11”) which provided another transition method in addition to the existing transition method by allowing entities to initially apply the new leases standard at the adoption date. In June 2020, the FASB issued ASU 2020-05, Revenue from Contracts with Customers (Topic 606) and Leases (Topic 842), which defers the effective date for ASU 2016-02 to annual periods beginning after December 15, 2021 and interim periods beginning after December 15, 2022 for private companies or EGCs following private company adoption dates. The standard was effective for public companies for periods beginning after December 31, 2018. The new standard originally required a modified retrospective transition for capital or operating leases existing at or entered into after the beginning of the earliest comparative period presented in the financial statements, but it does not require transition accounting for leases that expire prior to the date of the initial application. The Company expects to adopt the new standard in the fourth quarter of 2020. The Company is in the process of adopting the new standard, including evaluating completeness, measuring the impacts, establishing incremental borrowing rates, and designing and implementing processes and controls for adoption and post adoption periods. The Company expects the most significant effects of adoption to relate to (1) the recognition of new right-of-use assets and lease liabilities on the balance sheet for the Company’s facilities and certain other operating leases; and (2) the need to provide new disclosures about the Company’s leasing activities related to the amount, timing and uncertainty of cash flows arising from leases.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Credit Losses (Topic 326):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:8.37%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). This standard requires that credit losses be reported using an expected losses model rather than the incurred losses model that is currently used and establishes additional disclosures related to credit risks. <span style="color:#000000;">In November 2019, the FASB issued ASU 2019-10, Financial Instruments-Credit Losses (Topic 326), Derivative and Hedging (Topic 815) and Leases (Topic 842), which defers the effective date for ASU 2016-13 to interim and annual periods beginning after December 15, 2022 for private companies, EGCs following private company adoption dates, or public entities meeting the definition of smaller reporting companies as of the date of issuance of this update. The Company has not yet determined the effects, if any, that the adoption of ASU 2016-13 may have on its financial position, results of operations, cash flows, or disclosures. </span></p> <p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">3. Business Combinations</p> <p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:8.37%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On February 28, 2019, the Company completed the acquisition of all outstanding equity securities of <span style="color:#222222;">Solus, </span>whose principal assets included intangible assets related to supplier agreements. The Company undertook the acquisition to accelerate its penetration in the United Kingdom market. The purchase price, net of cash acquired, of $2.0 million was funded with an initial cash payment of approximately $1.6 million and a settlement of a $0.4 million receivable from a preexisting relationship. Additionally, the Company recognized $1.0 million in contingent consideration as compensation expense during 2019 and expects to recognize contingent consideration of $1.2 million as compensation expense in 2020. The acquisition has been accounted for as an acquisition of a business.</p> <p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:8.37%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the purchase price allocation that includes the fair values of the separately identifiable assets acquired and liabilities assumed as of February 28, 2019:</p> <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.3%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.3%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">466</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable</p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.3%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">411</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventory</p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.3%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">492</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaids and other assets</p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.3%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment</p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.3%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill</p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.3%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">592</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.8%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets</p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">455</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets acquired</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.3%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,420</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable and accrued expenses</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.3%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(241</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contract liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.3%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(75</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.8%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred taxes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.3%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(78</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.8%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities assumed</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.3%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(394</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.8%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total purchase price</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.3%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,026</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.3%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:8.37%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The excess of purchase consideration over the fair value of net tangible and identifiable intangible assets acquired was recorded as goodwill. The fair values assigned to tangible and identifiable intangible assets acquired and liabilities assumed are based on management’s estimates and assumptions. </p> <p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:8.37%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In determining the purchase price allocation, the Company considered, among other factors, the opportunity provided by a supplier agreement with the National Health Service. The fair value of the intangible assets associated with this agreement were estimated using a discounted cash flow method with the application of the multi-period excess earnings method. Under this method, an intangible asset’s fair value is equal to the present value of the incremental after-tax cash flows attributable to only the subject intangible assets after deducting contributory asset charges. An income and expenses forecast was built based upon specific intangible asset revenue and expense estimates.</p> <p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:8.37%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The rate used to discount the estimated future net cash flows to their present values for each intangible asset was based upon a weighted average cost of capital calculation. The discount rate was determined after consideration of market rates of return on debt and equity capital, the weighted average return on invested capital and the risk associated with achieving forecasted sales related to the assets acquired from <span style="color:#222222;">Solus.</span></p> <p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:8.37%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The total weighted average amortization period for the intangible assets is approximately 3.83 years. The intangible assets are being amortized on a straight-line basis, which is consistent with the pattern that the economic benefits of the intangible assets are expected to be utilized based upon estimated cash flows generated from such assets. Goodwill associated with the acquisition was primarily attributable to the market expansion opportunity in the United Kingdom. The goodwill attributable to the United Kingdom jurisdiction is not deductible for tax purposes.</p> <p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has included the financial results of Solus in the condensed consolidated financial statements from the date of acquisition. The transaction costs associated with the acquisition were approximately $0.2 million and were recorded in general and administrative expense as incurred during 2019.</p> <p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Pro Forma Financial Information</span></p> <p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:8.37%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following unaudited pro forma information for the three and six months ended June 30, 2019 presents consolidated information as if the Solus acquisition occurred on January 1, 2019, which is the first day of the Company’s fiscal year 2019:</p> <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:8.37%;font-family:Times New Roman;font-size:11pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.64%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.64%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended June 30,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.42%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six Months Ended June 30,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.64%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.42%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.64%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net revenue</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,986</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,522</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.64%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(12,880</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(25,788</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.64%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share, basic</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.76</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.52</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> </table></div> 2019-02-28 2000000.0 1600000 400000 1000000.0 1200000 The following table summarizes the purchase price allocation that includes the fair values of the separately identifiable assets acquired and liabilities assumed as of February 28, 2019: <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.3%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.3%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">466</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable</p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.3%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">411</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventory</p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.3%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">492</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaids and other assets</p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.3%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment</p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.3%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill</p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.3%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">592</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.8%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets</p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">455</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets acquired</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.3%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,420</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable and accrued expenses</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.3%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(241</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contract liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.3%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(75</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.8%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred taxes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.3%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(78</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.8%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities assumed</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.3%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(394</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.8%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total purchase price</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.3%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,026</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.3%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 466000 411000 492000 3000 1000 592000 455000 2420000 241000 75000 78000 394000 2026000 P3Y9M29D 200000 <p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:8.37%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following unaudited pro forma information for the three and six months ended June 30, 2019 presents consolidated information as if the Solus acquisition occurred on January 1, 2019, which is the first day of the Company’s fiscal year 2019:</p> <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:8.37%;font-family:Times New Roman;font-size:11pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.64%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.64%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended June 30,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.42%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six Months Ended June 30,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:54.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.64%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.42%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.64%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net revenue</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,986</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,522</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.64%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(12,880</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(25,788</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.64%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share, basic</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.76</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.42%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.52</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> </table></div> 11986000 24522000 -12880000 -25788000 -0.76 -1.52 <p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">4. Fair Value Measurements </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accordance with ASC 820, Fair Value Measurements and Disclosures, the Company generally defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company uses a three-tier fair value hierarchy, which classifies the inputs used in measuring fair values. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements), and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are described below: </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:8.37%;white-space:nowrap" valign="top"> <p style="margin-top:2pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"> </p></td> <td style="width:3.52%;white-space:nowrap" valign="top"> <p style="margin-top:2pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">•</span></p></td> <td valign="top"> <p style="margin-top:2pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-style:italic;font-family:Times New Roman;">Level 1 – </span><span style="font-family:Times New Roman;">inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. </span></p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.41%;text-indent:-7.04%;font-family:Times New Roman;font-size:11pt;"> </p> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:8.37%;white-space:nowrap" valign="top"> <p style="margin-top:2pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"> </p></td> <td style="width:3.52%;white-space:nowrap" valign="top"> <p style="margin-top:2pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">•</span></p></td> <td valign="top"> <p style="margin-top:2pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-style:italic;font-family:Times New Roman;">Level 2 –</span><span style="font-family:Times New Roman;"> inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. If the asset or liability has a specified (contractual) term, a Level 2 input must be observable for substantially the full term of the asset or liability. </span></p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.41%;text-indent:-7.04%;font-family:Times New Roman;font-size:11pt;"> </p> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:8.37%;white-space:nowrap" valign="top"> <p style="margin-top:2pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"> </p></td> <td style="width:3.52%;white-space:nowrap" valign="top"> <p style="margin-top:2pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">•</span></p></td> <td valign="top"> <p style="margin-top:2pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-style:italic;font-family:Times New Roman;">Level 3 – </span><span style="font-family:Times New Roman;">inputs are unobservable inputs for the asset or liability in which there is little, if any, market activity for the asset or liability at the measurement date. </span></p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s cash equivalents primarily consist of money market deposits which total approximately $132.8 million at June 30, 2020 and are valued based on Level 1 of the fair value hierarchy. As described in Note 8 “Debt”, during 2019, the Company granted warrants to purchase 19,789 shares of common stock in connection with an amendment to its financing arrangement. These equity-classified warrants were valued using the Black-Scholes pricing model, which falls within Level 3 of the fair value hierarchy. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The assumptions used in the Black-Scholes pricing model were as follows at the date of grant:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:8.37%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.14%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend yield</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.14%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk free interest rate</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.4</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.14%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected stock price volatility</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60.9</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.14%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (years)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000467">10.0</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> 132800000 19789 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The assumptions used in the Black-Scholes pricing model were as follows at the date of grant:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:8.37%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.14%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend yield</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.14%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk free interest rate</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.4</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.14%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected stock price volatility</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60.9</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.14%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (years)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000467">10.0</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 0.000 0.024 0.609 <p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">5. Accounts Receivable </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable consists of the following: </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,614</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,574</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">International</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,428</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,908</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accounts receivable</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,042</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,482</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Allowance for doubtful accounts</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(590</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(239</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable, net of allowance for doubtful</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   accounts</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,452</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,243</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:2pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">No individual customer accounted for 10% or more of revenue for the three or six months ended June 30, 2020 or 2019. No individual customers accounted for 10% or more of total accounts receivable at either June 30, 2020 or December 31, 2019.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable consists of the following: </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,614</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,574</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">International</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,428</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,908</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accounts receivable</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,042</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,482</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Allowance for doubtful accounts</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(590</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(239</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable, net of allowance for doubtful</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   accounts</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,452</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,243</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 10614000 5574000 6428000 2908000 17042000 8482000 590000 239000 16452000 8243000 0 0 0 0 0.10 0.10 0.10 0.10 0 0 0.10 0.10 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">6. Inventories </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventories consist of the following: </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Component parts</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,010</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,948</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finished goods</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,631</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,189</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total inventory</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,641</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,137</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventories consist of the following: </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Component parts</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,010</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,948</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finished goods</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,631</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,189</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total inventory</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,641</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,137</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 9010000 4948000 9631000 4189000 18641000 9137000 <p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">7. Goodwill and Intangible Assets</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The changes in the carrying amount of goodwill and intangible assets during 2020 are as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:8.37%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Goodwill</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intangible Assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">588</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">353</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired during the period</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(56</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign currency exchange rate changes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(41</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(22</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at June 30, 2020</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">547</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">275</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:8.37%;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:8.37%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The following table presents a summary of acquired intangible assets:</span></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:7.04%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.12%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of June 30, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Period of</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">amortization</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Carrying</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer agreements</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000503">3.83</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">423</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(148</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total identifiable intangible assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">423</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(148</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"> </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The changes in the carrying amount of goodwill and intangible assets during 2020 are as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:8.37%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Goodwill</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intangible Assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">588</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">353</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired during the period</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(56</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign currency exchange rate changes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(41</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(22</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at June 30, 2020</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">547</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">275</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 588000 353000 56000 -41000 -22000 547000 275000 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:8.37%;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:8.37%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The following table presents a summary of acquired intangible assets:</span></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:7.04%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.12%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of June 30, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Period of</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">amortization</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Carrying</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer agreements</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000503">3.83</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">423</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(148</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.44%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total identifiable intangible assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">423</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.4%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(148</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> </table></div> 423000 148000 423000 148000 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">8. Debt </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Revolving Credit Line </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On November 16, 2016, the Company entered a Business Financing Agreement (the “Revolver Agreement”) with Western Alliance Bank, an Arizona corporation, which replaced its then-existing revolving line of credit. The Revolver Agreement made available $7.0 million of revolving credit upon the closing date. Availability under the Revolver Agreement is calculated based upon 80% of the eligible receivables (net of pre-paid deposits, pre-billed invoices, other offsets, and contras related to each specific account debtor). The original maturity date was September 30, 2018. The Company refinanced the Revolver Agreement in April 2018, increasing the credit line to $7.5 million and extending the maturity date to September 30, 2020 (the “Amended Revolver Agreement”). The principal is due upon maturity. <span style="color:#000000;">On March 22, 2019, the Company entered into an amendment to the Amended </span>Revolver Agreement <span style="color:#000000;">(as amended, the “2019 Amended Revolver Agreement”), which increased the allowable permitted indebtedness under the 2019 Amended Revolver Agreement in connection with the Company’s credit card program from $0.3 million to $0.5 million. On July 7, 2020, the Company entered into a second amendment to the Amended Revolver Agreement (as amended, the “2020 Amended Revolver Agreement”) which, under certain circumstances, reduces the amount of funds required to be held on deposit with Western Alliance Bank.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At June 30, 2020 the interest rate was 5.25%. The outstanding balance under the 2020 Amended Revolver Agreement was $4.5 million at June 30, 2020 and there was $3.0 million remaining availability based on eligible receivables. At December 31, 2019, the interest rate was 6.50%. The outstanding balance under the 2019 Amended <span style="color:#000000;">Revolver Agreement </span>was $3.5 million at December 31, 2019 and the remaining availability based on eligible receivables was $0.8 million. The 2020 Amended Revolver Agreement requires the Company to comply with a minimum liquidity covenant at all times. As of June 30, 2020, the Company was in compliance with all covenants. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The 2020 Amended Revolving Agreement is secured by substantially all of the Company’s assets, excluding intellectual property. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Term Loans </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:8.37%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On April 6, 2018, the Company entered into a Credit Agreement and Guaranty (the “Credit Agreement and Guaranty”) with Perceptive Credit Holdings II, LP (“Perceptive”). Pursuant to the Credit Agreement and Guaranty, a total of $42.5 million was available in three tranches. The first tranche was drawn down in the amount of $20.0 million on the closing date, April 6, 2018, which paid off a former loan agreement in full.<span style="Background-color:#FFFFFF;"> </span>In connection with this draw down, the Company granted Perceptive warrants to purchase 37,693 shares of Series D preferred stock which were converted into warrants to purchase shares of common stock at the time of the initial public offering. The warrants had an exercise price of $15.92 per share, were fully vested upon issuance, were exercisable at the option of the holder, in whole or in part, and would have expired in April 2028.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:8.37%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On July 20, 2018, pursuant to the Credit Agreement and Guaranty, the Company drew down the second tranche of $10.0 million. In connection with this draw down, the Company granted Perceptive warrants to purchase 18,846 shares of Series D preferred stock which were converted into warrants to purchase shares of common stock at the time of the initial public offering. The warrants had an exercise price of $15.92 per share, were fully vested upon issuance, were exercisable at the option of the holder, in whole or in part, and would have expired in July 2028.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:8.37%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On September 27, 2018, the Company entered into the first amendment to the Credit Agreement and Guaranty (as amended, the “Amended Credit Agreement and Guaranty”) with Perceptive. Pursuant to the Amended Credit Agreement and Guaranty, the Company was permitted to draw the final $12.5 million of availability at any time through March 31, 2019 and the minimum 2018 revenue requirement of $43.2 million that was required to draw down the final tranche was eliminated. Concurrently with the closing of the Amendment, the Company drew down $2.0 million of the remaining $12.5 million available. In connection with this draw down, the Company granted to Perceptive warrants to purchase 3,769 shares of its Series D preferred stock which were converted into warrants to purchase shares of common stock at the time of the initial public offering. The warrants had an exercise price of $15.92 per share, were fully vested upon issuance, were exercisable at the option of the holder, in whole or in part, and would have expired in September 2028.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March 22, 2019, the Company drew the remaining $10.5 million of availability under the Amended Credit Agreement and Guaranty. In connection with this draw down, the Company granted Perceptive warrants to purchase 19,789 shares of common stock. The warrants had an exercise price of $15.92 per share, were fully vested upon issuance, were exercisable at the option of the holder, in whole or in part, and would have expired in March 2029. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March 22, 2019, the Company entered into a second amendment to the Amended Credit Agreement and Guaranty increasing the allowable permitted indebtedness in connection with the Company’s credit card program from $0.3 million to $0.5 million. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On June 10, 2020, Perceptive exercised all of its outstanding warrants. See Note 10 “Warrants” for further details.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On June 16, 2020, the Company entered into a third amendment to the Amended Credit Agreement and Guaranty (the “2020 Amended Credit Agreement and Guaranty”), which amended the prepayment premium by clarifying the methodology for calculating Perceptive’s annualized internal rate of return under the term loan.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the 2020 Amended Credit Agreement and Guaranty, the outstanding principal amount accrues interest at an annual rate equal to 9.06% plus the greater of (a) one-month LIBOR and (b) 1.75% per year. At June 30, 2020, the interest rate was 10.81%. The outstanding balance, including accretion of the additional final payment due upon maturity and described below, was $42.6 million at June 30, 2020 and there was no remaining availability. The 2020 Amended Credit Agreement and Guaranty is secured by substantially all of the Company’s assets, including intellectual property.<span style="font-size:12pt;"> </span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On the maturity date, in addition to the payment of principal and accrued interest, the Company will be required to make a payment of 0.5% of the total amount borrowed under the 2020 Amended Credit Agreement and Guaranty unless the Company has already made such a payment in connection with an acceleration or prepayment of borrowings under the agreement. In the event the Company prepays all or part of the amounts borrowed under the 2020 Amended Credit and Guaranty prior to the maturity date, the Company will be subject to additional prepayment fees which decrease as the time to maturity decreases. The 2020 Amended Credit Agreement and Guaranty requires the Company to comply with a minimum liquidity covenant at all times and a minimum revenue covenant measured at the end of each fiscal quarter. As of June 30, 2020, the Company was in compliance with all covenants. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The annual principal maturities of the Company’s term loans as of June 30, 2020 are as follows: </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;"> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,592</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Discount on loans payable</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(663</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.2%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term loans payable</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41,929</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;"> </p> 7000000.0 0.80 2018-09-30 7500000 2020-09-30 300000 500000 0.0525 4500000 3000000.0 0.0650 3500000 800000 42500000 3 20000000.0 37693 15.92 2028-04 10000000.0 18846 15.92 2028-07 12500000 43200000 2000000.0 3769 15.92 2028-09 10500000 19789 15.92 2029-03 300000 500000 0.0906 one-month LIBOR 0.0175 0.1081 42600000 0 0.005 The 2020 Amended Credit Agreement and Guaranty requires the Company to comply with a minimum liquidity covenant at all times and a minimum revenue covenant measured at the end of each fiscal quarter. As of June 30, 2020, the Company was in compliance with all covenants. <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The annual principal maturities of the Company’s term loans as of June 30, 2020 are as follows: </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;"> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,592</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Discount on loans payable</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(663</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.2%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term loans payable</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41,929</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 0 0 0 42592000 663000 41929000 <p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">9. Commitments and Contingencies </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Legal Matters </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From time to time, the Company may become involved in various legal proceedings, including those that may arise in the ordinary course of business. The Company believes there is no litigation pending that could have, individually, or in the aggregate, a material adverse effect on the results of its operations or financial condition.</p> <p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">10. Warrants</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s warrant activity is summarized as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.4%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Common Stock Warrants</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">182,076</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14.84</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants granted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants exercised</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(80,097</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15.92</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at June 30, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101,979</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14.00</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On June 10, 2020, a warrant to purchase 80,097 shares of common stock was exercised on a net exercise basis. Upon exercise, the exercise price of $15.92 per share was satisfied through the Company’s withholding of 39,031 of the warrant shares and issuing 41,066 shares of common stock. </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:8.37%;font-size:12pt;font-family:Times New Roman;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On July 10, 2020, a warrant to purchase 20,891 shares of common stock held was exercised on a net exercise basis. Upon exercise, the exercise price of $14.00 per share was satisfied through the Company’s withholding of 6,905 of the warrant shares and issuing 13,986 shares of common stock to the holder. </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s warrant activity is summarized as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.4%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Common Stock Warrants</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">182,076</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14.84</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants granted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants exercised</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(80,097</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15.92</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at June 30, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101,979</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14.00</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 182076 14.84 80097 15.92 101979 14.00 80097 15.92 39031 41066 20891 14.00 6905 13986 <p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">11. Revenue</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Disaggregated Revenue </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table shows the Company’s net revenue disaggregated into categories the Company considers meaningful to depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors: </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.28%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.8%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended June 30,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.9%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six Months Ended June 30,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.8%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.9%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">US</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">International</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">US</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">International</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Net revenue by:</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product Revenue</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Capital Equipment</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,079</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,226</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,305</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,380</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,923</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,303</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Disposable</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,441</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,722</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,163</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,135</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,458</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,593</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subtotal Product Revenue</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,520</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,948</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,468</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,515</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,381</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49,896</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease Revenue</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Capital Equipment</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,620</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,634</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,247</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,278</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">435</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">511</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">752</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">151</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">903</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Service and Other Revenue</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">107</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">432</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">539</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">509</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">681</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,190</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.28%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total Revenue</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,682</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,470</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35,152</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,023</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,244</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,267</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.28%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.8%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended June 30,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.9%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six Months Ended June 30,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.8%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.9%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">US</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">International</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">US</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">International</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Net revenue by:</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product Revenue</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Capital Equipment</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,599</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,046</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,645</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,109</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,551</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,660</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Disposable</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,514</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,016</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,530</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,061</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,488</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,549</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subtotal Product Revenue</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,113</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,062</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,175</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,170</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,039</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,209</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease Revenue</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">284</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">284</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">947</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">947</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Service and Other Revenue</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">281</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">246</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">527</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">610</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">519</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,129</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.28%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total Revenue</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,678</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,308</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,986</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,727</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,558</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,285</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:2pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States and International net revenue is based on the customer location to which the product is shipped. No individual foreign country represents more than 10% of the Company’s total revenue. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Contract Balances from Contracts with Customers</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contract liabilities consist of deferred revenue and other contract liabilities associated with rebates and fees payable to GPOs, IDNs and distributor partners. Deferred revenues are included in accrued expenses and other liabilities in the accompanying consolidated balance sheets. The following table presents changes in contract liabilities during the six months ended June 30, 2020:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contract</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Deferred</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">137</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">344</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additions</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">261</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,195</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subtractions</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(137</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(469</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at June 30, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">261</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,070</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table shows the Company’s net revenue disaggregated into categories the Company considers meaningful to depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors: </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.28%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.8%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended June 30,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.9%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six Months Ended June 30,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.8%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.9%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">US</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">International</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">US</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">International</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Net revenue by:</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product Revenue</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Capital Equipment</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,079</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,226</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,305</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,380</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,923</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,303</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Disposable</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,441</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,722</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,163</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,135</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,458</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,593</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subtotal Product Revenue</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,520</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,948</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,468</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,515</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,381</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49,896</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease Revenue</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Capital Equipment</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,620</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,634</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,247</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,278</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">435</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">511</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">752</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">151</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">903</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Service and Other Revenue</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">107</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">432</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">539</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">509</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">681</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,190</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.28%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total Revenue</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,682</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,470</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35,152</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,023</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,244</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,267</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.28%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.8%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended June 30,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.9%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six Months Ended June 30,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.8%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.9%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">US</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">International</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">US</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">International</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Net revenue by:</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product Revenue</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Capital Equipment</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,599</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,046</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,645</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,109</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,551</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,660</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Disposable</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,514</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,016</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,530</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,061</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,488</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,549</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subtotal Product Revenue</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,113</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,062</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,175</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,170</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,039</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,209</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease Revenue</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">284</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">284</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">947</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">947</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Service and Other Revenue</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">281</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">246</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">527</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">610</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">519</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,129</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.28%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total Revenue</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,678</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,308</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,986</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,727</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,558</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.28%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,285</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 14079000 5226000 19305000 17380000 6923000 24303000 9441000 3722000 13163000 19135000 6458000 25593000 23520000 8948000 32468000 36515000 13381000 49896000 1620000 14000 1634000 2247000 31000 2278000 435000 76000 511000 752000 151000 903000 107000 432000 539000 509000 681000 1190000 25682000 9470000 35152000 40023000 14244000 54267000 1599000 1046000 2645000 3109000 1551000 4660000 6514000 2016000 8530000 14061000 3488000 17549000 8113000 3062000 11175000 17170000 5039000 22209000 284000 284000 947000 947000 281000 246000 527000 610000 519000 1129000 8678000 3308000 11986000 18727000 5558000 24285000 The following table presents changes in contract liabilities during the six months ended June 30, 2020: <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contract</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Deferred</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">137</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">344</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additions</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">261</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,195</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subtractions</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(137</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(469</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at June 30, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">261</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,070</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> 137000 344000 261000 1195000 137000 469000 261000 1070000 <p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">12. Stock-Based Compensation</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense was allocated based on the employees’ and non-employees’ functions as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.62%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six Months Ended</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of goods sold</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">74</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.12%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">145</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">138</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">199</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.12%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">400</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">255</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales and marketing</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">480</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">246</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.12%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">920</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">759</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">624</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">449</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,359</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,463</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,377</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">712</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,824</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,615</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Stock Options</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-bottom:0pt;margin-top:2pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company granted options to purchase 938,910 shares of common stock at exercise prices ranging from $10.60 to $39.01 per share, with a weighted average exercise price of $12.47 per share, during the six months ended June 30, 2020. The Company granted options to purchase 776,196 shares of common stock at exercise prices ranging from $17.15 to $19.28 per share, with a weighted average exercise price of $17.18 per share, during the six months ended June 30, 2019. The weighted average fair value of stock options granted during the six months ended June 30, 2020 and 2019 was $9.16 and $11.97, respectively. </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The weighted average assumptions used in the Black-Scholes options pricing model are as follows: </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six Months Ended June 30,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.5%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend yield</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.5%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk free interest rate</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.7</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.5</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.5%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected stock price volatility</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">87.6</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70.0</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.5%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (years)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000691">6.1</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000692">7.1</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Restricted Stock</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of restricted stock activity for the six months ended June 30, 2020 is as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Grant Date</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Unvested at December 31, 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">229,913</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.76</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted/purchased</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53,445</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.31</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(76,063</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.44</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Canceled</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(500</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.97</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Unvested at June 30, 2020</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">206,795</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.02</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Employee Stock Purchase Plan</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;"> </p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with our initial public offering in November 2018, the Company’s board of directors adopted the ESPP and a total of 166,500 shares of common stock were initially reserved for issuance under the ESPP. The number of shares of common stock available for issuance under the ESPP is increased on the first day of each calendar year beginning January 1, 2019 and each year thereafter until 2028 by the lessor of (i) 1% of the number of shares of common stock issued and outstanding on the immediately preceding December 31, and (ii) the number of shares of common stock determined by the Company’s board of directors up to such an initial maximum of 1,741,300 shares of common stock. The number of shares of common stock reserved under the plan at June 30, 2020 totals 512,048. </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-bottom:0pt;margin-top:2pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The ESPP provides for successive discreet offering periods of approximately six months or as determined by the plan administrator. The first offering period began on January 2, 2020. As of June 30, 2020, 36,389 shares of common stock were purchased by employees under the ESPP at a price of $9.88 per share, resulting in cash proceeds of $0.4 million. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The ESPP permits eligible employees to elect to purchase shares of common stock through fixed whole percentage contributions from eligible compensation during each offering period, not to exceed 10% of the eligible compensation a participant receives during an offering period and not to accrue at a rate which exceeds $25,000 of the fair value of the stock (determined on the grant date(s)) for each calendar year. A participant may purchase the lower of (a) a number of shares of common stock determined by dividing such participant’s accumulated payroll deductions on the exercise date by the option price, (b) 5,000 shares, or (c) such other lesser maximum number of shares as shall have been established by the plan administrator. </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amounts deducted and accumulated by the participant will be used to purchase shares of common stock at the end of each offering period. The purchase price of the shares will be 85% of the lower of the fair value of common stock on the first trading day of each offering period or on the purchase date. Participants may end their participation during an offering period up to ten days in advance of the exercise date and will be paid their accumulated contributions that have not been used to purchase shares of common stock. Participation ends automatically upon termination of employment.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of the purchase right for the ESPP option is estimated on the date of grant using the Black-Scholes pricing model with the following assumptions during 2020:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;"> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend yield</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.9%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk free interest rate</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.9%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000716">0.2% - 1.6%</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected stock price volatility</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.9%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000718">107.9% - 115.8%</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (years)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.9%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000720">0.4 - 0.5</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense was allocated based on the employees’ and non-employees’ functions as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.62%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six Months Ended</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of goods sold</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">74</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.12%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">145</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">138</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">199</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.12%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">400</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">255</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales and marketing</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">480</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">246</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.12%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">920</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">759</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">624</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">449</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,359</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,463</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,377</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">712</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,824</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,615</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 74000 27000 145000 138000 199000 -10000 400000 255000 480000 246000 920000 759000 624000 449000 1359000 1463000 1377000 712000 2824000 2615000 938910 10.60 39.01 12.47 776196 17.15 19.28 17.18 9.16 11.97 <p style="margin-top:2pt;margin-bottom:0pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The weighted average assumptions used in the Black-Scholes options pricing model are as follows: </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six Months Ended June 30,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.5%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend yield</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.5%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk free interest rate</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.7</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.5</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.5%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected stock price volatility</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">87.6</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70.0</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.5%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (years)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000691">6.1</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000692">7.1</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 0.000 0.000 0.017 0.025 0.876 0.700 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of restricted stock activity for the six months ended June 30, 2020 is as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Grant Date</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Unvested at December 31, 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">229,913</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.76</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted/purchased</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53,445</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.31</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(76,063</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.44</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Canceled</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(500</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.97</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Unvested at June 30, 2020</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">206,795</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.02</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 229913 3.76 53445 13.31 76063 3.44 500 10.97 206795 4.02 166500 The number of shares of common stock available for issuance under the ESPP is increased on the first day of each calendar year beginning January 1, 2019 and each year thereafter until 2028 by the lessor of (i) 1% of the number of shares of common stock issued and outstanding on the immediately preceding December 31, and (ii) the number of shares of common stock determined by the Company’s board of directors up to such an initial maximum of 1,741,300 shares of common stock. The number of shares of common stock reserved under the plan at June 30, 2020 totals 512,048. 0.01 1741300 512048 36389 9.88 400000 0.10 25000 5000 0.85 <p style="margin-top:2pt;margin-bottom:0pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of the purchase right for the ESPP option is estimated on the date of grant using the Black-Scholes pricing model with the following assumptions during 2020:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;"> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend yield</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.9%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk free interest rate</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.9%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000716">0.2% - 1.6%</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected stock price volatility</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.9%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000718">107.9% - 115.8%</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.88%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (years)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.9%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000720">0.4 - 0.5</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 0.000 <p style="margin-bottom:0pt;margin-top:2pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">13. Net Loss Per Share<span style="font-style:italic;"> </span></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company excluded the following potential common shares, based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.4%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of June 30,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options to purchase common stock</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,826,614</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,397,432</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants to purchase common stock</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101,979</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">182,076</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested restricted stock</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">206,795</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">305,220</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee stock purchase plan shares</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,473</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,154,861</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,884,728</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company excluded the following potential common shares, based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.4%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of June 30,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options to purchase common stock</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,826,614</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,397,432</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants to purchase common stock</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101,979</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">182,076</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unvested restricted stock</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">206,795</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">305,220</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee stock purchase plan shares</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,473</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.94%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,154,861</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,884,728</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 1826614 1397432 101979 182076 206795 305220 19473 2154861 1884728 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">14. Related Party Transactions</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:8.37%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Note 8 “Debt” for a discussion of the Company’s Amended Credit Agreement and Guaranty and related transactions with Perceptive, a holder of more than 5% of the Company’s common stock.</p> 0.05 XML 14 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2020
Jul. 29, 2020
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Jun. 30, 2020  
Document Fiscal Year Focus 2020  
Document Fiscal Period Focus Q2  
Entity Registrant Name Vapotherm, Inc.  
Entity Central Index Key 0001253176  
Current Fiscal Year End Date --12-31  
Entity Filer Category Accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Common Stock, Shares Outstanding   25,570,243
Entity Shell Company false  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity File Number 001-38740  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 46-2259298  
Entity Address, Address Line One 100 Domain Drive  
Entity Address, City or Town Exeter  
Entity Address, State or Province NH  
Entity Address, Postal Zip Code 03833  
City Area Code 603  
Local Phone Number 658-0011  
Document Quarterly Report true  
Document Transition Report false  
Title of 12(b) Security Common Stock, $0.001 par value per share  
Trading Symbol VAPO  
Security Exchange Name NYSE  
XML 15 R2.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Current assets    
Cash and cash equivalents $ 148,344 $ 71,655
Accounts receivable, net 16,452 8,243
Inventories 18,641 9,137
Prepaid expenses and other current assets 4,500 4,066
Total current assets 187,937 93,101
Property and equipment, net 17,204 15,086
Restricted cash 1,853 1,852
Goodwill 547 588
Intangible assets, net 275 353
Deferred income tax assets 66 66
Other long-term assets 954 844
Total assets 208,836 111,890
Current liabilities    
Accounts payable 6,789 3,375
Contract liabilities 261 137
Accrued expenses and other current liabilities 15,801 9,187
Short-term line of credit 4,492 3,491
Total current liabilities 27,343 16,190
Long-term loans payable, net 41,929 41,787
Other long-term liabilities 604 174
Total liabilities 69,876 58,151
Commitments and contingencies (Note 9)
Stockholders' equity    
Preferred stock ($0.001 par value) 25,000,000 shares authorized; no shares issued and outstanding as of June 30, 2020 and December 31, 2019
Common stock ($0.001 par value) 175,000,000 shares authorized as of June 30, 2020 and December 31, 2019, 25,493,058 and 20,851,531 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively 26 21
Additional paid-in capital 426,282 319,115
Accumulated other comprehensive income (loss) (31) 44
Accumulated deficit (287,317) (265,441)
Total stockholders' equity 138,960 53,739
Total liabilities and stockholders’ equity $ 208,836 $ 111,890
XML 16 R3.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (Unaudited) - $ / shares
Jun. 30, 2020
Dec. 31, 2019
Statement Of Financial Position [Abstract]    
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 25,000,000 25,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 175,000,000 175,000,000
Common stock, shares issued 25,493,058 20,851,531
Common stock, shares outstanding 25,493,058 20,851,531
XML 17 R4.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Income Statement [Abstract]        
Net revenue $ 35,152 $ 11,986 $ 54,267 $ 24,285
Cost of revenue 17,544 6,527 27,442 13,647
Gross profit 17,608 5,459 26,825 10,638
Operating expenses        
Research and development 3,895 3,167 7,257 6,440
Sales and marketing 14,858 9,432 28,175 18,593
General and administrative 5,627 4,532 10,878 9,411
Total operating expenses 24,380 17,131 46,310 34,444
Loss from operations (6,772) (11,672) (19,485) (23,806)
Other (expense) income        
Foreign currency loss (25)   (1) (9)
Interest income 60 213 185 416
Interest expense (1,295) (1,421) (2,590) (2,445)
Other     15  
Net loss (8,032) (12,880) (21,876) (25,844)
Other comprehensive income (loss), net of tax:        
Foreign currency translation adjustments (4) 2 (75) 2
Total other comprehensive income (loss) (4) 2 (75) 2
Total comprehensive loss $ (8,036) $ (12,878) $ (21,951) $ (25,842)
Net loss per share attributable to common stockholders - basic and diluted $ (0.35) $ (0.76) $ (0.99) $ (1.52)
Weighted-average number of shares used in calculating net loss per share, basic and diluted 23,090,613 17,055,628 21,986,774 17,019,002
XML 18 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCK STOCKHOLDERS' EQUITY (unaudited) - USD ($)
$ in Thousands
Total
At-The-Market offering
Common Stock
Common Stock
At-The-Market offering
Additional Paid-in Capital
Additional Paid-in Capital
At-The-Market offering
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2018 $ 51,561   $ 17   $ 265,926     $ (214,382)
Beginning balance, shares at Dec. 31, 2018     16,782,837          
Issuance of common stock upon exercise of options, shares     268          
Issuance of common stock warrants 293       293      
Issuance of restricted stock 226       226      
Issuance of restricted stock, shares     116,580          
Stock-based compensation expense 1,903       1,903      
Net loss (12,964)             (12,964)
Ending balance at Mar. 31, 2019 41,019   $ 17   268,348     (227,346)
Ending balance, shares at Mar. 31, 2019     16,899,685          
Beginning balance at Dec. 31, 2018 51,561   $ 17   265,926     (214,382)
Beginning balance, shares at Dec. 31, 2018     16,782,837          
Net loss (25,844)              
Ending balance at Jun. 30, 2019 29,349   $ 17   269,556   $ 2 (240,226)
Ending balance, shares at Jun. 30, 2019     17,166,368          
Beginning balance at Mar. 31, 2019 41,019   $ 17   268,348     (227,346)
Beginning balance, shares at Mar. 31, 2019     16,899,685          
Issuance of common stock upon exercise of options 193       193      
Issuance of common stock upon exercise of options, shares     122,497          
Issuance of common stock upon repayment of non-recourse loan 144       144      
Issuance of common stock upon repayment of non-recourse loan, Shares     79,854          
Issuance of common stock upon exercise of warrants, shares     12,164          
Issuance of restricted stock 159       159      
Issuance of restricted stock, shares     52,168          
Stock-based compensation expense 712       712      
Foreign currency translation adjustments 2           2  
Net loss (12,880)             (12,880)
Ending balance at Jun. 30, 2019 29,349   $ 17   269,556   2 (240,226)
Ending balance, shares at Jun. 30, 2019     17,166,368          
Beginning balance at Dec. 31, 2019 53,739   $ 21   319,115   44 (265,441)
Beginning balance, shares at Dec. 31, 2019     20,851,531          
Issuance of common stock upon exercise of warrants 40       40      
Issuance of common stock upon exercise of warrants, shares     24,687          
Issuance of restricted stock 58       58      
Issuance of restricted stock, shares     40,931          
Stock-based compensation expense 1,447       1,447      
Foreign currency translation adjustments (71)           (71)  
Net loss (13,844)             (13,844)
Ending balance at Mar. 31, 2020 41,369   $ 21   320,660   (27) (279,285)
Ending balance, shares at Mar. 31, 2020     20,917,149          
Beginning balance at Dec. 31, 2019 53,739   $ 21   319,115   44 (265,441)
Beginning balance, shares at Dec. 31, 2019     20,851,531          
Issuance of common stock under the Employee Stock Purchase Plan, shares     36,389          
Net loss (21,876)              
Ending balance at Jun. 30, 2020 138,960   $ 26   426,282   (31) (287,317)
Ending balance, shares at Jun. 30, 2020     25,493,058          
Beginning balance at Mar. 31, 2020 41,369   $ 21   320,660   (27) (279,285)
Beginning balance, shares at Mar. 31, 2020     20,917,149          
Issuance of common stock, net 93,827 $ 9,784 $ 4 $ 1 93,823 $ 9,783    
Issuance of common stock, net, Shares     3,852,500 511,648        
Issuance of common stock upon exercise of options 227       227      
Issuance of common stock upon exercise of options, shares     99,206          
Issuance of common stock under the Employee Stock Purchase Plan 359       359      
Issuance of common stock under the Employee Stock Purchase Plan, shares     36,389          
Issuance of common stock upon exercise of warrants, shares     41,066          
Issuance of restricted stock 53       53      
Issuance of restricted stock, shares     35,100          
Stock-based compensation expense 1,377       1,377      
Foreign currency translation adjustments (4)           (4)  
Net loss (8,032)             (8,032)
Ending balance at Jun. 30, 2020 $ 138,960   $ 26   $ 426,282   $ (31) $ (287,317)
Ending balance, shares at Jun. 30, 2020     25,493,058          
XML 19 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Cash flows from operating activities    
Net loss $ (21,876) $ (25,844)
Adjustments to reconcile net loss to net cash used in operating activities    
Stock-based compensation expense 2,824 2,615
Depreciation and amortization 2,148 1,407
Provision for bad debts 282 64
Provision for inventories (327) 697
Loss on disposal of property and equipment 3 81
Amortization of discount on debt 127 108
Changes in operating assets and liabilities, net of acquisition:    
Accounts receivable (8,542) 144
Inventories (9,204) 2,292
Prepaid expenses and other assets (547) 398
Accounts payable 3,380 (1,229)
Contract liabilities 125 (16)
Accrued expenses and other current liabilities 6,932 397
Net cash used in operating activities (24,675) (18,886)
Cash flows from investing activities    
Purchases of property and equipment (3,839) (2,164)
Acquisition of business, net of cash acquired   (1,560)
Net cash used in investing activities (3,839) (3,724)
Cash flows from financing activities    
Proceeds from issuance of common stock 94,156  
Common stock offering costs (471)  
Short-term line of credit 995 (7)
Proceeds from exercise of stock options and purchase of restricted stock 267 337
Proceeds on loans   10,500
Debt issuance costs   (322)
Net cash provided by financing activities 105,232 10,508
Effect of exchange rate changes on cash, cash equivalents and restricted cash (28) (13)
Net increase (decrease) in cash, cash equivalents and restricted cash 76,690 (12,115)
Cash, cash equivalents and restricted cash    
Beginning of period 73,507 60,022
End of period 150,197 47,907
Supplemental disclosures of cash flow information    
Interest paid during the period 2,422 2,290
Property and equipment purchases in accounts payable and accrued expenses 341 115
Issuance of warrants in conjunction with debt draw down   293
Issuance of common stock upon vesting of restricted stock 111 $ 385
At-The-Market offering    
Cash flows from financing activities    
Proceeds from issuance of common stock 9,926  
Employee Stock Purchase Plan    
Cash flows from financing activities    
Proceeds from issuance of common stock under the Employee Stock Purchase Plan $ 359  
XML 20 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Description of Business
6 Months Ended
Jun. 30, 2020
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Description of Business

1. Description of Business

Vapotherm, Inc. (the “Company”) was founded in 1993 and reincorporated under the laws of the State of Delaware in 2013. Since inception, the Company has focused on the development and commercialization of its proprietary high velocity products that are used to treat patients of all ages suffering from respiratory distress. The Company’s high velocity therapy delivers non-invasive ventilatory support by providing heated, humidified and oxygenated air at a high velocity to patients through a comfortable small-bore nasal interface. The Company’s Precision Flow systems, which use high velocity therapy, are clinically validated alternatives to, and address many limitations of, the current standard of care for the treatment of respiratory distress in a hospital setting.

The Company offers four versions of its Precision Flow systems: Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic and Precision Flow Heliox. The Company generates revenue from sales of its Precision Flow systems and related disposable products utilized with its Precision Flow systems. The Company also generates revenue from sales of the Precision Flow system’s companion products, which include the Vapotherm Transfer Unit 2.0, the Q50 compressor and various adaptors. The Company offers different options to its hospital customers for acquiring Precision Flow capital units, ranging from the purchase of the Precision Flow capital units with payment in full at the time of purchase, to financed purchases of the Precision Flow capital units, to bundled discounts involving the placement of Precision Flow capital units for use by the customer at no upfront charge in connection with the customer’s ongoing purchase of disposable products.

The Company sells Precision Flow systems to hospitals through a direct sales force in the United States and in the United Kingdom and through distributors in select other countries outside of the United States and United Kingdom. In addition, the Company utilizes clinical educators who are typically experienced users of high velocity therapy and who focus on medical education efforts to facilitate adoption and increase utilization. The Company is focused on physicians, respiratory therapists and nurses who work in acute hospital settings, including the emergency department (“ED”) and adult, pediatric and neonatal intensive care units (the “ICUs”). The Company’s relationship with these clinicians is particularly important, as it enables its products to follow patients through the care continuum.

In March 2020, the World Health Organization declared a global pandemic related to the novel coronavirus (“COVID-19”). The Company’s high velocity therapy is a first-line therapy for treating respiratory distress, which is experienced by many COVID-19 patients. The Journal of the American Medical Association published data from mainland China in April 2020 suggesting that 19% of all COVID-19 patients experience respiratory distress and require some amount of respiratory support. The Company’s hospital customers around the world are using its technology to support the respiratory distress experienced by many COVID-19 patients so that they can triage their sickest patients using a limited number of ventilators. As a result, the Company has seen a significant increase in worldwide demand for its products from both new and existing accounts in the first six months of 2020.

Since inception, the Company has financed its operations primarily through public offerings of its common stock, private placements of its convertible preferred stock, sales of its Precision Flow systems and amounts borrowed under its credit facilities. The Company has devoted the majority of its resources to research and development activities related to its Precision Flow systems, including regulatory initiatives and sales and marketing activities. The Company has invested heavily in its sales and marketing function by increasing the number of sales representatives and clinical educators to facilitate adoption and increase utilization of its high velocity therapy products and expanded its digital marketing initiatives and medical education programs.

The Company is subject to risks common to companies in the medical device industry, including, but not limited to, risks relating to the successful development and commercialization of its Precision Flow products, fluctuations in operating results and financial risks, protection of proprietary knowledge and patent risks, dependence on key personnel and collaborative partners, competition, technological and manufacturing risks, customer acceptance and demand, compliance with the Food and Drug Administration and other governmental regulations, management of growth and effectiveness of marketing by the Company and by third parties.

On November 16, 2018, the Company completed an initial public offering of 4,600,000 shares of common stock, which included the full exercise by the underwriters of their option to purchase 600,000 shares of common stock, at a price of $14.00 per share, which raised net proceeds of $57.4 million after deducting the underwriting discount of $4.5 million and offering expenses of $2.5 million.

On February 28, 2019, the Company acquired its United Kingdom based distributor. See Note 3 “Business Combinations” to these condensed consolidated financial statements for details of this transaction.

In August 2019, the Company completed a public offering of 3,570,750 shares of common stock, which included the full exercise by the underwriters of their option to purchase 465,750 shares of common stock, at a price of $14.50 per share, which raised net proceeds of $48.3 million after deducting the underwriting discount of $3.1 million and offering expenses of $0.4 million.

On December 20, 2019, the Company entered into an Open Market Sales Agreement (the “ATM Agreement”) with Jefferies LLC (“Jefferies”) under which the Company may offer and sell its common stock having aggregate sales proceeds of up to $50.0 million from time to time through Jefferies as its sales agents. During April 2020, the Company sold 511,648 shares of common stock pursuant to the ATM Agreement for gross proceeds of $10.2 million, or $9.8 million net of commissions and offering expenses.

In May 2020, the Company completed a public offering of 3,852,500 shares of common stock, which included the full exercise by the underwriters of their option to purchase 502,500 shares of common stock, at a price of $26.00 per share, which raised net proceeds of $93.8 million after deducting the underwriting discount of $6.0 million and offering expenses of $0.3 million.

 

XML 21 R8.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies
6 Months Ended
Jun. 30, 2020
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

 

Basis of Presentation

 

The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The information included in this Quarterly Report on Form 10-Q should be read in conjunction with our audited consolidated financial statements and the accompanying notes included in our Annual Report on Form 10-K for the year ended December 31, 2019 (the “2019 Form 10-K”). Our accounting policies are described in the “Notes to Consolidated Financial Statements” in our 2019 Form 10-K and updated, as necessary, in this report. The year-end condensed consolidated balance sheet data presented for comparative purposes was derived from our audited financial statements but does not include all disclosures required by U.S. GAAP.

Principles of Consolidation

These condensed consolidated financial statements include the financial statements of Solus Medical Ltd. (“Solus”), a wholly owned subsidiary of the Company based in the United Kingdom, which was acquired in the first quarter of 2019. All intercompany accounts and transactions have been eliminated upon consolidation.

Segment Information

Operating segments are defined as components of an enterprise for which separate discrete financial information is available and evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company globally manages the business within one reporting segment, Vapotherm, Inc. and two reporting units, Vapotherm and Solus. Segment information is consistent with how management reviews the business, makes investing and resource allocation decisions and assesses operating performance.

 

The majority of the Company’s long-term assets are located in the United States. Long-term assets located outside the United States total $0.1 million as of each of June 30, 2020 and December 31, 2019.

Use of Estimates

The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires the Company to make judgments, assumptions, and estimates that affect the reported amounts of assets, liabilities, revenue and expenses, and the related disclosure of contingent assets and liabilities. The Company evaluates its estimates on an ongoing basis. The Company bases its estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Significant estimates relied upon in preparing these condensed consolidated financial statements include calculation of stock-based compensation, valuation of warrants, fair values of acquired assets and liabilities, including goodwill and intangibles assets, realizability of inventories, allowance for bad debt, accrued expenses and the valuation allowances against deferred income tax assets. Actual results may differ from these estimates.

Unaudited Interim Financial Information

The accompanying condensed consolidated balance sheet as of June 30, 2020, and the condensed consolidated statements of comprehensive loss, stockholders’ equity and of cash flows for the three and six months ended June 30, 2020 and 2019 are unaudited. The unaudited interim condensed consolidated financial statements have been prepared on the same basis as the audited annual consolidated financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of June 30, 2020 and the results of its operations and its cash flows for the three and six months ended June 30, 2020 and 2019. The financial data and other information disclosed in these notes related to the three and six months ended June 30, 2020 and 2019 are also unaudited. The results of operations for the three and six months ended June 30, 2020 are not necessarily indicative of the operating results for the full year or for any other subsequent interim period.

 

Reclassification

Certain amounts in 2019 have been reclassified to conform to the presentation in 2020.

Concentrations of Credit Risk

As of June 30, 2020, the Company’s financial instruments were comprised of cash and cash equivalents, restricted cash, accounts receivable, accounts payable and debt, the carrying amounts of which approximated fair value due to the short-term nature and market interest rates. All of the Company’s cash and cash equivalents are maintained at creditworthy financial institutions. At June 30, 2020, deposits exceed the amount of any insurance provided.

The Company extends credit to customers in the normal course of business but does not require collateral or any other security to support amounts due. Management performs ongoing credit evaluations of the Company’s customers. An allowance for potentially uncollectible accounts is provided based on history, economic conditions, and composition of the accounts receivable aging. In some cases, the Company makes allowances for specific customers based on these and other factors. Provisions for the allowance for doubtful accounts are recorded in general and administrative expenses in the accompanying condensed consolidated statements of comprehensive loss.

 

Foreign Currency and Foreign Operations

The functional currency of the Company is the currency of the primary economic environment in which the entity operates, which is the U.S. dollar. For our non-U.S. subsidiary that transacts in a functional currency other than the U.S. dollar, assets and liabilities are translated at current rates of exchange as of the balance sheet date. Income and expense items are translated at the average foreign currency exchange rates for the period. Adjustments resulting from the translation of the financial statements of its foreign operations into U.S. dollars are excluded from the determination of net loss and are recorded in accumulated other comprehensive income (loss), a separate component of stockholders’ equity.

Realized foreign currency gains or losses arising from transactions denominated in foreign currencies are recorded in other (expense) income in the condensed consolidated statements of comprehensive loss. Unrealized foreign currency gains or losses arising from transactions denominated in foreign currencies are recorded in accumulated other comprehensive income (loss).

 

Cash, Cash Equivalents, and Restricted Cash

 

The Company considers all highly liquid temporary investments purchased with original maturities of 90 days or less to be cash equivalents. The Company holds restricted cash related to certificates of deposits and collateral in relation to lease agreements. As of June 30, 2020, $0.5 million of our $150.2 million of cash, cash equivalents and restricted cash balance was located outside the United States.

 

The following table presents the components of total cash, cash equivalents, and restricted cash as set forth in the Company’s condensed consolidated statements of cash flows:

 

 

 

June 30,

2020

 

 

December 31,

2019

 

Cash and cash equivalents

 

$

148,344

 

 

$

71,655

 

Restricted cash

 

 

1,853

 

 

 

1,852

 

Total cash, cash equivalents, and restricted cash

 

$

150,197

 

 

$

73,507

 

 

Product Warranty

 

The Company provides its customers with a standard one-year warranty on its capital equipment sales. Warranty costs are accrued based on actual historical trends and estimated at time of sale. The warranty liability is included within accrued expenses and other liabilities in the condensed consolidated balance sheets. A roll-forward of the Company’s warranty liability from December 31, 2019 to June 30, 2020 is as follows:

 

Balance at December 31, 2019

 

$

225

 

Provisions for warranty obligations

 

 

670

 

Settlements

 

 

(127

)

Balance at June 30, 2020

 

$

768

 

 

Insurance

Effective January 1, 2020, the Company was self-insured for certain obligations related to health insurance. The Company also purchases stop-loss insurance to protect itself from material losses. Judgments and estimates are used in determining the potential value associated with reported claims and for events that have occurred but have not been reported. The Company’s estimates consider expected claim experience and other factors. Receivables for insurance recoveries are recorded as assets, on an undiscounted basis. The Company’s liabilities are based on estimates, and, while the Company believes that its accruals are adequate, the ultimate liability may be significantly different from the amounts recorded. Changes in claims experience, the Company’s ability to settle claims or other estimates and judgments used by management could have a material impact on the amount and timing of expense for any period.

 

Revenue Recognition

The Company’s revenue is primarily derived from the sale of products, leases and services. Product revenue consists of capital equipment and single-use disposables that are shipped and billed to customers both domestically and internationally. The Company’s main capital equipment products are the Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, Vapotherm Transfer Unit 2.0 and Q50 compressor. The Company’s main disposable products are single-use disposables and nasal interfaces, or cannulas, and adaptors. Lease revenue consists of two components which include capital equipment that the Company leases out to its customers and, in certain situations, an allocation from disposable revenue to other lease revenue upon the sale of disposable products in bundled arrangements involving the placement of Precision Flow capital units for use by the customer at no upfront charge in connection with the customer’s ongoing purchase of disposable products. Service revenue consists of fees associated with routine service of capital units and the sale of extended service contracts and preventative maintenance plans, which are purchased by a small portion of the Company’s customer base. In addition, the Company sells small quantities of component parts in the United States, United Kingdom and to third-party international service centers who provide service on Precision Flow capital units outside of the United States. Freight revenue is based upon actual freight costs plus a percentage markup of such costs associated with the shipment of products domestically, and to a lesser extent, internationally, and is included in service revenue. Rebates and fees consist of contractually obligated administrative fees and percentage-of-sales rebates paid to Group Purchasing Organizations (“GPOs”), Integrated Delivery Networks (“IDNs”) and distributor partners and accounted for as a reduction of service revenue.

Under Financial Accounting Standard Board (“FASB”) Accounting Standards Codifications (“ASC”) 606, Revenue from Contracts with Customers (“ASC 606”), revenue is recognized when a customer obtains control of promised goods or services, in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and assesses whether each promised good or service is distinct and determines those that are performance obligations. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. Sales, value-added, and other taxes collected on behalf of third parties are excluded from revenue. The Company’s standard payment terms are generally 30 days from the date of sale.

Contracts with customers may contain multiple performance obligations. For such arrangements, the transaction price is allocated to each performance obligation based on the estimated relative stand-alone selling prices of the promised products or services underlying each performance obligation. The Company determines stand-alone selling prices based on the price at which the performance obligation is sold separately. If the stand-alone selling price is not observable through past transactions, the Company estimates the stand-alone selling price taking into account available information such as market conditions and internally approved pricing guidelines related to the performance obligations.

When determining the transaction price of a contract, an adjustment is made if payment from a customer occurs either significantly before or significantly after performance, resulting in a significant financing component. Applying the practical expedient in paragraph ASC 606-10-32-18, the Company does not assess whether a significant financing component exists if the period between when the Company performs its obligations under the contract and when the customer pays is one year or less. None of the Company’s contracts contained a significant financing component during the six months ended June 30, 2020 or 2019.

The Company’s contracts with its customers have a duration of less than one year. Therefore, the Company has elected to apply the practical expedient in paragraph ASC 340-40-25-4 and recognizes the incremental costs of obtaining contracts as an expense. These costs are included in sales and marketing expense in the accompanying condensed consolidated statements of comprehensive loss.

Lease Revenue

The Company also enters into agreements to lease its capital equipment. For such sales, the Company accounts for revenue under ASC 840, Leases, and assesses and classifies these transactions as sales-type or operating leases based on whether the lease transfers ownership of the equipment to the lessee by the end of the lease term. This criterion is met in situations in which the lease agreement provides for the transfer of title at or shortly after the end of the lease term. Equipment included in arrangements including transfer of title are accounted for as sales-type leases and the Company recognizes the total value of the lease payments due over the lease term to revenue at the inception of the lease. The Company records the current value of future lease payments under prepaid expenses and other current assets in the accompanying condensed consolidated balance sheets; these amounts totaled $1.8 and $0.9 million at June 30, 2020 and December 31, 2019, respectively. Equipment included in arrangements that do not include the transfer of title, nor any of the capital lease criteria, are accounted for as operating leases and revenue is recognized on a straight-line basis as it becomes receivable monthly over the term of the lease.

The Company also enters into agreements involving the placement of Precision Flow capital units for use by the customer at no upfront charge in connection with the customer’s ongoing purchase of disposable products. In these bundled arrangements, revenue recognized for the sale of the disposables is allocated between disposable revenue and other lease revenue based on the estimated relative stand-alone selling prices of the individual performance obligations.

Shipping and Handling Costs

Amounts billed to customers for shipping and handling are included in service revenue. Shipping and handling costs are included in costs of sales. The total costs of shipping and handling for the three months ended June 30, 2020 and 2019 was $0.8 and $0.2 million, respectively. Shipping and handlings costs for the six months ended June 30, 2020 and 2019 totaled $1.1 and $0.5 million, respectively.

Sales and Value-Added Taxes

When required by local jurisdictions, the Company bills its customers for sales tax and value-added tax calculated on each sales invoice and records a liability for the sales and value-added tax payable, which is included in accrued expenses and other liabilities in the condensed consolidated balance sheets. Sales tax and value-added tax billed to a customer are not included in the Company’s revenue.

Timing and Amount of Revenue Recognition

The Company recognizes revenue on product sales and service of its capital equipment and product sales of disposables to its end users. In each instance, revenue is generally recognized when the customer obtains control of the Company’s product, which generally occurs at a point in time upon shipment based on the contractual shipping terms of a contract.

Product and service revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or services to a customer. To the extent the transaction price includes variable consideration, the Company estimates the amount of variable consideration that should be included in the transaction price utilizing the expected value amount method to which the Company expects to be entitled. As such, revenue on sales is recorded net of prompt pay discounts and payments made to GPOs, IDNs and distributors. Variable consideration is included in the transaction price if, in the Company’s judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. Determination of whether to include estimated amounts in the transaction price is based largely on an assessment of the Company’s anticipated performance and all information (historical, current and forecasted) that is reasonably available. The Company believes that the estimates it has established are reasonable based upon current facts and circumstances. Applying different judgments to the same facts and circumstances could result in different estimates.

Stock-Based Compensation

The Company maintains an equity incentive plan to provide long-term incentives for employees, consultants, and members of the board of directors. The plan allows for the issuance of non-statutory and incentive stock options, restricted stock, unrestricted stock, stock units, including restricted stock units, and stock appreciation rights to employees, consultants and non-employee directors. The Company recognizes stock-based compensation expense for awards of equity instruments to employees and non-employees based on the grant date fair value of those awards in accordance with ASC Topic 718, Stock Compensation (“ASC 718”). ASC 718 requires all equity-based compensation awards, including grants of restricted shares and stock options, to be recognized as expense in the condensed consolidated statements of comprehensive loss based on their grant date fair values.

The fair value of each option grant is estimated on the grant date using the Black-Scholes option pricing model. The fair value is then amortized on a straight-line basis over the requisite service period of the awards, which is generally the vesting period. For performance-based awards, the related compensation cost is amortized over the performance period on an accelerated attribution basis. Compensation cost associated with performance awards is based on fair value on the date of grant and the number of units expected to be earned after assessing the probability that certain performance criteria will be met and the associated targeted payout level that is forecasted will be achieved. Cumulative adjustments are recorded each quarter to reflect estimated outcomes of the performance-related conditions until the results are determined and settled. Use of a valuation model requires management to make certain assumptions with respect to selected model inputs, including the expected life (weighted average period of time that the options granted are expected to be outstanding), the volatility of the Company’s common stock and an assumed risk-free interest rate. Expected volatility is calculated based on historical volatility of a group of publicly traded companies that the Company considers a peer group. The expected life is estimated using the simplified method for “plain vanilla” options. The risk-free interest rate is based on U.S. Treasury rates with a remaining term that approximates the expected life assumed at the date of grant. No dividend yield is assumed as the Company does not pay, and does not expect to pay, dividends on its common stock. The Company estimates forfeitures based on historical experience with pre-vested forfeitures. To the extent actual forfeitures differ from the estimate, the difference is recorded to compensation expense in the period of the forfeiture.

The Company recognizes stock-based expense for shares issued pursuant to its 2018 Employee Stock Purchase Plan (“ESPP”) on a straight-line basis over the related offering period. The Company estimates the fair value of shares to be issued under the ESPP based on a combination of options valued using the Black-Scholes option pricing model. The expected life is determined based on the contractual term. Dividend yield and forfeiture rates are estimated in a manner similar to option grants described above and expected volatility is based on the Company’s historical volatility.

 

Income Tax

The Company accounts for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the condensed consolidated financial statements or in the Company’s tax returns. Deferred taxes are determined based on the difference between the financial reporting and tax basis of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of deferred tax assets will not be realized, a valuation allowance is established through a charge to income tax expense. Potential for recovery of deferred tax assets is evaluated by estimating the future taxable profits expected and considering prudent and feasible tax planning strategies.

The Company accounts for uncertainty in income taxes recognized in the condensed consolidated financial statements by applying a two-step process to determine the amount of tax benefit to be recognized. First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities. If the tax position is deemed more likely than not to be sustained, the tax position is then assessed to determine the amount of benefit to recognize in the condensed consolidated financial statements. The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement. The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate as well as the related net interest and penalties.

The Company’s major tax jurisdictions are the United States, New Hampshire and the United Kingdom. There is no provision or benefit for income taxes for the three or six months ended June 30, 2020 or 2019 because the Company has historically incurred operating losses and maintains a full valuation allowance against its United States net deferred tax assets.

Utilization of the net operating loss and tax credit carryforwards may be subject to a substantial annual limitation under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended (the “Code”) due to ownership change limitations that have occurred previously or that could occur in the future. These ownership changes may limit the amount of net operating loss and tax credit carryforwards that can be utilized to offset future taxable income and reduce taxes, respectively. The Company has not currently completed an evaluation of ownership changes through June 30, 2020 or December 31, 2019 to assess whether utilization of the Company’s net operating loss and tax credit carryforwards would be subject to an annual limitation under Sections 382 and 383 of the Code. To the extent an ownership change is determined to have occurred under Sections 382 and 383 of the Code, the net operating loss and tax credit carryforwards may be subject to limitation.

 

Recently Issued Accounting Pronouncements

 

As an emerging growth company (“EGC”), the Jumpstart Our Business Startups Act (the “JOBS Act”) allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The Company has elected to use the adoption dates applicable to private companies. As a result, the Company’s consolidated financial statements may not be comparable to the financial statements of issuers who are required to comply with the effective date for new or revised accounting standards that are applicable to public companies. The Company expects it will no longer qualify as an EGC as of December 31, 2020 and, at that time, will begin to adopt accounting pronouncements at dates applicable to public companies.

Leases (Topic 842):

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) (“ASU 2016-02”). ASU 2016-02 establishes a comprehensive new lease accounting model. The new standard clarifies the definitions of a lease, requires a dual approach to lease classification similar to current lease classifications, and causes lessees to recognize leases on the balance sheet as a lease liability with a corresponding right-of-use asset for leases with a lease term of more than twelve months. In July 2018, the FASB issued ASU No. 2018-11 Leases (Topic 842) (“ASU 2018-11”) which provided another transition method in addition to the existing transition method by allowing entities to initially apply the new leases standard at the adoption date. In June 2020, the FASB issued ASU 2020-05, Revenue from Contracts with Customers (Topic 606) and Leases (Topic 842), which defers the effective date for ASU 2016-02 to annual periods beginning after December 15, 2021 and interim periods beginning after December 15, 2022 for private companies or EGCs following private company adoption dates. The standard was effective for public companies for periods beginning after December 31, 2018. The new standard originally required a modified retrospective transition for capital or operating leases existing at or entered into after the beginning of the earliest comparative period presented in the financial statements, but it does not require transition accounting for leases that expire prior to the date of the initial application. The Company expects to adopt the new standard in the fourth quarter of 2020. The Company is in the process of adopting the new standard, including evaluating completeness, measuring the impacts, establishing incremental borrowing rates, and designing and implementing processes and controls for adoption and post adoption periods. The Company expects the most significant effects of adoption to relate to (1) the recognition of new right-of-use assets and lease liabilities on the balance sheet for the Company’s facilities and certain other operating leases; and (2) the need to provide new disclosures about the Company’s leasing activities related to the amount, timing and uncertainty of cash flows arising from leases.

 

Credit Losses (Topic 326):

 

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). This standard requires that credit losses be reported using an expected losses model rather than the incurred losses model that is currently used and establishes additional disclosures related to credit risks. In November 2019, the FASB issued ASU 2019-10, Financial Instruments-Credit Losses (Topic 326), Derivative and Hedging (Topic 815) and Leases (Topic 842), which defers the effective date for ASU 2016-13 to interim and annual periods beginning after December 15, 2022 for private companies, EGCs following private company adoption dates, or public entities meeting the definition of smaller reporting companies as of the date of issuance of this update. The Company has not yet determined the effects, if any, that the adoption of ASU 2016-13 may have on its financial position, results of operations, cash flows, or disclosures.

XML 22 R9.htm IDEA: XBRL DOCUMENT v3.20.2
Business Combinations
6 Months Ended
Jun. 30, 2020
Business Combinations [Abstract]  
Business Combinations

3. Business Combinations

On February 28, 2019, the Company completed the acquisition of all outstanding equity securities of Solus, whose principal assets included intangible assets related to supplier agreements. The Company undertook the acquisition to accelerate its penetration in the United Kingdom market. The purchase price, net of cash acquired, of $2.0 million was funded with an initial cash payment of approximately $1.6 million and a settlement of a $0.4 million receivable from a preexisting relationship. Additionally, the Company recognized $1.0 million in contingent consideration as compensation expense during 2019 and expects to recognize contingent consideration of $1.2 million as compensation expense in 2020. The acquisition has been accounted for as an acquisition of a business.

The following table summarizes the purchase price allocation that includes the fair values of the separately identifiable assets acquired and liabilities assumed as of February 28, 2019:

 

 

 

 

 

Cash

$

466

 

Accounts receivable

411

 

Inventory

492

 

Prepaids and other assets

3

 

Property and equipment

1

 

Goodwill

592

 

Intangible assets

455

 

Total assets acquired

 

2,420

 

Accounts payable and accrued expenses

 

(241

)

Contract liabilities

 

(75

)

Deferred taxes

 

(78

)

Total liabilities assumed

 

(394

)

Total purchase price

$

2,026

 

 

 

 

 

 

The excess of purchase consideration over the fair value of net tangible and identifiable intangible assets acquired was recorded as goodwill. The fair values assigned to tangible and identifiable intangible assets acquired and liabilities assumed are based on management’s estimates and assumptions.

In determining the purchase price allocation, the Company considered, among other factors, the opportunity provided by a supplier agreement with the National Health Service. The fair value of the intangible assets associated with this agreement were estimated using a discounted cash flow method with the application of the multi-period excess earnings method. Under this method, an intangible asset’s fair value is equal to the present value of the incremental after-tax cash flows attributable to only the subject intangible assets after deducting contributory asset charges. An income and expenses forecast was built based upon specific intangible asset revenue and expense estimates.

The rate used to discount the estimated future net cash flows to their present values for each intangible asset was based upon a weighted average cost of capital calculation. The discount rate was determined after consideration of market rates of return on debt and equity capital, the weighted average return on invested capital and the risk associated with achieving forecasted sales related to the assets acquired from Solus.

The total weighted average amortization period for the intangible assets is approximately 3.83 years. The intangible assets are being amortized on a straight-line basis, which is consistent with the pattern that the economic benefits of the intangible assets are expected to be utilized based upon estimated cash flows generated from such assets. Goodwill associated with the acquisition was primarily attributable to the market expansion opportunity in the United Kingdom. The goodwill attributable to the United Kingdom jurisdiction is not deductible for tax purposes.

The Company has included the financial results of Solus in the condensed consolidated financial statements from the date of acquisition. The transaction costs associated with the acquisition were approximately $0.2 million and were recorded in general and administrative expense as incurred during 2019.

Pro Forma Financial Information

The following unaudited pro forma information for the three and six months ended June 30, 2019 presents consolidated information as if the Solus acquisition occurred on January 1, 2019, which is the first day of the Company’s fiscal year 2019:

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2019

 

 

2019

 

Net revenue

 

$

11,986

 

 

$

24,522

 

Net loss

 

$

(12,880

)

 

$

(25,788

)

Net loss per share, basic

 

$

(0.76

)

 

$

(1.52

)

XML 23 R10.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value Measurements
6 Months Ended
Jun. 30, 2020
Fair Value Disclosures [Abstract]  
Fair Value Measurements

4. Fair Value Measurements

In accordance with ASC 820, Fair Value Measurements and Disclosures, the Company generally defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company uses a three-tier fair value hierarchy, which classifies the inputs used in measuring fair values. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements), and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are described below:

 

 

Level 1 – inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.

 

 

Level 2 – inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. If the asset or liability has a specified (contractual) term, a Level 2 input must be observable for substantially the full term of the asset or liability.

 

 

Level 3 – inputs are unobservable inputs for the asset or liability in which there is little, if any, market activity for the asset or liability at the measurement date.

The Company’s cash equivalents primarily consist of money market deposits which total approximately $132.8 million at June 30, 2020 and are valued based on Level 1 of the fair value hierarchy. As described in Note 8 “Debt”, during 2019, the Company granted warrants to purchase 19,789 shares of common stock in connection with an amendment to its financing arrangement. These equity-classified warrants were valued using the Black-Scholes pricing model, which falls within Level 3 of the fair value hierarchy.

The assumptions used in the Black-Scholes pricing model were as follows at the date of grant:

 

Expected dividend yield

 

0.0

%

Risk free interest rate

 

2.4

%

Expected stock price volatility

 

60.9

%

Expected term (years)

 

10.0

 

 

XML 24 R11.htm IDEA: XBRL DOCUMENT v3.20.2
Accounts Receivable
6 Months Ended
Jun. 30, 2020
Receivables [Abstract]  
Accounts Receivable

5. Accounts Receivable

Accounts receivable consists of the following:

 

 

 

June 30,

2020

 

 

December 31,

2019

 

United States

 

$

10,614

 

 

$

5,574

 

International

 

 

6,428

 

 

 

2,908

 

Total accounts receivable

 

 

17,042

 

 

 

8,482

 

Less: Allowance for doubtful accounts

 

 

(590

)

 

 

(239

)

Accounts receivable, net of allowance for doubtful

   accounts

 

$

16,452

 

 

$

8,243

 

 

No individual customer accounted for 10% or more of revenue for the three or six months ended June 30, 2020 or 2019. No individual customers accounted for 10% or more of total accounts receivable at either June 30, 2020 or December 31, 2019.

XML 25 R12.htm IDEA: XBRL DOCUMENT v3.20.2
Inventories
6 Months Ended
Jun. 30, 2020
Inventory Disclosure [Abstract]  
Inventories

6. Inventories

Inventories consist of the following:

 

 

 

June 30,

2020

 

 

December 31,

2019

 

Component parts

 

$

9,010

 

 

$

4,948

 

Finished goods

 

 

9,631

 

 

 

4,189

 

Total inventory

 

$

18,641

 

 

$

9,137

 

 

XML 26 R13.htm IDEA: XBRL DOCUMENT v3.20.2
Goodwill and Intangible Assets
6 Months Ended
Jun. 30, 2020
Goodwill And Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets

7. Goodwill and Intangible Assets

The changes in the carrying amount of goodwill and intangible assets during 2020 are as follows:

 

 

 

Goodwill

 

 

Intangible Assets

 

Balance at December 31, 2019

 

$

588

 

 

$

353

 

Acquired during the period

 

 

-

 

 

 

-

 

Amortization

 

 

-

 

 

 

(56

)

Foreign currency exchange rate changes

 

 

(41

)

 

 

(22

)

Balance at June 30, 2020

 

$

547

 

 

$

275

 

 

The following table presents a summary of acquired intangible assets:

 

 

 

As of June 30, 2020

 

 

 

Period of

amortization

 

 

Gross

Carrying

Amount

 

 

Accumulated

Amortization

 

Customer agreements

 

 

3.83

 

 

$

423

 

 

$

(148

)

Total identifiable intangible assets

 

 

 

 

 

$

423

 

 

$

(148

)

 

XML 27 R14.htm IDEA: XBRL DOCUMENT v3.20.2
Debt
6 Months Ended
Jun. 30, 2020
Debt Disclosure [Abstract]  
Debt

8. Debt

Revolving Credit Line

On November 16, 2016, the Company entered a Business Financing Agreement (the “Revolver Agreement”) with Western Alliance Bank, an Arizona corporation, which replaced its then-existing revolving line of credit. The Revolver Agreement made available $7.0 million of revolving credit upon the closing date. Availability under the Revolver Agreement is calculated based upon 80% of the eligible receivables (net of pre-paid deposits, pre-billed invoices, other offsets, and contras related to each specific account debtor). The original maturity date was September 30, 2018. The Company refinanced the Revolver Agreement in April 2018, increasing the credit line to $7.5 million and extending the maturity date to September 30, 2020 (the “Amended Revolver Agreement”). The principal is due upon maturity. On March 22, 2019, the Company entered into an amendment to the Amended Revolver Agreement (as amended, the “2019 Amended Revolver Agreement”), which increased the allowable permitted indebtedness under the 2019 Amended Revolver Agreement in connection with the Company’s credit card program from $0.3 million to $0.5 million. On July 7, 2020, the Company entered into a second amendment to the Amended Revolver Agreement (as amended, the “2020 Amended Revolver Agreement”) which, under certain circumstances, reduces the amount of funds required to be held on deposit with Western Alliance Bank.

At June 30, 2020 the interest rate was 5.25%. The outstanding balance under the 2020 Amended Revolver Agreement was $4.5 million at June 30, 2020 and there was $3.0 million remaining availability based on eligible receivables. At December 31, 2019, the interest rate was 6.50%. The outstanding balance under the 2019 Amended Revolver Agreement was $3.5 million at December 31, 2019 and the remaining availability based on eligible receivables was $0.8 million. The 2020 Amended Revolver Agreement requires the Company to comply with a minimum liquidity covenant at all times. As of June 30, 2020, the Company was in compliance with all covenants.

The 2020 Amended Revolving Agreement is secured by substantially all of the Company’s assets, excluding intellectual property.

Term Loans

On April 6, 2018, the Company entered into a Credit Agreement and Guaranty (the “Credit Agreement and Guaranty”) with Perceptive Credit Holdings II, LP (“Perceptive”). Pursuant to the Credit Agreement and Guaranty, a total of $42.5 million was available in three tranches. The first tranche was drawn down in the amount of $20.0 million on the closing date, April 6, 2018, which paid off a former loan agreement in full. In connection with this draw down, the Company granted Perceptive warrants to purchase 37,693 shares of Series D preferred stock which were converted into warrants to purchase shares of common stock at the time of the initial public offering. The warrants had an exercise price of $15.92 per share, were fully vested upon issuance, were exercisable at the option of the holder, in whole or in part, and would have expired in April 2028.

On July 20, 2018, pursuant to the Credit Agreement and Guaranty, the Company drew down the second tranche of $10.0 million. In connection with this draw down, the Company granted Perceptive warrants to purchase 18,846 shares of Series D preferred stock which were converted into warrants to purchase shares of common stock at the time of the initial public offering. The warrants had an exercise price of $15.92 per share, were fully vested upon issuance, were exercisable at the option of the holder, in whole or in part, and would have expired in July 2028.

On September 27, 2018, the Company entered into the first amendment to the Credit Agreement and Guaranty (as amended, the “Amended Credit Agreement and Guaranty”) with Perceptive. Pursuant to the Amended Credit Agreement and Guaranty, the Company was permitted to draw the final $12.5 million of availability at any time through March 31, 2019 and the minimum 2018 revenue requirement of $43.2 million that was required to draw down the final tranche was eliminated. Concurrently with the closing of the Amendment, the Company drew down $2.0 million of the remaining $12.5 million available. In connection with this draw down, the Company granted to Perceptive warrants to purchase 3,769 shares of its Series D preferred stock which were converted into warrants to purchase shares of common stock at the time of the initial public offering. The warrants had an exercise price of $15.92 per share, were fully vested upon issuance, were exercisable at the option of the holder, in whole or in part, and would have expired in September 2028.

On March 22, 2019, the Company drew the remaining $10.5 million of availability under the Amended Credit Agreement and Guaranty. In connection with this draw down, the Company granted Perceptive warrants to purchase 19,789 shares of common stock. The warrants had an exercise price of $15.92 per share, were fully vested upon issuance, were exercisable at the option of the holder, in whole or in part, and would have expired in March 2029.

On March 22, 2019, the Company entered into a second amendment to the Amended Credit Agreement and Guaranty increasing the allowable permitted indebtedness in connection with the Company’s credit card program from $0.3 million to $0.5 million.

On June 10, 2020, Perceptive exercised all of its outstanding warrants. See Note 10 “Warrants” for further details.

On June 16, 2020, the Company entered into a third amendment to the Amended Credit Agreement and Guaranty (the “2020 Amended Credit Agreement and Guaranty”), which amended the prepayment premium by clarifying the methodology for calculating Perceptive’s annualized internal rate of return under the term loan.

Pursuant to the 2020 Amended Credit Agreement and Guaranty, the outstanding principal amount accrues interest at an annual rate equal to 9.06% plus the greater of (a) one-month LIBOR and (b) 1.75% per year. At June 30, 2020, the interest rate was 10.81%. The outstanding balance, including accretion of the additional final payment due upon maturity and described below, was $42.6 million at June 30, 2020 and there was no remaining availability. The 2020 Amended Credit Agreement and Guaranty is secured by substantially all of the Company’s assets, including intellectual property. 

On the maturity date, in addition to the payment of principal and accrued interest, the Company will be required to make a payment of 0.5% of the total amount borrowed under the 2020 Amended Credit Agreement and Guaranty unless the Company has already made such a payment in connection with an acceleration or prepayment of borrowings under the agreement. In the event the Company prepays all or part of the amounts borrowed under the 2020 Amended Credit and Guaranty prior to the maturity date, the Company will be subject to additional prepayment fees which decrease as the time to maturity decreases. The 2020 Amended Credit Agreement and Guaranty requires the Company to comply with a minimum liquidity covenant at all times and a minimum revenue covenant measured at the end of each fiscal quarter. As of June 30, 2020, the Company was in compliance with all covenants.

The annual principal maturities of the Company’s term loans as of June 30, 2020 are as follows:

 

2020

 

 

-

 

2021

 

 

-

 

2022

 

 

-

 

2023

 

 

42,592

 

Less: Discount on loans payable

 

 

(663

)

Long-term loans payable

 

$

41,929

 

 

XML 28 R15.htm IDEA: XBRL DOCUMENT v3.20.2
Commitments and Contingencies
6 Months Ended
Jun. 30, 2020
Commitments And Contingencies Disclosure [Abstract]  
Commitments and Contingencies

9. Commitments and Contingencies

Legal Matters

From time to time, the Company may become involved in various legal proceedings, including those that may arise in the ordinary course of business. The Company believes there is no litigation pending that could have, individually, or in the aggregate, a material adverse effect on the results of its operations or financial condition.

XML 29 R16.htm IDEA: XBRL DOCUMENT v3.20.2
Warrants
6 Months Ended
Jun. 30, 2020
Warrants And Rights Note Disclosure [Abstract]  
Warrants

10. Warrants

The Company’s warrant activity is summarized as follows:

 

 

 

Common Stock Warrants

 

 

 

Number of

Shares

 

 

Weighted

Average

Exercise

Price

 

Outstanding at December 31, 2019

 

 

182,076

 

 

$

14.84

 

Warrants granted

 

 

-

 

 

 

-

 

Warrants exercised

 

 

(80,097

)

 

 

15.92

 

Outstanding at June 30, 2020

 

 

101,979

 

 

$

14.00

 

 

On June 10, 2020, a warrant to purchase 80,097 shares of common stock was exercised on a net exercise basis. Upon exercise, the exercise price of $15.92 per share was satisfied through the Company’s withholding of 39,031 of the warrant shares and issuing 41,066 shares of common stock.

 

On July 10, 2020, a warrant to purchase 20,891 shares of common stock held was exercised on a net exercise basis. Upon exercise, the exercise price of $14.00 per share was satisfied through the Company’s withholding of 6,905 of the warrant shares and issuing 13,986 shares of common stock to the holder.

 

XML 30 R17.htm IDEA: XBRL DOCUMENT v3.20.2
Revenue
6 Months Ended
Jun. 30, 2020
Revenue From Contract With Customer [Abstract]  
Revenue

11. Revenue

Disaggregated Revenue

The following table shows the Company’s net revenue disaggregated into categories the Company considers meaningful to depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors:

 

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

 

2020

 

2020

 

 

 

US

 

 

International

 

 

Total

 

US

 

 

International

 

 

Total

 

Net revenue by:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product Revenue

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capital Equipment

 

$

14,079

 

 

$

5,226

 

 

$

19,305

 

$

17,380

 

 

$

6,923

 

 

$

24,303

 

Disposable

 

 

9,441

 

 

 

3,722

 

 

 

13,163

 

 

19,135

 

 

 

6,458

 

 

 

25,593

 

Subtotal Product Revenue

 

 

23,520

 

 

 

8,948

 

 

 

32,468

 

 

36,515

 

 

 

13,381

 

 

 

49,896

 

Lease Revenue

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

Capital Equipment

 

 

1,620

 

 

 

14

 

 

 

1,634

 

 

2,247

 

 

 

31

 

 

 

2,278

 

Other

 

 

435

 

 

 

76

 

 

 

511

 

 

752

 

 

 

151

 

 

 

903

 

Service and Other Revenue

 

 

107

 

 

 

432

 

 

 

539

 

 

509

 

 

 

681

 

 

 

1,190

 

Total Revenue

 

$

25,682

 

 

$

9,470

 

 

$

35,152

 

$

40,023

 

 

$

14,244

 

 

$

54,267

 

 

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

 

2019

 

2019

 

 

 

US

 

 

International

 

 

Total

 

US

 

 

International

 

 

Total

 

Net revenue by:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product Revenue

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capital Equipment

 

$

1,599

 

 

$

1,046

 

 

$

2,645

 

$

3,109

 

 

$

1,551

 

 

$

4,660

 

Disposable

 

 

6,514

 

 

 

2,016

 

 

 

8,530

 

 

14,061

 

 

 

3,488

 

 

 

17,549

 

Subtotal Product Revenue

 

 

8,113

 

 

 

3,062

 

 

 

11,175

 

 

17,170

 

 

 

5,039

 

 

 

22,209

 

Lease Revenue

 

 

284

 

 

 

-

 

 

 

284

 

 

947

 

 

 

-

 

 

 

947

 

Service and Other Revenue

 

 

281

 

 

 

246

 

 

 

527

 

 

610

 

 

 

519

 

 

 

1,129

 

Total Revenue

 

$

8,678

 

 

$

3,308

 

 

$

11,986

 

$

18,727

 

 

$

5,558

 

 

$

24,285

 

 

United States and International net revenue is based on the customer location to which the product is shipped. No individual foreign country represents more than 10% of the Company’s total revenue.

Contract Balances from Contracts with Customers

Contract liabilities consist of deferred revenue and other contract liabilities associated with rebates and fees payable to GPOs, IDNs and distributor partners. Deferred revenues are included in accrued expenses and other liabilities in the accompanying consolidated balance sheets. The following table presents changes in contract liabilities during the six months ended June 30, 2020:

 

 

 

Contract

Liabilities

 

 

Deferred

Revenue

 

Balance at December 31, 2019

 

$

137

 

 

$

344

 

Additions

 

 

261

 

 

 

1,195

 

Subtractions

 

 

(137

)

 

 

(469

)

Balance at June 30, 2020

 

$

261

 

 

$

1,070

 

 

XML 31 R18.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation
6 Months Ended
Jun. 30, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock-Based Compensation

12. Stock-Based Compensation

Stock-based compensation expense was allocated based on the employees’ and non-employees’ functions as follows:

 

 

 

Three Months Ended

June 30,

 

 

Six Months Ended

June 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Cost of goods sold

 

$

74

 

 

$

27

 

 

$

145

 

 

$

138

 

Research and development

 

 

199

 

 

 

(10

)

 

 

400

 

 

 

255

 

Sales and marketing

 

 

480

 

 

 

246

 

 

 

920

 

 

 

759

 

General and administrative

 

 

624

 

 

 

449

 

 

 

1,359

 

 

 

1,463

 

Total

 

$

1,377

 

 

$

712

 

 

$

2,824

 

 

$

2,615

 

 

Stock Options

 

The Company granted options to purchase 938,910 shares of common stock at exercise prices ranging from $10.60 to $39.01 per share, with a weighted average exercise price of $12.47 per share, during the six months ended June 30, 2020. The Company granted options to purchase 776,196 shares of common stock at exercise prices ranging from $17.15 to $19.28 per share, with a weighted average exercise price of $17.18 per share, during the six months ended June 30, 2019. The weighted average fair value of stock options granted during the six months ended June 30, 2020 and 2019 was $9.16 and $11.97, respectively.

 

The weighted average assumptions used in the Black-Scholes options pricing model are as follows:

 

 

 

 

Six Months Ended June 30,

 

 

 

2020

 

 

2019

 

Expected dividend yield

 

 

0.0

%

 

 

0.0

%

Risk free interest rate

 

 

1.7

%

 

 

2.5

%

Expected stock price volatility

 

 

87.6

%

 

 

70.0

%

Expected term (years)

 

 

6.1

 

 

 

7.1

 

 

Restricted Stock

A summary of restricted stock activity for the six months ended June 30, 2020 is as follows:

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

Grant Date

 

 

 

Shares

 

 

Fair Value

 

Unvested at December 31, 2019

 

 

229,913

 

 

$

3.76

 

Granted/purchased

 

 

53,445

 

 

 

13.31

 

Vested

 

 

(76,063

)

 

 

3.44

 

Canceled

 

 

(500

)

 

 

10.97

 

Unvested at June 30, 2020

 

 

206,795

 

 

$

4.02

 

 

Employee Stock Purchase Plan

 

In connection with our initial public offering in November 2018, the Company’s board of directors adopted the ESPP and a total of 166,500 shares of common stock were initially reserved for issuance under the ESPP. The number of shares of common stock available for issuance under the ESPP is increased on the first day of each calendar year beginning January 1, 2019 and each year thereafter until 2028 by the lessor of (i) 1% of the number of shares of common stock issued and outstanding on the immediately preceding December 31, and (ii) the number of shares of common stock determined by the Company’s board of directors up to such an initial maximum of 1,741,300 shares of common stock. The number of shares of common stock reserved under the plan at June 30, 2020 totals 512,048.

 

The ESPP provides for successive discreet offering periods of approximately six months or as determined by the plan administrator. The first offering period began on January 2, 2020. As of June 30, 2020, 36,389 shares of common stock were purchased by employees under the ESPP at a price of $9.88 per share, resulting in cash proceeds of $0.4 million.

The ESPP permits eligible employees to elect to purchase shares of common stock through fixed whole percentage contributions from eligible compensation during each offering period, not to exceed 10% of the eligible compensation a participant receives during an offering period and not to accrue at a rate which exceeds $25,000 of the fair value of the stock (determined on the grant date(s)) for each calendar year. A participant may purchase the lower of (a) a number of shares of common stock determined by dividing such participant’s accumulated payroll deductions on the exercise date by the option price, (b) 5,000 shares, or (c) such other lesser maximum number of shares as shall have been established by the plan administrator.

 

Amounts deducted and accumulated by the participant will be used to purchase shares of common stock at the end of each offering period. The purchase price of the shares will be 85% of the lower of the fair value of common stock on the first trading day of each offering period or on the purchase date. Participants may end their participation during an offering period up to ten days in advance of the exercise date and will be paid their accumulated contributions that have not been used to purchase shares of common stock. Participation ends automatically upon termination of employment.

 

The fair value of the purchase right for the ESPP option is estimated on the date of grant using the Black-Scholes pricing model with the following assumptions during 2020:

 

Expected dividend yield

 

0.0%

 

Risk free interest rate

 

0.2% - 1.6%

 

Expected stock price volatility

 

107.9% - 115.8%

 

Expected term (years)

 

0.4 - 0.5

 

 

XML 32 R19.htm IDEA: XBRL DOCUMENT v3.20.2
Net Loss Per Share
6 Months Ended
Jun. 30, 2020
Earnings Per Share [Abstract]  
Net Loss Per Share

13. Net Loss Per Share

 

The Company excluded the following potential common shares, based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:

 

 

 

As of June 30,

 

 

 

2020

 

 

2019

 

Options to purchase common stock

 

 

1,826,614

 

 

 

1,397,432

 

Warrants to purchase common stock

 

 

101,979

 

 

 

182,076

 

Unvested restricted stock

 

 

206,795

 

 

 

305,220

 

Employee stock purchase plan shares

 

 

19,473

 

 

-

 

 

 

 

2,154,861

 

 

 

1,884,728

 

XML 33 R20.htm IDEA: XBRL DOCUMENT v3.20.2
Related Party Transactions
6 Months Ended
Jun. 30, 2020
Related Party Transactions [Abstract]  
Related Party Transactions

14. Related Party Transactions

 

See Note 8 “Debt” for a discussion of the Company’s Amended Credit Agreement and Guaranty and related transactions with Perceptive, a holder of more than 5% of the Company’s common stock.

XML 34 R21.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies (Policies)
6 Months Ended
Jun. 30, 2020
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

 

The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The information included in this Quarterly Report on Form 10-Q should be read in conjunction with our audited consolidated financial statements and the accompanying notes included in our Annual Report on Form 10-K for the year ended December 31, 2019 (the “2019 Form 10-K”). Our accounting policies are described in the “Notes to Consolidated Financial Statements” in our 2019 Form 10-K and updated, as necessary, in this report. The year-end condensed consolidated balance sheet data presented for comparative purposes was derived from our audited financial statements but does not include all disclosures required by U.S. GAAP.

Principles of Consolidation

Principles of Consolidation

These condensed consolidated financial statements include the financial statements of Solus Medical Ltd. (“Solus”), a wholly owned subsidiary of the Company based in the United Kingdom, which was acquired in the first quarter of 2019. All intercompany accounts and transactions have been eliminated upon consolidation.

Segment Information

Segment Information

Operating segments are defined as components of an enterprise for which separate discrete financial information is available and evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company globally manages the business within one reporting segment, Vapotherm, Inc. and two reporting units, Vapotherm and Solus. Segment information is consistent with how management reviews the business, makes investing and resource allocation decisions and assesses operating performance.

 

The majority of the Company’s long-term assets are located in the United States. Long-term assets located outside the United States total $0.1 million as of each of June 30, 2020 and December 31, 2019.

Use of Estimates

Use of Estimates

The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires the Company to make judgments, assumptions, and estimates that affect the reported amounts of assets, liabilities, revenue and expenses, and the related disclosure of contingent assets and liabilities. The Company evaluates its estimates on an ongoing basis. The Company bases its estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Significant estimates relied upon in preparing these condensed consolidated financial statements include calculation of stock-based compensation, valuation of warrants, fair values of acquired assets and liabilities, including goodwill and intangibles assets, realizability of inventories, allowance for bad debt, accrued expenses and the valuation allowances against deferred income tax assets. Actual results may differ from these estimates.

Unaudited Interim Financial Information

Unaudited Interim Financial Information

The accompanying condensed consolidated balance sheet as of June 30, 2020, and the condensed consolidated statements of comprehensive loss, stockholders’ equity and of cash flows for the three and six months ended June 30, 2020 and 2019 are unaudited. The unaudited interim condensed consolidated financial statements have been prepared on the same basis as the audited annual consolidated financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of June 30, 2020 and the results of its operations and its cash flows for the three and six months ended June 30, 2020 and 2019. The financial data and other information disclosed in these notes related to the three and six months ended June 30, 2020 and 2019 are also unaudited. The results of operations for the three and six months ended June 30, 2020 are not necessarily indicative of the operating results for the full year or for any other subsequent interim period.

Reclassification

Reclassification

Certain amounts in 2019 have been reclassified to conform to the presentation in 2020.

Concentrations of Credit Risk

Concentrations of Credit Risk

As of June 30, 2020, the Company’s financial instruments were comprised of cash and cash equivalents, restricted cash, accounts receivable, accounts payable and debt, the carrying amounts of which approximated fair value due to the short-term nature and market interest rates. All of the Company’s cash and cash equivalents are maintained at creditworthy financial institutions. At June 30, 2020, deposits exceed the amount of any insurance provided.

The Company extends credit to customers in the normal course of business but does not require collateral or any other security to support amounts due. Management performs ongoing credit evaluations of the Company’s customers. An allowance for potentially uncollectible accounts is provided based on history, economic conditions, and composition of the accounts receivable aging. In some cases, the Company makes allowances for specific customers based on these and other factors. Provisions for the allowance for doubtful accounts are recorded in general and administrative expenses in the accompanying condensed consolidated statements of comprehensive loss.

Foreign Currency and Foreign Operations

Foreign Currency and Foreign Operations

The functional currency of the Company is the currency of the primary economic environment in which the entity operates, which is the U.S. dollar. For our non-U.S. subsidiary that transacts in a functional currency other than the U.S. dollar, assets and liabilities are translated at current rates of exchange as of the balance sheet date. Income and expense items are translated at the average foreign currency exchange rates for the period. Adjustments resulting from the translation of the financial statements of its foreign operations into U.S. dollars are excluded from the determination of net loss and are recorded in accumulated other comprehensive income (loss), a separate component of stockholders’ equity.

Realized foreign currency gains or losses arising from transactions denominated in foreign currencies are recorded in other (expense) income in the condensed consolidated statements of comprehensive loss. Unrealized foreign currency gains or losses arising from transactions denominated in foreign currencies are recorded in accumulated other comprehensive income (loss).

Cash, Cash Equivalents, and Restricted Cash

Cash, Cash Equivalents, and Restricted Cash

 

The Company considers all highly liquid temporary investments purchased with original maturities of 90 days or less to be cash equivalents. The Company holds restricted cash related to certificates of deposits and collateral in relation to lease agreements. As of June 30, 2020, $0.5 million of our $150.2 million of cash, cash equivalents and restricted cash balance was located outside the United States.

 

The following table presents the components of total cash, cash equivalents, and restricted cash as set forth in the Company’s condensed consolidated statements of cash flows:

 

 

 

June 30,

2020

 

 

December 31,

2019

 

Cash and cash equivalents

 

$

148,344

 

 

$

71,655

 

Restricted cash

 

 

1,853

 

 

 

1,852

 

Total cash, cash equivalents, and restricted cash

 

$

150,197

 

 

$

73,507

 

Product Warranty

Product Warranty

 

The Company provides its customers with a standard one-year warranty on its capital equipment sales. Warranty costs are accrued based on actual historical trends and estimated at time of sale. The warranty liability is included within accrued expenses and other liabilities in the condensed consolidated balance sheets. A roll-forward of the Company’s warranty liability from December 31, 2019 to June 30, 2020 is as follows:

 

Balance at December 31, 2019

 

$

225

 

Provisions for warranty obligations

 

 

670

 

Settlements

 

 

(127

)

Balance at June 30, 2020

 

$

768

 

 

Insurance

Insurance

Effective January 1, 2020, the Company was self-insured for certain obligations related to health insurance. The Company also purchases stop-loss insurance to protect itself from material losses. Judgments and estimates are used in determining the potential value associated with reported claims and for events that have occurred but have not been reported. The Company’s estimates consider expected claim experience and other factors. Receivables for insurance recoveries are recorded as assets, on an undiscounted basis. The Company’s liabilities are based on estimates, and, while the Company believes that its accruals are adequate, the ultimate liability may be significantly different from the amounts recorded. Changes in claims experience, the Company’s ability to settle claims or other estimates and judgments used by management could have a material impact on the amount and timing of expense for any period.

Revenue Recognition

Revenue Recognition

The Company’s revenue is primarily derived from the sale of products, leases and services. Product revenue consists of capital equipment and single-use disposables that are shipped and billed to customers both domestically and internationally. The Company’s main capital equipment products are the Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, Vapotherm Transfer Unit 2.0 and Q50 compressor. The Company’s main disposable products are single-use disposables and nasal interfaces, or cannulas, and adaptors. Lease revenue consists of two components which include capital equipment that the Company leases out to its customers and, in certain situations, an allocation from disposable revenue to other lease revenue upon the sale of disposable products in bundled arrangements involving the placement of Precision Flow capital units for use by the customer at no upfront charge in connection with the customer’s ongoing purchase of disposable products. Service revenue consists of fees associated with routine service of capital units and the sale of extended service contracts and preventative maintenance plans, which are purchased by a small portion of the Company’s customer base. In addition, the Company sells small quantities of component parts in the United States, United Kingdom and to third-party international service centers who provide service on Precision Flow capital units outside of the United States. Freight revenue is based upon actual freight costs plus a percentage markup of such costs associated with the shipment of products domestically, and to a lesser extent, internationally, and is included in service revenue. Rebates and fees consist of contractually obligated administrative fees and percentage-of-sales rebates paid to Group Purchasing Organizations (“GPOs”), Integrated Delivery Networks (“IDNs”) and distributor partners and accounted for as a reduction of service revenue.

Under Financial Accounting Standard Board (“FASB”) Accounting Standards Codifications (“ASC”) 606, Revenue from Contracts with Customers (“ASC 606”), revenue is recognized when a customer obtains control of promised goods or services, in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and assesses whether each promised good or service is distinct and determines those that are performance obligations. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. Sales, value-added, and other taxes collected on behalf of third parties are excluded from revenue. The Company’s standard payment terms are generally 30 days from the date of sale.

Contracts with customers may contain multiple performance obligations. For such arrangements, the transaction price is allocated to each performance obligation based on the estimated relative stand-alone selling prices of the promised products or services underlying each performance obligation. The Company determines stand-alone selling prices based on the price at which the performance obligation is sold separately. If the stand-alone selling price is not observable through past transactions, the Company estimates the stand-alone selling price taking into account available information such as market conditions and internally approved pricing guidelines related to the performance obligations.

When determining the transaction price of a contract, an adjustment is made if payment from a customer occurs either significantly before or significantly after performance, resulting in a significant financing component. Applying the practical expedient in paragraph ASC 606-10-32-18, the Company does not assess whether a significant financing component exists if the period between when the Company performs its obligations under the contract and when the customer pays is one year or less. None of the Company’s contracts contained a significant financing component during the six months ended June 30, 2020 or 2019.

The Company’s contracts with its customers have a duration of less than one year. Therefore, the Company has elected to apply the practical expedient in paragraph ASC 340-40-25-4 and recognizes the incremental costs of obtaining contracts as an expense. These costs are included in sales and marketing expense in the accompanying condensed consolidated statements of comprehensive loss.

Lease Revenue

Lease Revenue

The Company also enters into agreements to lease its capital equipment. For such sales, the Company accounts for revenue under ASC 840, Leases, and assesses and classifies these transactions as sales-type or operating leases based on whether the lease transfers ownership of the equipment to the lessee by the end of the lease term. This criterion is met in situations in which the lease agreement provides for the transfer of title at or shortly after the end of the lease term. Equipment included in arrangements including transfer of title are accounted for as sales-type leases and the Company recognizes the total value of the lease payments due over the lease term to revenue at the inception of the lease. The Company records the current value of future lease payments under prepaid expenses and other current assets in the accompanying condensed consolidated balance sheets; these amounts totaled $1.8 and $0.9 million at June 30, 2020 and December 31, 2019, respectively. Equipment included in arrangements that do not include the transfer of title, nor any of the capital lease criteria, are accounted for as operating leases and revenue is recognized on a straight-line basis as it becomes receivable monthly over the term of the lease.

The Company also enters into agreements involving the placement of Precision Flow capital units for use by the customer at no upfront charge in connection with the customer’s ongoing purchase of disposable products. In these bundled arrangements, revenue recognized for the sale of the disposables is allocated between disposable revenue and other lease revenue based on the estimated relative stand-alone selling prices of the individual performance obligations.

Shipping and Handling Costs

Shipping and Handling Costs

Amounts billed to customers for shipping and handling are included in service revenue. Shipping and handling costs are included in costs of sales. The total costs of shipping and handling for the three months ended June 30, 2020 and 2019 was $0.8 and $0.2 million, respectively. Shipping and handlings costs for the six months ended June 30, 2020 and 2019 totaled $1.1 and $0.5 million, respectively.

Sales and Value-Added Taxes

Sales and Value-Added Taxes

When required by local jurisdictions, the Company bills its customers for sales tax and value-added tax calculated on each sales invoice and records a liability for the sales and value-added tax payable, which is included in accrued expenses and other liabilities in the condensed consolidated balance sheets. Sales tax and value-added tax billed to a customer are not included in the Company’s revenue.

Timing and Amount of Revenue Recognition

Timing and Amount of Revenue Recognition

The Company recognizes revenue on product sales and service of its capital equipment and product sales of disposables to its end users. In each instance, revenue is generally recognized when the customer obtains control of the Company’s product, which generally occurs at a point in time upon shipment based on the contractual shipping terms of a contract.

Product and service revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or services to a customer. To the extent the transaction price includes variable consideration, the Company estimates the amount of variable consideration that should be included in the transaction price utilizing the expected value amount method to which the Company expects to be entitled. As such, revenue on sales is recorded net of prompt pay discounts and payments made to GPOs, IDNs and distributors. Variable consideration is included in the transaction price if, in the Company’s judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. Determination of whether to include estimated amounts in the transaction price is based largely on an assessment of the Company’s anticipated performance and all information (historical, current and forecasted) that is reasonably available. The Company believes that the estimates it has established are reasonable based upon current facts and circumstances. Applying different judgments to the same facts and circumstances could result in different estimates.

Stock-Based Compensation

Stock-Based Compensation

The Company maintains an equity incentive plan to provide long-term incentives for employees, consultants, and members of the board of directors. The plan allows for the issuance of non-statutory and incentive stock options, restricted stock, unrestricted stock, stock units, including restricted stock units, and stock appreciation rights to employees, consultants and non-employee directors. The Company recognizes stock-based compensation expense for awards of equity instruments to employees and non-employees based on the grant date fair value of those awards in accordance with ASC Topic 718, Stock Compensation (“ASC 718”). ASC 718 requires all equity-based compensation awards, including grants of restricted shares and stock options, to be recognized as expense in the condensed consolidated statements of comprehensive loss based on their grant date fair values.

The fair value of each option grant is estimated on the grant date using the Black-Scholes option pricing model. The fair value is then amortized on a straight-line basis over the requisite service period of the awards, which is generally the vesting period. For performance-based awards, the related compensation cost is amortized over the performance period on an accelerated attribution basis. Compensation cost associated with performance awards is based on fair value on the date of grant and the number of units expected to be earned after assessing the probability that certain performance criteria will be met and the associated targeted payout level that is forecasted will be achieved. Cumulative adjustments are recorded each quarter to reflect estimated outcomes of the performance-related conditions until the results are determined and settled. Use of a valuation model requires management to make certain assumptions with respect to selected model inputs, including the expected life (weighted average period of time that the options granted are expected to be outstanding), the volatility of the Company’s common stock and an assumed risk-free interest rate. Expected volatility is calculated based on historical volatility of a group of publicly traded companies that the Company considers a peer group. The expected life is estimated using the simplified method for “plain vanilla” options. The risk-free interest rate is based on U.S. Treasury rates with a remaining term that approximates the expected life assumed at the date of grant. No dividend yield is assumed as the Company does not pay, and does not expect to pay, dividends on its common stock. The Company estimates forfeitures based on historical experience with pre-vested forfeitures. To the extent actual forfeitures differ from the estimate, the difference is recorded to compensation expense in the period of the forfeiture.

The Company recognizes stock-based expense for shares issued pursuant to its 2018 Employee Stock Purchase Plan (“ESPP”) on a straight-line basis over the related offering period. The Company estimates the fair value of shares to be issued under the ESPP based on a combination of options valued using the Black-Scholes option pricing model. The expected life is determined based on the contractual term. Dividend yield and forfeiture rates are estimated in a manner similar to option grants described above and expected volatility is based on the Company’s historical volatility.

Income Tax

Income Tax

The Company accounts for income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the condensed consolidated financial statements or in the Company’s tax returns. Deferred taxes are determined based on the difference between the financial reporting and tax basis of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of deferred tax assets will not be realized, a valuation allowance is established through a charge to income tax expense. Potential for recovery of deferred tax assets is evaluated by estimating the future taxable profits expected and considering prudent and feasible tax planning strategies.

The Company accounts for uncertainty in income taxes recognized in the condensed consolidated financial statements by applying a two-step process to determine the amount of tax benefit to be recognized. First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities. If the tax position is deemed more likely than not to be sustained, the tax position is then assessed to determine the amount of benefit to recognize in the condensed consolidated financial statements. The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement. The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate as well as the related net interest and penalties.

The Company’s major tax jurisdictions are the United States, New Hampshire and the United Kingdom. There is no provision or benefit for income taxes for the three or six months ended June 30, 2020 or 2019 because the Company has historically incurred operating losses and maintains a full valuation allowance against its United States net deferred tax assets.

Utilization of the net operating loss and tax credit carryforwards may be subject to a substantial annual limitation under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended (the “Code”) due to ownership change limitations that have occurred previously or that could occur in the future. These ownership changes may limit the amount of net operating loss and tax credit carryforwards that can be utilized to offset future taxable income and reduce taxes, respectively. The Company has not currently completed an evaluation of ownership changes through June 30, 2020 or December 31, 2019 to assess whether utilization of the Company’s net operating loss and tax credit carryforwards would be subject to an annual limitation under Sections 382 and 383 of the Code. To the extent an ownership change is determined to have occurred under Sections 382 and 383 of the Code, the net operating loss and tax credit carryforwards may be subject to limitation.

Recently Adopted Accounting Pronouncements

Recently Issued Accounting Pronouncements

 

As an emerging growth company (“EGC”), the Jumpstart Our Business Startups Act (the “JOBS Act”) allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The Company has elected to use the adoption dates applicable to private companies. As a result, the Company’s consolidated financial statements may not be comparable to the financial statements of issuers who are required to comply with the effective date for new or revised accounting standards that are applicable to public companies. The Company expects it will no longer qualify as an EGC as of December 31, 2020 and, at that time, will begin to adopt accounting pronouncements at dates applicable to public companies.

Leases (Topic 842):

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) (“ASU 2016-02”). ASU 2016-02 establishes a comprehensive new lease accounting model. The new standard clarifies the definitions of a lease, requires a dual approach to lease classification similar to current lease classifications, and causes lessees to recognize leases on the balance sheet as a lease liability with a corresponding right-of-use asset for leases with a lease term of more than twelve months. In July 2018, the FASB issued ASU No. 2018-11 Leases (Topic 842) (“ASU 2018-11”) which provided another transition method in addition to the existing transition method by allowing entities to initially apply the new leases standard at the adoption date. In June 2020, the FASB issued ASU 2020-05, Revenue from Contracts with Customers (Topic 606) and Leases (Topic 842), which defers the effective date for ASU 2016-02 to annual periods beginning after December 15, 2021 and interim periods beginning after December 15, 2022 for private companies or EGCs following private company adoption dates. The standard was effective for public companies for periods beginning after December 31, 2018. The new standard originally required a modified retrospective transition for capital or operating leases existing at or entered into after the beginning of the earliest comparative period presented in the financial statements, but it does not require transition accounting for leases that expire prior to the date of the initial application. The Company expects to adopt the new standard in the fourth quarter of 2020. The Company is in the process of adopting the new standard, including evaluating completeness, measuring the impacts, establishing incremental borrowing rates, and designing and implementing processes and controls for adoption and post adoption periods. The Company expects the most significant effects of adoption to relate to (1) the recognition of new right-of-use assets and lease liabilities on the balance sheet for the Company’s facilities and certain other operating leases; and (2) the need to provide new disclosures about the Company’s leasing activities related to the amount, timing and uncertainty of cash flows arising from leases.

 

Credit Losses (Topic 326):

 

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). This standard requires that credit losses be reported using an expected losses model rather than the incurred losses model that is currently used and establishes additional disclosures related to credit risks. In November 2019, the FASB issued ASU 2019-10, Financial Instruments-Credit Losses (Topic 326), Derivative and Hedging (Topic 815) and Leases (Topic 842), which defers the effective date for ASU 2016-13 to interim and annual periods beginning after December 15, 2022 for private companies, EGCs following private company adoption dates, or public entities meeting the definition of smaller reporting companies as of the date of issuance of this update. The Company has not yet determined the effects, if any, that the adoption of ASU 2016-13 may have on its financial position, results of operations, cash flows, or disclosures.

XML 35 R22.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2020
Accounting Policies [Abstract]  
Components of Cash, Cash Equivalents and Restricted Cash

The following table presents the components of total cash, cash equivalents, and restricted cash as set forth in the Company’s condensed consolidated statements of cash flows:

 

 

 

June 30,

2020

 

 

December 31,

2019

 

Cash and cash equivalents

 

$

148,344

 

 

$

71,655

 

Restricted cash

 

 

1,853

 

 

 

1,852

 

Total cash, cash equivalents, and restricted cash

 

$

150,197

 

 

$

73,507

 

Summary of Roll-Forward Warranty Liability A roll-forward of the Company’s warranty liability from December 31, 2019 to June 30, 2020 is as follows:

 

Balance at December 31, 2019

 

$

225

 

Provisions for warranty obligations

 

 

670

 

Settlements

 

 

(127

)

Balance at June 30, 2020

 

$

768

 

 

XML 36 R23.htm IDEA: XBRL DOCUMENT v3.20.2
Business Combinations (Tables)
6 Months Ended
Jun. 30, 2020
Business Combinations [Abstract]  
Summary of Purchase Price Allocation The following table summarizes the purchase price allocation that includes the fair values of the separately identifiable assets acquired and liabilities assumed as of February 28, 2019:

 

 

 

 

 

Cash

$

466

 

Accounts receivable

411

 

Inventory

492

 

Prepaids and other assets

3

 

Property and equipment

1

 

Goodwill

592

 

Intangible assets

455

 

Total assets acquired

 

2,420

 

Accounts payable and accrued expenses

 

(241

)

Contract liabilities

 

(75

)

Deferred taxes

 

(78

)

Total liabilities assumed

 

(394

)

Total purchase price

$

2,026

 

 

 

 

 

Summary of Business Acquisition Pro Forma Information

The following unaudited pro forma information for the three and six months ended June 30, 2019 presents consolidated information as if the Solus acquisition occurred on January 1, 2019, which is the first day of the Company’s fiscal year 2019:

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2019

 

 

2019

 

Net revenue

 

$

11,986

 

 

$

24,522

 

Net loss

 

$

(12,880

)

 

$

(25,788

)

Net loss per share, basic

 

$

(0.76

)

 

$

(1.52

)

XML 37 R24.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value Measurements (Tables)
6 Months Ended
Jun. 30, 2020
Warrants  
Schedule of Assumptions Used in Black-Scholes Options Pricing Model at the Date of Grant

The assumptions used in the Black-Scholes pricing model were as follows at the date of grant:

 

Expected dividend yield

 

0.0

%

Risk free interest rate

 

2.4

%

Expected stock price volatility

 

60.9

%

Expected term (years)

 

10.0

 

XML 38 R25.htm IDEA: XBRL DOCUMENT v3.20.2
Accounts Receivable (Tables)
6 Months Ended
Jun. 30, 2020
Receivables [Abstract]  
Summary of Accounts Receivable

Accounts receivable consists of the following:

 

 

 

June 30,

2020

 

 

December 31,

2019

 

United States

 

$

10,614

 

 

$

5,574

 

International

 

 

6,428

 

 

 

2,908

 

Total accounts receivable

 

 

17,042

 

 

 

8,482

 

Less: Allowance for doubtful accounts

 

 

(590

)

 

 

(239

)

Accounts receivable, net of allowance for doubtful

   accounts

 

$

16,452

 

 

$

8,243

 

XML 39 R26.htm IDEA: XBRL DOCUMENT v3.20.2
Inventories (Tables)
6 Months Ended
Jun. 30, 2020
Inventory Disclosure [Abstract]  
Schedule of Inventories

Inventories consist of the following:

 

 

 

June 30,

2020

 

 

December 31,

2019

 

Component parts

 

$

9,010

 

 

$

4,948

 

Finished goods

 

 

9,631

 

 

 

4,189

 

Total inventory

 

$

18,641

 

 

$

9,137

 

XML 40 R27.htm IDEA: XBRL DOCUMENT v3.20.2
Goodwill and Intangible Assets (Tables)
6 Months Ended
Jun. 30, 2020
Goodwill And Intangible Assets Disclosure [Abstract]  
Schedule of Changes in Carrying Amount of Goodwill and Intangible Assets

The changes in the carrying amount of goodwill and intangible assets during 2020 are as follows:

 

 

 

Goodwill

 

 

Intangible Assets

 

Balance at December 31, 2019

 

$

588

 

 

$

353

 

Acquired during the period

 

 

-

 

 

 

-

 

Amortization

 

 

-

 

 

 

(56

)

Foreign currency exchange rate changes

 

 

(41

)

 

 

(22

)

Balance at June 30, 2020

 

$

547

 

 

$

275

 

Summary of Acquired Intangible Assets

 

The following table presents a summary of acquired intangible assets:

 

 

 

As of June 30, 2020

 

 

 

Period of

amortization

 

 

Gross

Carrying

Amount

 

 

Accumulated

Amortization

 

Customer agreements

 

 

3.83

 

 

$

423

 

 

$

(148

)

Total identifiable intangible assets

 

 

 

 

 

$

423

 

 

$

(148

)

XML 41 R28.htm IDEA: XBRL DOCUMENT v3.20.2
Debt (Tables)
6 Months Ended
Jun. 30, 2020
Debt Disclosure [Abstract]  
Schedule of Annual Principal Maturities of Term Loans

The annual principal maturities of the Company’s term loans as of June 30, 2020 are as follows:

 

2020

 

 

-

 

2021

 

 

-

 

2022

 

 

-

 

2023

 

 

42,592

 

Less: Discount on loans payable

 

 

(663

)

Long-term loans payable

 

$

41,929

 

XML 42 R29.htm IDEA: XBRL DOCUMENT v3.20.2
Warrants (Tables)
6 Months Ended
Jun. 30, 2020
Warrants And Rights Note Disclosure [Abstract]  
Summary of Warrants Activity

The Company’s warrant activity is summarized as follows:

 

 

 

Common Stock Warrants

 

 

 

Number of

Shares

 

 

Weighted

Average

Exercise

Price

 

Outstanding at December 31, 2019

 

 

182,076

 

 

$

14.84

 

Warrants granted

 

 

-

 

 

 

-

 

Warrants exercised

 

 

(80,097

)

 

 

15.92

 

Outstanding at June 30, 2020

 

 

101,979

 

 

$

14.00

 

XML 43 R30.htm IDEA: XBRL DOCUMENT v3.20.2
Revenue (Tables)
6 Months Ended
Jun. 30, 2020
Revenue From Contract With Customer [Abstract]  
Net Revenue Disaggregated into Categories

The following table shows the Company’s net revenue disaggregated into categories the Company considers meaningful to depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors:

 

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

 

2020

 

2020

 

 

 

US

 

 

International

 

 

Total

 

US

 

 

International

 

 

Total

 

Net revenue by:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product Revenue

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capital Equipment

 

$

14,079

 

 

$

5,226

 

 

$

19,305

 

$

17,380

 

 

$

6,923

 

 

$

24,303

 

Disposable

 

 

9,441

 

 

 

3,722

 

 

 

13,163

 

 

19,135

 

 

 

6,458

 

 

 

25,593

 

Subtotal Product Revenue

 

 

23,520

 

 

 

8,948

 

 

 

32,468

 

 

36,515

 

 

 

13,381

 

 

 

49,896

 

Lease Revenue

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

Capital Equipment

 

 

1,620

 

 

 

14

 

 

 

1,634

 

 

2,247

 

 

 

31

 

 

 

2,278

 

Other

 

 

435

 

 

 

76

 

 

 

511

 

 

752

 

 

 

151

 

 

 

903

 

Service and Other Revenue

 

 

107

 

 

 

432

 

 

 

539

 

 

509

 

 

 

681

 

 

 

1,190

 

Total Revenue

 

$

25,682

 

 

$

9,470

 

 

$

35,152

 

$

40,023

 

 

$

14,244

 

 

$

54,267

 

 

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

 

2019

 

2019

 

 

 

US

 

 

International

 

 

Total

 

US

 

 

International

 

 

Total

 

Net revenue by:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product Revenue

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capital Equipment

 

$

1,599

 

 

$

1,046

 

 

$

2,645

 

$

3,109

 

 

$

1,551

 

 

$

4,660

 

Disposable

 

 

6,514

 

 

 

2,016

 

 

 

8,530

 

 

14,061

 

 

 

3,488

 

 

 

17,549

 

Subtotal Product Revenue

 

 

8,113

 

 

 

3,062

 

 

 

11,175

 

 

17,170

 

 

 

5,039

 

 

 

22,209

 

Lease Revenue

 

 

284

 

 

 

-

 

 

 

284

 

 

947

 

 

 

-

 

 

 

947

 

Service and Other Revenue

 

 

281

 

 

 

246

 

 

 

527

 

 

610

 

 

 

519

 

 

 

1,129

 

Total Revenue

 

$

8,678

 

 

$

3,308

 

 

$

11,986

 

$

18,727

 

 

$

5,558

 

 

$

24,285

 

Schedule of Changes in Contract Liabilities The following table presents changes in contract liabilities during the six months ended June 30, 2020:

 

 

Contract

Liabilities

 

 

Deferred

Revenue

 

Balance at December 31, 2019

 

$

137

 

 

$

344

 

Additions

 

 

261

 

 

 

1,195

 

Subtractions

 

 

(137

)

 

 

(469

)

Balance at June 30, 2020

 

$

261

 

 

$

1,070

 

 

XML 44 R31.htm IDEA: XBRL DOCUMENT v3.20.2
Stock Plans and Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of Allocated Stock Based Compensation Expense

Stock-based compensation expense was allocated based on the employees’ and non-employees’ functions as follows:

 

 

 

Three Months Ended

June 30,

 

 

Six Months Ended

June 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Cost of goods sold

 

$

74

 

 

$

27

 

 

$

145

 

 

$

138

 

Research and development

 

 

199

 

 

 

(10

)

 

 

400

 

 

 

255

 

Sales and marketing

 

 

480

 

 

 

246

 

 

 

920

 

 

 

759

 

General and administrative

 

 

624

 

 

 

449

 

 

 

1,359

 

 

 

1,463

 

Total

 

$

1,377

 

 

$

712

 

 

$

2,824

 

 

$

2,615

 

Schedule of Weighted Average Assumptions Used in Black-Scholes Options Pricing Model

The weighted average assumptions used in the Black-Scholes options pricing model are as follows:

 

 

 

 

Six Months Ended June 30,

 

 

 

2020

 

 

2019

 

Expected dividend yield

 

 

0.0

%

 

 

0.0

%

Risk free interest rate

 

 

1.7

%

 

 

2.5

%

Expected stock price volatility

 

 

87.6

%

 

 

70.0

%

Expected term (years)

 

 

6.1

 

 

 

7.1

 

Summary of Restricted Stock Activity

A summary of restricted stock activity for the six months ended June 30, 2020 is as follows:

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

Grant Date

 

 

 

Shares

 

 

Fair Value

 

Unvested at December 31, 2019

 

 

229,913

 

 

$

3.76

 

Granted/purchased

 

 

53,445

 

 

 

13.31

 

Vested

 

 

(76,063

)

 

 

3.44

 

Canceled

 

 

(500

)

 

 

10.97

 

Unvested at June 30, 2020

 

 

206,795

 

 

$

4.02

 

Employee Stock Purchase Plan  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Schedule of Weighted Average Assumptions Used in Black-Scholes Options Pricing Model

The fair value of the purchase right for the ESPP option is estimated on the date of grant using the Black-Scholes pricing model with the following assumptions during 2020:

 

Expected dividend yield

 

0.0%

 

Risk free interest rate

 

0.2% - 1.6%

 

Expected stock price volatility

 

107.9% - 115.8%

 

Expected term (years)

 

0.4 - 0.5

 

XML 45 R32.htm IDEA: XBRL DOCUMENT v3.20.2
Net Loss Per Share (Tables)
6 Months Ended
Jun. 30, 2020
Earnings Per Share [Abstract]  
Schedule of Computation of Diluted Net Loss Per Share Attributable to Common Stockholders

The Company excluded the following potential common shares, based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:

 

 

 

As of June 30,

 

 

 

2020

 

 

2019

 

Options to purchase common stock

 

 

1,826,614

 

 

 

1,397,432

 

Warrants to purchase common stock

 

 

101,979

 

 

 

182,076

 

Unvested restricted stock

 

 

206,795

 

 

 

305,220

 

Employee stock purchase plan shares

 

 

19,473

 

 

-

 

 

 

 

2,154,861

 

 

 

1,884,728

 

XML 46 R33.htm IDEA: XBRL DOCUMENT v3.20.2
Description of Business - Additional Information (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Dec. 20, 2019
USD ($)
Nov. 16, 2018
USD ($)
$ / shares
shares
May 31, 2020
USD ($)
$ / shares
shares
Apr. 30, 2020
USD ($)
shares
Aug. 31, 2019
USD ($)
$ / shares
shares
Jun. 30, 2020
shares
Mar. 31, 2020
System
Jun. 30, 2020
USD ($)
Organization Consolidation And Presentation Of Financial Statements [Line Items]                
Entity founded year             1993  
Entity reincorporated year             2013  
Number of versions of precision flow systems | System             4  
Proceeds from issuance of common stock               $ 94,156
Common Stock                
Organization Consolidation And Presentation Of Financial Statements [Line Items]                
Number of shares issued | shares     3,852,500   3,570,750 3,852,500    
Exercise of underwriters option to purchase shares | shares     502,500   465,750      
Public offering price of common stock | $ / shares     $ 26.00   $ 14.50      
Proceeds from initial offering net of underwriting discounts and offering costs     $ 93,800   $ 48,300      
Underwriting discount     6,000   3,100      
Offering expenses     $ 300   $ 400      
Initial Public Offering | Common Stock                
Organization Consolidation And Presentation Of Financial Statements [Line Items]                
Number of shares issued | shares   4,600,000            
Exercise of underwriters option to purchase shares | shares   600,000            
Public offering price of common stock | $ / shares   $ 14.00            
Proceeds from initial offering net of underwriting discounts and offering costs   $ 57,400            
Underwriting discount   4,500            
Offering expenses   $ 2,500            
ATM Agreement                
Organization Consolidation And Presentation Of Financial Statements [Line Items]                
Number of shares issued | shares       511,648        
Gross proceeds from issuance of common stock       $ 10,200        
Proceeds from issuance of common stock       $ 9,800        
ATM Agreement | Jefferies LLC                
Organization Consolidation And Presentation Of Financial Statements [Line Items]                
Gross proceeds from issuance of common stock $ 50,000              
XML 47 R34.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies - Additional Information (Details)
3 Months Ended 6 Months Ended
Jun. 30, 2020
USD ($)
Jun. 30, 2019
USD ($)
Jun. 30, 2020
USD ($)
Segment
Jun. 30, 2019
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Summary Of Significant Accounting Policies [Line Items]            
Number of reporting segment | Segment     1      
Number of reporting units | Segment     2      
Maturity period of highly liquid investments with original maturities     90 days      
Cash, cash equivalents and restricted cash balance $ 150,197,000 $ 47,907,000 $ 150,197,000 $ 47,907,000 $ 73,507,000 $ 60,022,000
Standard product warranty period     1 year      
Standard payment term to customer     30 days      
Revenue, performance obligation, description of payment terms     When determining the transaction price of a contract, an adjustment is made if payment from a customer occurs either significantly before or significantly after performance, resulting in a significant financing component. Applying the practical expedient in paragraph ASC 606-10-32-18, the Company does not assess whether a significant financing component exists if the period between when the Company performs its obligations under the contract and when the customer pays is one year or less.      
Revenue, remaining performance obligation, amount 0 0 $ 0 $ 0    
Dividend yield assumed     0.00% 0.00%    
Provision or benefit for income taxes 0 0 $ 0 $ 0    
Shipping and Handling            
Summary Of Significant Accounting Policies [Line Items]            
Shipping and handling costs 800,000 $ 200,000 1,100,000 $ 500,000    
Prepaid Expenses and Other Current Assets            
Summary Of Significant Accounting Policies [Line Items]            
Current value of future lease payments 1,800,000   1,800,000   900,000  
Outside U.S.            
Summary Of Significant Accounting Policies [Line Items]            
Long-term assets 100,000   100,000   $ 100,000  
Cash, cash equivalents and restricted cash balance $ 500,000   $ 500,000      
XML 48 R35.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies - Components of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Jun. 30, 2019
Dec. 31, 2018
Accounting Policies [Abstract]        
Cash and cash equivalents $ 148,344 $ 71,655    
Restricted cash 1,853 1,852    
Total cash, cash equivalents, and restricted cash $ 150,197 $ 73,507 $ 47,907 $ 60,022
XML 49 R36.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies - Summary of Roll-Forward Warranty Liability (Details)
$ in Thousands
6 Months Ended
Jun. 30, 2020
USD ($)
Accounting Policies [Abstract]  
Balance, beginning of period $ 225
Provisions for warranty obligations 670
Settlements (127)
Balance, end of period $ 768
XML 50 R37.htm IDEA: XBRL DOCUMENT v3.20.2
Business Combinations - Additional Information (Details) - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Feb. 28, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2020
Dec. 31, 2019
Business Acquisition [Line Items]          
Purchase price, net of cash acquired     $ 1,560    
Solus          
Business Acquisition [Line Items]          
Acquisition date   Feb. 28, 2019      
Purchase price, net of cash acquired $ 2,000        
Initial cash payment 1,600        
Settlement of receivable from preexisting relationship $ 400        
Contingent consideration as compensation expense         $ 1,000
Weighted average amortization period for intangible assets   3 years 9 months 29 days      
Solus | General and administrative          
Business Acquisition [Line Items]          
Transaction costs associated with acquisition         $ 200
Solus | Scenario Forecast          
Business Acquisition [Line Items]          
Contingent consideration as compensation to be recognized       $ 1,200  
XML 51 R38.htm IDEA: XBRL DOCUMENT v3.20.2
Business Combinations - Summary of Purchase Price Allocation (Details) - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Feb. 28, 2019
Business Acquisition [Line Items]      
Goodwill $ 547 $ 588  
Solus      
Business Acquisition [Line Items]      
Cash     $ 466
Accounts receivable     411
Inventory     492
Prepaids and other assets     3
Property and equipment     1
Goodwill     592
Intangible assets     455
Total assets acquired     2,420
Accounts payable and accrued expenses     (241)
Contract liabilities     (75)
Deferred taxes     (78)
Total liabilities assumed     (394)
Total purchase price     $ 2,026
XML 52 R39.htm IDEA: XBRL DOCUMENT v3.20.2
Business Combinations - Summary of Business Acquisition Pro Forma Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2019
Business Combinations [Abstract]    
Net revenue $ 11,986 $ 24,522
Net loss $ (12,880) $ (25,788)
Net loss per share, basic $ (0.76) $ (1.52)
XML 53 R40.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value Measurements - Additional Information (Details) - USD ($)
$ in Millions
Jun. 30, 2020
Mar. 22, 2019
Amendment To Financing Arrangement | Common Stock Warrants    
Class Of Warrant Or Right [Line Items]    
Granted warrants to purchase shares   19,789
Level 1 | Money Market Deposits    
Class Of Warrant Or Right [Line Items]    
Cash equivalents $ 132.8  
XML 54 R41.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value Measurements - Schedule of Assumptions Used in Black-Scholes Options Pricing Model at the Date of Grant (Details)
Jun. 30, 2020
Class Of Warrant Or Right [Line Items]  
Expected term (years) 10 years
Expected Dividend Yield  
Class Of Warrant Or Right [Line Items]  
Key inputs used in valuation 0.000
Risk Free Interest Rate  
Class Of Warrant Or Right [Line Items]  
Key inputs used in valuation 0.024
Expected Stock Price Volatility  
Class Of Warrant Or Right [Line Items]  
Key inputs used in valuation 0.609
XML 55 R42.htm IDEA: XBRL DOCUMENT v3.20.2
Accounts Receivable - Summary of Accounts Receivable (Details) - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Accounts Notes And Loans Receivable [Line Items]    
Total accounts receivable $ 17,042 $ 8,482
Less: Allowance for doubtful accounts (590) (239)
Accounts receivable, net of allowance for doubtful accounts 16,452 8,243
United States    
Accounts Notes And Loans Receivable [Line Items]    
Total accounts receivable 10,614 5,574
International    
Accounts Notes And Loans Receivable [Line Items]    
Total accounts receivable $ 6,428 $ 2,908
XML 56 R43.htm IDEA: XBRL DOCUMENT v3.20.2
Accounts Receivable - Additional Information (Details) - Customer Concentration Risk - Customer
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Revenue          
Accounts Notes And Loans Receivable [Line Items]          
Number of customer accounted more than 10% 0 0 0 0  
Percentage of concentration risk 10.00% 10.00% 10.00% 10.00%  
Accounts Receivable          
Accounts Notes And Loans Receivable [Line Items]          
Number of customer accounted more than 10%     0   0
Percentage of concentration risk     10.00%   10.00%
XML 57 R44.htm IDEA: XBRL DOCUMENT v3.20.2
Inventories - Schedule of Inventories (Details) - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Inventory Disclosure [Abstract]    
Component parts $ 9,010 $ 4,948
Finished goods 9,631 4,189
Total inventory $ 18,641 $ 9,137
XML 58 R45.htm IDEA: XBRL DOCUMENT v3.20.2
Goodwill and Intangible Assets - Schedule of Changes in Carrying Amount of Goodwill and Intangible Assets (Details)
$ in Thousands
6 Months Ended
Jun. 30, 2020
USD ($)
Goodwill  
Balance at December 31, 2019 $ 588
Foreign currency exchange rate changes (41)
Balance at June 30, 2020 547
Intangible Assets  
Balance at December 31, 2019 353
Amortization (56)
Foreign currency exchange rate changes (22)
Balance at June 30, 2020 $ 275
XML 59 R46.htm IDEA: XBRL DOCUMENT v3.20.2
Goodwill and Intangible Assets - Summary of Acquired Intangible Assets (Details)
$ in Thousands
6 Months Ended
Jun. 30, 2020
USD ($)
Acquired Finite Lived Intangible Assets [Line Items]  
Gross Carrying Amount $ 423
Accumulated Amortization $ (148)
Customer Agreements  
Acquired Finite Lived Intangible Assets [Line Items]  
Period of amortization 3 years 9 months 29 days
Gross Carrying Amount $ 423
Accumulated Amortization $ (148)
XML 60 R47.htm IDEA: XBRL DOCUMENT v3.20.2
Debt - Additional Information (Details)
1 Months Ended 6 Months Ended
Jun. 16, 2020
Mar. 22, 2019
USD ($)
$ / shares
shares
Sep. 27, 2018
USD ($)
$ / shares
shares
Jul. 20, 2018
USD ($)
$ / shares
shares
Apr. 06, 2018
USD ($)
Tranche
$ / shares
shares
Nov. 16, 2016
USD ($)
Apr. 30, 2018
USD ($)
Jun. 30, 2020
USD ($)
Jun. 30, 2019
USD ($)
Dec. 31, 2019
USD ($)
Mar. 21, 2019
USD ($)
Debt Instrument [Line Items]                      
Proceeds from term loan                 $ 10,500,000    
Western Alliance Bank | Revolving Credit Line | Revolver Agreement                      
Debt Instrument [Line Items]                      
Line of credit made available under agreement           $ 7,000,000.0 $ 7,500,000        
Percentage of eligible receivables used as base to calculate line of credit availability           80.00%          
Line of credit, maturity date           Sep. 30, 2018 Sep. 30, 2020        
Western Alliance Bank | Revolving Credit Line | Revolver Agreement | Credit Card Program                      
Debt Instrument [Line Items]                      
Line of credit made available under agreement                     $ 300,000
Western Alliance Bank | Revolving Credit Line | 2019 Amended Revolver Agreement                      
Debt Instrument [Line Items]                      
Line of credit, interest rate                   6.50%  
Outstanding balance under line of credit                   $ 3,500,000  
Line of credit, remaining availability under agreement                   $ 800,000  
Western Alliance Bank | Revolving Credit Line | 2019 Amended Revolver Agreement | Credit Card Program                      
Debt Instrument [Line Items]                      
Line of credit made available under agreement   $ 500,000                  
Western Alliance Bank | Revolving Credit Line | 2020 Amended Revolver Agreement                      
Debt Instrument [Line Items]                      
Line of credit, interest rate               5.25%      
Outstanding balance under line of credit               $ 4,500,000      
Line of credit, remaining availability under agreement               3,000,000.0      
Perceptive Credit Holdings II, LP | Credit Agreement and Guaranty | Term Loan                      
Debt Instrument [Line Items]                      
Term loan, face amount         $ 42,500,000            
Number of tranches available under agreement | Tranche         3            
Proceeds from term loan   $ 10,500,000                  
Granted warrants to purchase shares | shares   19,789     37,693            
Warrants exercise price | $ / shares   $ 15.92     $ 15.92            
Warrants expiration, month and year   2029-03     2028-04            
Perceptive Credit Holdings II, LP | Credit Agreement and Guaranty | First Tranche | Term Loan                      
Debt Instrument [Line Items]                      
Proceeds from term loan         $ 20,000,000.0            
Perceptive Credit Holdings II, LP | Credit Agreement and Guaranty | Debt Instrument Second Tranche | Term Loan                      
Debt Instrument [Line Items]                      
Proceeds from term loan       $ 10,000,000.0              
Granted warrants to purchase shares | shares       18,846              
Warrants exercise price | $ / shares       $ 15.92              
Warrants expiration, month and year       2028-07              
Perceptive Credit Holdings II, LP | First Amendment to Credit Agreement and Guaranty | Term Loan                      
Debt Instrument [Line Items]                      
Term loan available to be drawn     $ 12,500,000                
Minimum revenue requirement to draw final tranche     43,200,000                
Perceptive Credit Holdings II, LP | First Amendment to Credit Agreement and Guaranty | Credit Card Program | Term Loan                      
Debt Instrument [Line Items]                      
Line of credit made available under agreement                     $ 300,000
Perceptive Credit Holdings II, LP | First Amendment to Credit Agreement and Guaranty | Debt Instrument Third Tranche | Term Loan                      
Debt Instrument [Line Items]                      
Proceeds from term loan     $ 2,000,000.0                
Granted warrants to purchase shares | shares     3,769                
Warrants exercise price | $ / shares     $ 15.92                
Warrants expiration, month and year     2028-09                
Perceptive Credit Holdings II, LP | Second Amendment to Credit Agreement and Guaranty | Credit Card Program | Term Loan                      
Debt Instrument [Line Items]                      
Line of credit made available under agreement   $ 500,000                  
Perceptive Credit Holdings II, LP | 2020 Amended Credit Agreement and Guaranty | Term Loan                      
Debt Instrument [Line Items]                      
Term loan, face amount               $ 42,600,000      
Term loan, interest rate 9.06%             10.81%      
Debt instrument rate 1.75%                    
Debt instrument, description one-month LIBOR                    
Term loan, remaining availability under agreement               $ 0      
Line of credit, covenant compliance description               The 2020 Amended Credit Agreement and Guaranty requires the Company to comply with a minimum liquidity covenant at all times and a minimum revenue covenant measured at the end of each fiscal quarter. As of June 30, 2020, the Company was in compliance with all covenants.      
Line of credit facility percentage of amount borrowed               0.50%      
XML 61 R48.htm IDEA: XBRL DOCUMENT v3.20.2
Debt - Schedule of Annual Principal Maturities of Term Loans (Details) - Loans Payable
$ in Thousands
Jun. 30, 2020
USD ($)
Debt Instrument [Line Items]  
2020 $ 0
2021 0
2022 0
2023 42,592
Less: Discount on loans payable (663)
Long-term loans payable $ 41,929
XML 62 R49.htm IDEA: XBRL DOCUMENT v3.20.2
Warrants - Summary of Warrants Activity (Details) - Common Stock Warrants - $ / shares
6 Months Ended
Jun. 10, 2020
Jun. 30, 2020
Class Of Warrant Or Right [Line Items]    
Number of shares, beginning balance   182,076
Number of shares, warrants exercised (80,097) (80,097)
Number of shares, ending balance   101,979
Weighted average exercise price, ending balance $ 15.92  
Weighted Average    
Class Of Warrant Or Right [Line Items]    
Weighted average exercise price, beginning balance   $ 14.84
Weighted average exercise price, warrants exercised   15.92
Weighted average exercise price, ending balance   $ 14.00
XML 63 R50.htm IDEA: XBRL DOCUMENT v3.20.2
Warrants - Additional Information (Details) - Common Stock Warrants - $ / shares
6 Months Ended
Jul. 10, 2020
Jun. 10, 2020
Jun. 30, 2020
Class Of Warrant Or Right [Line Items]      
Warrants to purchase of common stock shares, net exercised   80,097 80,097
Warrants exercise price   $ 15.92  
Number of warrants withhold upon warrants exercise   39,031  
Issuance of common stock upon exercise of warrants, shares   41,066  
Subsequent Event      
Class Of Warrant Or Right [Line Items]      
Warrants to purchase of common stock shares, net exercised 20,891    
Warrants exercise price $ 14.00    
Number of warrants withhold upon warrants exercise 6,905    
Issuance of common stock upon exercise of warrants, shares 13,986    
XML 64 R51.htm IDEA: XBRL DOCUMENT v3.20.2
Revenue - Net Revenue Disaggregated into Categories (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Disaggregation Of Revenue [Line Items]        
Total Revenue $ 35,152 $ 11,986 $ 54,267 $ 24,285
US        
Disaggregation Of Revenue [Line Items]        
Total Revenue 25,682 8,678 40,023 18,727
International        
Disaggregation Of Revenue [Line Items]        
Total Revenue 9,470 3,308 14,244 5,558
Product Revenue, Capital Equipment        
Disaggregation Of Revenue [Line Items]        
Total Revenue 19,305 2,645 24,303 4,660
Product Revenue, Capital Equipment | US        
Disaggregation Of Revenue [Line Items]        
Total Revenue 14,079 1,599 17,380 3,109
Product Revenue, Capital Equipment | International        
Disaggregation Of Revenue [Line Items]        
Total Revenue 5,226 1,046 6,923 1,551
Product Revenue, Disposable        
Disaggregation Of Revenue [Line Items]        
Total Revenue 13,163 8,530 25,593 17,549
Product Revenue, Disposable | US        
Disaggregation Of Revenue [Line Items]        
Total Revenue 9,441 6,514 19,135 14,061
Product Revenue, Disposable | International        
Disaggregation Of Revenue [Line Items]        
Total Revenue 3,722 2,016 6,458 3,488
Subtotal Product Revenue        
Disaggregation Of Revenue [Line Items]        
Total Revenue 32,468 11,175 49,896 22,209
Subtotal Product Revenue | US        
Disaggregation Of Revenue [Line Items]        
Total Revenue 23,520 8,113 36,515 17,170
Subtotal Product Revenue | International        
Disaggregation Of Revenue [Line Items]        
Total Revenue 8,948 3,062 13,381 5,039
Lease Revenue, Capital Equipment        
Disaggregation Of Revenue [Line Items]        
Total Revenue 1,634   2,278  
Lease Revenue, Capital Equipment | US        
Disaggregation Of Revenue [Line Items]        
Total Revenue 1,620   2,247  
Lease Revenue, Capital Equipment | International        
Disaggregation Of Revenue [Line Items]        
Total Revenue 14   31  
Lease Revenue, Other        
Disaggregation Of Revenue [Line Items]        
Total Revenue 511   903  
Lease Revenue, Other | US        
Disaggregation Of Revenue [Line Items]        
Total Revenue 435   752  
Lease Revenue, Other | International        
Disaggregation Of Revenue [Line Items]        
Total Revenue 76   151  
Service and Other Revenue        
Disaggregation Of Revenue [Line Items]        
Total Revenue 539 527 1,190 1,129
Service and Other Revenue | US        
Disaggregation Of Revenue [Line Items]        
Total Revenue 107 281 509 610
Service and Other Revenue | International        
Disaggregation Of Revenue [Line Items]        
Total Revenue $ 432 246 $ 681 519
Lease Revenue        
Disaggregation Of Revenue [Line Items]        
Total Revenue   284   947
Lease Revenue | US        
Disaggregation Of Revenue [Line Items]        
Total Revenue   $ 284   $ 947
XML 65 R52.htm IDEA: XBRL DOCUMENT v3.20.2
Revenue - Schedule of Changes in Contract Liabilities (Details)
$ in Thousands
6 Months Ended
Jun. 30, 2020
USD ($)
Contract Liabilities  
Balance at December 31, 2019 $ 137
Additions 261
Subtractions (137)
Balance at June 30, 2020 261
Deferred Revenue  
Balance at December 31, 2019 344
Additions 1,195
Subtractions (469)
Balance at June 30, 2020 $ 1,070
XML 66 R53.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation - Summary of Allocated Stock Based Compensation Expense (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Allocated stock based compensation expense $ 1,377 $ 712 $ 2,824 $ 2,615
Cost of goods sold        
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Allocated stock based compensation expense 74 27 145 138
Research and development        
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Allocated stock based compensation expense 199 (10) 400 255
Sales and marketing        
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Allocated stock based compensation expense 480 246 920 759
General and administrative        
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Allocated stock based compensation expense $ 624 $ 449 $ 1,359 $ 1,463
XML 67 R54.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation - Additional Information (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Nov. 30, 2018
Jun. 30, 2020
Jun. 30, 2020
Jun. 30, 2019
May 31, 2020
Aug. 31, 2019
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Stock options, granted     938,910 776,196    
Exercise price range, lower range limit     $ 10.60 $ 17.15    
Exercise price range, upper range limit     39.01 19.28    
Weighted average exercise price     12.47 17.18    
Weighted average fair value of stock options granted     $ 9.16 $ 11.97    
Common Stock            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Common stock shares issued   36,389 36,389      
Common stock price per share         $ 26.00 $ 14.50
Employee Stock Purchase Plan            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Common stock reserved for issuance 166,500 512,048 512,048      
Common stock reserved and available for future issuance maximum cumulative increase percentage on immediate preceding year end common stock issued and outstanding 1.00%          
Common stock reserved and available for issuance cumulatively increase description     The number of shares of common stock available for issuance under the ESPP is increased on the first day of each calendar year beginning January 1, 2019 and each year thereafter until 2028 by the lessor of (i) 1% of the number of shares of common stock issued and outstanding on the immediately preceding December 31, and (ii) the number of shares of common stock determined by the Company’s board of directors up to such an initial maximum of 1,741,300 shares of common stock. The number of shares of common stock reserved under the plan at June 30, 2020 totals 512,048.      
Initial maximum number of common stock determined by board of directors 1,741,300          
Cash proceeds from issuance of common stock     $ 359,000      
Maximum percentage to purchase shares of eligible compensation a participant receives during each offering period 10.00%          
Maximum amount of shares a participant can accrue at discounted rate of the fair market value. $ 25,000          
Maximum number of shares per participant 5,000          
Purchase price as a percentage of its market price on first trading day of each offering period 85.00%          
Employee Stock Purchase Plan | Common Stock            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Common stock price per share   $ 9.88 $ 9.88      
XML 68 R55.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation - Schedule of Weighted Average Assumptions Used in Black-Scholes Options Pricing Model (Details)
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Expected dividend yield 0.00% 0.00%
Risk free interest rate 1.70% 2.50%
Expected stock price volatility 87.60% 70.00%
Expected term (years) 6 years 1 month 6 days 7 years 1 month 6 days
Employee Stock Purchase Plan    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Expected dividend yield 0.00%  
Risk free interest rate, minimum 0.20%  
Risk free interest rate, maximum 1.60%  
Expected stock price volatility, minimum 107.90%  
Expected stock price volatility, maximum 115.80%  
Employee Stock Purchase Plan | Minimum    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Expected term (years) 4 months 24 days  
Employee Stock Purchase Plan | Maximum    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Expected term (years) 6 months  
XML 69 R56.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation - Summary of Restricted Stock Activity (Details) - Restricted Stock
6 Months Ended
Jun. 30, 2020
$ / shares
shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Shares, Unvested, Beginning balance | shares 229,913
Shares, Granted/purchased | shares 53,445
Shares, Vested | shares (76,063)
Shares, Canceled | shares (500)
Shares, Unvested Ending balance | shares 206,795
Weighted Average Grant Date Fair Value, Unvested, Beginning balance | $ / shares $ 3.76
Weighted Average Grant Date Fair Value, Granted/purchased | $ / shares 13.31
Weighted Average Grant Date Fair Value, Vested | $ / shares 3.44
Weighted Average Grant Date Fair Value, Canceled | $ / shares 10.97
Weighted Average Grant Date Fair Value, Unvested Ending balance | $ / shares $ 4.02
XML 70 R57.htm IDEA: XBRL DOCUMENT v3.20.2
Net Loss Per Share - Schedule of Computation of Diluted Net Loss Per Share Attributable to Common Stockholders (Details) - shares
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 2,154,861 1,884,728
Employee Stock Purchase Plan    
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 19,473  
Options to Purchase Common Stock    
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 1,826,614 1,397,432
Warrants to Purchase Common Stock    
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 101,979 182,076
Unvested Restricted Stock    
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 206,795 305,220
XML 71 R58.htm IDEA: XBRL DOCUMENT v3.20.2
Related Party Transactions - Additional Information (Details)
6 Months Ended
Jun. 30, 2020
Minimum [Member]  
Related Party Transaction [Line Items]  
Percentage of common stock held by holder 5.00%
EXCEL 72 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 73 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 74 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 75 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 233 376 1 false 63 0 false 8 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Sheet http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Statements 2 false false R3.htm 100020 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (Unaudited) Sheet http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSParentheticalUnaudited CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (Unaudited) Statements 3 false false R4.htm 100030 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) Sheet http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) Statements 4 false false R5.htm 100040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCK STOCKHOLDERS' EQUITY (unaudited) Sheet http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited CONDENSED CONSOLIDATED STATEMENTS OF STOCK STOCKHOLDERS' EQUITY (unaudited) Statements 5 false false R6.htm 100050 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Statements 6 false false R7.htm 100060 - Disclosure - Description of Business Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureDescriptionOfBusiness Description of Business Notes 7 false false R8.htm 100070 - Disclosure - Summary of Significant Accounting Policies Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 100080 - Disclosure - Business Combinations Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinations Business Combinations Notes 9 false false R10.htm 100090 - Disclosure - Fair Value Measurements Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 10 false false R11.htm 100100 - Disclosure - Accounts Receivable Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivable Accounts Receivable Notes 11 false false R12.htm 100110 - Disclosure - Inventories Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureInventories Inventories Notes 12 false false R13.htm 100120 - Disclosure - Goodwill and Intangible Assets Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureGoodwillAndIntangibleAssets Goodwill and Intangible Assets Notes 13 false false R14.htm 100130 - Disclosure - Debt Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureDebt Debt Notes 14 false false R15.htm 100140 - Disclosure - Commitments and Contingencies Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 15 false false R16.htm 100150 - Disclosure - Warrants Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrants Warrants Notes 16 false false R17.htm 100160 - Disclosure - Revenue Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenue Revenue Notes 17 false false R18.htm 100170 - Disclosure - Stock-Based Compensation Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensation Stock-Based Compensation Notes 18 false false R19.htm 100180 - Disclosure - Net Loss Per Share Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureNetLossPerShare Net Loss Per Share Notes 19 false false R20.htm 100190 - Disclosure - Related Party Transactions Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureRelatedPartyTransactions Related Party Transactions Notes 20 false false R21.htm 100200 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies 21 false false R22.htm 100210 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies 22 false false R23.htm 100220 - Disclosure - Business Combinations (Tables) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsTables Business Combinations (Tables) Tables http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinations 23 false false R24.htm 100230 - Disclosure - Fair Value Measurements (Tables) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurements 24 false false R25.htm 100240 - Disclosure - Accounts Receivable (Tables) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivableTables Accounts Receivable (Tables) Tables http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivable 25 false false R26.htm 100250 - Disclosure - Inventories (Tables) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureInventoriesTables Inventories (Tables) Tables http://vapotherm.com/20200630/taxonomy/role/DisclosureInventories 26 false false R27.htm 100260 - Disclosure - Goodwill and Intangible Assets (Tables) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsTables Goodwill and Intangible Assets (Tables) Tables http://vapotherm.com/20200630/taxonomy/role/DisclosureGoodwillAndIntangibleAssets 27 false false R28.htm 100270 - Disclosure - Debt (Tables) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtTables Debt (Tables) Tables http://vapotherm.com/20200630/taxonomy/role/DisclosureDebt 28 false false R29.htm 100280 - Disclosure - Warrants (Tables) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsTables Warrants (Tables) Tables http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrants 29 false false R30.htm 100290 - Disclosure - Revenue (Tables) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueTables Revenue (Tables) Tables http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenue 30 false false R31.htm 100300 - Disclosure - Stock Plans and Stock-Based Compensation (Tables) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureStockPlansAndStockBasedCompensationTables Stock Plans and Stock-Based Compensation (Tables) Tables 31 false false R32.htm 100310 - Disclosure - Net Loss Per Share (Tables) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureNetLossPerShareTables Net Loss Per Share (Tables) Tables http://vapotherm.com/20200630/taxonomy/role/DisclosureNetLossPerShare 32 false false R33.htm 100320 - Disclosure - Description of Business - Additional Information (Details) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails Description of Business - Additional Information (Details) Details 33 false false R34.htm 100330 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails Summary of Significant Accounting Policies - Additional Information (Details) Details 34 false false R35.htm 100340 - Disclosure - Summary of Significant Accounting Policies - Components of Cash, Cash Equivalents and Restricted Cash (Details) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesComponentsOfCashCashEquivalentsAndRestrictedCashDetails Summary of Significant Accounting Policies - Components of Cash, Cash Equivalents and Restricted Cash (Details) Details 35 false false R36.htm 100350 - Disclosure - Summary of Significant Accounting Policies - Summary of Roll-Forward Warranty Liability (Details) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfRollForwardWarrantyLiabilityDetails Summary of Significant Accounting Policies - Summary of Roll-Forward Warranty Liability (Details) Details 36 false false R37.htm 100360 - Disclosure - Business Combinations - Additional Information (Details) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsAdditionalInformationDetails Business Combinations - Additional Information (Details) Details 37 false false R38.htm 100370 - Disclosure - Business Combinations - Summary of Purchase Price Allocation (Details) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails Business Combinations - Summary of Purchase Price Allocation (Details) Details 38 false false R39.htm 100380 - Disclosure - Business Combinations - Summary of Business Acquisition Pro Forma Information (Details) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfBusinessAcquisitionProFormaInformationDetails Business Combinations - Summary of Business Acquisition Pro Forma Information (Details) Details 39 false false R40.htm 100390 - Disclosure - Fair Value Measurements - Additional Information (Details) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails Fair Value Measurements - Additional Information (Details) Details 40 false false R41.htm 100400 - Disclosure - Fair Value Measurements - Schedule of Assumptions Used in Black-Scholes Options Pricing Model at the Date of Grant (Details) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInBlackScholesOptionsPricingModelAtDateOfGrantDetails Fair Value Measurements - Schedule of Assumptions Used in Black-Scholes Options Pricing Model at the Date of Grant (Details) Details 41 false false R42.htm 100410 - Disclosure - Accounts Receivable - Summary of Accounts Receivable (Details) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivableSummaryOfAccountsReceivableDetails Accounts Receivable - Summary of Accounts Receivable (Details) Details 42 false false R43.htm 100420 - Disclosure - Accounts Receivable - Additional Information (Details) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetails Accounts Receivable - Additional Information (Details) Details 43 false false R44.htm 100430 - Disclosure - Inventories - Schedule of Inventories (Details) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails Inventories - Schedule of Inventories (Details) Details 44 false false R45.htm 100440 - Disclosure - Goodwill and Intangible Assets - Schedule of Changes in Carrying Amount of Goodwill and Intangible Assets (Details) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfChangesInCarryingAmountOfGoodwillAndIntangibleAssetsDetails Goodwill and Intangible Assets - Schedule of Changes in Carrying Amount of Goodwill and Intangible Assets (Details) Details 45 false false R46.htm 100450 - Disclosure - Goodwill and Intangible Assets - Summary of Acquired Intangible Assets (Details) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAcquiredIntangibleAssetsDetails Goodwill and Intangible Assets - Summary of Acquired Intangible Assets (Details) Details 46 false false R47.htm 100460 - Disclosure - Debt - Additional Information (Details) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails Debt - Additional Information (Details) Details 47 false false R48.htm 100470 - Disclosure - Debt - Schedule of Annual Principal Maturities of Term Loans (Details) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtScheduleOfAnnualPrincipalMaturitiesOfTermLoansDetails Debt - Schedule of Annual Principal Maturities of Term Loans (Details) Details 48 false false R49.htm 100480 - Disclosure - Warrants - Summary of Warrants Activity (Details) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsSummaryOfWarrantsActivityDetails Warrants - Summary of Warrants Activity (Details) Details 49 false false R50.htm 100490 - Disclosure - Warrants - Additional Information (Details) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails Warrants - Additional Information (Details) Details 50 false false R51.htm 100500 - Disclosure - Revenue - Net Revenue Disaggregated into Categories (Details) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueNetRevenueDisaggregatedIntoCategoriesDetails Revenue - Net Revenue Disaggregated into Categories (Details) Details 51 false false R52.htm 100510 - Disclosure - Revenue - Schedule of Changes in Contract Liabilities (Details) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueScheduleOfChangesInContractLiabilitiesDetails Revenue - Schedule of Changes in Contract Liabilities (Details) Details 52 false false R53.htm 100520 - Disclosure - Stock-Based Compensation - Summary of Allocated Stock Based Compensation Expense (Details) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfAllocatedStockBasedCompensationExpenseDetails Stock-Based Compensation - Summary of Allocated Stock Based Compensation Expense (Details) Details 53 false false R54.htm 100530 - Disclosure - Stock-Based Compensation - Additional Information (Details) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails Stock-Based Compensation - Additional Information (Details) Details 54 false false R55.htm 100540 - Disclosure - Stock-Based Compensation - Schedule of Weighted Average Assumptions Used in Black-Scholes Options Pricing Model (Details) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfWeightedAverageAssumptionsUsedInBlackScholesOptionsPricingModelDetails Stock-Based Compensation - Schedule of Weighted Average Assumptions Used in Black-Scholes Options Pricing Model (Details) Details 55 false false R56.htm 100550 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Activity (Details) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockActivityDetails Stock-Based Compensation - Summary of Restricted Stock Activity (Details) Details 56 false false R57.htm 100560 - Disclosure - Net Loss Per Share - Schedule of Computation of Diluted Net Loss Per Share Attributable to Common Stockholders (Details) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureNetLossPerShareScheduleOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails Net Loss Per Share - Schedule of Computation of Diluted Net Loss Per Share Attributable to Common Stockholders (Details) Details 57 false false R58.htm 100570 - Disclosure - Related Party Transactions - Additional Information (Details) Sheet http://vapotherm.com/20200630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails Related Party Transactions - Additional Information (Details) Details 58 false false All Reports Book All Reports vapo-10q_20200630.htm vapo-20200630.xsd vapo-20200630_cal.xml vapo-20200630_def.xml vapo-20200630_lab.xml vapo-20200630_pre.xml vapo-ex101_133.htm vapo-ex102_132.htm vapo-ex311_9.htm vapo-ex312_8.htm vapo-ex321_10.htm vapo-ex322_7.htm http://xbrl.sec.gov/country/2020-01-31 http://fasb.org/us-gaap/2020-01-31 http://fasb.org/srt/2020-01-31 http://xbrl.sec.gov/dei/2019-01-31 true true JSON 78 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "vapo-10q_20200630.htm": { "axisCustom": 0, "axisStandard": 25, "contextCount": 233, "dts": { "calculationLink": { "local": [ "vapo-20200630_cal.xml" ] }, "definitionLink": { "local": [ "vapo-20200630_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "vapo-10q_20200630.htm" ] }, "labelLink": { "local": [ "vapo-20200630_lab.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml", "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "vapo-20200630_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml" ] }, "schema": { "local": [ "vapo-20200630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 490, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2020-01-31": 14, "http://vapotherm.com/20200630": 1, "http://xbrl.sec.gov/dei/2019-01-31": 7, "total": 22 }, "keyCustom": 47, "keyStandard": 329, "memberCustom": 26, "memberStandard": 34, "nsprefix": "vapo", "nsuri": "http://vapotherm.com/20200630", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100090 - Disclosure - Fair Value Measurements", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancingReceivablesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100100 - Disclosure - Accounts Receivable", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivable", "shortName": "Accounts Receivable", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancingReceivablesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100110 - Disclosure - Inventories", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureInventories", "shortName": "Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100120 - Disclosure - Goodwill and Intangible Assets", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureGoodwillAndIntangibleAssets", "shortName": "Goodwill and Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100130 - Disclosure - Debt", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebt", "shortName": "Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100140 - Disclosure - Commitments and Contingencies", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureCommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "vapo:WarrantsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100150 - Disclosure - Warrants", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrants", "shortName": "Warrants", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "vapo:WarrantsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100160 - Disclosure - Revenue", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenue", "shortName": "Revenue", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100170 - Disclosure - Stock-Based Compensation", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensation", "shortName": "Stock-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100180 - Disclosure - Net Loss Per Share", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureNetLossPerShare", "shortName": "Net Loss Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)", "role": "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200630", "decimals": "-3", "lang": null, "name": "us-gaap:PrepaidExpenseAndOtherAssetsCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100190 - Disclosure - Related Party Transactions", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureRelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100200 - Disclosure - Summary of Significant Accounting Policies (Policies)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "vapo:ScheduleOfCashAndCashEquivalentsAndRestrictedCashTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100210 - Disclosure - Summary of Significant Accounting Policies (Tables)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "vapo:ScheduleOfCashAndCashEquivalentsAndRestrictedCashTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100220 - Disclosure - Business Combinations (Tables)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsTables", "shortName": "Business Combinations (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100230 - Disclosure - Fair Value Measurements (Tables)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_us-gaapStatementEquityComponentsAxis_us-gaapWarrantMember_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:FinancingReceivablesTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100240 - Disclosure - Accounts Receivable (Tables)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivableTables", "shortName": "Accounts Receivable (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FinancingReceivablesTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100250 - Disclosure - Inventories (Tables)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureInventoriesTables", "shortName": "Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100260 - Disclosure - Goodwill and Intangible Assets (Tables)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsTables", "shortName": "Goodwill and Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100270 - Disclosure - Debt (Tables)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtTables", "shortName": "Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "vapo:WarrantsTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100280 - Disclosure - Warrants (Tables)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsTables", "shortName": "Warrants (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "vapo:WarrantsTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200630", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD_xbrlishares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100020 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (Unaudited)", "role": "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSParentheticalUnaudited", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (Unaudited)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200630", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD_xbrlishares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100290 - Disclosure - Revenue (Tables)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueTables", "shortName": "Revenue (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100300 - Disclosure - Stock Plans and Stock-Based Compensation (Tables)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockPlansAndStockBasedCompensationTables", "shortName": "Stock Plans and Stock-Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100310 - Disclosure - Net Loss Per Share (Tables)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureNetLossPerShareTables", "shortName": "Net Loss Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:YearFounded", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100320 - Disclosure - Description of Business - Additional Information (Details)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails", "shortName": "Description of Business - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:YearFounded", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "p", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "U_vapoSegment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100330 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "shortName": "Summary of Significant Accounting Policies - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "U_vapoSegment", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100340 - Disclosure - Summary of Significant Accounting Policies - Components of Cash, Cash Equivalents and Restricted Cash (Details)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesComponentsOfCashCashEquivalentsAndRestrictedCashDetails", "shortName": "Summary of Significant Accounting Policies - Components of Cash, Cash Equivalents and Restricted Cash (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R36": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "vapo:ProductWarrantyPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StandardProductWarrantyAccrual", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100350 - Disclosure - Summary of Significant Accounting Policies - Summary of Roll-Forward Warranty Liability (Details)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfRollForwardWarrantyLiabilityDetails", "shortName": "Summary of Significant Accounting Policies - Summary of Roll-Forward Warranty Liability (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "vapo:ProductWarrantyPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StandardProductWarrantyAccrual", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20190101_20190630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100360 - Disclosure - Business Combinations - Additional Information (Details)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsAdditionalInformationDetails", "shortName": "Business Combinations - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_us-gaapBusinessAcquisitionAxis_vapoSolusMedicalLimitedMember_20200101_20200630", "decimals": null, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100370 - Disclosure - Business Combinations - Summary of Purchase Price Allocation (Details)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails", "shortName": "Business Combinations - Summary of Purchase Price Allocation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_us-gaapBusinessAcquisitionAxis_vapoSolusMedicalLimitedMember_20190228", "decimals": "-3", "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20190401_20190630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100380 - Disclosure - Business Combinations - Summary of Business Acquisition Pro Forma Information (Details)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfBusinessAcquisitionProFormaInformationDetails", "shortName": "Business Combinations - Summary of Business Acquisition Pro Forma Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20190401_20190630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200401_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100030 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited)", "role": "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200401_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "p", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_us-gaapDebtInstrumentAxis_vapoAmendmentToFinancingArrangementMember_us-gaapStatementClassOfStockAxis_vapoCommonStockWarrantsMember_20190322", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100390 - Disclosure - Fair Value Measurements - Additional Information (Details)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "shortName": "Fair Value Measurements - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_us-gaapDebtInstrumentAxis_vapoAmendmentToFinancingArrangementMember_us-gaapStatementClassOfStockAxis_vapoCommonStockWarrantsMember_20190322", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputExpectedDividendRateMember_20200630", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100400 - Disclosure - Fair Value Measurements - Schedule of Assumptions Used in Black-Scholes Options Pricing Model at the Date of Grant (Details)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInBlackScholesOptionsPricingModelAtDateOfGrantDetails", "shortName": "Fair Value Measurements - Schedule of Assumptions Used in Black-Scholes Options Pricing Model at the Date of Grant (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputExpectedDividendRateMember_20200630", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:FinancingReceivablesTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableGrossCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100410 - Disclosure - Accounts Receivable - Summary of Accounts Receivable (Details)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivableSummaryOfAccountsReceivableDetails", "shortName": "Accounts Receivable - Summary of Accounts Receivable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:FinancingReceivablesTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableGrossCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "vapo:NumberOfCustomer", "vapo:NumberOfCustomer", "p", "us-gaap:FinancingReceivablesTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20200401_20200630", "decimals": "INF", "first": true, "lang": null, "name": "vapo:NumberOfCustomer", "reportCount": 1, "unique": true, "unitRef": "U_vapoCustomer", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100420 - Disclosure - Accounts Receivable - Additional Information (Details)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetails", "shortName": "Accounts Receivable - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "vapo:NumberOfCustomer", "vapo:NumberOfCustomer", "p", "us-gaap:FinancingReceivablesTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20200401_20200630", "decimals": "INF", "first": true, "lang": null, "name": "vapo:NumberOfCustomer", "reportCount": 1, "unique": true, "unitRef": "U_vapoCustomer", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryPartsAndComponentsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100430 - Disclosure - Inventories - Schedule of Inventories (Details)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails", "shortName": "Inventories - Schedule of Inventories (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryPartsAndComponentsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100440 - Disclosure - Goodwill and Intangible Assets - Schedule of Changes in Carrying Amount of Goodwill and Intangible Assets (Details)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfChangesInCarryingAmountOfGoodwillAndIntangibleAssetsDetails", "shortName": "Goodwill and Intangible Assets - Schedule of Changes in Carrying Amount of Goodwill and Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": "-3", "lang": null, "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100450 - Disclosure - Goodwill and Intangible Assets - Summary of Acquired Intangible Assets (Details)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAcquiredIntangibleAssetsDetails", "shortName": "Goodwill and Intangible Assets - Summary of Acquired Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20190101_20190630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfLongTermDebt", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100460 - Disclosure - Debt - Additional Information (Details)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails", "shortName": "Debt - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_us-gaapCreditFacilityAxis_us-gaapRevolvingCreditFacilityMember_us-gaapDebtInstrumentAxis_vapoBusinessFinancingAgreementMember_us-gaapLineOfCreditFacilityAxis_vapoWesternAllianceBankMember_20161116", "decimals": "INF", "lang": null, "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_us-gaapLongtermDebtTypeAxis_us-gaapLoansPayableMember_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100470 - Disclosure - Debt - Schedule of Annual Principal Maturities of Term Loans (Details)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtScheduleOfAnnualPrincipalMaturitiesOfTermLoansDetails", "shortName": "Debt - Schedule of Annual Principal Maturities of Term Loans (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_us-gaapLongtermDebtTypeAxis_us-gaapLoansPayableMember_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "vapo:WarrantsTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_us-gaapStatementClassOfStockAxis_vapoCommonStockWarrantsMember_20191231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100480 - Disclosure - Warrants - Summary of Warrants Activity (Details)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsSummaryOfWarrantsActivityDetails", "shortName": "Warrants - Summary of Warrants Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "vapo:WarrantsTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_us-gaapStatementClassOfStockAxis_vapoCommonStockWarrantsMember_20191231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20181231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCK STOCKHOLDERS' EQUITY (unaudited)", "role": "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCK STOCKHOLDERS' EQUITY (unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20190331", "decimals": "INF", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "p", "vapo:WarrantsTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_us-gaapStatementClassOfStockAxis_vapoCommonStockWarrantsMember_20200610_20200610", "decimals": "INF", "first": true, "lang": null, "name": "vapo:ClassOfWarrantOrRightExercised", "reportCount": 1, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100490 - Disclosure - Warrants - Additional Information (Details)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails", "shortName": "Warrants - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "vapo:WarrantsTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_us-gaapStatementClassOfStockAxis_vapoCommonStockWarrantsMember_20200610", "decimals": "INF", "lang": null, "name": "vapo:ClassOfWarrantOrRightNumberOfWarrantsWithholdUponWarrantsExercise", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200401_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100500 - Disclosure - Revenue - Net Revenue Disaggregated into Categories (Details)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueNetRevenueDisaggregatedIntoCategoriesDetails", "shortName": "Revenue - Net Revenue Disaggregated into Categories (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200401_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerLiabilityCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100510 - Disclosure - Revenue - Schedule of Changes in Contract Liabilities (Details)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueScheduleOfChangesInContractLiabilitiesDetails", "shortName": "Revenue - Schedule of Changes in Contract Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerLiabilityCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200401_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100520 - Disclosure - Stock-Based Compensation - Summary of Allocated Stock Based Compensation Expense (Details)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfAllocatedStockBasedCompensationExpenseDetails", "shortName": "Stock-Based Compensation - Summary of Allocated Stock Based Compensation Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200401_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100530 - Disclosure - Stock-Based Compensation - Additional Information (Details)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails", "shortName": "Stock-Based Compensation - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "p", "us-gaap:CompensationRelatedCostsPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "reportCount": 1, "unitRef": "U_xbrlipure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100540 - Disclosure - Stock-Based Compensation - Schedule of Weighted Average Assumptions Used in Black-Scholes Options Pricing Model (Details)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfWeightedAverageAssumptionsUsedInBlackScholesOptionsPricingModelDetails", "shortName": "Stock-Based Compensation - Schedule of Weighted Average Assumptions Used in Black-Scholes Options Pricing Model (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": "3", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20191231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100550 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Activity (Details)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockActivityDetails", "shortName": "Stock-Based Compensation - Summary of Restricted Stock Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20191231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100560 - Disclosure - Net Loss Per Share - Schedule of Computation of Diluted Net Loss Per Share Attributable to Common Stockholders (Details)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureNetLossPerShareScheduleOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails", "shortName": "Net Loss Per Share - Schedule of Computation of Diluted Net Loss Per Share Attributable to Common Stockholders (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_srtRangeAxis_srtMinimumMember_20200101_20200630", "decimals": "INF", "first": true, "lang": null, "name": "vapo:PercentageOfCommonStockHeldByStockholder", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100570 - Disclosure - Related Party Transactions - Additional Information (Details)", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "shortName": "Related Party Transactions - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_srtRangeAxis_srtMinimumMember_20200101_20200630", "decimals": "INF", "first": true, "lang": null, "name": "vapo:PercentageOfCommonStockHeldByStockholder", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100050 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)", "role": "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100060 - Disclosure - Description of Business", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureDescriptionOfBusiness", "shortName": "Description of Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100070 - Disclosure - Summary of Significant Accounting Policies", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100080 - Disclosure - Business Combinations", "role": "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinations", "shortName": "Business Combinations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "vapo-10q_20200630.htm", "contextRef": "C_0001253176_20200101_20200630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 63, "tag": { "country_US": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "UNITED STATES", "terseLabel": "US", "verboseLabel": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivableSummaryOfAccountsReceivableDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueNetRevenueDisaggregatedIntoCategoriesDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r451" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r452" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line1", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r453" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r453" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r455" ], "lang": { "en-US": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r453" ], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r454" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r453" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r453" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r453" ], "lang": { "en-US": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r453" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r449" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security12b Title", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r450" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r53", "r108" ], "lang": { "en-US": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r266", "r269", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r424", "r427" ], "lang": { "en-US": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum [Member]", "verboseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfWeightedAverageAssumptionsUsedInBlackScholesOptionsPricingModelDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsSummaryOfWarrantsActivityDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r266", "r269", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r424", "r427" ], "lang": { "en-US": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum [Member]", "verboseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfWeightedAverageAssumptionsUsedInBlackScholesOptionsPricingModelDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsSummaryOfWarrantsActivityDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r174", "r244", "r247", "r395", "r423", "r425" ], "lang": { "en-US": { "role": { "label": "Product Or Service [Axis]", "terseLabel": "Product and Service" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueNetRevenueDisaggregatedIntoCategoriesDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r174", "r244", "r247", "r395", "r423", "r425" ], "lang": { "en-US": { "role": { "label": "Products And Services [Domain]", "terseLabel": "Product and Service" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueNetRevenueDisaggregatedIntoCategoriesDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r256", "r266", "r269", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r424", "r427" ], "lang": { "en-US": { "role": { "label": "Range [Axis]", "terseLabel": "Statistical Measurement" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfWeightedAverageAssumptionsUsedInBlackScholesOptionsPricingModelDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsSummaryOfWarrantsActivityDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r256", "r266", "r269", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r424", "r427" ], "lang": { "en-US": { "role": { "label": "Range [Member]", "terseLabel": "Statistical Measurement" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfWeightedAverageAssumptionsUsedInBlackScholesOptionsPricingModelDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsSummaryOfWarrantsActivityDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Repurchase Agreement Counterparty Name [Domain]", "terseLabel": "Counterparty Name" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r267" ], "lang": { "en-US": { "role": { "label": "Scenario Forecast [Member]", "terseLabel": "Scenario Forecast" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r267" ], "lang": { "en-US": { "role": { "label": "Scenario Unspecified [Domain]", "terseLabel": "Scenario" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r175", "r176", "r244", "r248", "r426", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446" ], "lang": { "en-US": { "role": { "label": "Segment Geographical [Domain]", "terseLabel": "Geographical" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivableSummaryOfAccountsReceivableDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueNetRevenueDisaggregatedIntoCategoriesDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r175", "r176", "r244", "r248", "r426", "r436", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447" ], "lang": { "en-US": { "role": { "label": "Statement Geographical [Axis]", "terseLabel": "Geographical" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivableSummaryOfAccountsReceivableDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueNetRevenueDisaggregatedIntoCategoriesDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r215", "r267", "r384" ], "lang": { "en-US": { "role": { "label": "Statement Scenario [Axis]", "terseLabel": "Scenario" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_WeightedAverageMember": { "auth_ref": [ "r388", "r390", "r393" ], "lang": { "en-US": { "role": { "label": "Weighted Average [Member]", "verboseLabel": "Weighted Average" } } }, "localname": "WeightedAverageMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsSummaryOfWarrantsActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesAndLoansReceivableLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accounts Notes And Loans Receivable [Line Items]", "terseLabel": "Accounts Notes And Loans Receivable [Line Items]" } } }, "localname": "AccountsNotesAndLoansReceivableLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivableSummaryOfAccountsReceivableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r39" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 10120.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableGrossCurrent": { "auth_ref": [ "r178", "r179" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivableSummaryOfAccountsReceivableDetails": { "order": 10010.0, "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable Gross Current", "terseLabel": "Total accounts receivable" } } }, "localname": "AccountsReceivableGrossCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivableSummaryOfAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]", "terseLabel": "Accounts Receivable" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r5", "r22", "r178", "r179" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivableSummaryOfAccountsReceivableDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 10240.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable Net Current", "terseLabel": "Accounts receivable, net", "totalLabel": "Accounts receivable, net of allowance for doubtful accounts" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivableSummaryOfAccountsReceivableDetails", "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r42" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 10140.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities Current", "terseLabel": "Accrued expenses and other current liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r25", "r57", "r58", "r59", "r415", "r432", "r433" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 10070.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income Loss Net Of Tax", "terseLabel": "Accumulated other comprehensive income (loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r56", "r59", "r60", "r112", "r113", "r114", "r339", "r428", "r429" ], "lang": { "en-US": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "Accumulated Other Comprehensive Income [Member]", "terseLabel": "Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Acquired Finite Lived Intangible Assets [Line Items]", "terseLabel": "Acquired Finite Lived Intangible Assets [Line Items]" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAcquiredIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r200" ], "lang": { "en-US": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite Lived Intangible Assets Weighted Average Useful Life", "terseLabel": "Weighted average amortization period for intangible assets" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r23" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 10060.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid In Capital Common Stock", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r270", "r272", "r298", "r299" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value", "terseLabel": "Stock-based compensation expense" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r272", "r289", "r297" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Allocated Share Based Compensation Expense", "terseLabel": "Allocated stock based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfAllocatedStockBasedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r29", "r180", "r186" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivableSummaryOfAccountsReceivableDetails": { "order": 10020.0, "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Allowance For Doubtful Accounts Receivable Current", "negatedLabel": "Less: Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivableSummaryOfAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r77", "r91", "r370" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 10210.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization Of Debt Discount Premium", "terseLabel": "Amortization of discount on debt" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r91", "r197", "r205" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization Of Intangible Assets", "negatedLabel": "Amortization" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfChangesInCarryingAmountOfGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r131" ], "lang": { "en-US": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureNetLossPerShareScheduleOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r131" ], "lang": { "en-US": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureNetLossPerShareScheduleOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureNetLossPerShareScheduleOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r131" ], "lang": { "en-US": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities Name [Domain]", "terseLabel": "Antidilutive Securities, Name" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureNetLossPerShareScheduleOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Arrangements And Nonarrangement Transactions [Member]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r105", "r157", "r166", "r172", "r184", "r333", "r340", "r352", "r400", "r413" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r6", "r7", "r52", "r105", "r184", "r333", "r340", "r352" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 10160.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets Current [Abstract]", "terseLabel": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r273", "r290" ], "lang": { "en-US": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r344", "r345" ], "lang": { "en-US": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis Of Accounting Policy Policy [Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r265", "r268" ], "lang": { "en-US": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r265", "r268", "r321", "r322" ], "lang": { "en-US": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1": { "auth_ref": [ "r316", "r317", "r318" ], "lang": { "en-US": { "role": { "documentation": "Date when the acquirer obtains control of the acquiree, in CCYY-MM-DD format.", "label": "Business Acquisition Effective Date Of Acquisition1", "terseLabel": "Acquisition date" } } }, "localname": "BusinessAcquisitionEffectiveDateOfAcquisition1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic": { "auth_ref": [ "r319", "r320" ], "lang": { "en-US": { "role": { "documentation": "The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Business Acquisition Pro Forma Earnings Per Share Basic", "terseLabel": "Net loss per share, basic" } } }, "localname": "BusinessAcquisitionProFormaEarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfBusinessAcquisitionProFormaInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "auth_ref": [ "r319", "r320" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.", "label": "Business Acquisition Pro Forma Information [Text Block]", "terseLabel": "Summary of Business Acquisition Pro Forma Information" } } }, "localname": "BusinessAcquisitionProFormaInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "auth_ref": [ "r319", "r320" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Business Acquisitions Pro Forma Net Income Loss", "terseLabel": "Net loss" } } }, "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfBusinessAcquisitionProFormaInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "auth_ref": [ "r319", "r320" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.", "label": "Business Acquisitions Pro Forma Revenue", "terseLabel": "Net revenue" } } }, "localname": "BusinessAcquisitionsProFormaRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfBusinessAcquisitionProFormaInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r315" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination Acquisition Related Costs", "terseLabel": "Transaction costs associated with acquisition" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": { "auth_ref": [ "r90", "r328" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.", "label": "Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1", "terseLabel": "Contingent consideration as compensation expense" } } }, "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r329" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "Business Combinations" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinations" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "auth_ref": [ "r324" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails": { "order": 10010.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of assets acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets", "totalLabel": "Total assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r324" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails": { "order": 10060.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents", "terseLabel": "Cash" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "auth_ref": [ "r324" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails": { "order": 10090.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets", "terseLabel": "Prepaids and other assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r324" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails": { "order": 10070.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables", "terseLabel": "Accounts receivable" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "auth_ref": [ "r324" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails": { "order": 10030.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable", "negatedLabel": "Accounts payable and accrued expenses" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": { "auth_ref": [ "r324" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails": { "order": 10040.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Deferred Revenue", "negatedLabel": "Contract liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "auth_ref": [ "r324" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails": { "order": 10050.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities", "negatedLabel": "Deferred taxes" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r324" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails": { "order": 10120.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill", "terseLabel": "Intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r323", "r324" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails": { "order": 10080.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory", "terseLabel": "Inventory" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r324" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails": { "order": 10020.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities", "negatedTotalLabel": "Total liabilities assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r323", "r324" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails": { "order": 10100.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment", "terseLabel": "Property and equipment" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "auth_ref": [ "r324" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net", "totalLabel": "Total purchase price" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r2", "r111", "r150" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Business Description And Basis Of Presentation [Text Block]", "terseLabel": "Description of Business" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDescriptionOfBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "auth_ref": [ "r96", "r97", "r98" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.", "label": "Capital Expenditures Incurred But Not Yet Paid", "terseLabel": "Property and equipment purchases in accounts payable and accrued expenses" } } }, "localname": "CapitalExpendituresIncurredButNotYetPaid", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r37", "r93" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesComponentsOfCashCashEquivalentsAndRestrictedCashDetails": { "order": 10010.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 }, "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 10230.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash And Cash Equivalents At Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesComponentsOfCashCashEquivalentsAndRestrictedCashDetails", "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of cash and cash equivalent balance.", "label": "Cash And Cash Equivalents [Axis]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash And Cash Equivalents Fair Value Disclosure", "terseLabel": "Cash equivalents" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r10", "r94", "r101", "r398" ], "lang": { "en-US": { "role": { "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.", "label": "Cash And Cash Equivalents Restricted Cash And Cash Equivalents Policy", "terseLabel": "Cash, Cash Equivalents, and Restricted Cash" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r87", "r93", "r99" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesComponentsOfCashCashEquivalentsAndRestrictedCashDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents", "periodEndLabel": "End of period", "periodStartLabel": "Beginning of period", "terseLabel": "Cash, cash equivalents and restricted cash balance", "totalLabel": "Total cash, cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesComponentsOfCashCashEquivalentsAndRestrictedCashDetails", "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract]", "terseLabel": "Cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r87", "r359" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r104", "r105", "r124", "r125", "r126", "r128", "r130", "r136", "r137", "r138", "r184", "r352" ], "lang": { "en-US": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class Of Stock [Domain]", "terseLabel": "Class of Stock" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureNetLossPerShareScheduleOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsSummaryOfWarrantsActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r226" ], "lang": { "en-US": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1", "periodEndLabel": "Weighted average exercise price, ending balance", "periodStartLabel": "Weighted average exercise price, beginning balance", "terseLabel": "Warrants exercise price" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsSummaryOfWarrantsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class Of Warrant Or Right [Line Items]", "terseLabel": "Class Of Warrant Or Right [Line Items]" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInBlackScholesOptionsPricingModelAtDateOfGrantDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsSummaryOfWarrantsActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r226" ], "lang": { "en-US": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights", "terseLabel": "Granted warrants to purchase shares" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class Of Warrant Or Right Outstanding", "periodEndLabel": "Number of shares, ending balance", "periodStartLabel": "Number of shares, beginning balance" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsSummaryOfWarrantsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r231", "r271" ], "lang": { "en-US": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class Of Warrant Or Right [Table]", "terseLabel": "Class Of Warrant Or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInBlackScholesOptionsPricingModelAtDateOfGrantDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsSummaryOfWarrantsActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r47", "r214", "r404", "r419" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 10020.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments And Contingencies", "terseLabel": "Commitments and contingencies (Note 9)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Commitments And Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r211", "r212", "r213", "r216" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments And Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureCommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r48" ], "lang": { "en-US": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common Stock Capital Shares Reserved For Future Issuance", "terseLabel": "Common stock reserved for issuance" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Common stock held by shareholders with par value plus amounts in excess of par value or issuance value (in cases of no-par value stock).", "label": "Common Stock Including Additional Paid In Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "CommonStockIncludingAdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r112", "r113" ], "lang": { "en-US": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r21" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock Par Or Stated Value Per Share", "terseLabel": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSParentheticalUnaudited" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r21" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSParentheticalUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r21" ], "lang": { "en-US": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock Shares Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSParentheticalUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r21", "r225" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock Shares Outstanding", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSParentheticalUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r21" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 10050.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock Value", "terseLabel": "Common stock ($0.001 par value) 175,000,000 shares authorized as of June 30, 2020 and December 31, 2019, 25,493,058 and 20,851,531 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationRelatedCostsPolicyTextBlock": { "auth_ref": [ "r100", "r275" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.", "label": "Compensation Related Costs Policy [Text Block]", "terseLabel": "Stock-Based Compensation" } } }, "localname": "CompensationRelatedCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r62", "r64", "r65", "r70", "r406", "r421" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income Net Of Tax", "totalLabel": "Total comprehensive loss" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r145", "r146", "r177", "r350", "r351" ], "lang": { "en-US": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r145", "r146", "r177", "r350", "r351", "r435" ], "lang": { "en-US": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk By Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r145", "r146", "r177", "r350", "r351", "r435" ], "lang": { "en-US": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk By Type [Axis]", "terseLabel": "Concentration Risk Type" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r141", "r411" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk Credit Risk", "terseLabel": "Concentrations of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r145", "r146", "r177", "r350", "r351" ], "lang": { "en-US": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk Percentage1", "terseLabel": "Percentage of concentration risk" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r145", "r146", "r177", "r350", "r351" ], "lang": { "en-US": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r101", "r335" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation Policy [Text Block]", "terseLabel": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [ "r234" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.", "label": "Contract With Customer Asset And Liability Table [Text Block]", "terseLabel": "Schedule of Changes in Contract Liabilities" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r232", "r233", "r245" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 10130.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract With Customer Liability", "terseLabel": "Contract liabilities" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Contract With Customer Liability [Abstract]", "terseLabel": "Contract Liabilities" } } }, "localname": "ContractWithCustomerLiabilityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueScheduleOfChangesInContractLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r232", "r233", "r245" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract With Customer Liability Current", "periodEndLabel": "Balance at June 30, 2020", "periodStartLabel": "Balance at December 31, 2019" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueScheduleOfChangesInContractLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r74", "r105", "r184", "r352" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited": { "order": 10150.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost Of Revenue", "terseLabel": "Cost of revenue" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost Of Sales [Member]", "terseLabel": "Cost of goods sold" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfAllocatedStockBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfSalesPolicyTextBlock": { "auth_ref": [ "r255" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.", "label": "Cost Of Sales Policy [Text Block]", "terseLabel": "Shipping and Handling Costs" } } }, "localname": "CostOfSalesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r144", "r177" ], "lang": { "en-US": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerContractsMember": { "auth_ref": [ "r326" ], "lang": { "en-US": { "role": { "documentation": "Entity's established relationships with its customers through contracts.", "label": "Customer Contracts [Member]", "terseLabel": "Customer Agreements" } } }, "localname": "CustomerContractsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAcquiredIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r224" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Debt" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r15", "r16", "r18", "r401", "r402", "r412" ], "lang": { "en-US": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument Basis Spread On Variable Rate1", "terseLabel": "Debt instrument rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentDescription": { "auth_ref": [ "r15", "r18", "r226", "r401", "r402", "r409", "r412" ], "lang": { "en-US": { "role": { "documentation": "Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.", "label": "Debt Instrument Description", "terseLabel": "Debt instrument, description" } } }, "localname": "DebtInstrumentDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r371", "r373" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument Face Amount", "terseLabel": "Term loan, face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r44", "r371" ], "lang": { "en-US": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Debt Instrument Interest Rate During Period", "terseLabel": "Term loan, interest rate" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtScheduleOfAnnualPrincipalMaturitiesOfTermLoansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r45" ], "lang": { "en-US": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument Name [Domain]", "terseLabel": "Debt Instrument, Name" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r45", "r109", "r226", "r227", "r228", "r229", "r370", "r371", "r373", "r410" ], "lang": { "en-US": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Debt Instrument [Table]", "terseLabel": "Debt Instrument [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtScheduleOfAnnualPrincipalMaturitiesOfTermLoansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r370", "r373" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtScheduleOfAnnualPrincipalMaturitiesOfTermLoansDetails": { "order": 10050.0, "parentTag": "us-gaap_LongTermDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument Unamortized Discount", "negatedLabel": "Less: Discount on loans payable" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtScheduleOfAnnualPrincipalMaturitiesOfTermLoansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r304", "r305" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 10210.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets Net", "terseLabel": "Deferred income tax assets" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueAndCreditsCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Deferred Revenue And Credits Current [Abstract]", "terseLabel": "Deferred Revenue" } } }, "localname": "DeferredRevenueAndCreditsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueScheduleOfChangesInContractLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r30" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred Revenue Current", "periodEndLabel": "Balance at June 30, 2020", "periodStartLabel": "Balance at December 31, 2019" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueScheduleOfChangesInContractLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r91", "r208" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 10170.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation And Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation Of Revenue [Line Items]", "terseLabel": "Disaggregation Of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueNetRevenueDisaggregatedIntoCategoriesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r244", "r247", "r248", "r249", "r250", "r251", "r252", "r253" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation Of Revenue [Table]", "terseLabel": "Disaggregation Of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueNetRevenueDisaggregatedIntoCategoriesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r244" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation Of Revenue Table [Text Block]", "terseLabel": "Net Revenue Disaggregated into Categories" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r300" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Disclosure Of Compensation Related Costs Share Based Payments [Text Block]", "terseLabel": "Stock-Based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r129" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share Basic And Diluted", "terseLabel": "Net loss per share attributable to common stockholders - basic and diluted" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r131", "r132", "r133", "r134" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Net Loss Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureNetLossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r359" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 10040.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents", "terseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]", "terseLabel": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfAllocatedStockBasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.", "label": "Employee Stock [Member]", "terseLabel": "Employee Stock Purchase Plan" } } }, "localname": "EmployeeStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureNetLossPerShareScheduleOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfWeightedAverageAssumptionsUsedInBlackScholesOptionsPricingModelDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockPlansAndStockBasedCompensationTables", "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r287" ], "lang": { "en-US": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Employee Stock Option [Member]", "terseLabel": "Options to Purchase Common Stock" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureNetLossPerShareScheduleOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r112", "r113", "r114", "r116", "r121", "r123", "r135", "r185", "r225", "r230", "r292", "r293", "r294", "r311", "r312", "r361", "r362", "r363", "r364", "r365", "r366", "r428", "r429", "r430" ], "lang": { "en-US": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsTables", "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r347" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques Table [Text Block]", "terseLabel": "Schedule of Assumptions Used in Black-Scholes Options Pricing Model at the Date of Grant" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r346", "r385", "r386", "r387" ], "lang": { "en-US": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value By Fair Value Hierarchy Level [Axis]", "terseLabel": "Fair Value Hierarchy and NAV" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r349" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r257", "r258", "r263", "r264", "r346", "r385" ], "lang": { "en-US": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value Inputs Level1 [Member]", "terseLabel": "Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r385", "r386", "r387" ], "lang": { "en-US": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Measurements Fair Value Hierarchy [Domain]", "terseLabel": "Fair Value Hierarchy and NAV" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinancingReceivablesTextBlock": { "auth_ref": [ "r182", "r183" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for financing receivable.", "label": "Financing Receivables [Text Block]", "terseLabel": "Accounts Receivable" } } }, "localname": "FinancingReceivablesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivable" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite Lived Intangible Asset Useful Life", "terseLabel": "Period of amortization" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAcquiredIntangibleAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r204" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite Lived Intangible Assets Accumulated Amortization", "negatedLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAcquiredIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r198", "r201", "r204", "r206", "r396", "r397" ], "lang": { "en-US": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite Lived Intangible Assets By Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAcquiredIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite Lived Intangible Assets Foreign Currency Translation Gain Loss", "terseLabel": "Foreign currency exchange rate changes" } } }, "localname": "FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfChangesInCarryingAmountOfGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r204", "r397" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite Lived Intangible Assets Gross", "terseLabel": "Gross Carrying Amount" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAcquiredIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r198", "r203" ], "lang": { "en-US": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite Lived Intangible Assets Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAcquiredIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r204", "r396" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite Lived Intangible Assets Net", "periodEndLabel": "Balance at June 30, 2020", "periodStartLabel": "Balance at December 31, 2019" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfChangesInCarryingAmountOfGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Finite Lived Intangible Assets Roll Forward", "terseLabel": "Intangible Assets" } } }, "localname": "FiniteLivedIntangibleAssetsRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfChangesInCarryingAmountOfGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinitelivedIntangibleAssetsAcquired1": { "auth_ref": [ "r199" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.", "label": "Finitelived Intangible Assets Acquired1", "terseLabel": "Acquired during the period" } } }, "localname": "FinitelivedIntangibleAssetsAcquired1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfChangesInCarryingAmountOfGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r353", "r355", "r357", "r358" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited": { "order": 10050.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain Loss Before Tax", "terseLabel": "Foreign currency loss" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r101", "r368" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions And Translations Policy [Text Block]", "terseLabel": "Foreign Currency and Foreign Operations" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "auth_ref": [ "r91" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 10200.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.", "label": "Gain Loss On Sale Of Property Plant Equipment", "negatedLabel": "Loss on disposal of property and equipment" } } }, "localname": "GainLossOnSaleOfPropertyPlantEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r75" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited": { "order": 10130.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General And Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r71" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General And Administrative Expense [Member]", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfAllocatedStockBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r191", "r192", "r399" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails": { "order": 10110.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 }, "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 10190.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Balance at June 30, 2020", "periodStartLabel": "Balance at December 31, 2019", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfChangesInCarryingAmountOfGoodwillAndIntangibleAssetsDetails", "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAcquiredDuringPeriod": { "auth_ref": [ "r193" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.", "label": "Goodwill Acquired During Period", "terseLabel": "Acquired during the period" } } }, "localname": "GoodwillAcquiredDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfChangesInCarryingAmountOfGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Goodwill And Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r207" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill And Intangible Assets Disclosure [Text Block]", "terseLabel": "Goodwill and Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureGoodwillAndIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r194" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill Foreign Currency Translation Gain Loss", "terseLabel": "Foreign currency exchange rate changes" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfChangesInCarryingAmountOfGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill Roll Forward", "terseLabel": "Goodwill" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsScheduleOfChangesInCarryingAmountOfGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r73", "r105", "r157", "r165", "r168", "r171", "r173", "r184", "r352" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited": { "order": 10090.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "I P O [Member]", "terseLabel": "Initial Public Offering" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r210" ], "lang": { "en-US": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfAllocatedStockBasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfAllocatedStockBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r106", "r122", "r123", "r156", "r306", "r313", "r314", "r422" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense Benefit", "terseLabel": "Provision or benefit for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r66", "r101", "r302", "r303", "r307", "r308", "r309", "r310", "r438" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax Policy [Text Block]", "terseLabel": "Income Tax" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r90" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 10250.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase Decrease In Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r90" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 10220.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase Decrease In Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": { "auth_ref": [ "r90" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 10270.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.", "label": "Increase Decrease In Accrued Liabilities And Other Operating Liabilities", "terseLabel": "Accrued expenses and other current liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r90" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 10260.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase Decrease In Contract With Customer Liability", "terseLabel": "Contract liabilities" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r90" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 10230.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase Decrease In Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Increase Decrease In Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities, net of acquisition:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r90" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 10240.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase Decrease In Prepaid Deferred Expense And Other Assets", "negatedLabel": "Prepaid expenses and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r196", "r202" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 10200.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets Net Excluding Goodwill", "terseLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r67", "r155", "r369", "r372", "r407" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited": { "order": 10070.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r85", "r88", "r95" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid Net", "terseLabel": "Interest paid during the period" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r190" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureInventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r31", "r189" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails": { "order": 10020.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory Finished Goods Net Of Reserves", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r4", "r51" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 10250.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory Net", "terseLabel": "Inventories", "totalLabel": "Total inventory" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails", "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPartsAndComponentsNetOfReserves": { "auth_ref": [ "r51", "r188" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails": { "order": 10010.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date for elements of machinery or equipment held for the purpose of replacing similar parts in the course of repair or maintenance.", "label": "Inventory Parts And Components Net Of Reserves", "terseLabel": "Component parts" } } }, "localname": "InventoryPartsAndComponentsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r76", "r154" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited": { "order": 10060.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income Interest", "terseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r375" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee Leases Policy [Text Block]", "terseLabel": "Lease Revenue" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r41", "r105", "r167", "r184", "r334", "r340", "r341", "r352" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 10010.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r28", "r105", "r184", "r352", "r403", "r417" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities And Stockholders Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities And Stockholders Equity [Abstract]", "terseLabel": "Liabilities and Stockholders\u2019 Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r43", "r105", "r184", "r334", "r340", "r341", "r352" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 10090.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities Current [Abstract]", "terseLabel": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r18", "r402", "r412" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Line Of Credit", "terseLabel": "Outstanding balance under line of credit" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityAxis": { "auth_ref": [ "r40", "r109" ], "lang": { "en-US": { "role": { "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.", "label": "Line Of Credit Facility [Axis]", "terseLabel": "Lender Name" } } }, "localname": "LineOfCreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityCovenantCompliance": { "auth_ref": [ "r14", "r17" ], "lang": { "en-US": { "role": { "documentation": "Identification of whether the entity has been in compliance with any credit facility debt covenants during the period.", "label": "Line Of Credit Facility Covenant Compliance", "terseLabel": "Line of credit, covenant compliance description" } } }, "localname": "LineOfCreditFacilityCovenantCompliance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityExpirationDate1": { "auth_ref": [ "r40" ], "lang": { "en-US": { "role": { "documentation": "Date the credit facility terminates, in CCYY-MM-DD format.", "label": "Line Of Credit Facility Expiration Date1", "terseLabel": "Line of credit, maturity date" } } }, "localname": "LineOfCreditFacilityExpirationDate1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": { "auth_ref": [ "r40" ], "lang": { "en-US": { "role": { "documentation": "The effective interest rate at the end of the reporting period.", "label": "Line Of Credit Facility Interest Rate At Period End", "terseLabel": "Line of credit, interest rate" } } }, "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityLenderDomain": { "auth_ref": [ "r40" ], "lang": { "en-US": { "role": { "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.", "label": "Line Of Credit Facility Lender [Domain]", "terseLabel": "Line of Credit Facility, Lender" } } }, "localname": "LineOfCreditFacilityLenderDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r40" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line Of Credit Facility Maximum Borrowing Capacity", "terseLabel": "Line of credit made available under agreement" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "auth_ref": [ "r40" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).", "label": "Line Of Credit Facility Remaining Borrowing Capacity", "terseLabel": "Line of credit, remaining availability under agreement" } } }, "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LinesOfCreditCurrent": { "auth_ref": [ "r15", "r401" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 10150.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Lines Of Credit Current", "terseLabel": "Short-term line of credit" } } }, "localname": "LinesOfCreditCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoansPayableMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Borrowing supported by a written promise to pay an obligation.", "label": "Loans Payable [Member]", "terseLabel": "Loans Payable" } } }, "localname": "LoansPayableMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtScheduleOfAnnualPrincipalMaturitiesOfTermLoansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongDurationContractsRevenueRecognitionPolicy": { "auth_ref": [ "r101", "r434" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for revenue recognition for long-duration contracts, including the timing of revenue recognition and the basis for determining the amount of revenue recognized, excluding fees earned on separate accounts.", "label": "Long Duration Contracts Revenue Recognition Policy", "terseLabel": "Timing and Amount of Revenue Recognition" } } }, "localname": "LongDurationContractsRevenueRecognitionPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r18", "r223", "r402", "r414" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtScheduleOfAnnualPrincipalMaturitiesOfTermLoansDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long Term Debt", "totalLabel": "Long-term loans payable" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtScheduleOfAnnualPrincipalMaturitiesOfTermLoansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "auth_ref": [ "r110", "r221" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtScheduleOfAnnualPrincipalMaturitiesOfTermLoansDetails": { "order": 10040.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Year Four", "terseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtScheduleOfAnnualPrincipalMaturitiesOfTermLoansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r110", "r221" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtScheduleOfAnnualPrincipalMaturitiesOfTermLoansDetails": { "order": 10030.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Year Three", "terseLabel": "2022" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtScheduleOfAnnualPrincipalMaturitiesOfTermLoansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r110", "r221" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtScheduleOfAnnualPrincipalMaturitiesOfTermLoansDetails": { "order": 10020.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Year Two", "terseLabel": "2021" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtScheduleOfAnnualPrincipalMaturitiesOfTermLoansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": { "auth_ref": [ "r110" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtScheduleOfAnnualPrincipalMaturitiesOfTermLoansDetails": { "order": 10010.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.", "label": "Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year", "terseLabel": "2020" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtScheduleOfAnnualPrincipalMaturitiesOfTermLoansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermLoansPayable": { "auth_ref": [ "r45" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 10100.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.", "label": "Long Term Loans Payable", "terseLabel": "Long-term loans payable, net" } } }, "localname": "LongTermLoansPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r45" ], "lang": { "en-US": { "role": { "documentation": "Information by type of long-term debt.", "label": "Longterm Debt Type [Axis]", "terseLabel": "Long-term Debt, Type" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtScheduleOfAnnualPrincipalMaturitiesOfTermLoansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r45", "r222" ], "lang": { "en-US": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Longterm Debt Type [Domain]", "terseLabel": "Long-term Debt, Type" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtScheduleOfAnnualPrincipalMaturitiesOfTermLoansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedDividendRateMember": { "auth_ref": [ "r347" ], "lang": { "en-US": { "role": { "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.", "label": "Measurement Input Expected Dividend Rate [Member]", "terseLabel": "Expected Dividend Yield" } } }, "localname": "MeasurementInputExpectedDividendRateMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInBlackScholesOptionsPricingModelAtDateOfGrantDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputPriceVolatilityMember": { "auth_ref": [ "r347" ], "lang": { "en-US": { "role": { "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.", "label": "Measurement Input Price Volatility [Member]", "terseLabel": "Expected Stock Price Volatility" } } }, "localname": "MeasurementInputPriceVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInBlackScholesOptionsPricingModelAtDateOfGrantDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "auth_ref": [ "r347" ], "lang": { "en-US": { "role": { "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.", "label": "Measurement Input Risk Free Interest Rate [Member]", "terseLabel": "Risk Free Interest Rate" } } }, "localname": "MeasurementInputRiskFreeInterestRateMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInBlackScholesOptionsPricingModelAtDateOfGrantDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r347" ], "lang": { "en-US": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]", "terseLabel": "Measurement Input Type" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInBlackScholesOptionsPricingModelAtDateOfGrantDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]", "terseLabel": "Measurement Input Type" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInBlackScholesOptionsPricingModelAtDateOfGrantDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MoneyMarketFundsMember": { "auth_ref": [ "r257" ], "lang": { "en-US": { "role": { "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.", "label": "Money Market Funds [Member]", "terseLabel": "Money Market Deposits" } } }, "localname": "MoneyMarketFundsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r87" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 10030.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided By Used In Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided By Used In Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r87" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 10020.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided By Used In Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided By Used In Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r87", "r89", "r92" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 10010.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided By Used In Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided By Used In Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r61", "r63", "r69", "r92", "r105", "r115", "r117", "r118", "r119", "r120", "r122", "r123", "r127", "r157", "r165", "r168", "r171", "r173", "r184", "r352", "r405", "r420" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited": { "order": 10010.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income Loss", "terseLabel": "Net loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited", "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements Policy Policy [Text Block]", "terseLabel": "Recently Adopted Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonUsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Countries excluding the United States of America (US).", "label": "Non Us [Member]", "terseLabel": "International", "verboseLabel": "Outside U.S." } } }, "localname": "NonUsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivableSummaryOfAccountsReceivableDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueNetRevenueDisaggregatedIntoCategoriesDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NoncurrentAssets": { "auth_ref": [ "r176" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.", "label": "Noncurrent Assets", "terseLabel": "Long-term assets" } } }, "localname": "NoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Nonoperating Income Expense [Abstract]", "terseLabel": "Other (expense) income" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r151" ], "lang": { "en-US": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number Of Reportable Segments", "terseLabel": "Number of reporting segment" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportingUnits": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.", "label": "Number Of Reporting Units", "terseLabel": "Number of reporting units" } } }, "localname": "NumberOfReportingUnits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingCostsAndExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.", "label": "Operating Costs And Expenses", "terseLabel": "Shipping and handling costs" } } }, "localname": "OperatingCostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited": { "order": 10100.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r157", "r165", "r168", "r171", "r173" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited": { "order": 10040.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income Loss", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable": { "auth_ref": [ "r374" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Future minimum rental payments in aggregate as of the balance sheet date under operating leases.", "label": "Operating Leases Future Minimum Payments Receivable", "terseLabel": "Current value of future lease payments" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Organization Consolidation And Presentation Of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r38" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 10220.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets Noncurrent", "terseLabel": "Other long-term assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r331", "r332", "r338" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited": { "order": 10020.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.", "label": "Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent", "totalLabel": "Total other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "auth_ref": [ "r55", "r57", "r354", "r356", "r360" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited": { "order": 10030.0, "parentTag": "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax", "terseLabel": "Foreign currency translation adjustments" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r54" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax", "terseLabel": "Foreign currency translation adjustments" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent [Abstract]", "terseLabel": "Other comprehensive income (loss), net of tax:" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r46" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 10110.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities Noncurrent", "terseLabel": "Other long-term liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r78" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited": { "order": 10080.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income Expense", "terseLabel": "Other" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r83" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 10120.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments Of Debt Issuance Costs", "negatedLabel": "Debt issuance costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r84" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 10070.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments Of Stock Issuance Costs", "negatedLabel": "Common stock offering costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r79", "r327" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments To Acquire Businesses Gross", "terseLabel": "Initial cash payment" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r79" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 10140.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments To Acquire Businesses Net Of Cash Acquired", "negatedLabel": "Acquisition of business, net of cash acquired", "terseLabel": "Purchase price, net of cash acquired" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r80" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 10130.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments To Acquire Property Plant And Equipment", "negatedLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r20" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock Par Or Stated Value Per Share", "terseLabel": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSParentheticalUnaudited" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r20" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSParentheticalUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r20" ], "lang": { "en-US": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock Shares Issued", "terseLabel": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSParentheticalUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r20" ], "lang": { "en-US": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSParentheticalUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r20" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 10040.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock Value", "terseLabel": "Preferred stock ($0.001 par value) 25,000,000 shares authorized; no shares issued and outstanding as of June 30, 2020 and December 31, 2019" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r6", "r35", "r36" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 10260.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense And Other Assets Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.", "label": "Prepaid Expenses And Other Current Assets [Member]", "terseLabel": "Prepaid Expenses and Other Current Assets" } } }, "localname": "PrepaidExpensesAndOtherCurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Prior Period Reclassification Adjustment Description", "terseLabel": "Reclassification" } } }, "localname": "PriorPeriodReclassificationAdjustmentDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r81" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 10050.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds From Issuance Of Common Stock", "terseLabel": "Proceeds from issuance of common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r82" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 10110.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds From Issuance Of Long Term Debt", "terseLabel": "Proceeds on loans", "verboseLabel": "Proceeds from term loan" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans": { "auth_ref": [ "r81", "r291" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 10080.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.", "label": "Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans", "terseLabel": "Proceeds from issuance of common stock under the Employee Stock Purchase Plan", "verboseLabel": "Cash proceeds from issuance of common stock" } } }, "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromShortTermDebt": { "auth_ref": [ "r82" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 10090.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.", "label": "Proceeds From Short Term Debt", "terseLabel": "Short-term line of credit" } } }, "localname": "ProceedsFromShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r1", "r61", "r63", "r86", "r105", "r115", "r122", "r123", "r157", "r165", "r168", "r171", "r173", "r184", "r331", "r336", "r337", "r342", "r343", "r352", "r408" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 10150.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Profit Loss", "terseLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r11", "r12", "r209", "r418" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 10170.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property Plant And Equipment Net", "terseLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r72", "r187" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 10180.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Provision For Doubtful Accounts", "terseLabel": "Provision for bad debts" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivablesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Receivables [Abstract]" } } }, "localname": "ReceivablesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r376", "r377", "r378", "r381", "r382" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r301", "r448" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited": { "order": 10110.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research And Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research And Development Expense [Member]", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfAllocatedStockBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash And Cash Equivalents Cash And Cash Equivalents [Member]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCashNoncurrent": { "auth_ref": [ "r8", "r13", "r99", "r437" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesComponentsOfCashCashEquivalentsAndRestrictedCashDetails": { "order": 10020.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 }, "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 10180.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash Noncurrent", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCashNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesComponentsOfCashCashEquivalentsAndRestrictedCashDetails", "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r131" ], "lang": { "en-US": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]", "terseLabel": "Restricted Stock", "verboseLabel": "Unvested Restricted Stock" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureNetLossPerShareScheduleOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r24", "r230", "r295", "r416", "r431", "r433" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 10080.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings Accumulated Deficit", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r112", "r113", "r114", "r116", "r121", "r123", "r185", "r292", "r293", "r294", "r311", "r312", "r428", "r430" ], "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Revenue From Contract With Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r152", "r153", "r164", "r169", "r170", "r174", "r175", "r177", "r243", "r244", "r395" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue From Contract With Customer Excluding Assessed Tax", "terseLabel": "Total Revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueNetRevenueDisaggregatedIntoCategoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r234", "r235", "r236", "r237", "r238", "r239", "r241", "r242", "r246", "r254" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue From Contract With Customer [Text Block]", "terseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenue" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms": { "auth_ref": [ "r236" ], "lang": { "en-US": { "role": { "documentation": "Description of payment terms in contract with customer. Includes, but is not limited to, timing of payment, existence of financing component, variability of consideration and constraint on variable consideration.", "label": "Revenue Performance Obligation Description Of Payment Terms", "terseLabel": "Revenue, performance obligation, description of payment terms" } } }, "localname": "RevenuePerformanceObligationDescriptionOfPaymentTerms", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r102", "r103" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue Recognition Policy [Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r240" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue Remaining Performance Obligation", "terseLabel": "Revenue, remaining performance obligation, amount" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r68", "r105", "r152", "r153", "r164", "r169", "r170", "r174", "r175", "r177", "r184", "r352", "r408" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited": { "order": 10140.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Net revenue" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Line" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale Of Stock Name Of Transaction [Domain]", "terseLabel": "Sale of Stock" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfWeightedAverageAssumptionsUsedInBlackScholesOptionsPricingModelDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockPlansAndStockBasedCompensationTables", "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited", "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r145", "r177" ], "lang": { "en-US": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Sales Revenue Net [Member]", "terseLabel": "Revenue" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": { "auth_ref": [ "r50" ], "lang": { "en-US": { "role": { "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule Of Accounts Notes Loans And Financing Receivable [Table]", "terseLabel": "Schedule Of Accounts Notes Loans And Financing Receivable [Table]" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivableSummaryOfAccountsReceivableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "auth_ref": [ "r50" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule Of Accounts Notes Loans And Financing Receivable [Text Block]", "terseLabel": "Summary of Accounts Receivable" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": { "auth_ref": [ "r198" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.", "label": "Schedule Of Acquired Finite Lived Intangible Asset By Major Class [Table]", "terseLabel": "Schedule Of Acquired Finite Lived Intangible Asset By Major Class [Table]" } } }, "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsSummaryOfAcquiredIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock": { "auth_ref": [ "r198" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the characteristics, including initial carrying value, residual amount, weighted average useful life, of finite-lived intangible assets acquired during the period by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.", "label": "Schedule Of Acquired Finite Lived Intangible Assets By Major Class [Text Block]", "terseLabel": "Summary of Acquired Intangible Assets" } } }, "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r131" ], "lang": { "en-US": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]", "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureNetLossPerShareScheduleOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r131" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]", "terseLabel": "Schedule of Computation of Diluted Net Loss Per Share Attributable to Common Stockholders" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureNetLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r321", "r322" ], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule Of Business Acquisitions By Acquisition [Table]", "terseLabel": "Schedule Of Business Acquisitions By Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r272", "r288", "r297" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]", "terseLabel": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfAllocatedStockBasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r272", "r288", "r297" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]", "terseLabel": "Summary of Allocated Stock Based Compensation Expense" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockPlansAndStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": { "auth_ref": [ "r195" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.", "label": "Schedule Of Intangible Assets And Goodwill Table [Text Block]", "terseLabel": "Schedule of Changes in Carrying Amount of Goodwill and Intangible Assets" } } }, "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r9", "r32", "r33", "r34" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule Of Inventory Current Table [Text Block]", "terseLabel": "Schedule of Inventories" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureInventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r221" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.", "label": "Schedule Of Maturities Of Long Term Debt Table [Text Block]", "terseLabel": "Schedule of Annual Principal Maturities of Term Loans" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "auth_ref": [ "r220" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.", "label": "Schedule Of Product Warranty Liability Table [Text Block]", "terseLabel": "Summary of Roll-Forward Warranty Liability" } } }, "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r325" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule Of Recognized Identified Assets Acquired And Liabilities Assumed Table [Text Block]", "terseLabel": "Summary of Purchase Price Allocation" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r107", "r379", "r380" ], "lang": { "en-US": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule Of Related Party Transactions By Related Party [Table]", "terseLabel": "Schedule Of Related Party Transactions By Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r273", "r290" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]", "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfWeightedAverageAssumptionsUsedInBlackScholesOptionsPricingModelDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockActivityDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockPlansAndStockBasedCompensationTables" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": { "auth_ref": [ "r282" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule Of Share Based Payment Award Employee Stock Purchase Plan Valuation Assumptions Table [Text Block]", "terseLabel": "Schedule of Weighted Average Assumptions Used in Black-Scholes Options Pricing Model" } } }, "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockPlansAndStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.", "label": "Schedule Of Sharebased Compensation Restricted Stock And Restricted Stock Units Activity Table [Text Block]", "terseLabel": "Summary of Restricted Stock Activity" } } }, "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockPlansAndStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r231", "r271" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Schedule Of Stockholders Equity Note Warrants Or Rights [Text Block]", "terseLabel": "Summary of Warrants Activity" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r101", "r158", "r159", "r160", "r161", "r162", "r163", "r175" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Reporting Policy Policy [Text Block]", "terseLabel": "Segment Information" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SelfInsuranceReservePolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for self-insurance reserves, including, but not limited to incurred but not reported reserves (IBNR).", "label": "Self Insurance Reserve Policy [Text Block]", "terseLabel": "Insurance" } } }, "localname": "SelfInsuranceReservePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited": { "order": 10120.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling And Marketing Expense", "terseLabel": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingAndMarketingExpenseMember": { "auth_ref": [ "r71" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing selling and marketing expense.", "label": "Selling And Marketing Expense [Member]", "terseLabel": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfAllocatedStockBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ServiceOtherMember": { "auth_ref": [ "r247" ], "lang": { "en-US": { "role": { "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, financial service, and other financial service, classified as other.", "label": "Service Other [Member]", "terseLabel": "Service and Other Revenue" } } }, "localname": "ServiceOtherMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueNetRevenueDisaggregatedIntoCategoriesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r90" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 10160.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share Based Compensation", "terseLabel": "Stock-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r277" ], "lang": { "en-US": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period", "negatedLabel": "Shares, Canceled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r280" ], "lang": { "en-US": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value", "terseLabel": "Weighted Average Grant Date Fair Value, Canceled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r278" ], "lang": { "en-US": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number", "periodEndLabel": "Shares, Unvested Ending balance", "periodStartLabel": "Shares, Unvested, Beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r278" ], "lang": { "en-US": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value", "periodEndLabel": "Weighted Average Grant Date Fair Value, Unvested Ending balance", "periodStartLabel": "Weighted Average Grant Date Fair Value, Unvested, Beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r279" ], "lang": { "en-US": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period", "negatedLabel": "Shares, Vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r279" ], "lang": { "en-US": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value", "terseLabel": "Weighted Average Grant Date Fair Value, Vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r285" ], "lang": { "en-US": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate", "terseLabel": "Expected dividend yield", "verboseLabel": "Dividend yield assumed" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfWeightedAverageAssumptionsUsedInBlackScholesOptionsPricingModelDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r284" ], "lang": { "en-US": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate", "terseLabel": "Expected stock price volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfWeightedAverageAssumptionsUsedInBlackScholesOptionsPricingModelDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum", "terseLabel": "Expected stock price volatility, maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfWeightedAverageAssumptionsUsedInBlackScholesOptionsPricingModelDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum", "terseLabel": "Expected stock price volatility, minimum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfWeightedAverageAssumptionsUsedInBlackScholesOptionsPricingModelDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r286" ], "lang": { "en-US": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate", "terseLabel": "Risk free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfWeightedAverageAssumptionsUsedInBlackScholesOptionsPricingModelDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum", "terseLabel": "Risk free interest rate, maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfWeightedAverageAssumptionsUsedInBlackScholesOptionsPricingModelDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum", "terseLabel": "Risk free interest rate, minimum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfWeightedAverageAssumptionsUsedInBlackScholesOptionsPricingModelDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]", "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfWeightedAverageAssumptionsUsedInBlackScholesOptionsPricingModelDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockActivityDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockPlansAndStockBasedCompensationTables" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": { "auth_ref": [ "r290" ], "lang": { "en-US": { "role": { "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Rate", "terseLabel": "Maximum percentage to purchase shares of eligible compensation a participant receives during each offering period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee": { "auth_ref": [ "r290" ], "lang": { "en-US": { "role": { "documentation": "The highest quantity of shares an employee can purchase under the plan per period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee", "terseLabel": "Maximum number of shares per participant" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross", "terseLabel": "Stock options, granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r281" ], "lang": { "en-US": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average fair value of stock options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r271", "r274" ], "lang": { "en-US": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]", "terseLabel": "Award Type" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price", "terseLabel": "Weighted average exercise price" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": { "auth_ref": [ "r287" ], "lang": { "en-US": { "role": { "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit", "terseLabel": "Exercise price range, lower range limit" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": { "auth_ref": [ "r287" ], "lang": { "en-US": { "role": { "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit", "terseLabel": "Exercise price range, upper range limit" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r283", "r296" ], "lang": { "en-US": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1", "terseLabel": "Expected term (years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfWeightedAverageAssumptionsUsedInBlackScholesOptionsPricingModelDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Purchase price of common stock expressed as a percentage of its fair value.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent", "terseLabel": "Purchase price as a percentage of its market price on first trading day of each offering period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued Price Per Share", "terseLabel": "Public offering price of common stock", "verboseLabel": "Common stock price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares Outstanding", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_ShippingAndHandlingMember": { "auth_ref": [ "r247" ], "lang": { "en-US": { "role": { "documentation": "Packing and transport of product.", "label": "Shipping And Handling [Member]", "terseLabel": "Shipping and Handling" } } }, "localname": "ShippingAndHandlingMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r111" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StandardProductWarrantyAccrual": { "auth_ref": [ "r219" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.", "label": "Standard Product Warranty Accrual", "periodEndLabel": "Balance, end of period", "periodStartLabel": "Balance, beginning of period" } } }, "localname": "StandardProductWarrantyAccrual", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfRollForwardWarrantyLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardProductWarrantyAccrualPayments": { "auth_ref": [ "r217" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties.", "label": "Standard Product Warranty Accrual Payments", "negatedLabel": "Settlements" } } }, "localname": "StandardProductWarrantyAccrualPayments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfRollForwardWarrantyLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardProductWarrantyAccrualWarrantiesIssued": { "auth_ref": [ "r218" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.", "label": "Standard Product Warranty Accrual Warranties Issued", "terseLabel": "Provisions for warranty obligations" } } }, "localname": "StandardProductWarrantyAccrualWarrantiesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfRollForwardWarrantyLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r19", "r20", "r21", "r104", "r105", "r124", "r125", "r126", "r128", "r130", "r136", "r137", "r138", "r184", "r225", "r352" ], "lang": { "en-US": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Statement Class Of Stock [Axis]", "terseLabel": "Class of Stock" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureNetLossPerShareScheduleOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsSummaryOfWarrantsActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r49", "r112", "r113", "r114", "r116", "r121", "r123", "r135", "r185", "r225", "r230", "r292", "r293", "r294", "r311", "r312", "r361", "r362", "r363", "r364", "r365", "r366", "r428", "r429", "r430" ], "lang": { "en-US": { "role": { "documentation": "Information by component of equity.", "label": "Statement Equity Components [Axis]", "terseLabel": "Equity Components" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsTables", "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsTables", "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited", "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement Of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement Of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement Of Stockholders Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r112", "r113", "r114", "r135", "r395" ], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsTables", "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited", "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssued1": { "auth_ref": [ "r96", "r97", "r98" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The fair value of stock issued in noncash financing activities.", "label": "Stock Issued1", "terseLabel": "Issuance of common stock upon vesting of restricted stock" } } }, "localname": "StockIssued1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "auth_ref": [ "r20", "r21", "r225", "r230" ], "lang": { "en-US": { "role": { "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.", "label": "Stock Issued During Period Shares Employee Stock Purchase Plans", "positiveLabel": "Common stock shares issued", "terseLabel": "Issuance of common stock under the Employee Stock Purchase Plan, shares" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r20", "r21", "r225", "r230" ], "lang": { "en-US": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period Shares New Issues", "terseLabel": "Issuance of common stock, net, Shares", "verboseLabel": "Number of shares issued" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "auth_ref": [ "r225", "r230" ], "lang": { "en-US": { "role": { "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.", "label": "Stock Issued During Period Shares Restricted Stock Award Gross", "terseLabel": "Issuance of restricted stock, shares" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r20", "r21", "r225", "r230", "r276" ], "lang": { "en-US": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Stock Issued During Period Shares Stock Options Exercised", "terseLabel": "Issuance of common stock upon exercise of options, shares" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": { "auth_ref": [ "r20", "r21", "r225", "r230" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.", "label": "Stock Issued During Period Value Employee Stock Purchase Plan", "terseLabel": "Issuance of common stock under the Employee Stock Purchase Plan" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r20", "r21", "r225", "r230" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period Value New Issues", "terseLabel": "Issuance of common stock, net" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "auth_ref": [ "r20", "r21", "r225", "r230" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.", "label": "Stock Issued During Period Value Restricted Stock Award Gross", "terseLabel": "Issuance of restricted stock" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r49", "r225", "r230" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period Value Stock Options Exercised", "terseLabel": "Issuance of common stock upon exercise of options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r21", "r26", "r27", "r105", "r181", "r184", "r352" ], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 10030.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders Equity", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total stockholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited", "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Stockholders Equity [Abstract]", "terseLabel": "Stockholders' equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r367", "r383" ], "lang": { "en-US": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r367", "r383" ], "lang": { "en-US": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r367", "r383" ], "lang": { "en-US": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Subsidiary Sale Of Stock [Axis]", "terseLabel": "Sale of Stock" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfWeightedAverageAssumptionsUsedInBlackScholesOptionsPricingModelDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockPlansAndStockBasedCompensationTables", "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited", "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental disclosures of cash flow information" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r330" ], "lang": { "en-US": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Type Of Arrangement [Axis]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r139", "r140", "r142", "r143", "r147", "r148", "r149" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use Of Estimates", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrants", "verboseLabel": "Warrants to Purchase Common Stock" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsTables", "http://vapotherm.com/20200630/taxonomy/role/DisclosureNetLossPerShareScheduleOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Warrants And Rights Note Disclosure [Abstract]" } } }, "localname": "WarrantsAndRightsNoteDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": { "auth_ref": [ "r348" ], "lang": { "en-US": { "role": { "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.", "label": "Warrants And Rights Outstanding Measurement Input", "terseLabel": "Key inputs used in valuation" } } }, "localname": "WarrantsAndRightsOutstandingMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInBlackScholesOptionsPricingModelAtDateOfGrantDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r348" ], "lang": { "en-US": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants And Rights Outstanding Term", "terseLabel": "Expected term (years)" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInBlackScholesOptionsPricingModelAtDateOfGrantDetails" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Weighted Average Number Of Share Outstanding Basic And Diluted", "terseLabel": "Weighted-average number of shares used in calculating net loss per share, basic and diluted" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_YearFounded": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Year the entity was founded, in CCYY format.", "label": "Year Founded", "terseLabel": "Entity founded year" } } }, "localname": "YearFounded", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "gYearListItemType" }, "vapo_AmendmentToFinancingArrangementMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Amendment to financing arrangement.", "label": "Amendment To Financing Arrangement [Member]", "terseLabel": "Amendment To Financing Arrangement" } } }, "localname": "AmendmentToFinancingArrangementMember", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "vapo_AtTheMarketAgreementMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "At the market agreement.", "label": "At The Market Agreement [Member]", "terseLabel": "ATM Agreement" } } }, "localname": "AtTheMarketAgreementMember", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "vapo_AtTheMarketFacilityMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "At-the-market.", "label": "At The Market Facility [Member]", "terseLabel": "At The Market Facility" } } }, "localname": "AtTheMarketFacilityMember", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited" ], "xbrltype": "domainItemType" }, "vapo_AtTheMarketOfferingMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "At-the-market offering.", "label": "At The Market Offering [Member]", "terseLabel": "At-The-Market offering" } } }, "localname": "AtTheMarketOfferingMember", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited", "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited" ], "xbrltype": "domainItemType" }, "vapo_BusinessCombinationOfContingentConsiderationAsCompensationToBeRecognized": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Business combination of contingent consideration as compensation to be recognized.", "label": "Business Combination Of Contingent Consideration As Compensation To Be Recognized", "terseLabel": "Contingent consideration as compensation to be recognized" } } }, "localname": "BusinessCombinationOfContingentConsiderationAsCompensationToBeRecognized", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "vapo_BusinessCombinationSettlementOfAccountsReceivable": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Business combination settlement of accounts receivable.", "label": "Business Combination Settlement Of Accounts Receivable", "terseLabel": "Settlement of receivable from preexisting relationship" } } }, "localname": "BusinessCombinationSettlementOfAccountsReceivable", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "vapo_BusinessFinancingAgreementMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Business financing agreement.", "label": "Business Financing Agreement [Member]", "terseLabel": "Revolver Agreement" } } }, "localname": "BusinessFinancingAgreementMember", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "vapo_CapitalEquipmentLeaseRevenueMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Capital equipment lease revenue.", "label": "Capital Equipment Lease Revenue [Member]", "terseLabel": "Lease Revenue, Capital Equipment" } } }, "localname": "CapitalEquipmentLeaseRevenueMember", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueNetRevenueDisaggregatedIntoCategoriesDetails" ], "xbrltype": "domainItemType" }, "vapo_CapitalEquipmentProductRevenueMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Capital equipment product revenue.", "label": "Capital Equipment Product Revenue [Member]", "terseLabel": "Product Revenue, Capital Equipment" } } }, "localname": "CapitalEquipmentProductRevenueMember", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueNetRevenueDisaggregatedIntoCategoriesDetails" ], "xbrltype": "domainItemType" }, "vapo_CashAndCashEquivalentsMaturityDateDescription": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cash and cash equivalents maturity date description.", "label": "Cash And Cash Equivalents Maturity Date Description", "terseLabel": "Maturity period of highly liquid investments with original maturities" } } }, "localname": "CashAndCashEquivalentsMaturityDateDescription", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "vapo_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercised": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Class of warrant or right exercise price of warrants or rights exercised.", "label": "Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Exercised", "terseLabel": "Weighted average exercise price, warrants exercised" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercised", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsSummaryOfWarrantsActivityDetails" ], "xbrltype": "perShareItemType" }, "vapo_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsGranted": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Class of warrant or right exercise price of warrants or rights granted.", "label": "Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Granted", "terseLabel": "Weighted average exercise price, warrants granted" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsGranted", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsSummaryOfWarrantsActivityDetails" ], "xbrltype": "perShareItemType" }, "vapo_ClassOfWarrantOrRightExercised": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Class of warrant or right exercised.", "label": "Class Of Warrant Or Right Exercised", "negatedLabel": "Number of shares, warrants exercised", "terseLabel": "Warrants to purchase of common stock shares, net exercised" } } }, "localname": "ClassOfWarrantOrRightExercised", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsSummaryOfWarrantsActivityDetails" ], "xbrltype": "sharesItemType" }, "vapo_ClassOfWarrantOrRightExpirationMonthAndYear": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Class of warrant or right, expiration month and year.", "label": "Class Of Warrant Or Right Expiration Month And Year", "terseLabel": "Warrants expiration, month and year" } } }, "localname": "ClassOfWarrantOrRightExpirationMonthAndYear", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "gYearMonthItemType" }, "vapo_ClassOfWarrantOrRightGranted": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Class of warrant or right granted.", "label": "Class Of Warrant Or Right Granted", "terseLabel": "Number of shares, warrants granted" } } }, "localname": "ClassOfWarrantOrRightGranted", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsSummaryOfWarrantsActivityDetails" ], "xbrltype": "sharesItemType" }, "vapo_ClassOfWarrantOrRightNumberOfWarrantsWithholdUponWarrantsExercise": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Class of warrant or right number of warrants withhold upon warrants exercise.", "label": "Class Of Warrant Or Right Number Of Warrants Withhold Upon Warrants Exercise", "terseLabel": "Number of warrants withhold upon warrants exercise" } } }, "localname": "ClassOfWarrantOrRightNumberOfWarrantsWithholdUponWarrantsExercise", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "vapo_CommonStockReservedAndAvailableForFutureIssuanceCumulativelyIncreaseDescription": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Common stock reserved and available for future issuance, cumulatively increase description.", "label": "Common Stock Reserved And Available For Future Issuance Cumulatively Increase Description", "terseLabel": "Common stock reserved and available for issuance cumulatively increase description" } } }, "localname": "CommonStockReservedAndAvailableForFutureIssuanceCumulativelyIncreaseDescription", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "vapo_CommonStockReservedAndAvailableForFutureIssuanceMaximumCumulativeIncreasePercentageOnImmediatePrecedingYearEndCommonStockIssuedAndOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Common stock reserved and available for future issuance maximum cumulative increase percentage on immediate preceding year end common stock issued and outstanding.", "label": "Common Stock Reserved And Available For Future Issuance Maximum Cumulative Increase Percentage On Immediate Preceding Year End Common Stock Issued And Outstanding", "terseLabel": "Common stock reserved and available for future issuance maximum cumulative increase percentage on immediate preceding year end common stock issued and outstanding" } } }, "localname": "CommonStockReservedAndAvailableForFutureIssuanceMaximumCumulativeIncreasePercentageOnImmediatePrecedingYearEndCommonStockIssuedAndOutstanding", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "vapo_CommonStockWarrantsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Common stock warrants.", "label": "Common Stock Warrants [Member]", "terseLabel": "Common Stock Warrants" } } }, "localname": "CommonStockWarrantsMember", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsSummaryOfWarrantsActivityDetails" ], "xbrltype": "domainItemType" }, "vapo_CreditAgreementAndGuarantyMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Credit agreement and guaranty.", "label": "Credit Agreement And Guaranty [Member]", "terseLabel": "Credit Agreement and Guaranty" } } }, "localname": "CreditAgreementAndGuarantyMember", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "vapo_CreditCardProgramMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Credit card program.", "label": "Credit Card Program [Member]", "terseLabel": "Credit Card Program" } } }, "localname": "CreditCardProgramMember", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "vapo_DebtInstrumentAvailableToBeDrawn": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Debt instrument available to be drawn.", "label": "Debt Instrument Available To Be Drawn", "terseLabel": "Term loan available to be drawn" } } }, "localname": "DebtInstrumentAvailableToBeDrawn", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "vapo_DebtInstrumentFirstTrancheMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt instrument, first tranche.", "label": "Debt Instrument First Tranche [Member]", "terseLabel": "First Tranche" } } }, "localname": "DebtInstrumentFirstTrancheMember", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "vapo_DebtInstrumentNumberOfTranches": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt instrument, number of tranches.", "label": "Debt Instrument Number Of Tranches", "terseLabel": "Number of tranches available under agreement" } } }, "localname": "DebtInstrumentNumberOfTranches", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "vapo_DebtInstrumentRemainingAvailabilityUnderAgreement": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Debt instrument remaining availability under agreement.", "label": "Debt Instrument Remaining Availability Under Agreement", "terseLabel": "Term loan, remaining availability under agreement" } } }, "localname": "DebtInstrumentRemainingAvailabilityUnderAgreement", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "vapo_DebtInstrumentSecondTrancheMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt instrument, second tranche.", "label": "Debt Instrument Second Tranche [Member]", "terseLabel": "Debt Instrument Second Tranche" } } }, "localname": "DebtInstrumentSecondTrancheMember", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "vapo_DebtInstrumentThirdTrancheMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt instrument, third tranche.", "label": "Debt Instrument Third Tranche [Member]", "terseLabel": "Debt Instrument Third Tranche" } } }, "localname": "DebtInstrumentThirdTrancheMember", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "vapo_DecreaseInContractWithCustomerLiabilityCurrent": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Decrease in contract with customer liability current.", "label": "Decrease In Contract With Customer Liability Current", "negatedLabel": "Subtractions" } } }, "localname": "DecreaseInContractWithCustomerLiabilityCurrent", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueScheduleOfChangesInContractLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "vapo_DecreaseInDeferredRevenueCurrent": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Decrease in deferred revenue current.", "label": "Decrease In Deferred Revenue Current", "negatedLabel": "Subtractions" } } }, "localname": "DecreaseInDeferredRevenueCurrent", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueScheduleOfChangesInContractLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "vapo_DisposableProductRevenueMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disposable product revenue.", "label": "Disposable Product Revenue [Member]", "terseLabel": "Product Revenue, Disposable" } } }, "localname": "DisposableProductRevenueMember", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueNetRevenueDisaggregatedIntoCategoriesDetails" ], "xbrltype": "domainItemType" }, "vapo_EntityReincorporationYear": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Entity reincorporation year.", "label": "Entity Reincorporation Year", "terseLabel": "Entity reincorporated year" } } }, "localname": "EntityReincorporationYear", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "gYearItemType" }, "vapo_FirstAmendmentToCreditAgreementAndGuarantyMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "First amendment to credit agreement and guaranty.", "label": "First Amendment To Credit Agreement And Guaranty [Member]", "terseLabel": "First Amendment to Credit Agreement and Guaranty" } } }, "localname": "FirstAmendmentToCreditAgreementAndGuarantyMember", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "vapo_IncreaseInContractWithCustomerLiabilityCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Increase in contract with customer liability current.", "label": "Increase In Contract With Customer Liability Current", "terseLabel": "Additions" } } }, "localname": "IncreaseInContractWithCustomerLiabilityCurrent", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueScheduleOfChangesInContractLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "vapo_IncreaseInDeferredRevenueCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Increase in deferred revenue current.", "label": "Increase In Deferred Revenue Current", "terseLabel": "Additions" } } }, "localname": "IncreaseInDeferredRevenueCurrent", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueScheduleOfChangesInContractLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "vapo_InitialMaximumNumberOfCommonStockDeterminedByBoardOfDirectors": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Initial maximum number of common stock determined by board of directors.", "label": "Initial Maximum Number Of Common Stock Determined By Board Of Directors", "terseLabel": "Initial maximum number of common stock determined by board of directors" } } }, "localname": "InitialMaximumNumberOfCommonStockDeterminedByBoardOfDirectors", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "vapo_IssuanceOfCommonStockUponExerciseOfWarrantsShares": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Issuance of common stock upon exercise of warrants shares.", "label": "Issuance Of Common Stock Upon Exercise Of Warrants Shares", "terseLabel": "Issuance of common stock upon exercise of warrants, shares" } } }, "localname": "IssuanceOfCommonStockUponExerciseOfWarrantsShares", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited" ], "xbrltype": "sharesItemType" }, "vapo_IssuanceOfCommonStockUponExerciseOfWarrantsValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Issuance of common stock upon exercise of warrants value.", "label": "Issuance Of Common Stock Upon Exercise Of Warrants Value", "terseLabel": "Issuance of common stock upon exercise of warrants" } } }, "localname": "IssuanceOfCommonStockUponExerciseOfWarrantsValue", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited" ], "xbrltype": "monetaryItemType" }, "vapo_IssuanceOfCommonStockWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Issuance of common stock warrants.", "label": "Issuance Of Common Stock Warrants", "terseLabel": "Issuance of common stock warrants" } } }, "localname": "IssuanceOfCommonStockWarrants", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited" ], "xbrltype": "monetaryItemType" }, "vapo_IssuanceOfWarrantInConjunctionWithDebtDrawDown": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Issuance of warrant in conjunction with debt draw down.", "label": "Issuance Of Warrant In Conjunction With Debt Draw Down", "terseLabel": "Issuance of warrants in conjunction with debt draw down" } } }, "localname": "IssuanceOfWarrantInConjunctionWithDebtDrawDown", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "vapo_JefferiesLimitedLiabilityCompanyMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Jefferies Limited Liability Company.", "label": "Jefferies Limited Liability Company [Member]", "terseLabel": "Jefferies LLC" } } }, "localname": "JefferiesLimitedLiabilityCompanyMember", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "vapo_LeaseRevenueMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lease revenue.", "label": "Lease Revenue [Member]", "terseLabel": "Lease Revenue" } } }, "localname": "LeaseRevenueMember", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueNetRevenueDisaggregatedIntoCategoriesDetails" ], "xbrltype": "domainItemType" }, "vapo_LineOfCreditFacilityPercentageOfAmountBorrowed": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line of credit facility percentage of amount borrowed.", "label": "Line Of Credit Facility Percentage Of Amount Borrowed", "terseLabel": "Line of credit facility percentage of amount borrowed" } } }, "localname": "LineOfCreditFacilityPercentageOfAmountBorrowed", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "vapo_MaximumAmountOfSharesParticipantCanAccrueAtDiscountedRateOfFairMarketValue": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Maximum amount of shares a participant can accrue at discounted rate of the fair market value.", "label": "Maximum Amount Of Shares Participant Can Accrue At Discounted Rate Of Fair Market Value", "terseLabel": "Maximum amount of shares a participant can accrue at discounted rate of the fair market value." } } }, "localname": "MaximumAmountOfSharesParticipantCanAccrueAtDiscountedRateOfFairMarketValue", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "vapo_MinimumRevenueRequirementToDrawFinalTranche": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Minimum revenue requirement to draw final tranche.", "label": "Minimum Revenue Requirement To Draw Final Tranche", "terseLabel": "Minimum revenue requirement to draw final tranche" } } }, "localname": "MinimumRevenueRequirementToDrawFinalTranche", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "vapo_NumberOfCustomer": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of customer.", "label": "Number Of Customer", "terseLabel": "Number of customer accounted more than 10%" } } }, "localname": "NumberOfCustomer", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "vapo_NumberOfVersionsOfPrecisionFlowSystems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of versions of precision flow systems.", "label": "Number Of Versions Of Precision Flow Systems", "terseLabel": "Number of versions of precision flow systems" } } }, "localname": "NumberOfVersionsOfPrecisionFlowSystems", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "vapo_OfferingExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Offering expenses .", "label": "Offering Expenses", "terseLabel": "Offering expenses" } } }, "localname": "OfferingExpenses", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "vapo_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Organization consolidation and presentation of financial statements.", "label": "Organization Consolidation And Presentation Of Financial Statements [Line Items]", "terseLabel": "Organization Consolidation And Presentation Of Financial Statements [Line Items]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "vapo_OrganizationConsolidationAndPresentationOfFinancialStatementsTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Organization consolidation and presentation of financial statements.", "label": "Organization Consolidation And Presentation Of Financial Statements [Table]", "terseLabel": "Organization Consolidation And Presentation Of Financial Statements [Table]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsTable", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "vapo_OtherLeaseRevenueMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Other lease revenue.", "label": "Other Lease Revenue [Member]", "terseLabel": "Lease Revenue, Other" } } }, "localname": "OtherLeaseRevenueMember", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueNetRevenueDisaggregatedIntoCategoriesDetails" ], "xbrltype": "domainItemType" }, "vapo_PercentageOfCommonStockHeldByStockholder": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage of common stock held by stockholder.", "label": "Percentage Of Common Stock Held By Stockholder", "terseLabel": "Percentage of common stock held by holder" } } }, "localname": "PercentageOfCommonStockHeldByStockholder", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "vapo_PercentageOfEligibleReceivablesUsedAsBaseToCalculateLineOfCreditAvailability": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage of eligible receivables used as base to calculate line of credit availability.", "label": "Percentage Of Eligible Receivables Used As Base To Calculate Line Of Credit Availability", "terseLabel": "Percentage of eligible receivables used as base to calculate line of credit availability" } } }, "localname": "PercentageOfEligibleReceivablesUsedAsBaseToCalculateLineOfCreditAvailability", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "vapo_PerceptiveCreditHoldingsIILPMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Perceptive Credit Holdings II, LP.", "label": "Perceptive Credit Holdings I I L P [Member]", "terseLabel": "Perceptive Credit Holdings II, LP" } } }, "localname": "PerceptiveCreditHoldingsIILPMember", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "vapo_ProceedsFromExerciseOfStockOptionsAndPurchaseOfRestrictedStock": { "auth_ref": [], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 10100.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Proceeds from exercise of stock options and purchase of restricted stock.", "label": "Proceeds From Exercise Of Stock Options And Purchase Of Restricted Stock", "terseLabel": "Proceeds from exercise of stock options and purchase of restricted stock" } } }, "localname": "ProceedsFromExerciseOfStockOptionsAndPurchaseOfRestrictedStock", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "vapo_ProceedsFromIssuanceOfCommonStockGross": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Proceeds from issuance of common stock gross.", "label": "Proceeds From Issuance Of Common Stock Gross", "terseLabel": "Gross proceeds from issuance of common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStockGross", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "vapo_ProceedsFromIssuanceOfCommonStockNetOfUnderwritingDiscountsAndOfferingExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Proceeds from issuance of common stock net of underwriting discounts and offering expenses.", "label": "Proceeds From Issuance Of Common Stock Net Of Underwriting Discounts And Offering Expenses", "terseLabel": "Proceeds from initial offering net of underwriting discounts and offering costs" } } }, "localname": "ProceedsFromIssuanceOfCommonStockNetOfUnderwritingDiscountsAndOfferingExpenses", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "vapo_ProductRevenueMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Product revenue.", "label": "Product Revenue [Member]", "terseLabel": "Subtotal Product Revenue" } } }, "localname": "ProductRevenueMember", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureRevenueNetRevenueDisaggregatedIntoCategoriesDetails" ], "xbrltype": "domainItemType" }, "vapo_ProductWarrantyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Product warranty.", "label": "Product Warranty Policy [Text Block]", "terseLabel": "Product Warranty" } } }, "localname": "ProductWarrantyPolicyTextBlock", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "vapo_ProvisionForInventories": { "auth_ref": [], "calculation": { "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 10190.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Provision for inventories.", "label": "Provision For Inventories", "terseLabel": "Provision for inventories" } } }, "localname": "ProvisionForInventories", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "vapo_SalesAndValueAddedTaxesPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Sales and value added taxes.", "label": "Sales And Value Added Taxes Policy [Text Block]", "terseLabel": "Sales and Value-Added Taxes" } } }, "localname": "SalesAndValueAddedTaxesPolicyTextBlock", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "vapo_ScheduleOfCashAndCashEquivalentsAndRestrictedCashTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule of cash and cash equivalents and restricted cash.", "label": "Schedule Of Cash And Cash Equivalents And Restricted Cash Table [Text Block]", "terseLabel": "Components of Cash, Cash Equivalents and Restricted Cash" } } }, "localname": "ScheduleOfCashAndCashEquivalentsAndRestrictedCashTableTextBlock", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "vapo_SecondAmendmentToCreditAgreementAndGuarantyMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Second amendment to credit agreement and guaranty.", "label": "Second Amendment To Credit Agreement And Guaranty [Member]", "terseLabel": "Second Amendment to Credit Agreement and Guaranty" } } }, "localname": "SecondAmendmentToCreditAgreementAndGuarantyMember", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "vapo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsPurchasesInPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based compensation arrangement by share-based payment award, equity instruments other than options, grants/purchases in period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants Purchases In Period", "terseLabel": "Shares, Granted/purchased" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsPurchasesInPeriod", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "vapo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsPurchasesInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based compensation arrangement by share-based payment award, equity instruments other than options, grants/purchases in period, weighted average grant date fair value.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants Purchases In Period Weighted Average Grant Date Fair Value", "terseLabel": "Weighted Average Grant Date Fair Value, Granted/purchased" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsPurchasesInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "vapo_SharesIssuedDuringPeriodOnExerciseOfUnderwritersOptionToPurchaseShares": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Shares issued during period on exercise of underwriter option to purchase shares.", "label": "Shares Issued During Period On Exercise Of Underwriters Option To Purchase Shares", "terseLabel": "Exercise of underwriters option to purchase shares" } } }, "localname": "SharesIssuedDuringPeriodOnExerciseOfUnderwritersOptionToPurchaseShares", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "vapo_SolusMedicalLimitedMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Solus Medical Limited.", "label": "Solus Medical Limited [Member]", "terseLabel": "Solus" } } }, "localname": "SolusMedicalLimitedMember", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsAdditionalInformationDetails", "http://vapotherm.com/20200630/taxonomy/role/DisclosureBusinessCombinationsSummaryOfPurchasePriceAllocationDetails" ], "xbrltype": "domainItemType" }, "vapo_StandardPaymentTermsToCustomer": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Standard payment terms to customer.", "label": "Standard Payment Terms To Customer", "terseLabel": "Standard payment term to customer" } } }, "localname": "StandardPaymentTermsToCustomer", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "vapo_StandardProductWarrantyPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Standard product warranty period.", "label": "Standard Product Warranty Period", "terseLabel": "Standard product warranty period" } } }, "localname": "StandardProductWarrantyPeriod", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "vapo_StockIssuedDuringPeriodSharesRepaymentOfNonRecourseLoans": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Stock issued during period shares repayment of non-recourse loans.", "label": "Stock Issued During Period Shares Repayment Of Non Recourse Loans", "terseLabel": "Issuance of common stock upon repayment of non-recourse loan, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesRepaymentOfNonRecourseLoans", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited" ], "xbrltype": "sharesItemType" }, "vapo_StockIssuedDuringPeriodValueRepaymentOfNonRecourseLoans": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Stock issued during period value repayment of non-recourse loans.", "label": "Stock Issued During Period Value Repayment Of Non Recourse Loans", "terseLabel": "Issuance of common stock upon repayment of non-recourse loan" } } }, "localname": "StockIssuedDuringPeriodValueRepaymentOfNonRecourseLoans", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKSTOCKHOLDERSEQUITYUnaudited" ], "xbrltype": "monetaryItemType" }, "vapo_SummaryOfSignificantAccountingPoliciesLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Summary of significant accounting policies.", "label": "Summary Of Significant Accounting Policies [Line Items]", "terseLabel": "Summary Of Significant Accounting Policies [Line Items]" } } }, "localname": "SummaryOfSignificantAccountingPoliciesLineItems", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "vapo_SummaryOfSignificantAccountingPoliciesTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Summary of significant accounting policies.", "label": "Summary Of Significant Accounting Policies [Table]", "terseLabel": "Summary Of Significant Accounting Policies [Table]" } } }, "localname": "SummaryOfSignificantAccountingPoliciesTable", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "vapo_TermLoanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Term loan.", "label": "Term Loan [Member]", "terseLabel": "Term Loan" } } }, "localname": "TermLoanMember", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "vapo_ThirdAmendmentToCreditAgreementAndGuarantyMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Third amendment to credit agreement and guaranty.", "label": "Third Amendment To Credit Agreement And Guaranty [Member]", "terseLabel": "2020 Amended Credit Agreement and Guaranty" } } }, "localname": "ThirdAmendmentToCreditAgreementAndGuarantyMember", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "vapo_TwoThousandNineteenAmendedRevolverAgreementMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two thousand nineteen amended revolver agreement.", "label": "Two Thousand Nineteen Amended Revolver Agreement [Member]", "terseLabel": "2019 Amended Revolver Agreement" } } }, "localname": "TwoThousandNineteenAmendedRevolverAgreementMember", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "vapo_TwoThousandTwentyAmendedRevolverAgreementMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two thousand twenty amended revolver agreement.", "label": "Two Thousand Twenty Amended Revolver Agreement [Member]", "terseLabel": "2020 Amended Revolver Agreement" } } }, "localname": "TwoThousandTwentyAmendedRevolverAgreementMember", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "vapo_UnauditedInterimFinancialInformationPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Unaudited interim financial information.", "label": "Unaudited Interim Financial Information Policy [Text Block]", "terseLabel": "Unaudited Interim Financial Information" } } }, "localname": "UnauditedInterimFinancialInformationPolicyTextBlock", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "vapo_UnderwritingDiscount": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Underwriting discount.", "label": "Underwriting Discount", "terseLabel": "Underwriting discount" } } }, "localname": "UnderwritingDiscount", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "vapo_WarrantsTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The entire disclosure of warrants.", "label": "Warrants [Text Block]", "terseLabel": "Warrants" } } }, "localname": "WarrantsTextBlock", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureWarrants" ], "xbrltype": "textBlockItemType" }, "vapo_WesternAllianceBankMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Western alliance bank.", "label": "Western Alliance Bank [Member]", "terseLabel": "Western Alliance Bank" } } }, "localname": "WesternAllianceBankMember", "nsuri": "http://vapotherm.com/20200630", "presentation": [ "http://vapotherm.com/20200630/taxonomy/role/DisclosureDebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" } }, "unitCount": 8 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18726-107790" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04.(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r111": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r134": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r182": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/subtopic&trid=2196772" }, "r183": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/subtopic&trid=2196816" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r207": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r213": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r216": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(2))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(3))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1),(c)(5)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r224": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r254": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r255": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "705", "URI": "http://asc.fasb.org/topic&trid=2122478" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f(1))", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e1043-128460" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e845-128460" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e848-128460" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479" }, "r329": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30226-110892" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30304-110892" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r368": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "http://asc.fasb.org/topic&trid=2175825" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121578510&loc=d3e41551-112718" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918666-209980" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r382": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(a)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "605", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r449": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r451": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-13" }, "r452": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1-" }, "r453": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r454": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r455": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a-c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586" } }, "version": "2.1" } ZIP 79 0001564590-20-036135-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-20-036135-xbrl.zip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�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Ő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

THVD ^1[BL_I(R*\M,#T\EBTLB(4-Q &.?O MB##5YG>];)>$,'D2N-ZV%M(ZEF/%QMS +-CZLD,F$J#P-XXY^.F'J$UG+Y[N MY0ELQ^Y1(&;KPGBP0[0L7_,2!RYDM873OQ]2-HG_DA2/Y_"^.,^BS^?XLU(] MFA%9Z_>^5-AX?P!,G-:QMWTK,(B2 @)I* F(@2@@D;0G_\3)BZ[B=^ M-^PLRA_?(?PYMWPNK(..DU?"CNCZ>QR,L@*,5\AO@O4#UOT46(\"IS"S1NF2 M?C?CSJ];O$5R3,[#(S#!E]$.@8(5M!4@ *A3]S,UR")+8>IR+!>/87SZ_"F' M\66Z)FLX]HS]BL3^IZ0@>;E)Q#6A;HZ8/CV^M\>2BC:N^(@2P% *?/@(I #PE*(4 EA=+L[,6WB83;I+C2K&^H?\L< MI8K*7-MW4_E1AY9QOQ["T:BP9TZ6[?[.>6A/3\G238)@8^OW#GN'Z]"52>E!0:9E)/V!V)>27]+?][0('F@@9$LGL.=!KU:8=]QO5-T7Z+% M=1_+ER*R\Z;ZN17YXT(F97;F=#:QNBA8-EU\8CBUUK,,X)0N_UEC][" M1$-N)%$6X/2HBF5B7SB'>S)_))$X!E_M<%8D_]1VB$$RYC@,D'7O&G5F[+@D MJK$+PR]4T,(:Z@L8&=0!"JU^6"F!XFLQ5YZ6GN/#?;$]H-5F@P]D;M1]-)U[R[- _#[*&:G,8&DE$I081W5A0P+:B-". ')"DA>]M?YQ&BA\][P9WE U!R#R/&::*+S70< M.))-QZ,L^6ITG9:O\4F^[$BM !?C*/K9:ZLE+NLM.\9/Q)CQ#UL:=584K^+!4/FCT2 ,#Q.'4*LK.AUZ?(H,%2\+82 MNAL%Z"9R,LW[&HJ$7"+E;G7>Z4]*R_)Y_:CGZH:&RL+$0\%EYMLT.1[X->T! MG,3G< NS#,87_*1LE<;L*M^*Y4MV/J3&P268*AQ]>)W@*X\;>9Z)V95(GGB& MZHM:1C#HI.JJ7QC@"FXMX9=B "$'.]KA-V-7(V8P<1)Z'3V[RT!+8CXR&D'< MP^:,3%_VG$.H+MH'F5+.V=!>\/ H99O78W!-Y$IG.&4K2WI]Z>R0%W@'LRNQ MM?!LYU@CI%WB.,C*P]Z,8%??A G5\=0 'G1#!>TN#,PA%RW!I?R!% "4$LSN MLB2&9 >2M%6V)S.%H]C?KR5&+E^/@K,';R]1*^7>EP[SAS"+\W]!:QN9E M;626;ADCLSJSE!K36M)<[>=>J9C+S/?8=.*%#M4I;C0YB@&XB)"( 1^74ZEO M +'11;7I+JC->S$M# ^E>VVYMYNF@]2=0SS S?]-TT0R7XKCJB _[L"C.E\> MRBH.70H1Q*66:_XL&VWT24_H,]@HMR*9@E&]GPY5BPI992Y>MJ1%RX4\]((_ M XBQN9(7 &>KZE:P9=UC.>-V[1]-F.>J_SO2RNDA3U*8$\-C?29IG!%_T7J8 M6X^N0U0'^/BI?R@+CZBCW@ON96$22Z$C(4"@#JL"^9#+CJI\$?".NVW%6[8U M9;/P:A3=F=-F/^GR- G4! O;EY ?V^7%T^7#\^;!87CHNR2-THVOA>T@=><0 M#W#SO[#=2N9+<5P5Y,<=>%3GRT-9Q:%+(<)8V-:ZN':^LZ>5+(\3L[KH.4S< MRT7)6O??I.<)Q#!<51U(K*W3X$%#+;PH.]#W<.-,*U/1&UE*=89SS7OM@W3L MER9=='VL-,_JKX?B[1:RE[5J\O,@D Z5H;&>YKZ73V(/WWN/3[2/.BCN8[>AE7=. TR+B M!O &40_=SBCY5^0W.T"^SV-!!N,DE .=48QZ_+5#;<'BT>E1C ^@C-@%C:M4_=HZV2J0WAPJIL_>>J$;30M.E9@^!"-IC*4I4H,]KSI0)D[V'/H(.-B M57M$UL>. VNB4JY8@MQIZ$>I?-FPCDHW)+2O4RHQ_5]: M5U$^"E8\JN)AT-5E@[Q>1%&XC0HS5:?.=DR=[8%;0 + MB3V; MH%S0MCGC?N#G.<'#?H\@/32($!WL.X0_7Z9;G.WXZU@&J90R28LG[M18>*C) MJ3%F[SP@G!\R?ON:)4GTW@E91Y:BA!'6=%'&AJI>"**H TP6;"A74&,[9V-Y M8G8D#%U'2?P1:C[]T/JJ36>I!BGW_B09 -98-3ZP8G5:WAI24M"'!1Y15&!Z M1RV54^+TAO+D*3=[LX'USHV3@D;/RY3UBXM/#\5'7/P5LG'K9=>J-&V2*34> M7DJ4.MIZE)5W[ F4J-7FEK\!VFK0%X8[:1L -@5A*6"723)_S:3.%4BV@/ % MA#$@G)GKVA=75O5;OT19%J4%:RWZ]T.ZH7,?[>[)WF/*HL_G^+.'-VLO:[<< M/G,)F"UO*B' 9]ICE#ZB!6(B!XB)(,L<.&J->;T%@KGHJ5H.F;55Y2]3T2&? M#P[9SZ) 7H:"\5NMS+_Q/8MDL$;'K]DU+]?LR8^R'8!V.?-DN7P7.'A(>2$! M(5/O\@XF8;NT*>X'O]03^)?L? MG<-\DR5[(>AIE"UDO<.?BE.D683!!/JYIZCS\W]?%7C36Y" IT36).QO#+D1# M5"P>C^VEZO;5V)(-D'R"FWP48,+JBIMBFKA-'M)DFVQH5\TC<8RF!E6*%OFP M$@8=SF#/%R,CK#NWN20/)K MM09!?IB._5S=1=?/K%SG%%RH5X*K([GJ5]^4JX*:%.?E^:G52F",HE/#Z^#@ M/MQWVF&PQC<$X[ 9]BIS&9 -1 U0,9TSLK^+DNSG"!U@)8Y19!^F8X[6$%VG M&%%&@'&J(1->:%?""^OH;XK0WB6%440?(>36SCS&[YJU?8 1Y;8;KU^;T\8& M [>"\H)&9B0$S!>=;^ &)D_TM-XH*'=^W1R)#G).]5^C'US<'4("*ZAHDB@K MKXK7I#"+LL.$+'QYB+#'EYTK=F%8DQI26$MQ0:,B(VS9S*#AZ_,%6-K$C(IK/(<%KE=4-8D M; Z=%B.G6$K.[&"XX@TX\Y"CN1GJV$KI4T1\);&,Y@!=RI[MV>,\45IUU&75 M"[+?P4QF, 0/:B=0I?0^GW7[^;UF!$X\+"RI@C9DC5M MRY,\/!;Y1UQ N\Q#F:2Y1RNR<.K*DB=OH\2XT@OC,.1$0Q==;*CBL()$?3J5 M+.QOM7L2MFU=LQ;,/,'T .E;,'2>HO#2R_)GA[S .YB9%=$HDK0IK%%BX;C8 MAO'DS^9(KKRS@.0;7"S011<;JGB*66M$(*,EACI-;[;J,0X*SHLPQ<&E@YX* MEP*53ER9<9^_G/[9*^CE(Z8W$-$'J]@C2.RATWOZSJE\+5J7T^P0Q);5 M!'[3S=K#I5[: ^?5\8O+"W.'$:,P\89-Q G5UP05@9/ZRKRVGVKKHEL3PAUR+KWB8G.1OOM]&P#5/Q M5%Q;MPN"<3S*A%&/)5K4M=H6/?/_:]9'19&B15,.)0X>^JBP9GJXV4PO#$_4 MA!&;*7,9D*$Z6F0YW&Z/]2S_,VL99*WOJH6S#=.Q*2'JI^OC18(DW21[Q!^^ M:? .P[V4X,(ZZ@L9FK*6J]Y'>7Z?N84/=+_J!NYQYF2F4B1HT1=0A8&'G6#. MMO[R4!ANI(<@-E+D(M!"3:!*EN%,4)]RN-Y>Y$5"[ =J/4W9_J8Y($U*[OV$ MT*?S3UDM86D:5@M=*"E8K]/V41HLI]NA4LBO[T]79&D"LQ%E+47K]0 M3A""'BW2&F@ ,W*,ISULF9/1H0__V0L_L3M4[^.K.O/FWS MF4.7EX\-TB;;,&9P8WRQK6Z7AB4JU_\X YP[:+,'%?_Z\Q;3;]AL(*U/9"4> M2?[;609)M*$_:>[7]).QVA/H(^OCQEZ-&=^Q8=P 91>&!ZJ@A374%S RJ ,4 MAH0:*GYZ2^(,)@_I&7UI,MTTSQ_3F/T3<>NQV+VQ8&+1_="4J8>NP%P4(&5A MMV?E+]=[F(74Y]W>(K S$!:+/NH!OG&L2&_KU24)(-^E;Z'3B\CD/Q?_."1/ M$:)EAS?EB9L3OC[\S5N)RP\5#*Q#X01&YR8 M!W8)QY)- 556P&_@MPRA;0/='^(2V>[776 M0W@%HQS:[#X-DC%':("L>^]A;$!0G1)4T,$:Z@H8"21!H'P 9Q2 ?]![HNOM M+5D'VKC'$!6;S?0^JAZ*Z!Z3_9Z69-%]D_\D_P?1?[!;M&&XB@)06%UUX8)2 M'G#D!2TF8HRL_*1GLX(17J4Q>]-M%<2^;&!P!ZA9/ M[/F[B'('!64?PGZ&)H[80*$+P*P1RDK &.=7C#5@O.VW/*8<%*J/9R7' VKC M"6 "O<+IP_F!G[[)ED9Y7^:ME7+J$;9(?708N3?7NV0GY]W5CM[%+0RSR6<@61=]OK*NX#5/7UPULR[LX>+51:L2-*JU[,*BZ^MW9 N MF-A0HPL!KLRA>QL#S3]O7J8;O(-D%K=PN'X:-F_M==/T<3A .=%$)@PG&D4$ MJVHI5.VCMN(#\(./\'/MFG2&4_+CAK_X;GWC49^V.7*ZO+Q4AQ-NZ)DL$/"> MAKKZ3?"&0&'XFS'RV%;K2T-9^"UAWH^IB[N4?5M%FT<8'Q!M_-=9ST-[R#=* M?N[HV]4&>TBV?$PW*NSX^MEU$C+1Q>"&EBO1]2'[ =;JEN@OLZK B?X]B#TI M1P:#70*T9.-HO2"TQRF#G]Y%Z"Q_U*]^7(PJY*:8](_U=J"N;W6L!L"$FK5N MJ%1CJW[J*HGN$Y04S_KQTYRV17!,ZC[0>Y)K,#1"L$--R,!MZO@RJ M,Y X1.N%&4]'&*JD Y5X\KUN*2!+/&HB B'C_)'J]) G*[N8:;CLZTO6C_9R G-]<[?Q.\NMM1]_+IB71M!J18UM I^Y;2GMMIW M49+Q.AH^NS=F]0\PHLV"XW5*9MQ#EB7I _G 1YQF\I^LXRG]OG#_S6.:_., M<_-<>B*!+&YD3R&@A]FRMIG),J$]OZO]*6>]N$C,C#:_O2*?PK32:2W^2C-S MNL_] <=$05$!BD<(SJ."D7E/#3>,:#"M&>-9K.&K,%D1%:G$LM1.I/6M;%Z* M#=:TKD!(RCY5%QWPELRE\*"2?OYU0+7<$B=*[ '@_ I'K+F#Z"66/M!#Q>3) MP>Z$ 1L7BTEMME[7"E(:4#$.(X:Y,(?.O05#_2\8^HX]@Q)V)@I@LK!P44I3 M,X@PHL)E^@13XM?/O.U*X6*#?A-;23O))3>NMIP=KJPBDJ7 EV' MA(J3)^3(MB 83(D^9/KW'./Z<(.3&(Y7)NT%8D9U?/SU[)%*0.$Q6 M'F=D!?S,DK>R]%Y*Q,[0*XE%+AB>8^L:2(^/:R&S0&/H]/P6N&Q.+O$/* S( M6-OAAOI.GS]$?\?9&6TF:IVJFW)SD[:9 #@K6I M]*3Q-J LWRPZDWIA$EPBP$3JB"FGSX")!9A<8<23#U%QR-A>QGI+;RK=P6QW M#N^=9/FJM%T8A1HOSQN::7J($!"/.I&?*J'HGZE(?,476J30-(+.N* #P-( M[_#Y&K3D7^R.'\.7BA!2OL!NJSUB%!.;I?60Q3/=>9"':.OL)GEX['IN7LO1 MM9FX, !-IEZ3 LF53 5%\A1@E:&I&72ZNI'F%PMYA_/7Y0!<$+:A5]G!.@-< MF#FCP'F21P\/&7Q@APZTG(K=.#:?VA4)FD.MQ,#/R_'R.G9-!/X\$ 9GY,>' M@#;S]'#%1NI=!(;"-9L<>6D>!W/VB5A>]_\E*1[/#GF!=S!CJX':Z:=%D;\1 M>:LW'7393;=_)V2K'\^&X:XV-H =*'^!> O'+C&E @ I 5].-X[B@RK\OWV, M,LCZ0]3;#JQH9O# ;VB>/E>?N8Z>Z>]6]+H*&X1A"F[+U$E^9B>$QUA!DS;* M&!SW[0!U^>@>3?V#0D; A"3F1<4=[+O ],485]=B8 *[\A.Q MQA3:I\^K)(67!=QIO8[K@IN%&5ES]]%H<]QP1NR&2@>8>*$$)7_4(8?S.1M7"RW+QT+H2+R=14S'W64_5DXN88[ FZ M/[OK#X(><'S)-M87!N^/4\1CNVLV".._9!*7)AE2&%RE11(GZ$ D(XG[1M0B M77S9H$,,XW?$B.EP#X5(V2^B+"7I14X28*81V[I@9]R=%(0ZDL;S664E _WG M.168&!JM/;C">4[7)F+27A7$"N_)9ZFUT?H#O-N1+]6K3D*+CL[-L;OVV"G0 M+\_TNFJ3:P*"2D(@1014QH9MTI6V$+-FDRZ[R%YG> -AG%/6ER3+I ]/KK?< MRIF1$Y]8;S^EQ- _4W'3A_,DY_;[>07JH6>TI*AQ!>V)H_]NM0#%^O M-3,1 75WD @A60-:'HIR-CNFD%V3.M1$!;&4E5V:PD): (6X(?2D]61^V".^ MKTW3'<3UVF&(+-#6*!1]5DA+]QH'06ZB8)5NMVC $A M #X:)APZ.INAGSF061,*^1J3)LFP,).09OI[N1>7,THA M&+)CX\(>4#1RF@N2&!?/-S!)-SC;8_X\UU]AI-0T;XR"H6GW4O1BK9P;R)KL MP#/A%X+AC0.$U=1F9!X?#[0/WGK[,[$]N@5.FUY#8I;DYW<(?[Y]SE4+H+3( M&1J.&GDO5L19TY#V))C3G_>2/=@2_B#G H1@5IK 8@,-FV5KV4.4)O^4#Q3F M&"4Q/SI*8\(JEQI?;T6KH C=DM_P\L(KG8H\I^Q,,T,G[/WDDS71R'JW)AM; MTNYKTE%+WTKYR*)8"AB"G3NV)^P!N.G]1+G WAFK.?S#8;WSOWQCQ(:<^(55 MI7Q0]E(__&@82T,H=MA6%XMN.I>"@4HRM1L72U(0FE W?EXKO5[K-Q>O?HA@\P/U(UQE(1A[.TGZ64.7O'VUSO&$$228PCSJ@(^6%%I@6)1 M#QJKNP^@9&(_0_D677@D,1_"!W!&E?R..O_G65&;2LB_VM,(^=7?SNC!!LSV M458\?XQV1UU% \IIS0E(UZ] Q^I3RF M,.@;*#?N2W]J#_<<[Z(D5;5R#8)F:"@S^"K\01\_;*3&16 EW*GB6ILD.GR, ML[9.[?X+LIP;YE?)+BE@U5Z"EB9%Z;-FFJ=*SC#-4"/O)?TK60/!N]8$0W / M(174Q!,;*'8!V-7C7@VXJS/[=''*8:"C$?29GD(:N<0C N?;6E>J%_>7IBF7 M^UM*2O*RR44/C]]A6J,1ZVQS-;YFOA53(^/>?,6I_Y;39Z?]86QS=>D<#R@E M(/T*HZ=T@2!L[]6>BT$Z;*)>":)D&@$, S5&T&(#_NID"%-65S3:4FJ45BQK ME*@Q0#(!2*;\>7=\6*RC_ S^Y.C,1+,[G$'EGF] M2- >MI#*(1LQI;O8,>^O=GQ9NA F+DI"N4R "R7;4*QI8Q2A)6+W=-$#$LB53%U'WMBR.!W5YN]V5-U:.J]&A2P\ZI#[ MW)G<_MWSZ%Y2J$*CEKSCENWHFN_[#.<.K^\*FE(-K5P(TVV*K!6?$'4@!W%?R3#QBY M'ZNSBK/RF/0]Q ]9M'\D0B&=.LH! F952KT$/61;-0[S%X^-0X&5-!2DVJ4/ M2"Z@SF:Z LM;^- >HUY!Y0 !0[WW$7SQYCX*!5;24)!JE^;.N;2,7;?2T(2ZMF+"A6W8/C*8Y;F&,=IC:K6PL5CQ#WF27&N,[B/DEB> M.]&SX.(19F>'+*,O+-#7/@TR(!VJYH"I<_%1 ,!XEP=V[%"?L0>"/W\J-9!N MT08P8W-%+P=2U(/FJ@?-*:_J7F7-+98NK^KMFZKXN6EXH:RH7Y MD6 T_X)[$ (\II[0U(V:FEYGY6M>DVTF"=[4L07O7&\S:8" E;J/"7Y=)CZ M"%925)#:;UH\#^N2SUP9U^UCLM\GZ0.1Y3^))1#Z#_H)U@ 1F\K1'J(^WM_E MK)@O2&9AI$KC^&!EE06+!6K!L*K!X/ >Z2SE&*:'I5JSYMF&>-&\HCQ#+8HVCF_E%1< 6#I#B-7QPHJQ"]X@B:7H]H*BQ,&'H\ M@2+P:1@!7\>PF_H&D.99;.N[5J>KN;?X*IP^OR"]V( IH\[!7_WA,-Z'I MNCJFW2ANTJJ5IIY%^2-)H>E_+OYQ2)XB1">+#U%!GWQ[/H\*> [S39:PBZ4J MYFM"U;"848N+EP)5RIHM!#?T!U@) 79""A 3,4!$P>'M$S0 D1A[[+_@3S@O>=^9P4CP!GR4.21DC"G[BXOS6#%D2T M8>9-%]CLAQIS4*J&L@%6C^P*=31_4?NDA]Z#A,')L8M3O\^J MMW_9W^_Y$>F+T0(N(B2T<$=_9J,\UL5)ES*L;_04A&B4Q6(/]).9M M$)2GHA$JIG7T0U3]W(40'.E],;87_UGP%-$IA'E%#3&LKL-PT6ELU8U XV!/ MSO^ 4&LL\LA'\A+M1Z8^^&JSR0X14@D"JI0L-KP'*;M!AQL2X9055XUB MG!-P#TG*01]>9FV>% QNLN,(->RPGB;#QFG4BP2WH-Q(_#.1O5?;2@P<*EV? MDVP=-6^<*CN[2.-V;@99OZS1K$QS/S77Z'SPYY@7<:3>['R-BNN3K) M>EX2?L+(.^QL SN!9)%V@!HF &HB@$J&^H$'ZSU= MCPCS1($;2"N">>_B8Z49>/T806MTAQEX].I,,N[U[V@WWBYR8D]6Q/?8W.5Z4>KR MKF[%!8O(D<\P-JP(1[O#LL.W'$Z)X\;TM38B >^]0;?1'MA6Z^ES]1'ARZO/ M9*'\+DJRGVDH7^7Y8<>2Y9R.@1:(G"=/20S3^"8J]-^$\"N,Y?L%/H7ST4Q) MT@?/"40QK=X][,9>F)GT68I)3*_]O(5_%%^\F\Z%G8XG3 )01%_&*F"GBB5C2&%%]06*BO VS@,0)C)= (*- M[>G3Z2%/4ICGQ(?ODY2Y<'7:NMZ**YJ::UQ3RH8'(-JC"5W2XSD%6BA+"49:Y#6 [!(RZKG?PHN\=L'O$D+Z&GM(NDOS-QU5>GYON M\"DD(N"'-/FG6CF48X;N[-M(@.G,GKUR(>6C/U8"DE24?K1*& I,IACJ$4+* M0#W"SL8&',4"RF'_<;1.W#S"^(#@>BME7VW^<2#9 4O73I]K_U)^Z<"+95>4Q>"YLNU?ZMURY]LT69J!]@6@Z5ACGS![:M_ILZ\':.E/V80&C3H'2?F%I<& M\6G (Z[3H M,6Z,@FD59!]%/S6JE!L0[(#@%\+*91P:K*:P,&%HY-.4E8-:4[\2HYJP;8.9 MLGEO^6K/[0:F499@HP>BFE^V?*6H3LS':&>:@U]VT[C36K^+!Q(1N&8>@\,>%Q!X:F\;>&2QUP/1O%S MSG)>,7TS:I",[4EO)UGW'B".?*LY-JPW? ^$J*ENDP_3M3"NH+&IMQMYGGN8/W,(59A%9IO(IW29KD!3UN?8*B ML$;_Z0-%@N9@*3'P\=0L8\L*QZ,&XS \2@](;*3/18"&FGC1HO(FS[)H;*YW M0(_WP*_D0P.6IRHU.D[WZ$NZTYRE:#SV,.-QRC%HPR\SG&O-Y>.T+![M'*'M8_%)[$[T4997FL.( M,\J885W]A8Z/B![E/>0[+"LA0,4/,(;VI\@SW4%H[)DW[AI45PP -0@212#\ M0E8$]/)I!A'O;/F8[!<[]/;D4&,/:JI@$X.X=C';3?0.%?45?5?7Y_*S1_KC M9;IB?4MZZ\2ODN@^04GQ;)3_>1?)/N7P+**'CA>J=Q\@7Y>',5-,;:0=J>PD M2'\E!CD4'VL&VI"A?GN7?(,)#B[)KYGH-);V?K,2W\N,,N.%)R//;M]J>FE* M&;*N(3-9YJDF]Y(!7?P^Q6EO-%_9ZY0G$9'OD\['E?=1HX 5& MQ#'S\Q47!V'\&DS-:XQLO(-:V[)9D M7U[(.[8C3S&N!<^+M!F?44S!!H,/6HTYY#J#^RB173')Y]?%(\STGS^?2< P M#%A98!\MW1@W_KPMIIR">M%]7KN=(E$Y@5S]?$5@JQ*[*GF_ASA>8!@<(P\UX!O7339*Q8Z(62S\N+N^-&Z"G. MCF#Y51B"H( M%H9-CPKJ8W$O6;[8_%7=+KTM_I5@_:ILT.]F06G3XBL\+:6C '(8"PZT\^X2 MA+4%X'1]CXL(B;AX1W\6(5&A/'RIL7&:A7MXJ_*E++D7OY(6>P;U/XBSU.OH M6;>_\<2"A6&JHX+Z>"&^//#>!PTG^AX)%JJ-MP3U$7UIM6\6;0J *K9? M0[#M,\[)@FTGME^'(K?6#!@3& :!A@"/05]^Z.=C%K6618 M#]?Z-C)/P2_0B+>H,+>XR";/C3I5_Q%.41DT+L+DAC@FDJ^#F7VCF<^BHYFR M8=E',S6T7J@1N8AF4M+>L$:DG3B<2=G>)6E2P*ODZ?@(_Q>8/#R2S&#U!+/H M 7[*X?: KI*MUNZ?'1]SF[+AZ[Y<1K("$><%HAW.BN2?W(SV,$MP+%[V#K*N MQHFU8)?H+-DRD#PL$^&!2P*8*!U5**7Q"'$ EP=0@>9/@FKM_FYH/RL8G^'< MNLRDEZK36::'BWO_O\NB-(\VS-LWE 7U;KQ)*$OP.2E$*\$0W[W4@'HXTQA4 M]G)@'#3=JTZ0UK]#AC+F8]\NK1 C(F_KW"EV7U5@Z@?_!I,_'@9 M&FWL&8*+=4.HZ&@=6EP,7(I.1Y$4;XA<#0(ZE?-)E5Q$69JD#_DUS&X?HPR> M1GFRL?3!$=I.L1WDY<\CZ:(3Y)31";BGK()U436@ASU50UK6:RS&[JBO=.MXQVB8@Y?/U4//?$H+]J8 M47 #ZPPP?N!7QC&0-T<4X,+J"@P7&F2-BA=O>1YTG'4@L?8)0?,MZ%^5@U^D\\:A)V *D*HZ_:)[4@[G)-=0TO"LYC M1ZWS[G;9F1Z2+!5QF>X/1\?C07.D\_OD/C: 2Y=' M]2DJ8 R.O85SXK/8V[G>>Q2]F>E_:IV.=7/'(2H6J7TO53^=R-G\PWY0:OH\ MZ6IK'":LKKAP(4$U-%8=:,R3[=W O,B235&V,F^-O_NW^O.+'1]S5&WX?G6N MZ,08L$OE+QEXX?"5(*#?]P>BPCR3YP>7*?'> UWVZ2:.7=\V M5_PQ-?=V3WF BDD8%C\ AY73W@*1YVZGB?Y:X[Q8[2#^KMZ_31(*J8?S>O M4QA@B?6U&CYNC>>52M#N,"@9UQ_/M'_N<<*A(=51S94.WA)O80*(<_G; F]^ MT\T*!XB8A^E>HKY*./ 6,!YAS)3CP&!E704+@G"/D@LHRS88HWD2R/I0]5/' MKF];5\O4J'T=UC^ P7&5TI%VPM-WNRI)F+>C?/ ,[W8X931%N9/&UM88!BEUR/ !H2?[9"W MJT;R*DGA)9DF]0YZ1R@YKN,L*4]:9DNY L8VY%K;8_S&ZFU;V@P;J_8,9PC3 MA$4390G)>9)O$*:54/8U%)U$79_?=S#Q=*P+0SO-U8=RM,ZB5YN+@6VT"J-6 MQ53Q#F%2^WB@\RM)N.'FD+'^*6<10C ^?99SL/B@_:RGP\IQJ%5G[=Z-WU/Z MM".!S&D*7+5,8I?%0O%L1_8Q-JOJ@K%P6QB=E[E ;%%:B@2X3+22O\R%Y1>F MOB=:*U)F%9AW1!6Z&Y3]-"RJ!GIH>BC=J#CQ(E1 >87AM:/H8%6-A8H$&@)A MGAW*K@'K[U0.47$+AJ^=RZ4Y1O].YIC6PL5CQ#WFN3_2'C1]EY@6*YXG3TD, MT_@F*J!!\9\&57> ]7-Q[U"2%Y#,P%\3B )I$6P ZH"'C:EU.0#V>N QFI3U M;,6W+;7<)/EO[S((+\GRA R[<..30U3=0=K/Q;U/4EZ ,@.2&X,Q3)]4 '7 M)\?4NAP >WVR!\U0G/*:]E#^&:.HH.ULG^W]L8>@.R0[&7B<&?D)$>,**K9A M>N,PF@...*#412#7ZWYMW.;R.[FKLB+I -M461^*O(C2.$D?VGK2<3\]NN98 MZO!Q[XS_$SZ#A-_&/>3$)Y,4/$7H$(73:=4(7VRCWR5A*=RSW%JD9Q:<-:CQ M!D?N&Y"3WL%LY\HQ.2T_ %+:'F=#\LL=^/891EG^N_ ]KP&:HK=5"@P=($6O MH@RG+C+>/,+X@.!Z*Q]4_8@+F%_A**4Z*0NB;^ &)D^T/9=V'SEC%A:UL68L MW7NC%(2>X90OUC)9 !.&64)5=5[)$U:'.ELKP8Z@6:A%(._&T!$;&\0_VF%!_/IOE1Z'/+S^:7UHJF^[T?(3S.YQZ7F?Z",/=$U( MEO S'Z-W*!4?#W]^!0HS_?3Q\N[B'-S>K>XN;JV*1*7S?<3I)V^UK6RSAK\( M$*')G_6IQ1+Z,!)UX\IOKTSJ0M5IVCS*HL;#PR6R9MQC+S2QV%>/=E>A58UJ MXXQ-=;T43)%K.+WZ9R7-^PSGN7CBVL0K^RC9X]9-VT+$Z3)Q)C[ % M>#J,?+QK?@7S_"=0BL$>G8N%(*4/!N)X1FAC*V4O ]F6EY9@$M9 \@9=SCOJ MME9QZ",LW$X2M?=;5\?3PPE(84'OHD:FUJQV8U)6X9X=\@+O-"Y*'G_1\&)> MFY"7:Y&BMI?H% WKR>8C$<5H6I>4CM'W<[JQQY&4,)<BN,TG*)5)/VOSQJ +M!C^K28^@X#7A4Y4[SU#;?1@CFXKU$DIWIEVCU$+ X M]N@BZ*$0,J2G/8=1P$K*"5+C\AB)JE#I>DNA;?#\-EULVWEJB M'2_ZPO"!46@&]\_<>()?& ;VS.9J#7*<4)IG$8P!,=P!>(XBKAA324&CA$:A4/?1 M%KT\Y( QV.$,@N(Q2L';-_\MU-&@QD#66R#)SSWA7\.,_B)Z@&^M9OP&'8?3 M2XVN>[NJB#/;:CA)%DX,4\%L:/8_TF'(^/3/_S56$WO-9?I$&./L^3K*V V% M,[S;XY2V#?L(B_7V!N8P>X):JTMUFN9HJ?+PTN>4,P)[RCH,1]*&$9NJ*#, G,V!=BZ_&Q,?PN Z,B[2IP81W6_,AD<(>Z^&HF7K":2Q\21@&KMY@E.+XMR#0M+.0T0JP$,*(O5F[8FA[\\/8$?/_F[8\S^>=J\X]#DL'X M_) EZ<,U$]G$4;OIV!M1%UT?1Y*<"X@9&U \0L#A"\N9!]'J\.I^[86,3-O/ M2W0X*W ]@HQ7AR'Q!B8/*2\BWCS?95&:([;R?1\EZ17.M3)<':KVD(US\9#O M4= M[)1\D<;'$_)_'5((?GA#)^/OWTP<6^A:HX!7R1.,+]."Z"2Y1W"5Y[#(#?-G M58KF-JC&PXU$+QR*]4M+D$Q!H^AGI?QKH\%:M*V@R;H*V6"'6K>T'(JB4Y;9^=XZ[@@&HJQ7R, M=@;W![5)>P&XB]74[GO2P)G*$;P'#X*OYL7]FE\8T&K>W(8X@$N-119MBMSJ M,F.3A),+CJ)&H%V(S<0/EX0Q\@'OQ)GIIQQN#^@JV6KM0:G1 M\Y&:5/2]7'9-<,SZQ@9WQJ6%H%).V=;D$M!2R1X!9PHHUV#<+&?-T1VM^ 0M M+YD_H^WAE@[O#1]EV3,MQECM:&N"T#VK!9K:2JVFP- !4EN+,8;A.-)JLSGL M#H@6)-0/OQVY5B]U+UCV:5@YI>$+9:GJN/N5K;^ZK- MQ'I[@1+&L^IIF)/Y-U[EIU$.[_!9A#9, IK[KK=G)$U.BM53E!#F[.ED%;_U MP-2PW;Y+(;RTZF_V:X%"Q-K3".*MXR@']T1,4&"PD8("1-RP-V2G>&C@'-X7EVE>9,P&M$L).K]N'@T[R+G/)"D34'$)ZQ!_" ^L MH*@ =8\,U>[%WNL>]R[:,&_3/0'OIV&N_3Z:[LW_"J8QS (Z]QJ%!*NJ*53U M"P]@NW>T+QV?'26?>8Z:NT;,34/_;'FAP6H*"Q.&>DB2&$A>@#*S[\/J>01H0/C9WBVPROS< MYGQ39'NM\!C&Y*66Z[G/\CSG=T'D=\^X[M'?,BC M-/Y(N!40IJL=W>6(I?Y,O=V LJ%M:7/R$@^(%* 08H!4R $B+@C(I#4&%2/, MT<=VNE\6TO6P0IM> <$4^(@Q,XU1!!UJQ9(]D/P'QCO75LL=&>AZN\HRVD"" M"J*[V])#P#SEZR3HXV$.1!AC^J[*$P0U=H B5O_WNG@D2+&'E1I?"B-?'P80 M*^DU2+"D(Q$"[%)W#9%9]FQJ M#G2#[B-*I^PWIM1!LZ@QE<'M,F;7%]0H_5 MO_RN]\Z,H3E@2RP6!KWPXCIO]JI.DSNHLW>6D_.%_%F4Q=<9?LBBG6;FW?M] MPZRKAYZ7+%IL8FP(,[#GW$)(E,<@P2JJ"E']'?OT_,8J3]"&_O+RZUHPT*J1L+AP,DO9WC8"QE8<> MDC&XO#P!5]B M^QTMAJ?;#]JEYYW?MRC9[*#GH:*6<'E%V0#*YP103F$LM0?QP"IZ"E'WJ%)[ MJ76F])E*S5L#-2@P[Z'@3OG>BLD78_H#=>,#N@H3@0$'<%07?D?(7N$HU5U2 MMKYFNIYHD/&S(*1Z0X1'"(E:C[;Q@#H"TFP]'C"U4@8.EEP>1$4M*1UOF):+ ML%4:OS]$693JE.HI$K+:P^LG[',OM=Q882<5#X)O")ZGC!O64F/0&'5LN*X: M $FFKK9>?0\(]8QE51N+,T]OWB-^EV0Y.P':/$)-3Q\G9&A%8X2]>#I+09*2 MZPG84KZ@X(Q#<'5EX+"6'H,&J=DUF (BF-B[]C0#$*[=OES?&(LGU[Z%Q*)B M%[[=2 J_;OWM5&3900YT_.%-?+N]M2#T^WQR-,Z=G MH80=I[!B#NPLD]D2,I!>N;%'KR;PP]MM+\HF ^SB!6=8P] MKQ_F&3/J'NY=QW G6&+V8\#1)2$'YAIN## #7G8+TZ3%H MD(82$,;35_[A:T ]Z4=C+,YP]$\HY5'I\R8?08C'XU_KTS>7NHEX:H);4ER@B; 5Z&]G#0&4&\W MX);6 @6C9Q4QXQ-'5QWM*S]$7Y+=87>*LPQ_IKUBHCWYBUK3>3.Z;MMO]O'Q MUS55S-R[*(:R_SN"X,":1@>9@3X2#_5884O"5Q4P[6CSZI@#DKN0+)W M5"X>U",)1_7R'EY(>(EZ0TB;6R1MR@$5CR5-IW$<$3.;: X9#1>Q(1?N&&_#\61:-^I MS@4@-A+;*YZ ,0W S2Y38F4P+VZ(/*N"O[-XD<:V[M9+UBV(/6S\NU\B&(,L M:/<;0W?$#0?5NR D1]Q2\@:4.5@50#PW2OC/Z*&F+N@*&?=.M#X4>1&E],(@ MR> 0ZUG.%S#-["T\?QIS&)<>X='D YAO;B"])D0LP/G2?XBRVUC5S\G_Q)-) MWHTESG+V 13P'YF4QK2_+*Q'IJ:2O=9^@$FUS\<#W2U?;T6A@=*&M1(9)T4D M;;+3U/FDC"MU/U'KDX=P1*:(6W>I3[*. MBL$.\)Z)("'8G0G>V%3GT[_126(NY*^?FY_5U6FX.A^J:'JZ-4LO(Y^ +6$# MHH!>?Q]%I_>@KJVQ4)'H.:JC;,!* 8E0IM&Z17T\FC)-3ZM"&5T/2F*@)&>3 M[*R&(RWN.L,;"./\'?&%RSP_T$7R>DL;+MR)G@YN1O4$LWM<';T(KH"Z("AD M5)CZB:7N20)FFR2'UUE"-2'^F(N_YEH' X8,+%X+,F'HX9D[P8+D%YPUV%/> M8<1Y.]2Q$V4O$F$1F'@Z2>*08 /6&6!\@!0#,#EJ'\G+S^0#9Q#!YM,]IBT9 MGK1RYP6.4 ':<0%FG*^'5O#_2ITVB#X$.2TE*6&_@$TP.\@?\X)!GO7(XI M:?JV#Q+)D[)9:=$TM# -'EZ,3?"G_8&I .2_I034W*BML9>W4$A7T$S QJ8* M#SIT="ZPNR.&ZQ60KR'UK(%*=K2PZ!2"<+< M!KHS%F4$IM]1KM>TG!\R(B,O+#'?7^ZGZ&J/LX^#U[WG *NI-)'LW8L>UNT^@U&\3G^.LH1F*#>Z1<3J-%V!V,_#TS6M M^OP1J.,I8-GK>F/Z7 IN/>['V +.%ZQ3(#DS=YRZM+BID7.8;[)DSU(58Y=K M$'&%58VH=ZXQ!__5UQO!D_P@F88WR6L"/%)NW:?F98"):CAVE%=+MJ#B:S]+SA%S!SH& MJ 7<90Y[!-[F]6@N #@=';&GQYJB-+^.GND23?^Y\:YOVSP1U*;FXX$FP@,( M)H$$QGX(\+ARPE,WZM#TG _PR0K%#_QN>@+S&[B/GFDNF*^WUUF2;I)]A'C> M'M-*S7=)OHF0Z@T!=[SL7M>RX>VG U@H_N7(!K!K?2\=[]+3R6+WKGQXK9(' M5 +1F:X4"90RT5]SJ?3*Q":/#I_N,_84$6KT)[&*DI\7SQ\IWPS0\X_Q M-?/VEEZ7B*6Q5U^FS(D!D21X1R;<]383##E,:0"4HQ=W_GZI[MQ VO'HU9S"A"5"&7GSZAX7Z= -B&Y>N-+M(.*T=FHHRZW'\ MIS3:X:Q(_@GC<[($L+OBW$G,U5EP!W%+$'_D(*;P(2I@+/>F8)[_!"0'@%-V MCIJ#?4B[5>H8]I[9]ZHS7+R&CWQK_$KX9IPJ36= 5Y'0T7R%BPA=55'N57G_ M-S"/Z%1]S\SD%;7) MDORK/5&27_WMAF ,5U\2I2YBK2_HVTV#@(>'GZB=Y$5"]\X_P"@_9 'TV.O6 M,NY41A :%=,?HPI^I70MCRC5#5']N/WH*Q:J\_8.6=#F>'RNWJF00/3:-$HG M)^=*9OD+I,$8QJLGF$6Z!MKS93.5=A+ST6)(,@*"T_SV.@P"'M5/< I'W9J> MTK#%E6(]@VY]R4RO#2+^KH6/ZW(J\^U6->[51C!J1;H:=6>=_&T=3>ML?LE0 MC74B'JQ3/!H4D'5VJAKW:B,8M2)=C4[7"J_6/U]GYW&Y;*0(XULCM2:NB@"4?J[V%6X^BI M19O3[<;N+J?2_#[+/G1BLW$)(QI%Z+W7L;C:U.L\XAM J-S4"WQ[<8S M1T2_2/OA@HUW8KR>O9VD?R\C-Y\"KHZ/@<:Y3&CWF#4+"98'LCG1.20?TF*QT>,XD][G,K?2>W8I4MZG%RF3#J< M)TZ;JL?7RA#P64@'#D2\X\@0;.ID9$F#Z9,^;E.TEKD]W.?P'P>"[L43;5], MU*Q:!#1*PCP%["'IH3*C9 08)T!9A;$-/88,5E17H"B@ 0"<%!NY<(5S3.]B M6SJ#).(4"$[T:W>(%C[#+E%76;!8#+L%YS2S8^BWPNDAX P$;W5[+12"](/^ MMC@#6@I2]7VVKU8B$T+H,GC(Z)$M60:N MM^()DCMZV4QG,ABF8W'-<8"NA\;1#6X4-ODDRZ^,X\SU7%J@81TEA@P0LL9& M<>\IVB=%A"[^<4CV=&/D.L/Q85,(+NKYD08QTQTD!>)^-HDX8P E9[#GK.4K M34'L_.C@B+55&CQF]8 FN$A7.0$2P5(.!W/Q9".3TVU[#* U3/UBT;YWLI)\ MCW,:7:R"P1@9TQ>P!LGZ>>ZJ9!FBYRO"A37T%S T@WY>">#@M8$)!E--\M*^ M?/FTE2<[]=_)O/8Z/%=5[EDKC[8)VWNB=__SY73M'.$*1CET MDUEWD7*4HQV3GBBK1I1Q2.ZJ@5]?1MVGS,"Q:K129[!,F4O[&E5O)MT8HC/W M7Q>/,+/P^=[O&QI/#STOWLUXA>?18Y!@%56%J/X!AV5\[9W4J_C",[G56'JC MHX-"F#W1DC,JD<$I8<>W+R/Y=&O]GIWY=.AP)IQH$KP*;?I3F/D<3WJ3SW<. M7I+R.\<%,;OUG%]=)2F\+.!.JV9RG);S<[:2]J2'H90K8&S#/A$]1G'\5+2E MT= 1&S\=50++BV\)$=X1J,XPF8JC34&K'\X.>8%W,+OXLD$'>GM@E>>0_/_X M+OJBXVY&Y,WQ-&#GX;%AMK$85$)J@S)VH-X%(BJ<5KHH%0!("5B!$) R@%(( M(*4 1 S;Y/,RW61T]KU,NP9^E8@WG,\.60;5FM0;D35,I?38>$EHI0@@2<%& M(D?+WL!&(H>D'.173) 0\EY#X+&%YHWNS)]#+P:J2];T^%>+C9^3>KA, S4$ M'EMH?HH;68/2K.YS]D>=Y$>1H,6%?14&[A.<C1\X2=TTGBN!7&*;^X#:("D-C)MF# #V]/P/=O MWOZX +_KF ?TM;H$Y%2=3C"UW_R;(\FN3P2K.$YH*C,2_4,=BL"K7"=ZFPSG<0C* 6&R F&\S]!&RWECH)NQ]*R$6;.5164@K,V7XCC<+AK1IN3U@ M:4KCA*RW "8TI?JB/V134H;O>%EO;DJ.S@N;_%=I?$;^E12YD,1D+:].T^:] M2#4>'LX1I2$&=6JAC2,VU>52,$/=< '"%@B^,L&9;VEO'N['*#B#Z:M?L(_' M=!7-A8E'GY-X6';['(;WA?8$&-27UO[P\)S'3;IXGL0Q/(,R7=!UN"!V5(B] M>83Q <'U]F*W1_@90E$T>TM[S9P2K<=G>+>':[3!#RE]KON: MC>T,YT6NW>3#DP 6-%[0 M/EL/&,**;1B>H0,@-M#D L!"+9SH=E*- M(Q LY[O=B! M\4WC#U'V&RS(S\;^-4[+YOK=,&T/62N+?-2M=I)C&$ZE#!G6 M55_H\,@TCC-CKE2RF]N1W.2\5R;WKIRS-K<#QZ*X]VKG:?]5:'?!?!DB]HSR M"S,Z-*>]>8EP0D 8=RM8Q%^=P*5*T=PTU#AX.%20?$4[['N&]Z:.-^2\PP@: MFMAB,PTO T?4AK#792_&(/23LG?'-]I(^P'2-<7I<_61Z^B9_FKU.5]QG.]5[&\<'>(O-T+XZ'M00+ IAS/%%[5'"RY81'<\(3X/0" M34>N7/PT8:?B#\M-\'$0B/Y C$0EMR314(#Y3M"P^$?:;G*Q!V0OF2S:5_RMY@9(3E>X+L7RN'QQ)^;D[ZV''"W]VJ?.DMDUP%^1 M+6HLL7/#-79IXF(4K1@<6JRU 8C]\3PJX+LHR7Z.T,%MO'4M6BA;1J.B3A!W MMX07>*+,:&E=7M^H?,G[E.H&[&T/4Q']K\Q8_>]]'L5E]@E QP+H8 ;C=4M MC3PK_O8A29/=8>>R_H7(>X]+5Q8,[ 6-OG@6E#-P MWVV()9PG3TD,T_B&F("/#0+.!<2"#7A.X%#MB#J M*:CB)IGQU869(6RJ"N>A"IAP 5O"!B2"#\@(HX5/W-J6YV*JU@/QQ5N9L^FX MFEE!37# +)>*#J3LX&;0_XP1(4/;%_'\;C7P>,.9KNWVH'2DQ26 MMNI%*H]AD?QR![Y]AE&6_RZ@8.C7Q-HQT"-H+]>9&QCG,Y>ZCM[C%*&YMEUT1YC^2[Y:Z92C2;2S+#UGZ32^JE M5R 3\55'77Y4L]?[9Y#7/K<7!AO1T9RP!XO)[)M4 P*8/=]7D"&UJGWSUWLY M+-J=D+=8":$7X7P>@>>UIRFZ)3(Q[PAXJR^)5I%]ZXL6%R?JA#S<U$=0RD5MO8)?*?')KX4;G^=7.DEC6GKT,=K!<[R+DG2:$IPA_G/4 M-_3+\_*]T:L5.2F4&4/G)5J,N]*76I2B=_&IL(!*"W[E\L[0+Z;($KI:8!60 M1AUBN@A8M1DY)NBE"XQ@PVL_PW#_83BPDI:"5#WJUOIL/5R\)= ?P,O="NK<;5<1(#WO%:SW&8: MJ=I\P=J9V"I%?6$YF*K2\,6D 3\SK]/9TIY>IA"#;E-&+ZW2A?=S3B]]JN^Q MPTEF^BXL7[S-S1-1^1!>8!Q]A[,M3((+I1UBA6C91V+Z#*AG=.F$7GY([3?) M2:)J#Z9?@_G-$UO+4:B$UR#T[G$GI7KBI+V/ LB?E/90 BT[<7(_,UC1EU*X M,M&5N0 K6T[ Y_9%4_9A$--;=M6=TZ^R D;K[FF@(DY70S/!S!+&;7:G\H:8 M0:G+[^NX1.WJ[[^.4_2<8MJ3EG"OS0?G +.=STQPQ3[H>='E 8]JS'H)!T O MTR_Z3XBL'65A&5=SVT"%./9J#F"^,?8TG68&E6D:V\B^C#^.P[&N; M4L2&]H% M9#Y1$_B$/U*9P3SS21?V1&>G@=,>;JG82?_LO;YS@3I *=8N;^\ M?9;V::+N-J/CTT:BSAU.V94$^NQL]D04D!(=1 FB;Y03N-\=*-J7>7Z@_$1_ MOK/#[D!;BCS!RW230:)UDE%LZ+G2 URGE[L=C!,R@NL,;B 5]Z\PRHC@-6Z4 M(..U/A1Y$;%!*1\T!B:UX1EC4*/P8HV2ID8(WLG-Y*C!%N<@2T;)TC$ M0,&.CQ1LRJ&"1(R5'AJ*P0)".I'#!7LY7D ;DP#:.W%39Y^P03/FN!IV"(>* M0=G!T7EB4-*I'"7V1+K+-"F2" GQ>('(>EOC=PYI7YLDA?'I\RFFK6VWYPD1 MC\0@I?OX+K@81A(KKEX\7TA4>G+*9*)MHQM.&9=RT2J#>RH9_4PL90O!/=T8 M#G8'E9'YZ[IQY;_H67KP.JYFRK@2 M-P0_\F6!IA.5$L)35*W4!#^+]DD1(5YB*$=Q)+G.WI0!?3")Z&?.G:BD/)JH8OSY(2/!CI^M\[3D8K='^!E"]B%9U,5> MV71TFH#SA/I"5Q#*>6+$YU-WIS Y'RM[EXX,E?W.QTM C;'P%OST!5(V*B>C MN<[P!L(X?T?RUEL^1O8V*HDN9 HDVB51J?L RB&2K<%'^2,9-!<0T)5# M-7&T'-_V!$CXT&J'#VDAQW\=946R2?916IQ%Z6JSR0YP59PG^89^"K+7C]9; M>C[U(/3&7+ VW@]R)X&4G2 :VB,G'7MOCWAR!?24DV$0IB)B8("I( MJ)>"LA=]Z+>*1W&#:L<$#NKPYZ@#?KBDAAL.<\<[LM$:+*79$9EF*%2 M8T0F]UF:]-C:LK? 0!;82_:=',0LHP PVCR2 M[VXA^]=>X2IV\*5*JH;KHOA(R1A>JI$Z*Q"2%B[%!75Y1]Z56>JTW.7A<\S) M2]0=:JJ-RT777V+'MB8:K;\$7#BP*D E'C,K^AU6"L5%7%91.Y+4B* M7*8C_#/$=+=)EA>@R")VW!-'SVSU$O9*Q*^QNG@"3A'^EVN8]8AYKQ8P[SOB M96G33-RCK7\A\E*R1-6'FC\D*9TE)DD:M64*Y,76 1DG>TW]!.PXQX!BXY1V M.>7KZ@ULOQ8;=)9WZKVU#CZ,F?5"XRK/OL.*JU*FD&V:RSAE7.4-J'=NOQ09GBZMC9AU^7)6O+U>/S8>0L8Y(%8A=#TKI\27W>G7-4\G[)6>O M:E;J*\XJX/SU6*3O6%M:>36&%Y/$]L SSW3S"^(#@>KM*BR1.T($6\M["S2%+B@02C6_0(88Q+?ZE M>CCPRLOU]B+*: OG7)8VW]&;"%H!U3%G"Q-U*HF'YPB%?'3SOBXAJ$0$4D9 MA00U*>F7I)SLC)1;[*],UH%7=2>-I7Z,$/N%^&49')K1UO[_[JYFM6$8!K]* M'J#/,%C888-MC#+8(:>P>C3,F:'U87G[^2>)[32I?V8[:BZE)"#)_CX+R[*4 M))[MGU-;=O,"[G\;IRXG6.7A&,@*W84[AJW3R]FML M^[:)DIW-@>P*KA2R&YD!S^H+IA,)'2C+ MJN3JBDHJS+VBC+)4V0CS!?%[ASY+Z8J0<&@6A<9?/$-+4TK492+]#A&,]6.' MBCC/'EA8^J6B*DO$29G44U12DR6F<[0AV][#/XKF-A;"2"#' M-M&Y%B_,F>"Y%5Y%#F#<* 713\DBN8Q.:E"X&I.D 2NXIZ\IE\@(F M/-.$7?'X9KR%/B)=N\L-#K7 MGR+N+COC37B:U4M!C.26A\*T2=->G:BD[PK=%'Z&:[X%FA@-8<=L_M,;E)MD MPDPV,RH)DOB"A5D*BLGMLL)QM([H] 1P_' @K=I,NK$ M[3LFJ?K6!HDOQC>M%^:*Q;TWI?IBD/H#AO@W>S@\8C^\2/GN#U!+ P04 M" #N@@11(%HPCA9( >= 4 %0 '9A<&\M,C R,# V,S!?<')E+GAM;.U] MZ7/CN)+G]XW8_\%;\V4F=JO*=MT=TS,A7]7><5D>']WS]DL%34(2IRA"CX=L MO;]^ 5Z@)!Y($ 0ID!WO==N6D$C\ "02B3S^]=]?E\[1&GF^C=W?WYR\.WYS MA%P36[8[__U-Z+\U?-.VWQSY@>%:AH-=]/N;#?+?_/N__<__\:__Z^W;HXNK MZ]NCB1G8:W1A^Z:#_=!#__SPXU^._NOL_N;HQG9_/1L^.KK 9KA$;G#T]F@1 M!*O?WK]_>7EY9\ULU\=.&)#>_7OLV)7WN(8-^<'1A!.@H^N>WH]/C MT^.WQU_>?CAY//[VVZ>OOWW\^N[XY//IUR]?_O?Q\6_'QSD"?\;#.LK]\]O1 MIW?'[T[>??SR.??%.\/\9DA' M^G^.KEWSW='$<8[N:3/_Z![YR%LCZUU"U2&X_>:DX)$Y8#.:(PZ^CDJ_07][FW[M+?W3VY-3,L/O7GWK M#4'CZ"C&P\,.ND>S(_K?I_OKK,^UL<+! GG+: 51^(\_?SA^3[_V_A$M5PY9 M/S?Q<",Z"P_-?G]#6[U-OTR[^J>B[P:;%5GRODT^(0-_+\Y-8+QB%R\W,5OI M=DC_.W&M2S>P@\VU.\/>,L*TCMU[0N@GA%#Y6%8>67]N$'V;CGZK 7H-D&LA M*R5#!]#":"-V4H8<;&Z-GO;FD^ZBA>,C\]T:M\ JE>;.W8*<\K?A\AEYO#SNMVN!N7.RJB9$)3C' M%O=JW&[3 E.Q&)M8%A&@_ATF!Z3S_^P5A,4J"FTS_$ D/IIZ=QY>V_'!#F=Y MCT;;3-,YG7J/^,45XC??O&U6D_^0$Q6="#&[3: U=A^-UVN+R!A[9L?J'&S[ MUQ!IC6VB1&./",.HMV@=GN/0#;P-?/_5D&IM"%>V Y2U^^U:Q)<<.$9\MS," MXSST/#*_4&"+:;3&=-)#?$I2'8E,9NC#F"ZCT1K3#PMR5SS'RY7A;F"L;K=L M#U6\7-*-@3^7]RVQ>MA/'.Q:+DB?^/>1!4$6F>7+K0&S.::M\AJ# EP/Y4T;H'- M">G&BC!Q#.ZS=*=1FS86P@G8KA*U:4-*XC7R)L]T2YK^X;L9-OO%\95 Z_-1>VDZD8,P\O"WE)>L-%\&'/0M[O;TZ. MCT^.WQT?OSE:D95(36N_OSE]-RE;$8\$I7< M1]$W^PS'SAIG>'P:)AXE(HGA\FW8N.R=*1DR)Q]&9'94 X;-EV%B4ZS@9;"< M#E3HEFCG#)>!"M_R^Q6#9J#RM_"*G*'R8:"RM]"VP5 9M-0M,4YEZ'P!#)1/@Q;$94\Z#)Y!2^2R9[H,GL^#%LGYYU8& MR:!%<W%Y>W# MY07YX6%Z;R\.)O<3&[/+Q_^N+Q\?'ARC="R Q9/5AG?UH1P9_%N0DS7 M>LNDSC(SPW^.YCOTW\X-8Q5Q\1XY@9_^Y6T<)9NYSB1__GEC&\^V0\0W\B>N M%9E1%]@AJ]"__'M(%AZ/1PT_K7K_G^8C:C:&KKB^1X%!KKK6I>&Y1$[Z$Y.< MKB$-/;4NT,PV;2[?)@@U%:/*]3NE6X2:H#VT0$1A6"-J+EJB&^S[MRB8SAZ- M5\@0P:25C->R[%@\WQFV=>V>&RN;7+AR;Q2@(7)04S&J7(=_&D[(Y?M7WE8% MQW?IT2C&=&'S;F07Q+.1AXJJ]6(']+"CY\ Y=NGK"G)-@&CXC^9?K]1:[)G]@%@\5)6AC=_Y(M*@;3.Z3=\;&>.8+,:]NKWB= +B MJEJKX=I%_G1V3L2<'0CQ7=1>D5;AA>3:TPCV"B)J9*0;2>2_[&!Q'OH!45>R MS0=26&L(*9H/^LZ7;CJQR2BDT,WN%3ESJZ@H'D7AW:OAF&IH*EEEOH\"T$&< MME!V!L<=-CA^]PFHX/TBT7;C6Q.Y+"5L(- JJBH&,6U&QCNW";B(^OX\M5T M0FIV_(ZQ]6([7,ET8/14C$R$>[4(5\H+- MG6/$R:B(A%O1NP=P%U3342[78J=;=[9")[394OTG4##:Z8CA*-FD@-:B<@_Z&;;FTXD>4@ M.#<\;T-D-MQTQ4=0^9X64>5*"*CC79QIM=QF[S3369:E\P['[]MBMC@>>IV] M4PH-&Y=/$8M\TM-?I&91[R&SM^-8N(^>OA%\$@N#I2P+Y-#380",6_6!R^ : MPC[D@&M;LV(A'GHZ;X'AX=*<&6JC["JZ,3%\Y#MYX?9CRV28;7$.1U%5Y5MFF&DIZNN?PH ME3Q!L"B1H8OK]$&)(2)?./?IH!>U"O _'++X$KU%.OAYMAC-->=@$5AZ*U4P="J\2!A,0F#V:)\2ZS,?8@!IK?:!0/LIM!=C&$URJ]J ME\ ,J5/Y6EB?=(Y&)V6A"RA#;C!2'XQ:/93#$"J-Z,J@T?PF"[\[MJ"V&D]Y*+0PGG@@]AIS> MP@R('#1\,X-1\TUC!;5O1Q">HN2$:B-8Q>J6,='1W%$?LS!M>^'N\L .(B41"?\ M3\)@063$/QJ.(4]&\3C(LIYZT3:P(I7Y#GD13X+C*2>G/G]"H\U22ZJK\<"W M3!65KD8AMG'J**D?C8SMPTMQC"/HG<< []3I7@%-+H[[&UOWBFEMX)>*>-VK MJK6!77$Q#DV3/C8%D$O]T[U*FT00*\2?IK7B'ERG M%K&'1_+O'Y>WCP_3J_/IC[O[RS_(=Z[_O+R9/DA-\PKKJ*=V,';YL2U+FPGW(.W^@(CVH.*RUKZ>I*>L@V& M64M*D5EJ]S%-),5J)1EE294*N+C"'EE-;NP;9VZB#/2T4A61T:X5_>;$AX;U MWZ$?)'%G$=]WM-07^2 (//LY#*B#V"..+=(09!0S=@A8?S=LE[[83CS;)QO@ M(O3(O^-:A2)K3PD[7>*:?]VNF'P16Y&T+E7@0QABW$%&N=-0V5S>DN-]A6B1 M,W<>,Y!$38.GJ(*2HH1IB&@_@0#[>TU5)56*A68,5LH$C/$R&BI&4"Z\4G%U MAF;D.T!9"2*K9$^7+6P1:<9!3,G>W^8!*JT*FROE.T%-C&O66$G"0^22?AUR MHD^LI>W:=)YI'5(!255+2LEC$'((S3EAXH?A_4(Y0$%/0!54%"5Y1(9GTFP] M%VB-'!QE=! 82 VA3G:%D)Y53D3)+O&($+GS\ Q6&V2KF9K;J$]TSGLRTRZT M=L160S5K/.H,)"19&S5:$#T_,KN2R+HM)=&Y^;5N<+@(=?8B\EEKVS0 G)V= MP^S/'T>$"J0@2\IWJK7?+P"?BK.-Y98[UGHUU>L(F%NG8:G!])91(,RJ%%J6 M_TIOD04"K/8RPW(9R1=D!XM:P266)?"1+\(.7>#G#10,IZ\C3MSF*):41V]A MSV_FR^$',E:R]"!ZRS,A),MMV2SCA=X:FB!L.V\7#"UY0NY;C):+YM2%[Z#Q MJGNJ8LD:])9VD#-B^VF2I6.0K\L>Z"DJ[8F:1=?K?4+(=B/@F NIKA8L"%V^ M)MFG>9*P!UIR(F)AV?+E](%*H4H'MPROKZ/4YG5NS##[IK:0DDX M&Y#/^,/C]/P_HG_],;VYN+Q_N/S/I^O'O[7E.<[;W0'XC]<.186?0Y- \;W& M/QW[V#E5%:Z[G\<$P/I>:Y6\'YP'98D:*Z[WR'*.;<*!DE)Z6;_^(R[)/19M MHV?#1Q8=)!EAQ/$](LO2)W+@ 7EKVT2Q>GZ/3#QW(RK@ZHCM\Z)LW\=!;OE[ M2RR+6'66Z&N3%\.SHG=CL&P0Z*'#T4?XMSGXN@ZJQ[Y_ZM.__*3=&*Z)IK-< M,-[3"KN7K\@S;9]\\)?AD4T<^#'X/ ,1I=SV"+BWJR!A>?RGA)LQRZAT+A4N MB1*(-PC%<=JA9RZ(@*.%KN2)A:HNNI8+I;S)D@L5'0BMRAH!O#(V<;SO+3V9 M3!S2NQ'FG,V&'<@<3R)36QM./?W.=V;TX32Z%/NI9 ,%;XI0[WH_MC7H*N*= MS_0M>HD^DB=R^Z6R&Z.K[@:B9D_O,J:#0E*,KPXP*&8ESM$M!R&C9,W>*@IF14X;-O6[;A;7(<35YMV+(M)Z(F0F0[XS;_NJJCH,2" M5)]V'3X@ %'%25E)YW%1U!(#%7RL L05C[G1F%3R')^4=+%@EYQ"<+%60D#I MR;O#@P^69M6$E([E,:Z7)/,QH :2K[)2F.%:P!$,.)5J%C MK]X"C!M#@ +.L-,[KHX;N[+;V%"BRCE.R?(+]_8)>:HO2+6&"PRSMK"(?+TC M= !V+%QO>6.HZ2WXFZ&V:T$=2O8'@+Z?LW@/)9M!Q5L!9U6\XX_2DZ:OXA>X MP/"" \.I(LFW_**[APL3WZLDRXXQD.SR(J#MO5,SU 92"4)XJ96X,;#L!@.Q M[X@ONUH$A[QQF[E-L6P10][WI&(@#JLEJ/*V2I2(:L<*??:BL>EJ7/& 5L>4:H;^.6KPJ?9TDPI.LXL4WUTNU- M5/(O;\50]29GR/GDX8^KF^E?[=67+.W@ /*"%#"O-K[I!!Q)D[5K M&(6+"_0<7'C&RP5^X?(W%B*KQ.L[5H>B5(QD:D-: ML-[\D=P?*%.@X7!0$]+(\X2913[O4D 6?OJ(1LM6;9E*N37TIMVHGK&' M!?:"IA.U0Z2[51<;)I[(M=8CTI]L"WN-"-YIGMAM4RTX79*\/M7*E^P^VU# M%-'I;JYSKVS-)W&+6+_..*%RQ0+4.QQU7$1$]LE>2%7ESGO$$Y/H3D0,A+[M M(M]'<9;\2,N*/P%916!T.QDIF8,5\H(-E7,!D8)4=XR*T#4:9P75?JU:B7NU MDGJ'H\Y*=$G=JX54%56RW;DT3DS3"Y%U8QO/-.Z'XN[&$8T9D[G/8,; IGUU M@\@Y=J-U1^W+YZ$?X"7R4K9 *:K I#M; 3BD9@5C TU&P4&LFS'=>6AEV-9% M\N26EEQ*5MN$G"$PK5"TAVY&3X6I2P;3>,-N$>IV==XC$]EK>0LT3Z^;D64R M+WG^$2PKSDU52:ZK)2V'\X_H\A>;:"YL/P*<[)>E'2XA@^,@IF),::VEJ1O' MB&ZI9T(:'R]%4W$F1U RYOD6_7KUB;QKMKYW*C.02OI?3 ?OP//F%C8_-!RYXZ9:O7. M5'NP>1U3+ROE7#Y$G>>#J0J*]&::D^:)[3I;6T5!\T#^AJ)\'2 M!\VC.4"H5>I*#+*!Q&")Y:0:=&AODYO/4+)Z-;ASXN*;,D-.[P2U>P58O8;M!<@=4OP_FSWE)"%^> M5R>#$"!K'( 9K'K?(%I8GR#'(HA*T^Z]O/\;PG;R@ \EAM7]TN ''0A89P, MVU&JBH7[LMS#@Y2J/('6VW;NNJAQ!JC>JJHD0"NS"K!LQ+I?_-M MXE$LP'#?28+"@-3;(- ,2"DY+> 5O+],8CU/L;X(%:=I9*A+_]D.[P%+BG1*JM[H/?A M)C<1KJQYR-=3D"ZU>UBCMI^SL%_;0KIX/]3:%KR9SAET>M\ZH-GDM]XE=[+? ML_H@\LVVFF#&7_H@ U/S=S$!,(6*93 \-5=UQ1?G=F44!I@""=ARI1_J:.I@ MGVRW"^2;GKV*?5#3![X4C,IB/IPT.JO74\>?@@#[M*\< T1-.3-\VZ>.UFSX MCV2X9PXPMZ\(=15I!:;>W' 3OV8B@GSLV%8:GY)G:SI+S!R&DRDK0OD')'78 MN:B2"QQNME(R;]1C!<4$E8F[AW"Y-+S-=/9@SUU[9IO42R3V;J350PGB9BY9 M&J?\@Q'M@4#D9%A%"I(J!H2D(B]%)>G']A@02B)60:5SF<4Q1 R?'#V%3RJ& MS_'RF0CPZ*T/*&JJ2/1 L!2RIU#1RO7+F&JD7-515"%&BE 5$235=#H7)5S# M+-!JZJ9(3V%R9=A>5%W[!S+H[TN4RY'**4TJ:?1 G!3SIV#'91TS7L2TD1I" M*J1'$0LBTJ.:3N?2@VN8F'MF]!0:Y=G4.25&73KV3L5% 7,J]E?JJ\&Z%905 MU814R(IW"^9P M"@@.2CT0&%5$/I+LM.K!GDXY4O*$$'5%XZV+LMT)*1#\ M--4\DE1R(_9PPDFRLK 6Q35/+I#7C1XH/ K:=T#J;?+F8IZNH;GDIMVUJ>0(*L@HJ0F\$[W(L*G MG$;G8J5V>)AK)O04!8DDO#.\8).K:@BUH-21Z8%P*&51R66EN.^&)ET06367 MLF*&Q&YC=;0ZERSHI<< Q[A.G3-V/T_ M8F,3_UM(=,%IJ_&_H[6E'HW7!B,KIZ'H1:WPEM-@0-PD58R/YHR\"+TT.CL2 MLWYBTZ)5PLC6H1_%O$%&"21?71#<^0U&48E&87&\;UUV\3N7T5,Q9@>D#.[=LE) M2?/KW)-#V5NC!J/B(B>TR\EI9H5FD#S/B1R27&24[.HXI5M=RK?=I)-@X=NL M'R7Q>]A#1"\[ITFQ7'-;VW>MZ%,S\M[V?YV3RX8= MT)]@0KZ"C(IQW-%+5)P9E0@UQ_#]2-V.+HY9U=%*E.*:^Z2#U#>_D*#6\ M'0QZU=N58?9AQ PJM1EXGT;P2L]MAM*7$:4&VAK#\=N(8P/=/ CB>'+(L2PW0\9SC-D0RR\4@!6IDSZ$['4P3T[," &\\2SM)R6&UWA -'%7 M8S@J.#9ZYKKY&*5M;,5Q'8T%\@*'41+BFS=V&YLX]EVR *, M>!%[@033%G.3R[HIOJ7O%1F$CTA./^,3GG+-L^F4C0][A68*\,96^MC7:6T0 MH<.LGE /CJX*)A76TYB89/OZ\97'PU?TS2KW=-6H; @W:27^0-D>2RYY_T#6 MM44FFB@-R(JS1D8,DWU"Q%BZ\^C.]?UP2>_8S<]M25V/]5:D"6IHO17IVL$)2];4)7L_]#RBW9$O MW&+72W^-_-MH^V1QF@O7_GN8W#^;U0[2@M<+<>#_0\AEY M$(9W&BK))$%$9;"AMEGL4E\9O#1LD/M\"0&EJV.'!W_R:HLME&)"2L?RN%\< MB)/YI.58&TN: @*MC;4[%4R_.-5:42M9O$7(%.^PH3@B\TDL7"M=&5Z?M<:K M^G3"I2KUO@ -EY.!V*.7\?#0&=?>RPJ:-BNNJS4\;C#PHA"%\TZ,CVX M99:RJ-00F7)!$T[[-]B(G(T+*O U-#H*=#.666RWS&*CR=$S*U6N:*&0U"EM MWP-QL\^;4CF3E?"+XQL"&2\9=33'I-_ Q&3C,[0#?V&NVQ=;;Y8?PW]LYIL%]C+4>T-[6OS[M,D[%)KBH3PN2T177([H^0!-ZRT*G9S[#7MP1.:84BKU?QA!Z$5& MJ.F,!J \$HXS7AJ*?%[:8XE2125*X5.CIRZ>54@3$1_%C7L@0G884RI&HKI" M"^R0U>+'SRG4;I1R-/7B G8-Y0FXD[%$80C*IL&T/ M1-(V7VH2$.Y7O:.Z<>[!K4&@DQ!Y1=7$C/G<0_-H3JD/, ->M(8:#\&QHF/K M[S;"%1TYIW H5_$&2 IM>SUOW=%A?>?$SX'%U23%HGRA='MPNO'SK%87STHA M;B=#2,,?(TZW B*COSRY-HT0">RUI%C@-OA0:Q+?*P$Y>3$\ZY(L.;Q!R?2' MGKD@WZ#+(///B2)J5BQN3@:0/(+8^)$>"1'51K"%*== MC%)X-$11.A-*,"SFDEZ-YI'3V=FF>'7<"(4R2.A-23A!?NG# R *FRN932.[ M[]X:2_)C+I\C/":"AYJ2487/OFW9AK?)<00.CB@GTI7,+]D#?MDF@,=4R.MT MK%BM><5JB6ME,/$BTO!* &X!JM93 A**WN90EJ M[V"B7>1=2 I/-^FWM*&DXF][8EHP0K"IT5S>JY@:R88VI;G'E5FO;U%P@WV? M2(H(,R%+=26-'EBEB_E3ZV#M!D0Q=$*RM(@@-Q-/H\M7TPG)(.,7F.4J#!(1 M?FEXKNW.&1%:3? _D'YUU):5EL(F3Y=.E>$XV(EOV(3$-+[$:' M,62[[1PX6'DY!Y(1XG<[(3B5[_O*5*CQ\55]+&@H6VB5RY87* M)7=.UQZ-E>7FH;AQ.W-&U('IK*A#^F@MC*+L;I6]I?F46Z)E$ST8I<<%^(FL MF(A83NL=-5G=JDE61 M=;3/:LS"+7J)/@)FX.*C*#23MR$UR4UG?Q+8Z&V7YDQ&!%'R\Y6#7QXV/N]S M+(B<$*^71+\*-O?(=DWLK7!<<^1OR.!Z1JVCH&)MT)ZNB#C)Z0P\"V"KF=BY MX\T-U_Y'6J2%E;TE8NTNI^),9UG!S2Q!C+]_GZ\]K21U)S36_XLB.8T(H26M M))JYNE'EVW W_"_O('("Z\?W@MS:(;_MKAORIY_W:)5(L+Q1D4 !71Q4)-:7K,]T% M[E%2T'A,JUEWNNN35O/Z;@I?,[E&H^_18?H>M:$C<'L12>M*Q3PUXE/$)"JI MP\[MIW*!PQ*7C>YN1+*W\N@\-#H/=>8\E%,V='<9:G/?0O)+GVJ'+$QU!^27 M/M7S!.&[IN'*:R3#Z*/6&,'$6JW%((/MDYZG00M"KMPDM"W7/FH'9JTA#8/M M?1EDG_5T!Q6SIV*@)9BAJ.(^\9:PNT5,\6-@O?QL4N ML-C+_:,R9+^-)R!T=O^L4 MXY.3$6.!DX[#"S]#^%2K%'#A1UV(/P% F#45+!B P&/1JOB4@^0RZ:V<#J124D>ITW*U^G,8U;I@.@4;,7 M]MJVR$*X)_(!'#/0+C-*?'A6B%I>W'D48D_D)R1JA(.(TC'<( *V?Q4&9$O^ ML%U[&2[3-#RLMIW0P#@I*\R<>X^H%3Z^$4?"A)Y4SXX=)X:%#)*3H,*Q%7*P M%0*8@$\K'(!6JF '8E% @>%:9,/G23WB--4L?W1/#9EFO'G8"LT@R8,WZTAHEA*R.\22,A^; M"W)(Y-8L]ZP!J:J8Q5OLFG'=P+CF$61B]MLJX3@QL]^C%?;H"1$EW@#Q74)! M/??T['I \R5T2U11$9-*7&KT_@6N5DY!Z:K19NW5*BX*_@<1HX3^'!YO4$&D MK>BD1-A'Z;'C?$X^+,*J@D#+/$^]I$-(1%5Q6Q4KY,Y#*\/.E&EJ\Z5WTO.\ MM(,O&0A5%:,\,QRJASTL$,UQ$V< @\>N5%'I:A30D)5R&HK.X">!Y;35K*W] MFYPKWQ&>>\9J002X Y,Y%01:XSFU..8[A0B>"@(MGJZP4"40316KN,#J)A!H M5$6ED91.R/R"; M?M1]P ?/GF&:V6M[O$\?&<5+CD]6PSBZ9.O MD. 6K->2AA*J4ZMKUJ"UMQM/] P: ]PPL-C]B 7R:.Q+W>#(++X[#R'TI-+B M@&L-(;I'B/$9DC"7H8MAI:=2T603BID_&:)Z'@R-C,V8SP#.,-38Y5@ZANP9 M),/O@\:.Q3+PVWO^8L@-7AX6(B?R")IA^E'/"[ZLU=CPE9S!K+&_==.E6^-U MP:+D!V_&X\"PQ*F&@:BQ&[6$_2[H3S6(&'!Y\-:YYC$XQQ._"DZH.V>&ZY?Q MU.?"==__=Q#9!B1 J,"=O,50S<-[7JB7((4N0<"YT=VI10R\\GW*\-+39B"^V&18!%NH](L#P^FSQI5] MB^A(SA7VJ+J?6ONR['IMJEDB#!R,;@4:G)K:&45F7<*X%]+%S7]455/ZZ=C' MSJFR>B 5G*0F%WEC8Q2['UWRJYTF3I(WRGW*W8]6WNA&I;"3<[IN4EJLN;N* M4^<%AA</ELNU%',A,6B9+O@4(,9EU%P.0^3Q.3W/S\B*M[Y-"- M&+TG00YD"%4U:@;IG.R?*]NU W1CKY%U36;(*T:SQKF];*$[K//'SKUJ/^(SL=Q.3 MR]D_^/1BR1TJ"0C>Y[:,5_;(YY\OZ(_7[F1)!7_I\++[Z4G#S=$.2[+6TP,* M B?B8CI+SD)@(B=1RDK"^Q.-YA$GNS?E$_E),D?^J:VGU?&(HE2VD;DOD522 M1E= 5^7NSATNE[,9,@,B>:GS*%U5V2="FY27CO8$D8>&CHV(DWY%+Y)4S M<:V)M21G)=6F*;+)0S\\_0$G024%:R.OA2Q,5SR71@VA#L<"S:A12::UQ \F M<@UR$[K"'C(-'U SNZIUV]P^N?X*F?;,1A8PM48Y@=93:Z1]"Z75V&XLEE(# M.Z'_ UDTR#LI>P2LD%Y!H2/)GARDNV6>Q,3[+K&NQ@3-Q%-&0HFAW5P@*Z25 M\PK8\,\VN=^XD[6(T^[HKB1DCJ^FT[DYCVN8N,EDZ9["I?$6P1Q[?"A^+W5R ML@:K'VH7^(F)ZX]XW/?V%YB%"H.M:[IG/&A9[@M" M+HMV-6J55GF&HY[97T1QA+WDZ)X.H@44=\K '7_2,WL.%#G1=V#=\T TE8>M MNQ*PU :#,\: %K*@)PR#=SRG\NN[F3\5RQLQ:E$U4J/4.X\ECM"IS&;1$T 6 MB)16+8]*;$\<)[T>27-7!?;44\]5WE%T\W#%I.NU12"R9[:1B8Q4JGS'V'JQ M'7JO3<\ZZMM-$W@@B^C!#=^\Y+#0T<,?#_.%3.?^H@"_>A8.#;^+1(0^&J\] M@+*,FT-#-4D;GOL@'5F2VZLK@#D8.WRLTRL=N3!#/244,W9H6,/K-+;1^Z&A MMGN'B"H+/));<7H<=P4H!V-*W',%8%#+H4S0[SR\0EZPN7-H@@+7HHDO5DM@ MWB!%#!T:MEOE.K9+>J05/;H580 &#PW[:Y%G+SL,H?%P;$\\USX!LFD83\FV MIF&_BJO\(W(O\?U L>;PRV@CD*>?R6;[-1%[SD@L%DC>(3E.!*_;71OUCT?T M*_U'VPA^VX;\<8#G0+W?,\-=P<';C\"# NS)=>6*9H5N)6UVLX[['I8 &U0W M[[@I0Y>&1^L*^W?(2\N+VN8VT. 'WAK:';U<^RE;9)/'>0AN@#EV 42['F,# MW_)*T&6 M[-UAU*;10*$-8*^C3HMW4=P9O6V?R"# M_AX%MDLL,R),OP=J$9QW%:5M'#< MKD3F M+K'[$&#S5[H&@-ZN%104XAOU#W=O+6JMJ()AG'@LSP#4H[6"B-!:F!!:%J7W MB*_(.>R:Y"3-Y4P!K@M.:BK0OD#/1+$B"D5(>[XUE@*.T.4TU(\ NE"*6JO@ M^@=VT>:'X?U"P57H6@#)4D=!!?=[M:%WCI3BO\+'V*R?[LYIZ"JLHJ)B%)D* M<.VNPL"_(3=5YP0^795DE(XCK]IF?_S#1AZY>BTV;?48BZ*&K MD)=B9[HA./ZCBHK2.6*JM9"5K)I.YU8*KF%BOFD92G$$C@6.X5MS*%41@,*O M"$D^23Z4@@EB)V<1KD5G_U J*, V=976IWO1!(#^C&7=!UC,EMY'BY3;&:Z_ M:0XE_!*VJXLL"D,IN%!ABRE%*&\O&DI49:W5#<,LA4,)K(3MQ HC\/:&_*PM M8/7&]/UKV9;%GZVL0\YWSMJ;0>%# M[5"B @5 ;/K.KS3BKUO7&):Q('*RCD;E/_DTWNS,,^7:1CX@>%:A+%' @;$ MO%U/2X6QOHJ+W%Q%]BU9H]NG.R3'&TE/Z3L81H4&_L0.V[_Y *NH=C%*F@"!FJ\N[+5M$<$K9Y155+L8Y2,9 M _PENHI*5Z. /C27TQB?EL>GY?%I6>DMO7PS#N4QN5:DU: UM+=BCH.L K&J M8W@H[\3-$*Q2U]@+BMXO .7B&-N' MF!5<)U/M?JWC+'W!_D=BMM?*Y&AP0@K&>M>]U&A=BGSMDU)Y6AN<8"HZ+S!AIMC M2,C>RT]3Q0AOL?LD$%6TU:R>3S]EU$?FNSE>OX\@\#8QG\DONRPF?_[Y],## M6?[; L#Y7I #C?RVRPWYT\\'-*?*QG>$YYZQ6M#T[/S6QQH"K?&QZ*30U\1RE L^R.-11[6B,,89?P-BJ"]#/!L-R%F3?:M.E5VEWF MVOTQ2\RV)D:\E^;)SO.L8;+9B8X3IV*V_5]WR*-_,.;H!.3^4DE'*,=2ZII] M'OH!7@+2*>TW',UK4M9*@N?>7,--;K6DE(QGMW,Q#[Q*,IV,XVPCXH572:8; MK"+GF8FEX(KD":VEUM"\R/B1LCAU: MH_UXM!_WW'X\&F8X#3/UNWTHOK#<,K02O5WI/Q3/6.XS%=>J +K;Y)M 5J[T M#<7]M5W95Q8"H'$:*HXK515FA6$ FB>QX;E.8X )8"A);+I]4-(\UX:(W;[$ MB#B4S!I-GCJJS<"L2)].M66N7:*KD4NGC7)I&W)_%'OC %+MP>,&+\<*[ 1I MKYNH-B2_@6"[G0J+1M8C$?.VOXA+7?JD^^GLGLR;MT8@,Q47.:7CNC.\*%#C M'"]7V$54KC0>7"U-I2/,/>\)V*0JR71^%O ,$HO,T%#L)Z( 5NU?AIW\6K*7"'D:]*1.[>S6LGLS#U?T'R@_K5[;GC>AF8(75*%;CJK:"VF MI*ABIP?:3>M#59$CA B5@"CP:[3'!5!1JJ;TT[&/G5-%>4_*.;G"'K+G;NQI M96X>/7*/<:*5\MVP76@AX88=*7E 7V(OL/\1]4Q5[VTN0<_H-934S:Q3!'A: M%Q[DHL1'K^,U*W4?=CX:(:+;@598-9V^KRNU' INXL+F2M=(@:[5Z*H.)-SY_4D, M"%PSA4.I5E^U_ LPRM\XI9LT5I%@>@@,+SA0>(H%+8-,[R<5(%@\IRU[C=([ MF@D(7:IRM1A5$V_&2[=1:(H(S;T3_4M+ZO7NB=Z+ M1QV6O2Z6>NV_VP![[/G3#.]HNK633DPS7(8.E9=YB2W)9EI*O6/K<)2>0=(8 M$UK=CNC)1[/0N;%GH(@K/GIJ C#C35*!\XU8&#.$KN)0YNA6)) UL)1$Q[OJ MA_'?V(MRZA;4$6VVR8I)=SS>LPUC"QK5"2*K.L"S;L_D.6P4YBG0T6C'/R3[ M3L/)'F( J?CFX[O8[(N7H7A$BHAR/DR+CZ>AQ)J*J@3%(5G;*LU0@D^E2P"8 MYCN4:%6A>P:7#,C?F-KT !X&FNFM>BC/M"TB66J#49Q"49E1\P(]!Q)3_O&2 MZX$YLI95D61X=-U-9^=DZNW@RC"C,E4LMI*<5Y&C^1GV//S"AE&;*@]*5L6] MKXBG<[Q&KN$&-)[(L6F"4LB%CY>B4)I".MW7+KE\A31Q\CVBRA7U_%^3N3:> MH[Z>R-+R)G,/18FYN2='@+**^=EFZP+YIF>OH.;J"B+JQW!F^+;_0 2$84W= M/PW/INH(S1'O@VA&8N-;?D,&?715$L[/ZS9>OY!2S?115=LP^])-/?5AN6[$..AM[FKKB 9ED M8P8V\L\-QT'6V6:7R\8H0+I2@<>=ATV$+/^*Z/77OA_2(=H5BG5'\9,G3Z$K?S)2M6/4E/YP;*_)9L&FJ M=U915CU:T;%T-R]YK6,2W*5^.TTGI91L5^-DY^D%5 WE(B2E3SZR)C[1>XG:0DX!,[)VY+G)7URX99S<3KN:SQ_&*U5%I4N3W'-:A78 M:Q0OJC^P0VO9^]?7-W? =-Y&P0]8]6F-GG;-" M0Q!:YU,\]8RFTV0O:*_'+I::4>00"3:IVBUV#_24*.C%,JMP+ M>+&"2:L8+]U-TUF.->C6+"'0=-W?$O4T0,B5O_)Y*0N-X"ST"7G?SS()BS)< M3TC]K4/,R;F_6< M@\L8%;06DBE_(9_H/N[$B=_.SPP74 6NCD)75IH;*GP] 2VVEE97(P+KM*4T MU,M%<$Q#87-5?#<+22BCT+E+7,W0< WZ0PD=J%JYF&=[#<7[OU9(U:"U+5:' MXMO/?5CA^L-U*+[\G%NR?C.>:@L1WS8LUG693[C>DKWRIH"Y+S4,KH]:P\6Y MZXKNL-N[[N- ("K;=>46"I:%2^\HH5H[#^8V2S'(]!96W) )F!Y9ZK)1@I6; MF+>%V&=M4:HVT>8HY['\.]:5,(3X_'U]3AO\.!@Z@2"'\,%K,*P-E,IPTMY?4!1O5/!R7 M1THQ /7.;L0!8 L1=QFZG_3.PM5P>>Y%:#+<]'8(:8A;:>1NAM_G(9FAN/'+ M 32H.P=X@57%ZS,(AZ2B5$)8GLHA ^O;X 4:5_(.AI?>Q8T BXLG'PN#37JY MG37RGO%! MWD1 ^4$S, ['?Q>+?YJ>1+(#+I/0WJ9!$!7E1^4@3?>70N_NI4O-D/K\^ O MLJ)I@S,(OXR[M<(64)0SFD$W'K B&<4S_+XJ.&.59K_/%1-QW=!PR)W ->V5 MX?PP@N3"1>[[B4>/8"'/QOWT)%^^V!@4)0D221T+21+;1O#TDVO$92:019%N MEI&UD)BJ%$TIBFPEW*.5L8D<(*:S;*%(5#4"H*P0YZ.?9'TCNL+()@ M#_T<_0MN=^R4?L]&'NMV%C7B79%]:3B\B=SE]:5WFE%9,TK.K#MC0V]X\&PY M1:W'Y'Y]3.XW)D$9DZ!4)T&1_B35XRNB<$2,WFYLLB)B=*]J6!\14W5 ,I2& M]% D[CQZ?#HZ&4C3B1FHH_F^T76+ :GWF= JD/&=?9A)0^1"&=M^AIE+I!)) M#FLA0TV>JV1%F=O#P*W8<^WX@_QC P>&T\U+2.H"]1 NEX:W83Y1$S.PUS2E MEM##!Y1L#]XYN%D>;,W$GXY][)S*K759V6/Z,7_!Y(:]*!O9=_I;R^/*^ABK M?'8P]FD8^('ATOPKC8>9H]7>'I2T&*7N(BG;I/M]T-):Z'!$^WJ3Z'AN&CWV M^%Z0&PGY;7<4Y$\_D]A2_K>=@D:M\18[O )YVV[4%F]_(3I!R)JLD6?, 6]C M%8W;XO6>YEB <;C5I%6^>%^W=AJ(R5&\7&+W(<#FK_0XA-92*J>@4-Y$_0M4 M_BAHK8+K!W)#B;PU\PQ 7S4KB'0FZ<$OG%545(PBN[:Y5JP%WN( -7OYY";9 MN74#.OBZ@*F!U8G@V &8:[L.I5Y$O=C;7V%;LGDH)2(J3C5]&',D4?5UXY6JSMT).0\QI<=JZ+# \]16X=&ML7>X;& M*%KY335#\:'@-'[5(;=EM&/82?8/56JV6 EC/( M,]CD!4'V\W5?_GY-'UQ8W0OIKGBK-"V:9BCR9ULY_B1=-=-4%/*^^6;(:AYU MKP#3(D&J>=9"10)@3[;*SV]0+%N5NU=-+,N.!W#MSK"WC%.)-G*MXB'9([>J M2G9%'KI8AKFQIA=UTU;$%][ @*Y[K)4:4LCR7AS3M6]K#7W:P6&#'HOVG M?TOY:.87 >MI="(Z1&>; ;B P)]JPV)T65B=)D8729&EXE^OBN,+A.CR\3H,M'A_BM3G'1WHN!5 M/JNQVL_RH/?BJK]NE..UMQ%/!VB)EO# /D#U0=!^GS?0G^JM1*A_H=,\ XF, M=0@SJ+;H!G+(R H8WQF2"G(\*WLZ2FH@W*(@^8E\9,SG7NQP<>T&^)S\,"<# M18+9B1OTT(.')1'N%=A2$F9H#:1S[$:F RH'SD,_P$OD7;Z:3DC]2B:^C\C_ MK$?C%6)7$2*O)+\@0Y_,_'26,"KT2E!/2\C.>X,,/UTV0 -O45,5J-YB]PE@ MC"YL5L^GGS+J(_/='*_?1UEAO$W,9_+++HO)GW\^/?!PEO]V6[&6#VA.[2K? M$9Y[QFIAFX;#;PVO(= :SZDU*-\I)%ZT@H 2(S[RUE1WI();X"6MH+70UHXH M--C?I>W%'I2,E1T8SN7?0WL591D29XR'E!"/=QZV0C,0XZJXL1 ?1-:OL$^O MR8TXJB,C91X;<?#9&,%@99YGGI)AQ"Q6-RV0T4(GBFZ MDHZ*D=3HFB+/@MPD.[^V0@>/>6=N* ^#7/L 5^U6W5\$:V4A1[<*R&)<2*%1QO +9'I4C%^[XNQQ M$A+B[]J5Q%\](35%&MM9 YUP3S2$N,Z\GW A5G22EZ:2<*^"TR65%AN!V>*A M)VG_RF)=B&S#O2V5=RA97==5#T8F(A X"8[OH_U]'^6<0F:HTKN4*FR+\.*8 M[?(6:ZWV,<<6%$RA,X%AJN#N>'!H0K6#-F),>IJ>L,VMOI=-ZX-TN=F[3(5- MO'2X;Q8,4+TC=<#WMW(T]_?V1^F2LH>GCPB"G.8'9J[4.Q!/&,)Z"Q/+WBA/ M,/;SG)&_D_<.E\\M):_N+%5C%&AX1A:0=8Z7*^3Z45]9-=B)$]W^AKO7#\'ZA@/PL/*QZ6FIL<3XBY^."L'%!#BX'1ZZ'PH/B M(J?&?NH'T]F#X2"!,-""QBIX)LHLN7QE/E@WR;:&9R:L(=3A6*!I"BO)*-GQ MV7.W'&$,#F=JB0%%$5V)1A,EIZQ7\+0<5YW=8\$4WX02S>VZ!Z$UK:!#,/M@0QR!2^.'5O8)99& M$N^@M]9R\;))DNP&V65MBRN:@'$>'01GF[W[W.3%\*R[D"@=1I9:-)?,D6P6 M$^C/V"872JPOQ;)DC_^S7?Z38L5I9M$XXR5A/9558!#;84+(OSN>2,_I[,JPO5@A^]-P0OXZ6#*[/(1U MDQUIX;-O>G9T9-#AJ%PVY3RH0/#.PR9"ED\]A%AJV7CBGXCH]HA>2Q@F>BD- M:"P M,LD (4.F_72M-@6-4UX:V31*^*:*#3T1G.%O:LP(.I0NG'.PV7H1!='9Y-Z M25V@3))PCU5ZOTI>P-8R9E)5%?C#F:NM?+);)L(E+OR-0@&NCZ-V1XEZZ5 MZRU>N:2OK5+T+6'7,M=JWETS)I)\-O%.3\>_-V;8NRR8>*^UC6FT)>+BT_ZU M&TO&OQ!-]$YF;XT\,N'1AQ=DNJDBQ:VU=<9:+_#VFXQJJ[:#5*QELM4=SO&6 MFX3! GO4AA-I9M&>C(<1'=];W-Y3 )Y6*^1%/]W82QM^BVV-CX-#\@:_] +) M/3YZL?=!>^R[AWV8-MM&][W&;=\NVR9,-VI]%7,*A8B7V%YC)?ZH?P]I[!+! M%;L$-KAW6 D!I:5K=WCPA+*VRK+SZ"W]VJ[^U:"J8/E*-!\(N09H63,0)5-CDV)WDFT5$Z) M+#OS4%)Z',#<[+VF*,T./9"Y:>D)D:4DT?R*> "G#L?+>HL99 8P70*N(QG@ M7S2/L)$*>!\=G]A,ZGT9[,%,UKK_97/Q57/#K_RY:.AVRI#7W++9SGDOZL>< MP?Y-?N8W[-MTJVF.?+F//,-6^FV#*&+/6/=%+2_B(IV)$_E)QP+$M!1AS&9&@9VWZWRYV1O5CBEH M0H[E96PR>B)MKMTSQS!_D:\3JGYB2Z(8$HWT![:0(S63;DM,]39K@/0!]]FS M.[,MY@9',VF89-A_8GJ)IT42Z'&6"%$E'N "7/7:?QXP'MOM(\HI5P>'\KWM M_[KR$+HF6AD1*T$?5G(E3WH@W/$JKN1)&<(B&E'5GGPD!]L)&-.6N#BX=5HL MV7HF: \0UZ*]UJN-?X"8IHOCPE[;%E%W>[%2MYGI-:;[M]7^QBOZ7I!#A/RV MBP;Y4VJ$XH\P*VC4&F_QP0KD;;M16[Q%7DDPSK::M,H7;V3:3H,QKG&,:QSC M&L>XQC&N<8QKU#FF8HQK'.,:Q[C&@][+.YJK[O&+Q9H]+KA7L,A$/=V*R^Y> MN/#VQ]"0+I9ZXC=4A\?V3;W%N-6>X'%X49FZA\?VRV.'WP[))FB,T>QX@HJ- M[VR"QD#-GNR@W3.5]9L9CYJ?M/M_^:I]"E@$<^:6WP.=)Y2 M[QHV3WK>NPYHGFH\S=A,:6ZJ.MB9VM]3"BQD77MHA\NEX6UH^3H_\&R*2FR4 M-0-R*PDV4AVO87WUUY^:&F_A]WV)W38:' M>E*Y02*_/QW[V#GMN<-/[7BOL#=#-@U2]P]DAF <'_;L_!DMQ7X5/Y'/M%#1 MH_;XCY//I"%8F(>^1@]!ZO8Z@(GX/S>2O\JD&/] UWD=QJ.;O&C6_SH%C^ZQ??*J6U'1@W% M%;Y8IDO)FEUU7 W&8;Y-90/7ZE.CDWWOW%TU%]']>G6'WRG91$F7^ZLXIVU@ M>(&>T]65K65TL^SGYMJU*C*G2WD>R]_B>7+1G.KAXTQ),[*W4:-IG*P67Y_8 MA,E/A1ZMB4MWG#(%[[6L%(WTJ]&H@73E'L&*I(SZ?Y\V)MC7:*QVT\^)A'GU ML6HM8[A"GV81[CW+BI1(CR,NUGJ4.L)%_^6HZ(0&*UJ;9&L^EX;FV.VX8OI]D*H*[:!2U5N*T0&8].D#S#(#S$983&5V#JGG_RZ Z3 #G>:>A M\IT9JT\-]^[DKYA;53VM SA1SC;%!, .5VVRH=9]J^%0&OAPR>E9B2S8 MU:$$7+3*:71^BZT=7J%;E9SI&YYOE=0-AQ7)I,&X:RDX7VKG;(B.7-RJ2EG> MTVWM:BB.62*P[2C3&53R2TCV+&FC"%AUCG\GTH^MGH'6_L%5<:'6/?$NOV$" M5UM/V'K4^YBHL#MQ)\0^T?M(Z+VF>5/@MGNJ=Y9:Z89P>;.1O@>PJ5"0CU;9 M(U\2/T3+GF]RN?3]B679\6"NW1GVEA$+8J]V3;KHP3.<$/LBX>M)96QCOETP M^P_D6&>;W.,==]0Y/T$U=OE"'(7>L.IIC?7:>'D;Z[7UN5X;4U;*Y-#99NL3 M<7,SJ(,.)890 ' ]K0GPV^/SH_X_W_?$S_UW MI^+]AS>G)T>B4FLT/NX=-1K'_6-WX5F]V1)](X-86QT&TF\T>F<541E;&W4: MC>ET6I_NU4-SU>A?-,9VXC]K^&$8J[IGOWMU3$,%QO9U<-&-O[;6DV<_22.PN!:&:N,N-ZO-^OM^GY3U&HT M8!!Z,[Q^9*![5!:&TXZ30C>Y">L6'$AU;=V)H./!783O/[ M@U$8V-I(3K0_Z_3U1,7B3$W%13B1@;L6ZS]5IT5W5E[_$ SBZ."P$;TNK,@3 M2E]?!1VCK\;Y@BN3P(>6Q#P*S:03A(%R2T\5S=<9A+[W&#K=(1&'N@A%E[I1LD84E/I,H4F8H M8_5?X>VR=W1^=BRZ[WIGQ_C?%_US=]##25RXZ%WVNWT7+6N[P4;T_. MNF=')["W[D\7O1[==+^F?TMBJT>S6U*Y+;>B5%[4G__X*),KRK#([X($[K6? MVU+ICW4L+M4P##S1G:C PW\K;.@.E"9#/Q<>M@UV!:VP5F$8'6$#&(AR)7Q)_)EY41;O9 M;E;%8,;K#92=*A6(CU!)[^),=$]/3Z")GGC3/?M[%4-$U^@_$7_$,#11:"0% M([&3+OU&!K_GJ])T_^B^/^__W+MX5Q4G9T?U^<#0F'"J3#:X?K]V4X->T0D^ M*YBL6[.'='Z!%0]J=K+J)*#0^- E!E[TCD[ZW=/+PP;=\7KK3#Q3,]L"&8>0 M1HE(&JM!!BS1CJ450^03J8//L'N/ASAS[D9&^^(YV7/KI=C!29G.-S+A1%AP MSBOBM0HW&/J)1Y/![A>(>*M-;+_4'XMTO9-F.!;M-A/V8Q5^X_MJ:/6U\F=5 MK*URO\UNSYW"I3CWMS^>"\Y3L3;,#;/(D\P7!Q-R"'/S0)824VW'/ !.-&&" M.%;D##[@>4M&MZ+K?76C.SO_6!44='IOSR]Z3L29Y"1)B10S@A;":=S9.NY; M]87HD]+JJY'M[#UGX)0&FTLR0L3NY_7G8H=#3+?ZI&=U=XB"HIWVO?)$(])/C3O M7_?WJ\UFD_[O',1W:G*NIW@L?1] 2L3)X#6!UP 51^%D$GI+UQ3I,.9<)9*8,LN%_29B;U*X\C< M+I-!K#T-EU0XF2T!14.B2L)'J)"A&8:^!-$Q$\R6-X,)QJ'P0V1K1#!:,+-= MW!LGN%=FK'LA"Q024.0KZ3 #MP/Z'4 >GJ*4RM;.($+-+1 \0?^!&L*V"J[+$L[=%SY"^J,0Q7!LARY#!NHJ)'[SY32% M>#W2+H[D6M2[N0P685011=V*.G,TY=Y\8<;_TFSE,E)[I1;&R@1M5&9L/QJ! MK((^Z*W'B-T93>8D =AR%B*&+EM$B)BH!=C@_&@L4=+JH:10A>BN$Y7AO8JV21NJ-,=,I15-5J:Q#\U,JI\1CMH4\QAP1B^ M/F ;[A:*[<.&]6[K9"W"7AOECVJ*GH66"KX,NU"X1;E'3A.FV \HA#(2O7%( MC?Q,!]7%!#8'%,AC1@%H4;#'))[R$7+-;3@3+^"9#+)2\8F:(4IAT&HYZ[Y\ M58"7:2;1 0*D33B*,+A#W""BB1='0G4!%-S*_CG#FND'-(Y\/:^;5V[D%(JI M'9E9&(LV'&6)1^06AS^&_E#$P2N"T7;5H'NK9H"S$")/C$-KG@+34$T8Y"4[ MPT!J&\$D-*/\D1XJ [L)4BPXDMI/C*(!,$TYRT"'N@&BUFYB&L>9F9((35=- M[3M$@<1I @ (")4-VSJEN5*%[HQ!D\\+9@]<'O"A$EPJ7Z$F7F\"T*;A M7U,* %!\#)-/,WV0J3HC:_O:5,]6=9(/ 1?:#,FG9#X>*B0("B8*7>I DU$" M! ]EI"U$\B=%:F[VL2\4FWWSVE3&V329Q^21_%8%FE^IBD)7U>&S:F%*[@]1 MD.94D. LA)":BG+F=D=O4G-5Q2F"*G%'.=V2 D#03P&7JP$ZCE MTYOC!;I1!J">)GK5#5PQCB&@6%FB"&L6"+DI;Y;[(*>61:VP["F7.4$"X(8FR^K4 M;LZ2S:H;*;E34 :KC9U=MYIW=NEUCILR->U)2978&&%C6>F^L>,Z(?X M6RT*6\R7B)YI6H#1.#?:QR$.]*?REE\L%1+;,8>^Q,-O8=2!'#*5Y5? MN[V3\P^G,K87C!:5]Q[B?T/2YRMM4I#)VPM_(+7MNK"]7!0@ M>5F3J#2]&)-E*@3X"2$W GU9EIEOJ,4PH2P<4VSF'D: .P#Z=@BPNL6S9B3' M_076BIS-%KO%V;(:%_Y(\(KTATQQ'Y49<;M5I Y&"^DV#4-%0I\H?'SE.L.2 M>$?A GU0XF!AN+T%)M6ATD_H(,OYJXO-;8;RY,75#\2]MNJLC2'-$$:TT,7? M, ._5>@^UHZS^G&_WKK5#*MFFQ6C=-"1,H2'AJ168!( JL0!$-8#$+IR:,1- MM&FBVC!Z&#MQ2]'MX\-FV7=<3R-O?3A$-B_SVXA6.]U\3^T(8ZBOD3(G9',!T46^P"V)$[]KA0W&L1C+QK1B3 DFS)L6]T#0U;720 MH%9:P+J/?7KDJ:3IYZM62%U"WO0BU/T_0WJLW7WY5+>Q\ M>HL[5<.R?#UZP,R55ZZLSW# VA'E!DAIL*J47+Y.=Q%=T/92[*+2AZ1Z-]0Z M453OI0' CDV87(WGU=X=YNQR^$3.*#%[:J!M]NP3;[K--U3_%N=;;;RKN(7: M&*ZJC<)N9Z:%N%K,I-S &A5W18%M+/<@$:%9723RA7UA-2GL_5(;8+XEM7U] MK!>K1NG^8@,E-=0\/A!B@\NK67;]=/5 M]58T;-IEP^:I-6PV[HF"E?LU>YO5KSDY$Q]/^OR!AH_T/.KY6P<7N9A(=SL8 M>>9!<*G)G!=QJ$[HL61._7(0XA;:-+$JJ*\'_#^@\OL>6'&[EH]^:B+=9W>Q M+7_\XH5A\B.+9R_J+]I+3?>E3/G2\Z)ATXC-=<_[4 =B$K,#&7N4ACO9; M]?;+3>-HW?_;D>6C5]YX\#\_VZOL;YW5W<%&Z MQY/CH72/S76/%,QD%,>AKSW1K+_8CZS@3(:2%*1M/N,KN-'3Y'7MVY.SSN,\ M]VF*[7,]_"%NOVOROPWC=-T&TH@;XI=P'(B+NCB5@6=F9?I]RCQL4?K-G).( M>@*>6>;G,C\__@/=>B=(\GQT/I'IOK'O\GV+PLX M*3V6VE?E/N63YF&+8GMB._XH=]RQ7+%1-^^/XG*_^7XF'5N6--U'H07"(\]7%1/J_7JQ2D[/L8" M ]>:P[__\7[*_& ^%G\_F'#OWG:.!VX0N).KTVGP3GT2N%/Z-1#?@V/;L803 M7)W^\F[H.L'QD$_L\?RJ;T^$SSIBQGKNA#OR.]_^4US5:E#SX+>_.0-_^N[] MR?2W1(_4(!_;]\Z59]^/X@[UAC 36/=JX(ZM9+]U*)X_1!S(E>-Z$SZ6C0>X M:4/X #YUA"SUP#V;0X],%3SXS?@^L@=VP&JPIC]D4L7FD+^N)C0JO/PQJ%_' M8AA<_5H]._]E9Y:Z\=GH7,/_?=;I5MD9ZW=9LV=C5J M;RIY%5+EZZ?U4[T>#@-86+TJ?_OKVWK]]-WZS4ALMAT X9FX/1/A6/!_D&RH M]NY(;XZZPYUP2W/5!W.]\MRQM&; )ZYSK]?%U\9MM__)Z'W.7:MTO5:G6%%TYA.,>*#7#9"(7@4?[BH>N/HK M-A*>"-R\39LZ'F:A8NQ.SNJ[I+<553J MW7P,3RUSI5:W#U2[MP'Y* MOM_@VC<:=Y)'1-RZPM0UQ.*K9%5?('.8Y(9T8DDTJ0S"-P. MF7O<_-)QQ/JJH_E"<&;ND#6FGCUF;RJL?EI[RPZ1&R)W@.^!MRSXR<2U[*$M MK"V97G9@&8:7)8.2\#8GO&GH^2%\QX X[H2)QY^=54_/<--7L>PTJ3*X)M0= M8F$+4SZG[V\] 3\23<&/$SNPHCF&/H9RHTT^-L,Q M3^[;BKTGON1*EK&Z7V["Y8,"QGA>;OG66][I?JLP5"F-C]V>42$A]=YU+=J( M!SX..4IO( ["[2+DG2_) X0Y84_E1>"'PZ%MVL(QY[BULY$-4BUJ@RA4#N:P M97\X[FPLK/N(WT?$%4G6N+MX?PS=,4AL_D[)"_LGL35Z_5:S;;#6JYI49-6[ M6QCT@ B^7BL:#S^? M)-GB:O5]5U3=G1O=(3]2YP2IY?U)8"UOW(_;D2>;2.Z2+5;WX#>#@RBASK \ MG6A:HA-/[FL?#4:9 Y^WBTNF4L4=].JM925D[?(#4HMA@&@*@Y*@^P3S?/]2 MIJ,D4Z)-A[\\_ LY _P+3&/_;K.D4U>2WNY(&AL;(Y;UF;0Y@LR=/O#?8(3D M,06R)64'-=J4JCOU;,>TIWR6Y04'Y"GV\(8]B+X*76^EP ML"@]S"V=,@-$U4PS]#P\I8?V$=[BT"O,!PW+4I/T03AP\(PX<(M[/IJLHDMZ M[/I8$6]VT"D=5"M#M/TZ+BW40#"R7@"T'-8;#Z( M5E&U,Q#8.BVU;:7L&=1,8@_@2$.38\']@(E_A] $[A,+9O E;);P3+))UT]_ M.6(-QX$"0*D6:Z%0[4#I'LHF,"LUH(SIOP)+ VO# ]KZ ,B9\6$@/(WE(1:S M8G&';N@!=3WCXNKZ/*%//4\D[9I>%;7%FI44/>C5"ER]\KBF6DNVH,JG]8]G M_;V:\Z:SH5>%#M*/7=T\KW5V,\0#ZL'"61SIVN6&1QH/)!SK1\]UL9-)S:1. M]&<._=G =58=W'73K57?:JQE+:LM#]9Z:FO5RRP]^&LI;JE]Y#,ZPR>6I-5# MWE%;FD.>/WMI1==[V;/%)>7HU%@/HEBQI%KC*<3"ESK)9^'9?G(9^%(?V2LZ MYU1GMS&/:;S19LF7*\97A"=?;H59RN7)E]HL^8T^2];A(DMCRH41970=>XCL M6*^2XMU:XSJL7?RREILL=[.X%+1ZRKE ]% MZK9Y!-& RA5I2\OJU^/:U>DS M:U?._+CVZ]F;VIM+G 3BR+UH&E-^+XX'GN!_'-.]><7',S[WWV4,5B\("R^5 MZQ=3KM7MN4*AKC"EH9#$A9[B)86:OIU/$>[DFYX]V$D-.L8A+V2\6/$4UHEL[D>D>:.[7+;B2QUN9L,G _2]V5;49 3_ M@":AM5%V(3-J<1+=%36=].E'C2)#[T,!I$DHO"5# MBT^P.ZP6CH,50V>' U@D\3T>?AI%D"V-#L_ #L) &@QB:\P2_" :7+2@$_MX:_O%C!8XMAP;ES)$_SE:5=6SCG"V#$^)89"V-M"IRFS*7A;:(&G MU]L+EHK#3(\]](_H#4LSK* +:8GP?U<)2U=(]?=E"5VS1$5M;.>K6"@FONW MP750Q,R:[L838\*AZFUC'@=:QO$O3J?KV2 -P^V]Y ^ ,R4=*Q@<1#X\0BNL M.*C(.Q8G*F:WRIGY>O;QXL:TK(2$E M)&0-)&3P\T%"^H] 0AE/1WP@ F#R>;=M/2T# MX+$J\1D[S_3SW7HK+P(TQU!-9MF^29(#2JY21I<6![*@<.:( ,5Y/U\C3Q,0 M JUS+<':AONZG@R5,36COTVK@]DHUW"?KE# [Y*N$"W_NDI+XA=NE58ON0I MNCB)A;EJC.Y>I+MP\D+1T^4E+><&-*?[T)MU%,T!1RDDYS4RV/]I]7IL&#J2 M]<*)^&R;GNN[PX 9WT$H444Y\P7%U<*QFT!CH_%<6A^'B'.+0]-,UT.=WW5( M>\<0,U2A?=>TJ5LRD$5V4%GW77$HE&*RA4@J)'4IM(Z_Y'S!]Q:7Y%+G$O0_&H%VW),LF: MS\ZK;VIIWORV>ED&0$0!$*\J J+9[5RW$'9_QVY[1M.X+D,9GBJES"*^(#JG MI@N:OXB##3 F49K_XH/LAX-_2>-\)4+$H?7-8[X] 9& .\(-?>;#4?>'W(S, MCF(EH!DA?PL\,P<6XCC" ^&"^ZX#FXACKHSTQQK+6^KB-3)CN3L5[[2<91Q$Y=:V(G":*4\+# M<#P_CL'I%R4M>10H$#2V>9N)%B6=IXZ7^"[,$*]O. T# ?6'T6&( H7WTTBV MH[10UZ"%3&154W@P=?1)BJ>A#$[9!%23Z9P!,8M"&RR96RUFA<#U8G*A3\08 MH9/2L<)!8T/AT+?1&-;% %1@F!E:4CW.2>J,0YDG'&5;8,V"DK* &)G% JP- M8H,6S3'L7PNE"RD]XNA:A5OX&E63LT4_%XYCHF)I!S[<':;(8_[I==>RC],> M9<_9LU/]ZS]]9UJG7A43EU%S6+EYVS(5A-H@O5I6KH5GVW%-^;R =RI;J1C$5A<2D"E? M$ 54J/36G=7.%V"K+;O*#S;<#AJQG 9K@8F(H$-C>P)2-^D7,C&#NC9D+('E MFB'6A%LS!DM$!(S7Y6>X*FT_UZV>GL??^&3Z3F\F'UW@7$%N@KET/^WVK?;Y M#V%FFGQ&EYIU??C%<#K;'G]MXM*3(++1KVCJTH.!V=J'10_L83L/+DB!F&+$ MO1>$@B$C(3KO)2B&3H O0#D!81/D*IF^AJ"+\[3@N/J*73N<6L9$NE+**I': MSY_ >_\L?>\Y<_@$9O'/AM'J?FES/^@1#Q'6+:S\!UQX^J8.94_XBEOLI>VN MD6KTFG:E9]SVC#NCTV]((RSFD/[6Z&$.Z99Q5YHMMK;$NJ )6Z$IBALW@7,3 M&44I"].Y2),<7<_Y&3M^-+/.%KBTTSY3"4/2[$73?;AIE)&FCS+7!:J=HGAS M::6^0EK1W$F]Z?M"LWTR/&EU0>F-2NOHD]EGSK0LY;V((R@\-K(E!2*TL[:: MUF0":IL4,:-8;ND\LA/?R-#P>_L!E3GI:5*^I&4NMO 445(9F4,K]D0%7BB5 M/7*9FT&9OVH#L.+3T/7R(:Y-=QF_^,*CTTUI]<,WZ64@C=)NL\Q@9CLK MR(F,T'5VKGN5>0L:HW #]&Z/D>52LB68.S!U8+T6^:&@$9FPE(9*KO&\K7B, M[SZ^;-+-18VKWK7$1!SINUW#EY;,?N?8Z8XS>TVP^BMF]K&=<8191T/@&5.9 MSY^'P,D(2T:XYXS0 M*ADA>D.AF3@L7(,A8BZ>Z/$T4H-O7& J#GX'LET#XP\?*-%O!8K=*P.WS.PZ MM,<1T*,2Y9Y1V1TDGGPPKZQH,A8A4U5N@=DBAEU\-\54OD9'^BCW$^S7'>!S M3_*M)E+ED0\B2T>((HJI4,V4GTK=/TYC ]\]V"XIVX>UHTS /&OSF31DRC(* M"Z_T;C<<6TFTXT 00L6,57C*Z4.X^,^19MVP,(EFGD,^#2@PHA'7Y?BZWCUW M;',A_2H[11>%9PGEI^4;DDB=?+P1OSH\DZT0"XRJ/K(1/V#FS%BL?W8#7"]5 MU5(Y3%1R QAF$Y;# QIB UM&5]&32P7GCJ%2:#:!B\2V0KAPB=#4?1^G7:BL MGQVF."HV0UKK^5%DPDEG@L$Q+NHE7IYRT; N0'6"=E2*;5*CL$[=I>-#;L.[5H,COL@]JHQ;3)1@9K%!UY M>S)UY BXE<^Y=BFX^:CC; P#>?AMWY=]FR6 MDLQNI48HQ99U8HMX@=0(+RZCQ FKX. ;#^I2BSY+1&60L5ZFZE?:3F[^IG1^ M<91Z;">$[ZH%^<*S8G_6Y^\LX79L'(O91^\$Z9\EZ 5IR5LRCL!+I0XEM#!9P&2,4P+SX?T+V R MTDCHIN \>APJE:CRF7K=(<'Y!V@0Q!V92X[OI7199&%S.4IPX9VHYR5-Z%0@_3 M98-[E15$)5?0W%W5\>;KN%6W"^-,T68>;<4=;C824)QFKF=)P(X-ES&75ADO MTI\P*=@C3U,K;BV-->G[JI+TK4=9>F=HGI(WWL)VK)==-#[%)3+X"86B>G7= M+M2R3S06#_V'Y0&:F2_'=F?EHD4$0A)^)LEH.6-"'HUK7^$95KR +>>%\&7N MBF%^R&>ZAI3.M*K(6U9O8/D/B^G>KAM>KIEQH>R94^-2]\++=!&Q)#V:R4V6 MKSV/S+ (?@G$G66'25?:#*D]E=H5W[S;',7)1'1Y>?.*13%L@+D5WK>VX[?I#T?)&R:<*]9E%^&H*" MHU<)&IK Q92 <--["L25Z;(:<.';IZK98J;;H3D+)XODDM@__&6T&KHP+) MC3.B#UPW3SSU^I),)E-C:E>3)*!7+5>RU@Z<3B]P(1O24L"TLFGH5=-=:.V] MSY6REM=JI34&CU/J-)INZ,E(-=S\4,*.+,$)@,9),*RA\/-LC.JD$/^02V'D5L%#(QZ9F+XA78*5EDW^\:G32;3<_U M_>/>PB@>73F+CR0P+*7Z*@R;2CZ)Q!F]<,$]$<<]+HR*Z XB-9K47Q+B5]15 M^5GUD&"EQ?%'D)!.KLBT;_(VX0C-\HN$B3%%3N273#<3ASZD':N/\" IW1PN MT=U"6D+5VY1AN%(B.D)AB)@N/K!785RQ21$AD-1+"JO43.PLPEZCMBD#WE > M\Z/7\58-M;(<:N)8UK+L%P_/8YIA*9=K\ZGQ18Y]I*4GI"4+K;/6IXB MH E7@'/%U6P)DG;"R4!J74A-\F.ID)7)K;O*\"Y&,.Y\%R,@TA]A:],WUY_I,34/$B\7[)X$X$R M3B3&A*\6R'B >&R)"2A/U8NGG4Z2L$H(6T)%=P0JNBT%K%K2XD3QP^&BYX_! M15]FW OF^Z:J[Q[AF'WZO8)K'5J]-LW;:- M.RR(D/9VJ]FG7W#A6?]3H\^^P1UR#97NOK3[K-6!#PW6N+V%D@1^Q\+X$56 MGQN=WUD7/NBQ?WSIM>ZN6\35WQ6;M,Z<'[\.5K1PV^M^;5T7969;+CTNV[-T MI*[,8GV=;]G9Q7'M_+3V+/,J>A:WWJ>"9W';I8,C^"P3PF/^+!W=&!VCUVBS M[H=VZT;EGP8&($668B,XW7((R()^KT:%2]/'DYD^+C5,'Q\Q3.1C'"8BXVS> ML3:^ 2(2[^VMKI[""A8XZX:L4P$IM3K0W>EBJ'9MYIVUKNVY".A@RWC$GATHR0/J<0N MR4_2 9O)-,4Y ,DWRQ#[50Z@L;K:@,&9MD^)T_T%% O3&$GWXMK>ZDL/L*LG M>V-FLW!<)OV%MO-(K(ZK%F$1:!H[11TW2,.^\-%O9[&0E.0]1G]5H@A8!6E- M+F<:'(:;@B7B03_*(&72%RT2HB[TJ*A(B-AJ\,E3 ]>VBYS,7ZH,H2Z2?^DM ML>8\AJ%78%.V[0,=1YK(\ VFKE=<.UH2_4M/3"39ZT[O.*DC>4N1W]*I.%/I ML&2^*K5H+^V FV3]J5>'=].F]/0W?[W+N5SI>0% M\HF._]M^FNI73&EU5:]>U'\IT^#LK6]S Y.$Z8Y=[^JO%^?XYR4-%(7=FA"S5+DFF1=BDU\IJ"+[_+"#@I,F<"I1296T(_Q@PU5:)#R$"<&JP(#K!^O&CG?/UGF<\Z>3 MIK,7/ 8?NKU>]YO1NTJLUHG^1TY\TH0B8;KNV/;8A)4)('5H$S N'9L MBKD4]%+3VATQ87ZE1<+K%NROI_3?ZUVL$_^$_<,=.:Q796W0(+QYR6CW>T?[ M=@#U-CH!.-M\\G_E6L97VQ3LUA.84T9!%YHC6PS91]OACHG/5G2'0RCD+9V4 M%W]?83."/K^LOKDH;=;[:[/>%EE76G:>7:T[6Z_6G3V+9><%N6SC^G.KT[KK M]QK]UE>#-6Z,3O^GL.MD=W;'AWN^9\/=N>7=;T+>E%_]"#/4;HU>T[@E MMM3L&=>M/OO4;5^W.C=WK-6JL/;MJ]G=DDV5;*HDY'TUD'^8;^8R>$;9\D78 MM_ P?@9!T0J-UYWB6P"A8Q,TY.86>'B[6:%$N#=&VXI[Y7R7D%3 MH.L%0YBQRSYSA]]K('9>$E&Q(8CGU^J;7TL0S_Z">$K$SD[>FR5B1QVNMM&Y M_DEBK_9/(-JKX>[<\NXW(9<8G1*CLP_#+=G43\VF2HQ.B=$I,3HE9]^!X>[< M\I8.F])A4SIL2HS.:[XA?EXW1.FS*3$ZK_! []5P=VYY2Y&O%/E*D:_$Z+S: MZ^'G%6%*>>]9,#H[",AY/3WN(=[G_8(^SD9!9,Q_/#_4$L#!!0 ( M .Z"!%%>$P%86P@ "!% 0 =F%P;RUE>#,Q,5\Y+FAT;>V<;7,:MQ;' MWW>FWT$ETXP] RP/=E,#\0S!I*&3VBXF]S:O[HB5 $VTJZVD!7,__3U'6AZ, M<8/S<(/)^@4@[9%T=! __D=:T_KIXJHS>'_=)6\&?[PEU^]>O>UU2*$4!/^N M=X+@8G#A+YR4*U4RT#0VP@H54QD$WEQ,.@'$QO) MDT J97B9658X__&'%M:Y9TX9/EMA)8<74YJH$K^M5ZO_.2N#$5P*%M=:P<+Z MIU*)7/Y&.BJ>&*;$=5C$9>&REH5-2K)LL:JQ!5="Q$S'MM&Y>?F2,6V-./8MC%4DC5# M)95N/*NX/W_9B/_R1A4;N^*(1D+.&P,1<4,N^8ST543CS!3=:L1*1U3ZH2R& M]SKM0>_J$I9A_^9=^W) !E>D_^YMEU3KM%0].:+'0?64^5>' M&XNKUV3PIDMNNIUW_=Z@U[TAW;\Z;]J7OW5)NS,@<+EZ5C\I'FX VC>D?7%U M/>A>W%D)$!"W.NJ5&EG$J-U_U;[LWI2N_GK;?;\(3ZU2J6U$9VWFU;5(K,5F M7X/1*Y+? :3)A+1U-"^2$ H1G-B)]0V_"R9F!+WSK\L2#ZR!:BR="@Y&2K- MN'Y9J!2@F90FH:&(Q\MR0AE;E!>!\DU*,'U)$\,;BQ=-,A/,3F#^$!PW@L8' M1J;9R!#:PJ(3;UHOGYW]W)Q-A.4E'!IG/],T*3SNC=GR3GRQ\'Z@B5I:$ MT)B*F-!X3M+8ZI3#A*GE$:@@Q DE$93 &4E&-(0J350$R8A5WNZ>0)&&+P.9%M'@#C:>/_NU5GW1 M-!GKLDTFE%5J-!)0=$#I$:JY0Q>@2" !P"/"#=) F F:HUD$DA)E)9:9,*%4 M)H5V*#:UDIYAB58A9U!MR!$@BW%@H.=2]S:2+ C<[8\].[)^@V%M#JD<<^K+S0*,[ T$)I[G)63# #+WQ)-GYHGSV M:\[.G)U?TRMZL.R\X :F !1QV>G'$5?$Q#FDJ=F]"6:P0PZXRD;R.;%*-70 M!ZSDY;I$U5Q2Q[\L*5Y!K)C)5[PH0&J"+T9)P:AUC@Z- M8 +BA!,0/G5WHCG&GE*#Z;3[NC N]W:24AD.#EF0L-@HH0#>,)44E3!,RSFQ M2LNAA4_RU_ MZ*E@2%%J5.Q(0PT0&+V M/IW6OLTFE*0Z =@:M[$0A@ NYX#;!!WSF&LJ@;EPA2<(+/4?K_J$U/%BT=F$.J1-XR!T^&O'0BBD0PVS935QN"^P@6'UQ^P:C M(RDT!+%I_#;F4*7V80]VD=1T:HV4L5"/ M]W!"7R:$CO[V=_V0HP>:C("N(/LVK#/'0V">.\K'4_XX7?IU[+V:4+/<-4#! MZ&C,F5/2$ \I/G"9'>9O&!4_.RY/%[OYT5..W:_MU>G!8O?3CI[<[9!L0>SB M2LRAMERGYDK7(?<>L7EP;W]TZ1I-F;!*FV6^[BJ@RR@2UG+^#\IYJ*AV\I0) M\,]U<@1L!:%J4 C#,X9V\87 _TX%N._@G\:A._,_SH^8]F'5YHS[A%3 M6TJ">Y$"$(C'S7AN'0H.S,I2[>51SXS3#Y@[^[U ESV[74QWL^;BQJ%'D3 [ ME?%G_=DNYWQ-"E(�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end